activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	32261	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1		CHEMBL68920	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	32261	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1		CHEMBL68920	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	32268	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21		CHEMBL69960	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	33407	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)NCCN2CCOCC2)[nH]c1/C=C1\C(=O)N(C)c2ncnc(Nc3ccc(F)c(Cl)c3)c21		CHEMBL443268	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	34279	CHEMBL761274	Selectivity for PDGFRbeta over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		0.3	CHEMBL1913	Homo sapiens	Selectivity		0.3
	34670	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	CCN(CC)CC(O)CNC(=O)c1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1		CHEMBL304271	=	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	37865	CHEMBL761274	Selectivity for PDGFRbeta over (KDR) kinase insert domain receptor	B	Cc1ccnc(Nc2ncc(-c3ccccc3)s2)c1		CHEMBL319065	=	Selectivity		0.5	CHEMBL1913	Homo sapiens	Selectivity		0.5
	40260	CHEMBL761274	Selectivity for PDGFRbeta over (KDR) kinase insert domain receptor	B	Cc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL98385	=	Selectivity		0.3	CHEMBL1913	Homo sapiens	Selectivity		0.3
	46271	CHEMBL761274	Selectivity for PDGFRbeta over (KDR) kinase insert domain receptor	B	Cc1cccnc1Nc1ncc(-c2ccccc2)s1		CHEMBL329713	=	Selectivity		1.0	CHEMBL1913	Homo sapiens	Selectivity		1.0
	46695	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	O=C1Nc2ncnc(Nc3ccc(F)c(Cl)c3)c2/C1=C/c1ccc(C(=O)NCCN2CCOCC2)[nH]1		CHEMBL302552	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	47934	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(ccn4Cc4ccccc4)c3)c21		CHEMBL67057	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	49321	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)c1C		CHEMBL432903	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	49324	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]c1C(=O)N1CCN(C)CC1		CHEMBL69964	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	49327	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(c3)CCC4)c21		CHEMBL65848	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	50205	CHEMBL761274	Selectivity for PDGFRbeta over (KDR) kinase insert domain receptor	B	c1ccc(-c2cnc(Nc3ccccn3)s2)cc1		CHEMBL98538	=	Selectivity		0.3	CHEMBL1913	Homo sapiens	Selectivity		0.3
	50669	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)NCCN2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21		CHEMBL69629	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	51819	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(N3CCCCC3)c21		CHEMBL68258	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	53213	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	CCN1CCN(C(=O)c2cc(C)c(/C=C3\C(=O)Nc4ncnc(Nc5ccc(F)c(Cl)c5)c43)[nH]2)CC1		CHEMBL66570	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	53970	CHEMBL761274	Selectivity for PDGFRbeta over (KDR) kinase insert domain receptor	B	Brc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL101464	=	Selectivity		0.3	CHEMBL1913	Homo sapiens	Selectivity		0.3
	54403	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)O)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21		CHEMBL305194	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	55133	CHEMBL761274	Selectivity for PDGFRbeta over (KDR) kinase insert domain receptor	B	Clc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL319789	=	Selectivity		0.1	CHEMBL1913	Homo sapiens	Selectivity		0.1
	58120	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(CCC(=O)O)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21		CHEMBL308645	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	58123	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c21		CHEMBL67003	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	62048	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)N2CCN(C)CC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21		CHEMBL305246	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	62055	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	C#Cc1cccc(Nc2ncnc3c2/C(=C/c2[nH]c(C(=O)NCCN4CCOCC4)cc2C)C(=O)N3)c1		CHEMBL69966	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	63368	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	CCN(CC)CCNC(=O)c1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1		CHEMBL69358	=	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	66031	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1c(C(=O)N2CCN(C)CC2)c[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21		CHEMBL304971	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	66034	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)N2CC(C)NC(C)C2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21		CHEMBL69071	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	66863	CHEMBL761274	Selectivity for PDGFRbeta over (KDR) kinase insert domain receptor	B	N#Cc1cnc(Nc2ccccn2)s1		CHEMBL101544	=	Selectivity		68.0	CHEMBL1913	Homo sapiens	Selectivity		68.0
	67212	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C)c(/C=C2\C(=O)N(C)c3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1		CHEMBL69709	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	68468	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	O=C1Nc2ncnc(Nc3ccc(F)c(Cl)c3)c2/C1=C/c1ccc[nH]1		CHEMBL69106	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	68471	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1cc(C(=O)NCCN2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(ccn4Cc4ccccc4)c3)c21		CHEMBL264382	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	69855	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	Cc1[nH]c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)c(C)c1CCC(=O)O		CHEMBL305782	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	69858	CHEMBL763442	Inhibitory activity towards tyrosine phosphorylation in cells expressing PDGF-receptor beta kinase	B	CCN(CC)CCNC(=O)c1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(Cl)cc4F)c32)[nH]1		CHEMBL308672	=	IC50	nM	5620.0	CHEMBL1913	Homo sapiens	IC50	uM	5.62
	78010	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)c1		CHEMBL432941	=	IC50	nM	680.0	CHEMBL1913	Homo sapiens	IC50	uM	0.68
	79179	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c2c(c1CCC(=O)O)CCCC2		CHEMBL420609	=	IC50	nM	19300.0	CHEMBL1913	Homo sapiens	IC50	uM	19.3
	80321	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2cc3c([nH]2)CCCC3)c1		CHEMBL419682	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	83550	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1cc2c([nH]1)CCCC2		CHEMBL88462	=	IC50	nM	13900.0	CHEMBL1913	Homo sapiens	IC50	uM	13.9
	84547	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)[nH]c2c1CCCC2		CHEMBL431996	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	85633	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	COc1ccc2c(c1)NC(=O)/C2=C\c1cc2c([nH]1)CCCC2		CHEMBL91250	=	IC50	nM	3460.0	CHEMBL1913	Homo sapiens	IC50	uM	3.46
	85642	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)[nH]c2c1CCCC2		CHEMBL88771	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM	0.04
	87621	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)cc1		CHEMBL91815	=	IC50	nM	5430.0	CHEMBL1913	Homo sapiens	IC50	uM	5.43
	88632	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL328029	=	IC50	nM	5460.0	CHEMBL1913	Homo sapiens	IC50	uM	5.46
	88641	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(Br)cc32)[nH]c2c1CCCC2		CHEMBL314995	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	91571	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL88483	=	IC50	nM	11500.0	CHEMBL1913	Homo sapiens	IC50	uM	11.5
	91580	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	O=C1Nc2cc(-c3ccccc3)ccc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL313746	=	IC50	nM	70600.0	CHEMBL1913	Homo sapiens	IC50	uM	70.6
	91589	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	510.0	CHEMBL1913	Homo sapiens	IC50	uM	0.51
	92601	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	10100.0	CHEMBL1913	Homo sapiens	IC50	uM	10.1
	96620	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2cc3c([nH]2)CCCC3)cc1		CHEMBL313500	=	IC50	nM	94010.0	CHEMBL1913	Homo sapiens	IC50	uM	94.01
	98656	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL89010	=	IC50	nM	1030.0	CHEMBL1913	Homo sapiens	IC50	uM	1.03
	98665	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)CCCC3)C(=O)N2		CHEMBL86531	<	IC50	nM	780.0	CHEMBL1913	Homo sapiens	IC50	uM	0.78
	99528	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c2c1CCCC2		CHEMBL315753	=	IC50	nM	240.0	CHEMBL1913	Homo sapiens	IC50	uM	0.24
	104505	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	O=C1Nc2ccc(Br)cc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL88606	=	IC50	nM	920.0	CHEMBL1913	Homo sapiens	IC50	uM	0.92
	104514	CHEMBL764822	Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c2c(c1CCC(=O)O)CCCC2		CHEMBL313821	=	IC50	nM	870.0	CHEMBL1913	Homo sapiens	IC50	uM	0.87
	177478	CHEMBL761273	Inhibition of PDGFRbeta	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	77.0	CHEMBL1913	Homo sapiens	Activity	%	77.0
	178791	CHEMBL761273	Inhibition of PDGFRbeta	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	96.0	CHEMBL1913	Homo sapiens	Activity	%	96.0
	182538	CHEMBL761273	Inhibition of PDGFRbeta	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	93.0	CHEMBL1913	Homo sapiens	Activity	%	93.0
	316955	CHEMBL766066	Inhibition of Platelet-derived growth factor receptor beta at ATP <Km	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL281872	=	IC50	nM	3400.0	CHEMBL1913	Homo sapiens	IC50	uM	3.4
	328357	CHEMBL766067	Inhibition of Platelet-derived growth factor receptor beta at ATP <Km	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL533849	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	430435	CHEMBL764168	Inhibition of Platelet-derived growth factor receptor beta (PDGF beta-R)	B	COc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL327300	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	uM	0.03
	475053	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	COc1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL300767	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	477357	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL432491	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	478716	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL60541	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	482440	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	O=C1Nc2cc(-c3ccccc3)ccc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL418301	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	483673	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL301639	=	IC50	nM	2100.0	CHEMBL1913	Homo sapiens	IC50	uM	2.1
	487122	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	O=C1Nc2cccc(C3CCNCC3)c2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL58224	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	493114	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	IC50	nM	18000.0	CHEMBL1913	Homo sapiens	IC50	uM	18.0
	494218	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	Cc1cccc2c1/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL57446	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	494222	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc2c1CCOC2=O		CHEMBL59073	=	IC50	nM	1400.0	CHEMBL1913	Homo sapiens	IC50	uM	1.4
	496462	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL293068	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	496466	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	O=C1Nc2ccc(Br)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL292864	=	IC50	nM	18000.0	CHEMBL1913	Homo sapiens	IC50	uM	18.0
	501315	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	CC(C)NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL299032	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	506107	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]cc3c1CCOC3=O)C(=O)N2		CHEMBL57256	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	507372	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	O=C1Nc2cccc(CCO)c2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL58483	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	511000	CHEMBL766058	Inhibitory activity was tested against Platelet-derived growth factor receptor beta	B	O=C1Nc2ccc(F)cc2/C1=C/c1[nH]cc2c1CCOC2=O		CHEMBL59110	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	512673	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(C(=O)O)cc21		CHEMBL435227	=	IC50	nM	4190.0	CHEMBL1913	Homo sapiens	IC50	uM	4.19
	512677	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(C(=O)O)cc21		CHEMBL435227	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	512708	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1c[nH]c(/C=C2\C(=O)Nc3cccc(C)c32)c1CCC(=O)O		CHEMBL147761	=	IC50	nM	2110.0	CHEMBL1913	Homo sapiens	IC50	uM	2.11
	512712	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1c[nH]c(/C=C2\C(=O)Nc3cccc(C)c32)c1CCC(=O)O		CHEMBL147761	=	IC50	nM	46400.0	CHEMBL1913	Homo sapiens	IC50	uM	46.4
	514075	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1		CHEMBL450622	=	IC50	nM	450.0	CHEMBL1913	Homo sapiens	IC50	uM	0.45
	514079	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1		CHEMBL450622	=	IC50	nM	8290.0	CHEMBL1913	Homo sapiens	IC50	uM	8.29
	514083	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	514087	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	16500.0	CHEMBL1913	Homo sapiens	IC50	uM	16.5
	520422	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c(C)c1CCC(=O)O		CHEMBL357803	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	520426	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c(C)c1CCC(=O)O		CHEMBL357803	=	IC50	nM	3650.0	CHEMBL1913	Homo sapiens	IC50	uM	3.65
	523090	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(S(N)(=O)=O)cc21		CHEMBL146697	=	IC50	nM	5980.0	CHEMBL1913	Homo sapiens	IC50	uM	5.98
	523094	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(S(N)(=O)=O)cc21		CHEMBL146697	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	523098	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C		CHEMBL146694	=	IC50	nM	2220.0	CHEMBL1913	Homo sapiens	IC50	uM	2.22
	523102	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C		CHEMBL146694	=	IC50	nM	940.0	CHEMBL1913	Homo sapiens	IC50	uM	0.94
	524403	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)c1		CHEMBL148514	=	IC50	nM	170.0	CHEMBL1913	Homo sapiens	IC50	uM	0.17
	524407	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)c1		CHEMBL148514	=	IC50	nM	180.0	CHEMBL1913	Homo sapiens	IC50	uM	0.18
	526967	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	10500.0	CHEMBL1913	Homo sapiens	IC50	uM	10.5
	526971	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	4540.0	CHEMBL1913	Homo sapiens	IC50	uM	4.54
	529803	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	CCOc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1		CHEMBL443296	=	IC50	nM	2380.0	CHEMBL1913	Homo sapiens	IC50	uM	2.38
	529807	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	CCOc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1		CHEMBL443296	=	IC50	nM	11300.0	CHEMBL1913	Homo sapiens	IC50	uM	11.3
	529811	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C		CHEMBL149243	=	IC50	nM	140.0	CHEMBL1913	Homo sapiens	IC50	uM	0.14
	529815	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C		CHEMBL149243	=	IC50	nM	1400.0	CHEMBL1913	Homo sapiens	IC50	uM	1.4
	531101	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)c(C)c1CCC(=O)O		CHEMBL149073	=	IC50	nM	1210.0	CHEMBL1913	Homo sapiens	IC50	uM	1.21
	531105	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)c(C)c1CCC(=O)O		CHEMBL149073	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	533735	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)cc1		CHEMBL148984	=	IC50	nM	3080.0	CHEMBL1913	Homo sapiens	IC50	uM	3.08
	533739	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)cc1		CHEMBL148984	=	IC50	nM	2780.0	CHEMBL1913	Homo sapiens	IC50	uM	2.78
	536423	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2cc(-c3ccccc3)ccc21		CHEMBL347074	=	IC50	nM	160.0	CHEMBL1913	Homo sapiens	IC50	uM	0.16
	536427	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2cc(-c3ccccc3)ccc21		CHEMBL347074	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	537816	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	510.0	CHEMBL1913	Homo sapiens	IC50	uM	0.51
	537820	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	28400.0	CHEMBL1913	Homo sapiens	IC50	uM	28.4
	537824	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccccc21		CHEMBL344319	=	IC50	nM	140.0	CHEMBL1913	Homo sapiens	IC50	uM	0.14
	537828	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccccc21		CHEMBL344319	=	IC50	nM	58400.0	CHEMBL1913	Homo sapiens	IC50	uM	58.4
	541593	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C		CHEMBL356245	=	IC50	nM	550.0	CHEMBL1913	Homo sapiens	IC50	uM	0.55
	541597	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C		CHEMBL356245	=	IC50	nM	2350.0	CHEMBL1913	Homo sapiens	IC50	uM	2.35
	543021	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)cc1		CHEMBL150151	=	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	543025	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)cc1		CHEMBL150151	=	IC50	nM	680.0	CHEMBL1913	Homo sapiens	IC50	uM	0.68
	544199	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL358728	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	544203	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL358728	=	IC50	nM	230.0	CHEMBL1913	Homo sapiens	IC50	uM	0.23
	546999	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O		CHEMBL149201	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	547003	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O		CHEMBL149201	=	IC50	nM	110.0	CHEMBL1913	Homo sapiens	IC50	uM	0.11
	548226	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c1CCC(=O)O		CHEMBL148744	=	IC50	nM	620.0	CHEMBL1913	Homo sapiens	IC50	uM	0.62
	548230	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1c[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c1CCC(=O)O		CHEMBL148744	=	IC50	nM	6700.0	CHEMBL1913	Homo sapiens	IC50	uM	6.7
	548234	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c(C)c1CCC(=O)O		CHEMBL150177	=	IC50	nM	1530.0	CHEMBL1913	Homo sapiens	IC50	uM	1.53
	548238	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c(C)c1CCC(=O)O		CHEMBL150177	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	550330	CHEMBL763441	Inhibitory activity against Platelet-derived growth factor receptor beta	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C		CHEMBL147112	=	IC50	nM	1420.0	CHEMBL1913	Homo sapiens	IC50	uM	1.42
	550334	CHEMBL871982	Inhibitory activity of compound against PDGF induced cell proliferation	F	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C		CHEMBL147112	=	IC50	nM	650.0	CHEMBL1913	Homo sapiens	IC50	uM	0.65
	572151	CHEMBL766059	Inhibition of Platelet derived growth factor receptor beta at 10 uM	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Inhibition	%	11.0	CHEMBL1913	Homo sapiens	Inhibition	%	11.0
	593298	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc(OC)c2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2c1		CHEMBL100305	=	IC50	nM	10900.0	CHEMBL1913	Homo sapiens	IC50	uM	10.9
	593299	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OCc1ccccc1		CHEMBL148047	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	594538	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL102301	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	594539	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCn1nnc2cc3c(N4CCN(C(=O)Nc5ccc(Oc6ccccc6)cc5)CC4)ncnc3cc21		CHEMBL144390	=	IC50	nM	290.0	CHEMBL1913	Homo sapiens	IC50	uM	0.29
	594540	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OC		CHEMBL319894	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	594541	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	S=C(NCc1ccccc1)N1CCN(c2ncnc3ccccc23)CC1		CHEMBL103447	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	595740	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3cc4c(cc23)OCCO4)CC1		CHEMBL359007	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	uM	0.07
	595741	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCCn1c(=O)n(CCC)c2cc3c(N4CCN(C(=O)Nc5ccc(Oc6ccccc6)cc5)CC4)ncnc3cc21		CHEMBL342280	=	IC50	nM	21000.0	CHEMBL1913	Homo sapiens	IC50	uM	21.0
	595742	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1OC		CHEMBL144725	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	597151	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2[nH]cnc3ncnc2-3)CC1		CHEMBL143986	=	IC50	nM	490.0	CHEMBL1913	Homo sapiens	IC50	uM	0.49
	597152	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	Nc1nc(N2CCN(C(=O)Nc3ccc(Oc4ccccc4)cc3)CC2)c2[nH]cnc2n1		CHEMBL344561	=	IC50	nM	1500.0	CHEMBL1913	Homo sapiens	IC50	uM	1.5
	597153	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	S=C(NCc1ccccc1)N1CCN(c2ccnc3ccc(Cl)cc23)CC1		CHEMBL423752	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	597154	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCn1c(=O)n(C)c2cc3c(N4CCN(/C(S)=N\Cc5ccccc5)CC4)ncnc3cc21		CHEMBL434262	=	IC50	nM	140.0	CHEMBL1913	Homo sapiens	IC50	uM	0.14
	597155	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCNc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1[N+](=O)[O-]		CHEMBL99729	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	597156	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OS(C)(=O)=O		CHEMBL144109	=	IC50	nM	10200.0	CHEMBL1913	Homo sapiens	IC50	uM	10.2
	599659	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OCC		CHEMBL148084	=	IC50	nM	310.0	CHEMBL1913	Homo sapiens	IC50	uM	0.31
	599660	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2cncc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL144593	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	599661	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2nncc3ccccc23)CC1		CHEMBL144368	=	IC50	nM	10300.0	CHEMBL1913	Homo sapiens	IC50	uM	10.3
	600847	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2cncc3ccccc23)CC1		CHEMBL264182	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	600848	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL106966	=	IC50	nM	850.0	CHEMBL1913	Homo sapiens	IC50	uM	0.85
	602060	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2nnc(Cl)c3ccccc23)CC1		CHEMBL359204	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	602061	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3ccccc23)CC1		CHEMBL103487	=	IC50	nM	380.0	CHEMBL1913	Homo sapiens	IC50	uM	0.38
	602062	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL146993	=	IC50	nM	650.0	CHEMBL1913	Homo sapiens	IC50	uM	0.65
	603316	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2nccc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL147916	=	IC50	nM	180.0	CHEMBL1913	Homo sapiens	IC50	uM	0.18
	603317	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ccnc3c(Cl)cccc23)CC1		CHEMBL143892	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	603318	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OC		CHEMBL103490	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	604833	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OCC		CHEMBL144687	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM	0.08
	604834	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	Cn1cnc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc21		CHEMBL144433	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	604835	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3ncccc23)CC1		CHEMBL342999	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	604836	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3cc4ccccc4cc23)CC1		CHEMBL144076	=	IC50	nM	390.0	CHEMBL1913	Homo sapiens	IC50	uM	0.39
	605863	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OCC(=O)O		CHEMBL148221	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	607021	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2cc(C(F)(F)F)nc3ccccc23)CC1		CHEMBL144340	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	607022	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	S=C(NCc1ccccc1)N1CCN(c2ncnc3cc4ccccc4cc23)CC1		CHEMBL144054	=	IC50	nM	1300.0	CHEMBL1913	Homo sapiens	IC50	uM	1.3
	607023	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1O		CHEMBL343241	=	IC50	nM	4590.0	CHEMBL1913	Homo sapiens	IC50	uM	4.59
	607024	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COCCOc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL147277	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM	0.08
	608299	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ccnc3cc(C(F)(F)F)ccc23)CC1		CHEMBL359194	=	IC50	nM	550.0	CHEMBL1913	Homo sapiens	IC50	uM	0.55
	609460	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOC(=O)c1cnc2cc(OC)c(OC)cc2c1N1CCN(/C(S)=N\Cc2ccccc2)CC1		CHEMBL147841	=	IC50	nM	3260.0	CHEMBL1913	Homo sapiens	IC50	uM	3.26
	609461	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCNc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1[N+](=O)[O-]		CHEMBL421206	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	609462	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1OC		CHEMBL100736	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM	0.04
	609463	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102911	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	610673	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3cc4c(cc23)OCO4)CC1		CHEMBL144749	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	611840	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c(OC)c1OC		CHEMBL100734	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	611841	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOC(=O)c1cnc2cc(OC)c(OC)cc2c1N1CCN(C(=O)Nc2ccc(Oc3ccccc3)cc2)CC1		CHEMBL357673	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	611842	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	C#CCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL148259	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	uM	0.07
	611843	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1C		CHEMBL359229	=	IC50	nM	180.0	CHEMBL1913	Homo sapiens	IC50	uM	0.18
	613075	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2nc(C)nc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL101127	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	613076	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2[nH]cnc3nncc2-3)CC1		CHEMBL147001	=	IC50	nM	170.0	CHEMBL1913	Homo sapiens	IC50	uM	0.17
	613077	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCn1cnc2cc3c(N4CCN(/C(S)=N\Cc5ccccc5)CC4)ncnc3cc21		CHEMBL144860	=	IC50	nM	2700.0	CHEMBL1913	Homo sapiens	IC50	uM	2.7
	613078	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OC		CHEMBL145259	=	IC50	nM	510.0	CHEMBL1913	Homo sapiens	IC50	uM	0.51
	614433	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCNc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1N		CHEMBL100542	=	IC50	nM	1440.0	CHEMBL1913	Homo sapiens	IC50	uM	1.44
	614434	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OS(C)(=O)=O		CHEMBL344091	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	uM	0.07
	615803	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCn1c(=O)n(CC)c2cc3c(N4CCN(C(=O)Nc5ccc(Oc6ccccc6)cc5)CC4)ncnc3cc21		CHEMBL424502	=	IC50	nM	780.0	CHEMBL1913	Homo sapiens	IC50	uM	0.78
	615804	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OCC#N		CHEMBL144077	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	615805	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCCCOc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1OC		CHEMBL148225	=	IC50	nM	1390.0	CHEMBL1913	Homo sapiens	IC50	uM	1.39
	615806	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	C=CCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL342515	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	617178	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	S=C(NCc1ccccc1)N1CCN(c2ncnc3cc4c(cc23)OCCO4)CC1		CHEMBL147056	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	617179	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCCCn1c(=O)n(CCCC)c2cc3c(N4CCN(C(=O)Nc5ccc(Oc6ccccc6)cc5)CC4)ncnc3cc21		CHEMBL145179	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	617180	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Cl)cc4)CC3)c2cc1OC		CHEMBL104325	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	618475	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2nncc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL146876	=	IC50	nM	810.0	CHEMBL1913	Homo sapiens	IC50	uM	0.81
	618476	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2nnc(Cc3ccccc3)c3ccccc23)CC1		CHEMBL147837	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	618477	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COCCOc1cc2c(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)ncnc2cc1OC		CHEMBL148382	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM	0.08
	619799	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	Cn1c(=O)n(C)c2cc3c(N4CCN(C(=O)Nc5ccc(Oc6ccccc6)cc5)CC4)ncnc3cc21		CHEMBL411229	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	620804	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2nc[nH]c3nc(O)nc2-3)CC1		CHEMBL147052	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	620805	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3cnc(F)cc23)CC1		CHEMBL144369	=	IC50	nM	13300.0	CHEMBL1913	Homo sapiens	IC50	uM	13.3
	620806	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	C=CCOc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1OC		CHEMBL344962	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	620807	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL424129	=	IC50	nM	290.0	CHEMBL1913	Homo sapiens	IC50	uM	0.29
	622105	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2nc(Cl)nc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL103326	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	622106	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	Cn1ncc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc21		CHEMBL146114	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	622107	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ccnc3ccccc23)CC1		CHEMBL144622	=	IC50	nM	270.0	CHEMBL1913	Homo sapiens	IC50	uM	0.27
	622108	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM	0.08
	623388	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccccc4)CC3)ncnc2cc1C		CHEMBL356129	=	IC50	nM	1540.0	CHEMBL1913	Homo sapiens	IC50	uM	1.54
	623389	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OCC(C)=O		CHEMBL144296	=	IC50	nM	300.0	CHEMBL1913	Homo sapiens	IC50	uM	0.3
	626080	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ccnc3ccc(Cl)cc23)CC1		CHEMBL356715	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	uM	0.13
	626081	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1OC(C)C		CHEMBL146020	=	IC50	nM	640.0	CHEMBL1913	Homo sapiens	IC50	uM	0.64
	626082	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL343209	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	627091	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3cc(OCc4ccccc4)c(OCc4ccccc4)cc23)CC1		CHEMBL144990	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	627092	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	S=C(NCc1ccccc1)N1CCN(c2[nH]cnc3ncnc2-3)CC1		CHEMBL144816	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	627093	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	C#CCOc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1OC		CHEMBL448729	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	628409	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCn1c(=O)n(C)c2cc3c(N4CCN(C(=O)Nc5ccc(Oc6ccccc6)cc5)CC4)ncnc3cc21		CHEMBL146078	=	IC50	nM	330.0	CHEMBL1913	Homo sapiens	IC50	uM	0.33
	629811	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1OC		CHEMBL103179	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	629812	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	S=C(NCc1ccccc1)N1CCN(c2ccnc3ccccc23)CC1		CHEMBL144574	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	629813	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCOc1cc2c(N3CCN(/C(S)=N\Cc4ccccc4)CC3)ncnc2cc1OC		CHEMBL100735	=	IC50	nM	620.0	CHEMBL1913	Homo sapiens	IC50	uM	0.62
	629814	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCCOc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1OC		CHEMBL144078	=	IC50	nM	190.0	CHEMBL1913	Homo sapiens	IC50	uM	0.19
	629815	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL339685	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	631006	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2nc(N3CCOCC3)nc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL103776	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	631007	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COC(=O)COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OC		CHEMBL144279	=	IC50	nM	6080.0	CHEMBL1913	Homo sapiens	IC50	uM	6.08
	632295	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1		CHEMBL147917	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	632296	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	S=C(NCc1ccccc1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1		CHEMBL144307	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	632297	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	S=C(NCc1ccccc1)N1CCN(c2ncnc3cc4c(cc23)OCO4)CC1		CHEMBL144862	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	632298	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	CCn1c(O)nc2cc3c(N4CCN(C(=O)Nc5ccc(Oc6ccccc6)cc5)CC4)ncnc3cc21		CHEMBL147325	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	632299	CHEMBL763439	Inhibition of platelet-derived growth factor receptor beta phosphorylation was measured in intact cells using a two-site enzyme linked immunosorbent assay (ELISA)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc([N+](=O)[O-])cc4)CC3)c2cc1OC		CHEMBL99743	=	IC50	nM	700.0	CHEMBL1913	Homo sapiens	IC50	uM	0.7
	714093	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL293712	=	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	714101	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CCOC(=O)CN1CCN(CCCc2c(/C=C3\C(=O)Nc4ccc(S(=O)(=O)NC)cc43)[nH]c3c2CCCC3)CC1		CHEMBL291759	>	IC50	nM	20000.0	CHEMBL1913	Homo sapiens	IC50	uM	20.0
	714961	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	716118	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCc1ccncc1		CHEMBL268731	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	716443	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2		CHEMBL56109	=	IC50	nM	5600.0	CHEMBL1913	Homo sapiens	IC50	uM	5.6
	717801	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2		CHEMBL56569	=	IC50	nM	6600.0	CHEMBL1913	Homo sapiens	IC50	uM	6.6
	719757	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCCN1CCN(C)CC1		CHEMBL430155	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	719767	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCOCC1		CHEMBL13354	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	721879	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C	Potential transcription error	CHEMBL13485	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	722194	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL59042	=	IC50	nM	2500.0	CHEMBL1913	Homo sapiens	IC50	uM	2.5
	723023	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	22900.0	CHEMBL1913	Homo sapiens	IC50	uM	22.9
	724250	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCn1cncn1		CHEMBL267293	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	724591	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2		CHEMBL292930	=	IC50	nM	8000.0	CHEMBL1913	Homo sapiens	IC50	uM	8.0
	726659	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c1C		CHEMBL13629	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	726669	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1		CHEMBL13608	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	727036	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2		CHEMBL55496	=	IC50	nM	4700.0	CHEMBL1913	Homo sapiens	IC50	uM	4.7
	732860	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCOCC1)CCCC3)C(=O)N2		CHEMBL296185	=	IC50	nM	18000.0	CHEMBL1913	Homo sapiens	IC50	uM	18.0
	735353	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2		CHEMBL300853	=	IC50	nM	13000.0	CHEMBL1913	Homo sapiens	IC50	uM	13.0
	735361	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2		CHEMBL57143	=	IC50	nM	9000.0	CHEMBL1913	Homo sapiens	IC50	uM	9.0
	738133	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL52513	=	IC50	nM	3300.0	CHEMBL1913	Homo sapiens	IC50	uM	3.3
	739285	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL54283	=	IC50	nM	11000.0	CHEMBL1913	Homo sapiens	IC50	uM	11.0
	740164	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCC1CCN(C)CC1		CHEMBL13983	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	741553	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN(C)C		CHEMBL13976	=	IC50	nM	0.5	CHEMBL1913	Homo sapiens	IC50	uM	0.0005
Not Determined	744626	CHEMBL761278	Inhibitory activity against PDGFRbeta tyrosine kinase; Not tested	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2		CHEMBL301143		IC50	nM		CHEMBL1913	Homo sapiens	IC50	uM	
	745574	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL275117	=	IC50	nM	17.0	CHEMBL1913	Homo sapiens	IC50	uM	0.017
	745974	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2		CHEMBL298566	=	IC50	nM	2300.0	CHEMBL1913	Homo sapiens	IC50	uM	2.3
Not Determined	749670	CHEMBL761278	Inhibitory activity against PDGFRbeta tyrosine kinase; Not tested	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2		CHEMBL55594		IC50	nM		CHEMBL1913	Homo sapiens	IC50	uM	
	751793	CHEMBL768949	Inhibition of Platelet-derived growth factor receptor beta (PDGF-Rbeta)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	752114	CHEMBL761277	Inhibitory activity against PDGFRbeta tyrosine kinase	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2		CHEMBL301271	=	IC50	nM	5100.0	CHEMBL1913	Homo sapiens	IC50	uM	5.1
	761549	CHEMBL770313	Inhibition of human Platelet-derived growth factor receptor at 50 uM (no effect)	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Concentration	uM	50.0	CHEMBL1913	Homo sapiens	Concentration	uM	50.0
	787255	CHEMBL770313	Inhibition of human Platelet-derived growth factor receptor at 50 uM (no effect)	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1S		CHEMBL14326	=	Concentration	uM	50.0	CHEMBL1913	Homo sapiens	Concentration	uM	50.0
	866058	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL330863	<	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	866059	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL330863	=	IC50	nM	51.0	CHEMBL1913	Homo sapiens	IC50	uM	0.051
	866061	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL330863	=	IC50	nM	39.0	CHEMBL1913	Homo sapiens	IC50	uM	0.039
	866078	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL338330	=	IC50	nM	145.0	CHEMBL1913	Homo sapiens	IC50	uM	0.145
	866079	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL338330	=	IC50	nM	175.0	CHEMBL1913	Homo sapiens	IC50	uM	0.175
	866292	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CC(C)c1cc(/C=C2\C(=O)Nc3ccccc32)cc(C(C)C)c1O		CHEMBL85021	=	IC50	nM	17500.0	CHEMBL1913	Homo sapiens	IC50	uM	17.5
	866297	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1cccc2c1/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL85403	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	867455	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OCCOC		CHEMBL124243	=	IC50	nM	160.0	CHEMBL1913	Homo sapiens	IC50	uM	0.16
	867456	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OCCOC		CHEMBL124243	=	IC50	nM	610.0	CHEMBL1913	Homo sapiens	IC50	uM	0.61
	867458	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCNCC1		CHEMBL338623	=	IC50	nM	6500.0	CHEMBL1913	Homo sapiens	IC50	uM	6.5
	867459	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCNCC1		CHEMBL338623	=	IC50	nM	7790.0	CHEMBL1913	Homo sapiens	IC50	uM	7.79
	868692	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCn1nccn1		CHEMBL124073	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	868693	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCn1nccn1		CHEMBL124073	=	IC50	nM	400.0	CHEMBL1913	Homo sapiens	IC50	uM	0.4
	868695	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	CCCCS(=O)(=O)CCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL125171	=	IC50	nM	112.0	CHEMBL1913	Homo sapiens	IC50	uM	0.112
	868696	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	CCCCS(=O)(=O)CCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL125171	=	IC50	nM	292.0	CHEMBL1913	Homo sapiens	IC50	uM	0.292
	868910	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	IC50	nM	12000.0	CHEMBL1913	Homo sapiens	IC50	uM	12.0
	868915	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	870006	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCOCC1		CHEMBL125761	=	IC50	nM	145.0	CHEMBL1913	Homo sapiens	IC50	uM	0.145
	870007	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCOCC1		CHEMBL125761	=	IC50	nM	140.0	CHEMBL1913	Homo sapiens	IC50	uM	0.14
	870009	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCC(F)(F)CC1		CHEMBL124089	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM	0.04
	870010	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCC(F)(F)CC1		CHEMBL124089	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	870012	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCC1=NCCN1C		CHEMBL332083	=	IC50	nM	12250.0	CHEMBL1913	Homo sapiens	IC50	uM	12.25
	870013	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCC1=NCCN1C		CHEMBL332083	=	IC50	nM	6750.0	CHEMBL1913	Homo sapiens	IC50	uM	6.75
	870187	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccc(Br)cc2/C1=C/c1ccc(N2CCOCC2)cc1		CHEMBL87080	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	870192	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	COc1ccc(/C=C2\C(=O)Nc3ccccc32)cc1C(C)(C)C		CHEMBL86945	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	871242	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN(C)C		CHEMBL340234	=	IC50	nM	76.0	CHEMBL1913	Homo sapiens	IC50	uM	0.076
	871243	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN(C)C		CHEMBL340234	=	IC50	nM	123.0	CHEMBL1913	Homo sapiens	IC50	uM	0.123
	871245	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OCCOC		CHEMBL125451	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	871246	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OCCOC		CHEMBL125451	=	IC50	nM	300.0	CHEMBL1913	Homo sapiens	IC50	uM	0.3
	871248	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL127748	=	IC50	nM	1300.0	CHEMBL1913	Homo sapiens	IC50	uM	1.3
	871249	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL127748	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	871251	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCN(C)CC1		CHEMBL125445	=	IC50	nM	750.0	CHEMBL1913	Homo sapiens	IC50	uM	0.75
	871252	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCN(C)CC1		CHEMBL125445	=	IC50	nM	662.0	CHEMBL1913	Homo sapiens	IC50	uM	0.662
	871402	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	60900.0	CHEMBL1913	Homo sapiens	IC50	uM	60.9
	872527	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	IC50	nM	26.0	CHEMBL1913	Homo sapiens	IC50	uM	0.026
	872528	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	IC50	nM	36.0	CHEMBL1913	Homo sapiens	IC50	uM	0.036
	872530	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	872556	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCC1CCCCC1		CHEMBL124439	=	IC50	nM	813.0	CHEMBL1913	Homo sapiens	IC50	uM	0.813
	872557	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCC1CCCCC1		CHEMBL124439	=	IC50	nM	19460.0	CHEMBL1913	Homo sapiens	IC50	uM	19.46
	872559	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL126699	<	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	872560	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL126699	=	IC50	nM	29.0	CHEMBL1913	Homo sapiens	IC50	uM	0.029
	872562	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL126699	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	872566	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCS(=O)(=O)CC(C)C		CHEMBL59735	=	IC50	nM	36.0	CHEMBL1913	Homo sapiens	IC50	uM	0.036
	872567	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCS(=O)(=O)CC(C)C		CHEMBL59735	=	IC50	nM	121.0	CHEMBL1913	Homo sapiens	IC50	uM	0.121
	872736	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2cc(F)ccc2/C1=C/c1ccc[nH]1		CHEMBL87208	=	IC50	nM	2800.0	CHEMBL1913	Homo sapiens	IC50	uM	2.8
	873662	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCn1ccnn1		CHEMBL127429	=	IC50	nM	335.0	CHEMBL1913	Homo sapiens	IC50	uM	0.335
	873663	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCn1ccnn1		CHEMBL127429	=	IC50	nM	380.0	CHEMBL1913	Homo sapiens	IC50	uM	0.38
	873665	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCn1ccnn1		CHEMBL125146	=	IC50	nM	2810.0	CHEMBL1913	Homo sapiens	IC50	uM	2.81
	873666	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCn1ccnn1		CHEMBL125146	=	IC50	nM	5920.0	CHEMBL1913	Homo sapiens	IC50	uM	5.92
	873668	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccc6[nH]ccc6c5)cc4)CC3)ncnc2c1		CHEMBL121829	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	873669	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccc6[nH]ccc6c5)cc4)CC3)ncnc2c1		CHEMBL121829	=	IC50	nM	180.0	CHEMBL1913	Homo sapiens	IC50	uM	0.18
	873671	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCC2(CC1)OCCO2		CHEMBL340431	=	IC50	nM	336.0	CHEMBL1913	Homo sapiens	IC50	uM	0.336
	873672	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCC2(CC1)OCCO2		CHEMBL340431	=	IC50	nM	222.0	CHEMBL1913	Homo sapiens	IC50	uM	0.222
	873828	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1n[nH]cc1Cl		CHEMBL87402	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	874751	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCn1cccc1		CHEMBL124872	=	IC50	nM	715.0	CHEMBL1913	Homo sapiens	IC50	uM	0.715
	874752	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCn1cccc1		CHEMBL124872	=	IC50	nM	2490.0	CHEMBL1913	Homo sapiens	IC50	uM	2.49
	874982	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1ccc(Br)cc1		CHEMBL86837	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	875952	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCn1ccnn1		CHEMBL126173	=	IC50	nM	1450.0	CHEMBL1913	Homo sapiens	IC50	uM	1.45
	875953	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCn1ccnn1		CHEMBL126173	=	IC50	nM	720.0	CHEMBL1913	Homo sapiens	IC50	uM	0.72
	875955	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL127635	=	IC50	nM	1410.0	CHEMBL1913	Homo sapiens	IC50	uM	1.41
	875956	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL127635	=	IC50	nM	1260.0	CHEMBL1913	Homo sapiens	IC50	uM	1.26
	875958	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCS(=O)(=O)CC1		CHEMBL339974	=	IC50	nM	2130.0	CHEMBL1913	Homo sapiens	IC50	uM	2.13
	875959	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCS(=O)(=O)CC1		CHEMBL339974	=	IC50	nM	2970.0	CHEMBL1913	Homo sapiens	IC50	uM	2.97
	876171	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CCc1ccc(/C=C2/C(=O)Nc3ccccc32)o1		CHEMBL328452	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	877220	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCn1cnnn1		CHEMBL125141	=	IC50	nM	507.0	CHEMBL1913	Homo sapiens	IC50	uM	0.507
	877221	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCn1cnnn1		CHEMBL125141	=	IC50	nM	1430.0	CHEMBL1913	Homo sapiens	IC50	uM	1.43
	877223	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	CCCS(=O)(=O)CCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL124369	=	IC50	nM	87.0	CHEMBL1913	Homo sapiens	IC50	uM	0.087
	877224	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	CCCS(=O)(=O)CCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL124369	=	IC50	nM	265.0	CHEMBL1913	Homo sapiens	IC50	uM	0.265
	877226	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1ccc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2c1		CHEMBL338827	=	IC50	nM	1250.0	CHEMBL1913	Homo sapiens	IC50	uM	1.25
	877227	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1ccc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2c1		CHEMBL338827	=	IC50	nM	3560.0	CHEMBL1913	Homo sapiens	IC50	uM	3.56
	877229	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCC(=O)CC1		CHEMBL333648	=	IC50	nM	1370.0	CHEMBL1913	Homo sapiens	IC50	uM	1.37
	877230	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCC(=O)CC1		CHEMBL333648	=	IC50	nM	601.0	CHEMBL1913	Homo sapiens	IC50	uM	0.601
	877411	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1cccc2c1/C(=C/c1ccc(N3CCN(C=O)CC3)cc1)C(=O)N2		CHEMBL89040	=	IC50	nM	24500.0	CHEMBL1913	Homo sapiens	IC50	uM	24.5
	877416	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CSc1ccc(/C=C2\C(=O)Nc3cccc(C)c32)s1		CHEMBL86432	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	878486	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCSCC1		CHEMBL341489	=	IC50	nM	450.0	CHEMBL1913	Homo sapiens	IC50	uM	0.45
	878487	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCSCC1		CHEMBL341489	=	IC50	nM	305.0	CHEMBL1913	Homo sapiens	IC50	uM	0.305
	878489	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OCCN1CCOCC1		CHEMBL125252	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	878490	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OCCN1CCOCC1		CHEMBL125252	=	IC50	nM	582.0	CHEMBL1913	Homo sapiens	IC50	uM	0.582
	878492	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCC(=N)N		CHEMBL419785	=	IC50	nM	871.0	CHEMBL1913	Homo sapiens	IC50	uM	0.871
	878493	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCC(=N)N		CHEMBL419785	=	IC50	nM	9100.0	CHEMBL1913	Homo sapiens	IC50	uM	9.1
	878680	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1cccc2c1/C(=C/c1ccc(N3CCOCC3)cc1)C(=O)N2		CHEMBL90277	=	IC50	nM	49900.0	CHEMBL1913	Homo sapiens	IC50	uM	49.9
	878685	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CC(C)c1cc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc(C(C)C)c1O		CHEMBL89723	=	IC50	nM	60400.0	CHEMBL1913	Homo sapiens	IC50	uM	60.4
	879713	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL445636	<	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	879714	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL445636	=	IC50	nM	22.0	CHEMBL1913	Homo sapiens	IC50	uM	0.022
	879716	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCC(C)CC1		CHEMBL445636	=	IC50	nM	73.0	CHEMBL1913	Homo sapiens	IC50	uM	0.073
	879720	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6ncccc56)cc4)CC3)c2cc1OCCOC		CHEMBL125811	=	IC50	nM	1.6	CHEMBL1913	Homo sapiens	IC50	uM	0.0016
	879721	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6ncccc56)cc4)CC3)c2cc1OCCOC		CHEMBL125811	=	IC50	nM	500.0	CHEMBL1913	Homo sapiens	IC50	uM	0.5
	879723	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL124487	=	IC50	nM	99.0	CHEMBL1913	Homo sapiens	IC50	uM	0.099
	879724	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL124487	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	879975	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCOCC2)cc1		CHEMBL86480	=	IC50	nM	33100.0	CHEMBL1913	Homo sapiens	IC50	uM	33.1
	879980	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCCC2)cc1		CHEMBL314217	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	879985	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	COc1c(Br)cc(/C=C2\C(=O)Nc3ccccc32)cc1C(C)(C)C		CHEMBL87746	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	881073	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCS(=O)(=O)CCC(C)C		CHEMBL339403	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	881074	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCS(=O)(=O)CCC(C)C		CHEMBL339403	=	IC50	nM	240.0	CHEMBL1913	Homo sapiens	IC50	uM	0.24
	882261	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCn1ccnc1		CHEMBL125304	=	IC50	nM	8180.0	CHEMBL1913	Homo sapiens	IC50	uM	8.18
	882262	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCn1ccnc1		CHEMBL125304	=	IC50	nM	5170.0	CHEMBL1913	Homo sapiens	IC50	uM	5.17
	882264	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)(C)C)cc4)CC3)c2cc1OCCOC		CHEMBL341258	=	IC50	nM	1.4	CHEMBL1913	Homo sapiens	IC50	uM	0.0014
	882265	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)(C)C)cc4)CC3)c2cc1OCCOC		CHEMBL341258	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM	0.08
	882267	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6[nH]ccc56)cc4)CC3)c2cc1OCCOC		CHEMBL125277	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	882268	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6[nH]ccc56)cc4)CC3)c2cc1OCCOC		CHEMBL125277	=	IC50	nM	32.0	CHEMBL1913	Homo sapiens	IC50	uM	0.032
	882270	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL340235	=	IC50	nM	424.0	CHEMBL1913	Homo sapiens	IC50	uM	0.424
	882271	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL340235	=	IC50	nM	97.0	CHEMBL1913	Homo sapiens	IC50	uM	0.097
	882414	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1ccc(O)cc1		CHEMBL313578	=	IC50	nM	8390.0	CHEMBL1913	Homo sapiens	IC50	uM	8.39
	882419	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	C/C(=C1\C(=O)Nc2ccccc21)c1ccc(N2CCCCC2)cc1		CHEMBL314798	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	882424	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CCOC(=O)c1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL316008	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	882429	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1sccc1Br		CHEMBL87783	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	882434	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1cc(Br)cs1		CHEMBL316268	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	882439	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C\c1ccco1		CHEMBL312826	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	883430	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCn1ncnn1		CHEMBL127786	=	IC50	nM	216.0	CHEMBL1913	Homo sapiens	IC50	uM	0.216
	883431	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCn1ncnn1		CHEMBL127786	=	IC50	nM	350.0	CHEMBL1913	Homo sapiens	IC50	uM	0.35
	883433	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCS(=O)(=O)CC1		CHEMBL124313	=	IC50	nM	494.0	CHEMBL1913	Homo sapiens	IC50	uM	0.494
	883434	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCS(=O)(=O)CC1		CHEMBL124313	=	IC50	nM	680.0	CHEMBL1913	Homo sapiens	IC50	uM	0.68
	883616	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c(C)c1C		CHEMBL313433	=	IC50	nM	65500.0	CHEMBL1913	Homo sapiens	IC50	uM	65.5
	884643	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	240.0	CHEMBL1913	Homo sapiens	IC50	uM	0.24
	884647	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCC(O)CC1		CHEMBL337920	=	IC50	nM	6150.0	CHEMBL1913	Homo sapiens	IC50	uM	6.15
	884648	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCC(O)CC1		CHEMBL337920	=	IC50	nM	3230.0	CHEMBL1913	Homo sapiens	IC50	uM	3.23
	886053	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL124035	=	IC50	nM	420.0	CHEMBL1913	Homo sapiens	IC50	uM	0.42
	886054	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL124035	=	IC50	nM	216.0	CHEMBL1913	Homo sapiens	IC50	uM	0.216
	886056	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL124035	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	886266	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCCCC2)cc1		CHEMBL315701	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	887249	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCn1nccn1		CHEMBL340439	=	IC50	nM	526.0	CHEMBL1913	Homo sapiens	IC50	uM	0.526
	887250	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCn1nccn1		CHEMBL340439	=	IC50	nM	520.0	CHEMBL1913	Homo sapiens	IC50	uM	0.52
	888409	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCCC1		CHEMBL124827	=	IC50	nM	178.0	CHEMBL1913	Homo sapiens	IC50	uM	0.178
	888410	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCCC1		CHEMBL124827	=	IC50	nM	210.0	CHEMBL1913	Homo sapiens	IC50	uM	0.21
	888584	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	COc1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL87810	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	889573	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL124895	=	IC50	nM	198.0	CHEMBL1913	Homo sapiens	IC50	uM	0.198
	889574	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL124895	=	IC50	nM	177.0	CHEMBL1913	Homo sapiens	IC50	uM	0.177
	889576	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCn1nccn1		CHEMBL338619	=	IC50	nM	943.0	CHEMBL1913	Homo sapiens	IC50	uM	0.943
	889577	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCn1nccn1		CHEMBL338619	=	IC50	nM	1660.0	CHEMBL1913	Homo sapiens	IC50	uM	1.66
	889579	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCS(=O)(=O)CC(F)(F)F		CHEMBL124983	=	IC50	nM	564.0	CHEMBL1913	Homo sapiens	IC50	uM	0.564
	889580	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCS(=O)(=O)CC(F)(F)F		CHEMBL124983	=	IC50	nM	1230.0	CHEMBL1913	Homo sapiens	IC50	uM	1.23
	889802	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1cccc2c1/C(=C/c1ccc(N(C)C)cc1)C(=O)N2		CHEMBL89809	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	889807	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cn1cc(Cl)c(/C=C2\C(=O)Nc3ccccc32)n1		CHEMBL89646	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	889812	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CC(C)c1ccc(/C=C2/C(=O)Nc3ccccc32)cc1		CHEMBL48760	=	IC50	nM	24200.0	CHEMBL1913	Homo sapiens	IC50	uM	24.2
	890894	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCC(F)(F)CC1		CHEMBL127731	=	IC50	nM	110.0	CHEMBL1913	Homo sapiens	IC50	uM	0.11
	890895	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCC(F)(F)CC1		CHEMBL127731	=	IC50	nM	165.0	CHEMBL1913	Homo sapiens	IC50	uM	0.165
	890897	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(C)cc5)cc4)CC3)c2cc1OCCOC		CHEMBL340137	=	IC50	nM	26.0	CHEMBL1913	Homo sapiens	IC50	uM	0.026
	890898	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(C)cc5)cc4)CC3)c2cc1OCCOC		CHEMBL340137	=	IC50	nM	206.0	CHEMBL1913	Homo sapiens	IC50	uM	0.206
	890900	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc6[nH]ccc6c5)cc4)CC3)c2cc1OC		CHEMBL124949	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	uM	0.009
	890901	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc6[nH]ccc6c5)cc4)CC3)c2cc1OC		CHEMBL124949	=	IC50	nM	167.0	CHEMBL1913	Homo sapiens	IC50	uM	0.167
	890903	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL339685	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM	0.04
	890904	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL339685	=	IC50	nM	525.0	CHEMBL1913	Homo sapiens	IC50	uM	0.525
	891084	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	20260.0	CHEMBL1913	Homo sapiens	IC50	uM	20.26
	892279	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CC(C)(C)c1cc(/C=C2\C(=O)Nc3ccccc32)cc(C(C)(C)C)c1O		CHEMBL89505	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	893122	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCC1		CHEMBL123667	=	IC50	nM	77.0	CHEMBL1913	Homo sapiens	IC50	uM	0.077
	893123	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCC1		CHEMBL123667	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	893125	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	CCS(=O)(=O)CCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL340144	=	IC50	nM	409.0	CHEMBL1913	Homo sapiens	IC50	uM	0.409
	893126	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	CCS(=O)(=O)CCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL340144	=	IC50	nM	530.0	CHEMBL1913	Homo sapiens	IC50	uM	0.53
	893128	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1		CHEMBL127886	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM	0.04
	893129	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1		CHEMBL127886	=	IC50	nM	920.0	CHEMBL1913	Homo sapiens	IC50	uM	0.92
	893314	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	COc1c(Br)cc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1C(C)(C)C		CHEMBL86944	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	893319	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CSc1ccc(/C=C2\C(=O)Nc3ccccc32)s1		CHEMBL89721	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	893324	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CN(C)c1ccc(/C=C2\C(=O)N(C)c3ccccc32)cc1		CHEMBL86921	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	894310	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL338597	=	IC50	nM	53.0	CHEMBL1913	Homo sapiens	IC50	uM	0.053
	894311	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL338597	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	894313	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6c5CCN6)cc4)CC3)c2cc1OCCOC		CHEMBL340157	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	894314	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6c5CCN6)cc4)CC3)c2cc1OCCOC		CHEMBL340157	=	IC50	nM	420.0	CHEMBL1913	Homo sapiens	IC50	uM	0.42
	894316	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OCCOC		CHEMBL125717	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	894317	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OCCOC		CHEMBL125717	=	IC50	nM	183.0	CHEMBL1913	Homo sapiens	IC50	uM	0.183
	894319	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(C(C)(C)C)cc5)cc4)CC3)c2cc1OCCOC		CHEMBL125721	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	uM	0.012
	894320	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(C(C)(C)C)cc5)cc4)CC3)c2cc1OCCOC		CHEMBL125721	=	IC50	nM	634.0	CHEMBL1913	Homo sapiens	IC50	uM	0.634
	894468	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=CN1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL315546	=	IC50	nM	5100.0	CHEMBL1913	Homo sapiens	IC50	uM	5.1
	894473	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=CN1CCN(c2ccc(/C=C3\C(=O)Nc4ccc(Br)cc43)cc2)CC1		CHEMBL88405	=	IC50	nM	13800.0	CHEMBL1913	Homo sapiens	IC50	uM	13.8
	894478	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1cc(C)c(/C=C2\C(=O)Nc3cccc(C)c32)[nH]1		CHEMBL330321	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	894483	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	IC50	nM	19400.0	CHEMBL1913	Homo sapiens	IC50	uM	19.4
	895429	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCOCC1		CHEMBL125898	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	895430	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCOCC1		CHEMBL125898	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	895432	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCOCC1		CHEMBL125898	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	895620	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CCc1ccc(/C=C2\C(=O)Nc3ccccc32)s1		CHEMBL314146	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	896677	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL107599	<	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	896678	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL107599	=	IC50	nM	35.0	CHEMBL1913	Homo sapiens	IC50	uM	0.035
	896680	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1C		CHEMBL107599	=	IC50	nM	74.0	CHEMBL1913	Homo sapiens	IC50	uM	0.074
	896684	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc6ccccc6c5)cc4)CC3)c2cc1OCCOC		CHEMBL340284	=	IC50	nM	0.4	CHEMBL1913	Homo sapiens	IC50	uM	0.0004
	896685	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc6ccccc6c5)cc4)CC3)c2cc1OCCOC		CHEMBL340284	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	896687	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OCCN1CCCCC1		CHEMBL127753	=	IC50	nM	501.0	CHEMBL1913	Homo sapiens	IC50	uM	0.501
	896688	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OCCN1CCCCC1		CHEMBL127753	=	IC50	nM	335.0	CHEMBL1913	Homo sapiens	IC50	uM	0.335
	896690	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OCCN1CCCCC1		CHEMBL125367	=	IC50	nM	198.0	CHEMBL1913	Homo sapiens	IC50	uM	0.198
	896691	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OCCN1CCCCC1		CHEMBL125367	=	IC50	nM	110.0	CHEMBL1913	Homo sapiens	IC50	uM	0.11
	897812	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6cnccc56)cc4)CC3)c2cc1OCCOC		CHEMBL123928	=	IC50	nM	0.4	CHEMBL1913	Homo sapiens	IC50	uM	0.0004
	897813	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6cnccc56)cc4)CC3)c2cc1OCCOC		CHEMBL123928	=	IC50	nM	120.0	CHEMBL1913	Homo sapiens	IC50	uM	0.12
	897815	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL341239	=	IC50	nM	79.0	CHEMBL1913	Homo sapiens	IC50	uM	0.079
	897816	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL341239	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	897818	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL444064	=	IC50	nM	1250.0	CHEMBL1913	Homo sapiens	IC50	uM	1.25
	897819	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL444064	=	IC50	nM	170.0	CHEMBL1913	Homo sapiens	IC50	uM	0.17
	897821	CHEMBL763440	Inhibition of wild type Platelet-derived growth factor receptor beta phosphorylation in CHO cells	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL444064	=	IC50	nM	250.0	CHEMBL1913	Homo sapiens	IC50	uM	0.25
	897984	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1ccc(N2CCOCC2)cc1		CHEMBL421548	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	897989	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	COc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1C(C)(C)C		CHEMBL86326	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	897994	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1ccc2c(c1)/C(=C/c1[nH]c(C)cc1C)C(=O)N2		CHEMBL89483	=	IC50	nM	25500.0	CHEMBL1913	Homo sapiens	IC50	uM	25.5
	897999	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C/c1ccc[nH]1		CHEMBL87325	=	IC50	nM	41700.0	CHEMBL1913	Homo sapiens	IC50	uM	41.7
	899101	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL125994	=	IC50	nM	168.0	CHEMBL1913	Homo sapiens	IC50	uM	0.168
	899102	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL125994	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	899314	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	COC(=O)CCc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL316009	=	IC50	nM	66000.0	CHEMBL1913	Homo sapiens	IC50	uM	66.0
	900251	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCC(F)(F)C1		CHEMBL125431	=	IC50	nM	29.0	CHEMBL1913	Homo sapiens	IC50	uM	0.029
	900252	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCC(F)(F)C1		CHEMBL125431	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	900254	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCO		CHEMBL334169	=	IC50	nM	5590.0	CHEMBL1913	Homo sapiens	IC50	uM	5.59
	900255	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCO		CHEMBL334169	=	IC50	nM	13970.0	CHEMBL1913	Homo sapiens	IC50	uM	13.97
	900257	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(Br)cc5)cc4)CC3)c2cc1OCCOC		CHEMBL125805	=	IC50	nM	2.4	CHEMBL1913	Homo sapiens	IC50	uM	0.0024
	900258	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(Br)cc5)cc4)CC3)c2cc1OCCOC		CHEMBL125805	=	IC50	nM	190.0	CHEMBL1913	Homo sapiens	IC50	uM	0.19
	901501	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN		CHEMBL442402	=	IC50	nM	3110.0	CHEMBL1913	Homo sapiens	IC50	uM	3.11
	901502	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN		CHEMBL442402	=	IC50	nM	15420.0	CHEMBL1913	Homo sapiens	IC50	uM	15.42
	901504	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OCCN1CCOCC1		CHEMBL340200	=	IC50	nM	5000.0	CHEMBL1913	Homo sapiens	IC50	uM	5.0
	901505	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OCCN1CCOCC1		CHEMBL340200	=	IC50	nM	2670.0	CHEMBL1913	Homo sapiens	IC50	uM	2.67
	901507	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL122572	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	901508	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL122572	=	IC50	nM	206.0	CHEMBL1913	Homo sapiens	IC50	uM	0.206
	901703	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CN1C(=O)/C(=C\c2ccc(Br)cc2)c2ccccc21		CHEMBL314021	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	902991	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CCc1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL420411	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	902996	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cn1cccc1/C=C1\C(=O)Nc2ccccc21		CHEMBL86631	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	903971	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCn1ccnn1		CHEMBL125028	=	IC50	nM	2240.0	CHEMBL1913	Homo sapiens	IC50	uM	2.24
	903972	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCn1ccnn1		CHEMBL125028	=	IC50	nM	4690.0	CHEMBL1913	Homo sapiens	IC50	uM	4.69
	903974	CHEMBL763437	Inhibition of platelet-derived growth factor receptor beta phosphorylation in MG63 cells in the absence of plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCn1nccn1		CHEMBL127581	=	IC50	nM	1200.0	CHEMBL1913	Homo sapiens	IC50	uM	1.2
	903975	CHEMBL763438	Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasma	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)ncnc2cc1OCCn1nccn1		CHEMBL127581	=	IC50	nM	2210.0	CHEMBL1913	Homo sapiens	IC50	uM	2.21
	904135	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	CN(C)c1ccc(/C=C2\C(=O)Nc3cc(F)ccc32)cc1		CHEMBL329367	=	IC50	nM	66000.0	CHEMBL1913	Homo sapiens	IC50	uM	66.0
	904140	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccccc2/C1=C/c1ccc(C(=O)O)cc1		CHEMBL313259	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	904145	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1ccc[nH]1		CHEMBL431025	=	IC50	nM	85400.0	CHEMBL1913	Homo sapiens	IC50	uM	85.4
	904150	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL316020	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	904155	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1cc(C)c(/C=C2\C(=O)Nc3cc(F)ccc32)[nH]1		CHEMBL87324	=	IC50	nM	18200.0	CHEMBL1913	Homo sapiens	IC50	uM	18.2
	904160	CHEMBL768947	Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK).	B	Cc1ccc(/C=C2/C(=O)Nc3ccccc32)o1		CHEMBL89697	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	915777	CHEMBL766062	Inhibition of Platelet-derived growth factor receptor beta at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	84.0	CHEMBL1913	Homo sapiens	Activity	%	84.0
Not Active	928433	CHEMBL761268	Percent platelet derived growth factor receptor (PDGFR) activity at 30 uM (NS = less than 5% activation)	F	Cn1cc(C2=C(O)C(O)=C(c3ccccc3)C(=O)C2=O)c2ccccc21		CHEMBL116306		Activation			CHEMBL1913	Homo sapiens	Activation	%	
Not Active	929699	CHEMBL761268	Percent platelet derived growth factor receptor (PDGFR) activity at 30 uM (NS = less than 5% activation)	F	O=C1C(O)=C(c2csc3ccccc23)C(=O)C(O)=C1c1ccccc1		CHEMBL117440		Activation			CHEMBL1913	Homo sapiens	Activation	%	
	931238	CHEMBL766062	Inhibition of Platelet-derived growth factor receptor beta at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	86.0	CHEMBL1913	Homo sapiens	Activity	%	86.0
	933851	CHEMBL761267	Percent platelet derived growth factor receptor (PDGFR) activity at 30 uM	F	C=CC(C)(C)c1[nH]c2ccccc2c1C1=C(O)C(O)=C(c2c[nH]c3c(CC=C(C)C)cccc23)C(=O)C1=O		CHEMBL18879	=	Activation	%	6.0	CHEMBL1913	Homo sapiens	Activation	%	6.0
Not Active	935339	CHEMBL761268	Percent platelet derived growth factor receptor (PDGFR) activity at 30 uM (NS = less than 5% activation)	F	O=C1C(O)=C(c2c[nH]c3ccccc23)C(=O)C(O)=C1c1ccccc1		CHEMBL117206		Activation			CHEMBL1913	Homo sapiens	Activation	%	
Not Active	936744	CHEMBL761268	Percent platelet derived growth factor receptor (PDGFR) activity at 30 uM (NS = less than 5% activation)	F	O=C1C(O)=C(c2coc3ccccc23)C(=O)C(O)=C1c1ccccc1		CHEMBL116907		Activation			CHEMBL1913	Homo sapiens	Activation	%	
Not Active	936747	CHEMBL763108	Percent platelet derived growth factor receptor (PDGFR) activity at 30 uM (NS = less than 5% activation)	F	O=C1C(O)=C(c2cccc3ccccc23)C(=O)C(O)=C1c1ccccc1		CHEMBL432971		Activation			CHEMBL1913	Homo sapiens	Activation	%	
Not Active	936751	CHEMBL761269	Percent platelet derived growth factor receptor (PDGFR) activity at 30 uM (NS = less than 5% activation)	F	COc1ccc(C2=C(O)C(O)=C(c3ccccc3)C(=O)C2=O)cc1		CHEMBL118856		Activation			CHEMBL1913	Homo sapiens	Activation	%	
Not Active	946064	CHEMBL763108	Percent platelet derived growth factor receptor (PDGFR) activity at 30 uM (NS = less than 5% activation)	F	O=C1C(O)=C(c2ccc3ccccc3c2)C(=O)C(O)=C1c1ccccc1		CHEMBL116893		Activation			CHEMBL1913	Homo sapiens	Activation	%	
	946808	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3ccccc23)CC1		CHEMBL103487	=	IC50	nM	380.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.38
	949373	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	Nc1cc2c(N3CCN(/C(S)=N\Cc4ccccc4)CC3)ncnc2cc1Cl		CHEMBL101227	=	IC50	nM	160.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.16
	949374	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CC(=O)Nc1cc2c(N3CCN(/C(S)=N\Cc4ccccc4)CC3)ncnc2cc1Cl		CHEMBL103599	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.0
	950692	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3ccc(F)cc23)CC1		CHEMBL420645	=	IC50	nM	350.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.35
	950693	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3cc([N+](=O)[O-])ccc23)CC1		CHEMBL100804	=	IC50	nM	2880.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	2.88
	950694	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CCOc1cc2c(N3CCN(/C(S)=N\Cc4ccccc4)CC3)ncnc2cc1OC		CHEMBL100735	=	IC50	nM	620.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.62
	952078	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3cc(Cl)c([N+](=O)[O-])cc23)CC1		CHEMBL430849	=	IC50	nM	1320.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.32
	953416	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL102301	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.09
	953417	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3ccc(I)cc23)CC1		CHEMBL322209	=	IC50	nM	5170.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	5.17
	958718	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	Cc1cccc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c12		CHEMBL103702	=	IC50	nM	6250.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	6.25
	958719	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc(OC)c2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2c1		CHEMBL100305	=	IC50	nM	10900.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	10.9
	959823	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CCOc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2cc1OC		CHEMBL100736	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.04
	961034	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1ccc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2c1		CHEMBL318345	=	IC50	nM	500.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.5
	961035	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(O)c1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1		CHEMBL101224	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	962286	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc([N+](=O)[O-])cc4)CC3)c2cc1OC		CHEMBL99743	=	IC50	nM	700.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.7
	962287	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3ccc([N+](=O)[O-])cc23)CC1		CHEMBL99635	=	IC50	nM	29700.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	29.7
	962288	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	Cc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1		CHEMBL323372	>	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.1
	962289	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	S=C(NCc1ccccc1)N1CCN(c2ncnc3cc(Cl)ccc23)CC1		CHEMBL100852	=	IC50	nM	5160.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	5.16
	962290	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3cc(F)c(F)cc23)CC1		CHEMBL100523	=	IC50	nM	970.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.97
	962291	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CCNc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1[N+](=O)[O-]		CHEMBL421206	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	963543	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	S=C(NCc1ccccc1)N1CCN(c2ncnc3ccccc23)CC1		CHEMBL103447	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	963544	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1		CHEMBL103456	=	IC50	nM	820.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.8200000000000001
	963545	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CCOc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OC		CHEMBL103490	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.15
	966369	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	Cc1ccc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2c1		CHEMBL323559	=	IC50	nM	540.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.54
	967602	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc12		CHEMBL322922	=	IC50	nM	10700.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	10.7
	967603	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CCNc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1N		CHEMBL100542	=	IC50	nM	1440.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.44
	968740	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1OC		CHEMBL103179	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	969917	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COC(=O)c1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1		CHEMBL100982	>	IC50	nM	750.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.75
	971310	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc2nc(Cl)nc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL103326	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	972598	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=[N+]([O-])c1cc2c(N3CCN(/C(S)=N\Cc4ccccc4)CC3)ncnc2cc1Cl		CHEMBL100841	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	973803	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc2nc(N3CCOCC3)nc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL103776	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	975055	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	>	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.08
	975056	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OC		CHEMBL319894	=	IC50	nM	550.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.55
	976250	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c(OC)c1OC		CHEMBL100734	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	976251	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	COc1cc2nc(C)nc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL101127	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	978646	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102911	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.01
	980076	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CCNc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1[N+](=O)[O-]		CHEMBL99729	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.2
	981240	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	Nc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1[N+](=O)[O-]		CHEMBL317106	=	IC50	nM	1160.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.16
	983764	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	CC(C)Oc1ccc2c(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)ncnc2c1		CHEMBL101113	=	IC50	nM	1120.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.12
	986271	CHEMBL768945	Inhibitory concentration against platelet-derived growth factor receptor beta phosphorylation in CHO cells	F	O=C(Nc1ccc(Oc2ccccc2)cc1)N1CCN(c2ncnc3ccc(Br)cc23)CC1		CHEMBL319255	=	IC50	nM	1380.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.38
	1006307	CHEMBL761276	Inhibition of PDGFRbeta tyrosine kinase.	B	O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O		CHEMBL141247	=	IC50	nM	5000.0	CHEMBL1913	Homo sapiens	IC50	uM	5.0
	1038868	CHEMBL763443	Inhibition of Platelet-derived growth factor receptor beta	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3		CHEMBL150894	=	IC50	nM	406.0	CHEMBL1913	Homo sapiens	IC50	nM	406.0
	1103808	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Cl)c(Cl)c4)CC3)c2cc1OC		CHEMBL104964	=	IC50	nM	1200.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.2
	1103809	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL105032	=	IC50	nM	1410.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.41
	1103810	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL104094	=	IC50	nM	18200.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	18.2
	1105048	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(F)cc4)CC3)c2cc1OC		CHEMBL318358	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	2.0
	1105049	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(Cl)cc4)CC3)c2cc1OC		CHEMBL103870	=	IC50	nM	790.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.79
	1106316	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL105711	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	1106317	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(Br)c(Cl)c4)CC3)c2cc1OC		CHEMBL102908	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.1
	1106335	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc([N+](=O)[O-])cc4)CC3)c2cc1OC		CHEMBL99743	=	IC50	nM	700.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.7
	1106336	CHEMBL766068	Inhibition of Platelet-derived growth factor receptor beta	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc([N+](=O)[O-])cc4)CC3)c2cc1OC		CHEMBL99743	=	IC50	nM	240.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.24
	1107517	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	CCc1ccc(NC(=O)N2CCN(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL320645	=	IC50	nM	1210.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.21
	1108573	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccccc4Cl)CC3)c2cc1OC		CHEMBL321504	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	1108574	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)C)cc4)CC3)c2cc1OC		CHEMBL104067	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.08
	1108575	CHEMBL766068	Inhibition of Platelet-derived growth factor receptor beta	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)C)cc4)CC3)c2cc1OC		CHEMBL104067	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.02
	1108593	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1ccc(NC(=O)N2CCN(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL106332	=	IC50	nM	5360.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	5.36
	1108594	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Cl)c([N+](=O)[O-])c4)CC3)c2cc1OC		CHEMBL421404	=	IC50	nM	1470.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.47
	1109709	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(F)cc4)CC3)c2cc1OC		CHEMBL104206	=	IC50	nM	6720.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	6.72
	1109710	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(I)cc4)CC3)c2cc1OC		CHEMBL104339	=	IC50	nM	290.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.29
	1109711	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	CCCCc1ccc(NC(=O)N2CCN(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL450338	=	IC50	nM	210.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.21
	1109713	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4cccc(C(=O)O)c4)CC3)c2cc1OC		CHEMBL104924	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	1112110	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.08
	1112111	CHEMBL766069	Inhibition of Platelet-derived growth factor receptor beta	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.13
	1112129	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4cc(Cl)cc(Cl)c4)CC3)c2cc1OC		CHEMBL104862	=	IC50	nM	9210.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	9.21
	1113310	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	CCCCc1ccc(NC(=S)N2CCN(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL103082	=	IC50	nM	510.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.51
	1113321	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccccc4[N+](=O)[O-])CC3)c2cc1OC		CHEMBL105689	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	1114581	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Br)cc4)CC3)c2cc1OC		CHEMBL323336	=	IC50	nM	530.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.53
	1114582	CHEMBL766068	Inhibition of Platelet-derived growth factor receptor beta	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Br)cc4)CC3)c2cc1OC		CHEMBL323336	=	IC50	nM	270.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.27
	1115744	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(C(C)C)cc4)CC3)c2cc1OC		CHEMBL105259	=	IC50	nM	720.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.72
	1118182	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccccc4[N+](=O)[O-])CC3)c2cc1OC		CHEMBL102383	=	IC50	nM	1240.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.24
	1119387	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	CCCc1ccc(NC(=O)N2CCN(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL102686	=	IC50	nM	110.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.11
	1119388	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(C)cc5)cc4)CC3)c2cc1OC		CHEMBL105227	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.02
	1120493	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(-c5ccccc5)cc4)CC3)c2cc1OC		CHEMBL106068	=	IC50	nM	260.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.26
	1122837	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C)cc4)CC3)c2cc1OC		CHEMBL320864	=	IC50	nM	9960.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	9.960000000000004
	1122838	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(=O)O)cc4)CC3)c2cc1OC		CHEMBL106967	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	1124018	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL104896	=	IC50	nM	370.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.37
	1124019	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1ccc(NC(=S)N2CCN(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1OC		CHEMBL103003	=	IC50	nM	1140.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.14
	1125277	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(SC)cc4)CC3)c2cc1OC		CHEMBL103066	=	IC50	nM	480.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.48
	1125278	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc([S+](C)[O-])cc4)CC3)c2cc1OC		CHEMBL104427	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	1125279	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5OC)cc4)CC3)c2cc1OC		CHEMBL105622	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.1
	1125295	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc([N+](=O)[O-])cc4)CC3)c2cc1OC		CHEMBL106494	=	IC50	nM	330.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.33
	1126536	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccccc4)CC3)c2cc1OC		CHEMBL316770	=	IC50	nM	11100.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	11.1
	1126537	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OCc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL441272	=	IC50	nM	290.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.29
	1126538	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5cccc6ccccc56)cc4)CC3)c2cc1OC		CHEMBL103861	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.05
	1127779	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4cccc(Cl)c4)CC3)c2cc1OC		CHEMBL318581	=	IC50	nM	2060.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	2.06
	1127780	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)(C)C)cc4)CC3)c2cc1OC		CHEMBL105280	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.03
	1127781	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	CCOC(=O)c1ccc(NC(=O)N2CCN(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL317401	=	IC50	nM	740.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.74
	1130104	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4cccc([N+](=O)[O-])c4)CC3)c2cc1OC		CHEMBL105107	=	IC50	nM	2570.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	2.57
	1130105	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL106966	=	IC50	nM	850.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.85
	1130106	CHEMBL766068	Inhibition of Platelet-derived growth factor receptor beta	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL106966	=	IC50	nM	450.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.45
	1130123	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccncc5)cc4)CC3)c2cc1OC		CHEMBL102427	=	IC50	nM	2310.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	2.31
	1131273	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(S(C)(=O)=O)cc4)CC3)c2cc1OC		CHEMBL321323	=	IC50	nM	9420.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	9.42
	1131274	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(Cl)cc5)cc4)CC3)c2cc1OC		CHEMBL105183	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.02
	1131275	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(C(C)(C)C)cc4)CC3)c2cc1OC		CHEMBL105409	=	IC50	nM	290.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.29
	1131295	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Nc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL321990	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.08
	1132402	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL107901	=	IC50	nM	230.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.23
	1132409	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccccc4Cl)CC3)c2cc1OC		CHEMBL104090	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	10.0
	1132428	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc([N+](=O)[O-])cc5)cc4)CC3)c2cc1OC		CHEMBL319235	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	1133647	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4cccc([N+](=O)[O-])c4)CC3)c2cc1OC		CHEMBL322659	=	IC50	nM	190.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.19
	1133649	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4cccc(Cl)c4)CC3)c2cc1OC		CHEMBL103012	=	IC50	nM	440.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.4400000000000001
	1133650	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(SC)cc4)CC3)c2cc1OC		CHEMBL104922	=	IC50	nM	440.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.44
	1133651	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(Cl)c([N+](=O)[O-])c4)CC3)c2cc1OC		CHEMBL319024	=	IC50	nM	160.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.16
	1135199	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(C)cc4)CC3)c2cc1OC		CHEMBL321286	=	IC50	nM	1260.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.26
	1136365	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccccc4)CC3)c2cc1OC		CHEMBL319242	=	IC50	nM	3180.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	3.18
	1137611	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(O)cc4)CC3)c2cc1OC		CHEMBL102210	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	30.0
	1137612	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(Br)cc4)CC3)c2cc1OC		CHEMBL105239	=	IC50	nM	220.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.22
	1138868	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccc(N)cc5)cc4)CC3)c2cc1OC		CHEMBL102554	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.15
	1138869	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Cc5ccncc5)cc4)CC3)c2cc1OC		CHEMBL102330	=	IC50	nM	1040.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.04
	1138870	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\c4ccc(I)cc4)CC3)c2cc1OC		CHEMBL105702	=	IC50	nM	440.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.4400000000000001
	1140252	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Cl)cc4)CC3)c2cc1OC		CHEMBL104325	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	1.1
	1140260	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Cl)cc4Cl)CC3)c2cc1OC		CHEMBL322464	=	IC50	nM	21600.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	21.6
	1140261	CHEMBL768951	Inhibition of Platelet-derived growth factor receptor beta phosphorylation	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Cc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL103690	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM l-1	0.06
	1147932	CHEMBL768946	Inhibition of Platelet-derived growth factor receptor beta	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	680.0	CHEMBL1913	Homo sapiens	IC50	uM	0.68
	1151501	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	Cc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL78303	=	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	1152812	CHEMBL764169	In vitro inhibition of Platelet-derived growth factor receptor beta expressed in baculovirus	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	640.0	CHEMBL1913	Homo sapiens	IC50	nM	640.0
	1155308	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	FC(F)(F)c1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)ccc1Cl		CHEMBL77555	=	IC50	nM	4000.0	CHEMBL1913	Homo sapiens	IC50	uM	4.0
	1160549	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	c1ccc(-c2ccc(Nc3nnc(Cc4ccncc4)c4ccccc34)cc2)cc1		CHEMBL309331	=	IC50	nM	1400.0	CHEMBL1913	Homo sapiens	IC50	uM	1.4
	1163438	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	COc1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)ccc1Cl		CHEMBL75034	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	1164815	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	Oc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL306295	=	IC50	nM	4000.0	CHEMBL1913	Homo sapiens	IC50	uM	4.0
	1166093	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O		CHEMBL75232	=	IC50	nM	600.0	CHEMBL1913	Homo sapiens	IC50	uM	0.6
	1167469	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	c1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL74587	=	IC50	nM	2800.0	CHEMBL1913	Homo sapiens	IC50	uM	2.8
	1168754	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	FC(F)(F)c1cc(Br)cc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL77933	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	1168761	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	Fc1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc(C(F)(F)F)c1		CHEMBL74646	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	1170097	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1Cl		CHEMBL75196	=	IC50	nM	600.0	CHEMBL1913	Homo sapiens	IC50	uM	0.6
	1175205	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	CC(C)(C)c1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL431006	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	1175319	CHEMBL764169	In vitro inhibition of Platelet-derived growth factor receptor beta expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	477.0	CHEMBL1913	Homo sapiens	IC50	nM	477.0
	1175337	CHEMBL766057	In vitro inhibition of Platelet-derived growth factor receptor beta expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	nM	1100.0
	1175344	CHEMBL764169	In vitro inhibition of Platelet-derived growth factor receptor beta expressed in baculovirus	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	2220.0	CHEMBL1913	Homo sapiens	IC50	nM	2220.0
	1175361	CHEMBL766057	In vitro inhibition of Platelet-derived growth factor receptor beta expressed in baculovirus	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	37900.0	CHEMBL1913	Homo sapiens	IC50	nM	37900.0
	1179009	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	Cc1cc(C)cc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL74197	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	1180533	CHEMBL764169	In vitro inhibition of Platelet-derived growth factor receptor beta expressed in baculovirus	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O		CHEMBL75232	=	IC50	nM	490.0	CHEMBL1913	Homo sapiens	IC50	nM	490.0
	1181741	CHEMBL764645	Inhibition of PDGF- beta receptor kinase	B	COc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL75462	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	1183185	CHEMBL764169	In vitro inhibition of Platelet-derived growth factor receptor beta expressed in baculovirus	B	O=C(Nc1cccc(-c2cncc3ccccc23)c1)c1ccccc1NCc1ccncc1		CHEMBL347537	=	IC50	nM	357.0	CHEMBL1913	Homo sapiens	IC50	nM	357.0
	1232523	CHEMBL766065	Inhibition of purified Platelet-derived growth factor receptor beta kinase activity	B	CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7572	=	IC50	nM	300.0	CHEMBL1913	Homo sapiens	IC50	uM	0.3
	1232524	CHEMBL766064	Inhibition of Platelet-derived growth factor receptor beta kinase activity in Sf9-expressed GST-fusion protein	B	CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7572	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	uM	0.07
	1232525	CHEMBL766063	Inhibition of Platelet-derived growth factor receptor beta autophosphorylation in PAE cells	B	CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7572	=	IC50	nM	4900.0	CHEMBL1913	Homo sapiens	IC50	uM	4.9
	1233666	CHEMBL766065	Inhibition of purified Platelet-derived growth factor receptor beta kinase activity	B	CN(C)CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7432	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1233667	CHEMBL766064	Inhibition of Platelet-derived growth factor receptor beta kinase activity in Sf9-expressed GST-fusion protein	B	CN(C)CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7432	=	IC50	nM	1300.0	CHEMBL1913	Homo sapiens	IC50	uM	1.3
	1233668	CHEMBL766063	Inhibition of Platelet-derived growth factor receptor beta autophosphorylation in PAE cells	B	CN(C)CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7432	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1233680	CHEMBL845662	Inhibition of proliferation of inducible PDGF-B expressing sis-NIH3T3 cells	F	CN(C)CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7432	=	IC50	nM	3500.0	CHEMBL1913	Homo sapiens	IC50	uM	3.5
	1246862	CHEMBL766065	Inhibition of purified Platelet-derived growth factor receptor beta kinase activity	B	O=C(c1cc2ccccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL7735	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	1246863	CHEMBL766064	Inhibition of Platelet-derived growth factor receptor beta kinase activity in Sf9-expressed GST-fusion protein	B	O=C(c1cc2ccccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL7735	=	IC50	nM	600.0	CHEMBL1913	Homo sapiens	IC50	uM	0.6
	1246864	CHEMBL766063	Inhibition of Platelet-derived growth factor receptor beta autophosphorylation in PAE cells	B	O=C(c1cc2ccccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL7735	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	1246876	CHEMBL872824	Inhibition of proliferation of inducible PDGF-B expressing sis-NIH3T3 cells	F	O=C(c1cc2ccccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL7735	=	IC50	nM	3200.0	CHEMBL1913	Homo sapiens	IC50	uM	3.2
	1248122	CHEMBL766065	Inhibition of purified Platelet-derived growth factor receptor beta kinase activity	B	COCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7600	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	1248123	CHEMBL766064	Inhibition of Platelet-derived growth factor receptor beta kinase activity in Sf9-expressed GST-fusion protein	B	COCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7600	=	IC50	nM	4200.0	CHEMBL1913	Homo sapiens	IC50	uM	4.2
	1248124	CHEMBL766063	Inhibition of Platelet-derived growth factor receptor beta autophosphorylation in PAE cells	B	COCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7600	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1257911	CHEMBL764821	Inhibition of Mitogenesis, PDGF-BB, assay	F	COc1cc2ncc(N[C@H]3CC[C@H](O)CC3)nc2cc1OC		CHEMBL104466	=	IC50	nM	353.0	CHEMBL1913	Homo sapiens	IC50	uM	0.353
	1451204	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184227	=	IC50	nM	120.0	CHEMBL1913	Homo sapiens	IC50	uM	0.12
	1451213	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184227	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	1451214	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184227	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM	0.04
	1451222	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(=N\Cc4cc(C)on4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186698	=	IC50	nM	10450.0	CHEMBL1913	Homo sapiens	IC50	uM	10.45
	1451223	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(=N\Cc4ccc(C(C)C)cc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184188	=	IC50	nM	970.0	CHEMBL1913	Homo sapiens	IC50	uM	0.97
	1451224	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(=N\Cc4ccc(C(C)C)cc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184188	=	IC50	nM	920.0	CHEMBL1913	Homo sapiens	IC50	uM	0.92
	1451225	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccncc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL185510	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	uM	0.13
	1451226	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccncc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL185510	=	IC50	nM	240.0	CHEMBL1913	Homo sapiens	IC50	uM	0.24
	1451227	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C#N)cc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL186719	=	IC50	nM	120.0	CHEMBL1913	Homo sapiens	IC50	uM	0.12
	1451228	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C#N)cc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL186719	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	1451229	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccc5)nc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL363083	=	IC50	nM	280.0	CHEMBL1913	Homo sapiens	IC50	uM	0.28
	1451230	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccc5)nc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL363083	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	1451231	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccn5)cc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL186922	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	uM	0.13
	1451232	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccn5)cc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL186922	=	IC50	nM	220.0	CHEMBL1913	Homo sapiens	IC50	uM	0.22
	1451233	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5ccccc5)nc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL184642	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1451234	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5ccccc5)nc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL184642	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	1451235	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL364601	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	1451236	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL364601	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	1451237	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)c(C#N)cnc2cc1OCCCN1CCCCC1		CHEMBL364601	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	1451314	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL187960	=	IC50	nM	260.0	CHEMBL1913	Homo sapiens	IC50	uM	0.26
	1451315	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL187960	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1451316	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL184078	=	IC50	nM	160.0	CHEMBL1913	Homo sapiens	IC50	uM	0.16
	1451317	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL184078	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	1451318	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccco4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL185597	=	IC50	nM	310.0	CHEMBL1913	Homo sapiens	IC50	uM	0.31
	1451319	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccco4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL185597	=	IC50	nM	160.0	CHEMBL1913	Homo sapiens	IC50	uM	0.16
	1451320	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccco4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL185597	=	IC50	nM	290.0	CHEMBL1913	Homo sapiens	IC50	uM	0.29
	1451323	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5ccccn5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL185921	=	IC50	nM	1490.0	CHEMBL1913	Homo sapiens	IC50	uM	1.49
	1451324	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5ccccn5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL185921	=	IC50	nM	2130.0	CHEMBL1913	Homo sapiens	IC50	uM	2.13
	1451325	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5cccnc5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184382	=	IC50	nM	5190.0	CHEMBL1913	Homo sapiens	IC50	uM	5.19
	1451326	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5cccnc5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184382	=	IC50	nM	14800.0	CHEMBL1913	Homo sapiens	IC50	uM	14.8
	1451661	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cnc(C)cn4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184753	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	1451662	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cnc(C)cn4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184753	=	IC50	nM	140.0	CHEMBL1913	Homo sapiens	IC50	uM	0.14
	1451663	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cnc(C)cn4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184753	=	IC50	nM	1350.0	CHEMBL1913	Homo sapiens	IC50	uM	1.35
	1451666	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184235	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	1451667	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184235	=	IC50	nM	140.0	CHEMBL1913	Homo sapiens	IC50	uM	0.14
	1451668	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184235	=	IC50	nM	140.0	CHEMBL1913	Homo sapiens	IC50	uM	0.14
	1451671	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL361517	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	1451672	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL361517	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	uM	0.03
	1451673	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCCN1CCOCC1		CHEMBL360756	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	1451674	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCCN1CCOCC1		CHEMBL360756	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	1451675	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(Cl)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL365271	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	1451676	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(Cl)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL365271	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	1451677	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cccnc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184414	=	IC50	nM	320.0	CHEMBL1913	Homo sapiens	IC50	uM	0.32
	1451678	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cccnc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184414	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	1451679	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5ccccc5)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186618	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	uM	0.13
	1451695	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5ccncc5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183929	=	IC50	nM	5040.0	CHEMBL1913	Homo sapiens	IC50	uM	5.04
	1451696	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5ccncc5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183929	=	IC50	nM	9530.0	CHEMBL1913	Homo sapiens	IC50	uM	9.53
	1451697	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccncc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184180	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	1451698	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccncc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184180	=	IC50	nM	220.0	CHEMBL1913	Homo sapiens	IC50	uM	0.22
	1451699	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\c4ccncc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184180	=	IC50	nM	580.0	CHEMBL1913	Homo sapiens	IC50	uM	0.58
	1451702	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccn5)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184699	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1451703	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccn5)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184699	=	IC50	nM	220.0	CHEMBL1913	Homo sapiens	IC50	uM	0.22
	1451704	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccc5)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186718	=	IC50	nM	360.0	CHEMBL1913	Homo sapiens	IC50	uM	0.36
	1451705	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccc5)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186718	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1451708	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccc5)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186718	=	IC50	nM	270.0	CHEMBL1913	Homo sapiens	IC50	uM	0.27
	1451709	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccc5)cn4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL363901	=	IC50	nM	550.0	CHEMBL1913	Homo sapiens	IC50	uM	0.55
	1451710	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccc5)cn4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL363901	=	IC50	nM	1980.0	CHEMBL1913	Homo sapiens	IC50	uM	1.98
	1451769	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(-c5ccccc5)nc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186618	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	1451796	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL182515	=	IC50	nM	550.0	CHEMBL1913	Homo sapiens	IC50	uM	0.55
	1451797	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL182515	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	uM	0.07
	1451798	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183731	=	IC50	nM	470.0	CHEMBL1913	Homo sapiens	IC50	uM	0.47
	1451799	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183731	=	IC50	nM	450.0	CHEMBL1913	Homo sapiens	IC50	uM	0.45
	1451800	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL186905	=	IC50	nM	1180.0	CHEMBL1913	Homo sapiens	IC50	uM	1.18
	1451801	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL186905	=	IC50	nM	920.0	CHEMBL1913	Homo sapiens	IC50	uM	0.92
	1451802	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL425536	=	IC50	nM	21580.0	CHEMBL1913	Homo sapiens	IC50	uM	21.58
	1451803	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C#N)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL425536	=	IC50	nM	460.0	CHEMBL1913	Homo sapiens	IC50	uM	0.46
	1451804	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL187688	=	IC50	nM	390.0	CHEMBL1913	Homo sapiens	IC50	uM	0.39
	1451805	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL187688	=	IC50	nM	1010.0	CHEMBL1913	Homo sapiens	IC50	uM	1.01
	1452056	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccncc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL185605	=	IC50	nM	2450.0	CHEMBL1913	Homo sapiens	IC50	uM	2.45
	1452057	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccncc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL185605	=	IC50	nM	13400.0	CHEMBL1913	Homo sapiens	IC50	uM	13.4
	1452058	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C)o4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184129	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	1452059	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C)o4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184129	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM	0.08
	1452154	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C)o4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184129	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM	0.08
	1452157	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4csc(C)n4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186550	=	IC50	nM	450.0	CHEMBL1913	Homo sapiens	IC50	uM	0.45
	1452158	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4csc(C)n4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186550	=	IC50	nM	630.0	CHEMBL1913	Homo sapiens	IC50	uM	0.63
	1452159	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4csc(-c5ccc(C(F)(F)F)cc5)n4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL363057	=	IC50	nM	4470.0	CHEMBL1913	Homo sapiens	IC50	uM	4.47
	1452160	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4csc(-c5ccc(C(F)(F)F)cc5)n4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL363057	=	IC50	nM	3090.0	CHEMBL1913	Homo sapiens	IC50	uM	3.09
	1452161	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cnc(C)cn4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL187280	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	1452170	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cnc(C)cn4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL187280	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	1452171	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cnc(C)cn4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL187280	=	IC50	nM	250.0	CHEMBL1913	Homo sapiens	IC50	uM	0.25
	1452178	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cnc(C)cn4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL186612	=	IC50	nM	230.0	CHEMBL1913	Homo sapiens	IC50	uM	0.23
	1452179	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cnc(C)cn4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL186612	=	IC50	nM	1360.0	CHEMBL1913	Homo sapiens	IC50	uM	1.36
	1452180	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184244	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	1452197	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL186923	=	IC50	nM	540.0	CHEMBL1913	Homo sapiens	IC50	uM	0.54
	1452198	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCOCC1		CHEMBL186923	=	IC50	nM	180.0	CHEMBL1913	Homo sapiens	IC50	uM	0.18
	1452199	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL365199	=	IC50	nM	470.0	CHEMBL1913	Homo sapiens	IC50	uM	0.47
	1452200	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Br)cc4)CC3)ncnc2cc1OCCN1CCCC1		CHEMBL365199	=	IC50	nM	350.0	CHEMBL1913	Homo sapiens	IC50	uM	0.35
	1452201	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccncc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL435098	=	IC50	nM	400.0	CHEMBL1913	Homo sapiens	IC50	uM	0.4
	1452202	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccncc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL435098	=	IC50	nM	240.0	CHEMBL1913	Homo sapiens	IC50	uM	0.24
	1452203	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\c4ccncc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL435098	=	IC50	nM	980.0	CHEMBL1913	Homo sapiens	IC50	uM	0.98
	1452206	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4cccnc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184352	=	IC50	nM	4980.0	CHEMBL1913	Homo sapiens	IC50	uM	4.98
	1452207	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4cccnc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184352	=	IC50	nM	3760.0	CHEMBL1913	Homo sapiens	IC50	uM	3.76
	1452208	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Cl)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184082	=	IC50	nM	510.0	CHEMBL1913	Homo sapiens	IC50	uM	0.51
	1452209	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Cl)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184082	=	IC50	nM	890.0	CHEMBL1913	Homo sapiens	IC50	uM	0.89
	1452210	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Cl)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184082	=	IC50	nM	360.0	CHEMBL1913	Homo sapiens	IC50	uM	0.36
	1452213	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184118	=	IC50	nM	1060.0	CHEMBL1913	Homo sapiens	IC50	uM	1.06
	1452214	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184118	=	IC50	nM	4100.0	CHEMBL1913	Homo sapiens	IC50	uM	4.1
	1452215	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Cl)nn4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184254	=	IC50	nM	1330.0	CHEMBL1913	Homo sapiens	IC50	uM	1.33
	1452307	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(Cl)nn4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184254	=	IC50	nM	420.0	CHEMBL1913	Homo sapiens	IC50	uM	0.42
	1452308	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccnc(C#N)c4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186889	=	IC50	nM	1790.0	CHEMBL1913	Homo sapiens	IC50	uM	1.79
	1452309	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccnc(C#N)c4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186889	=	IC50	nM	1540.0	CHEMBL1913	Homo sapiens	IC50	uM	1.54
	1452310	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccn5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186851	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	1452568	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184244	=	IC50	nM	1030.0	CHEMBL1913	Homo sapiens	IC50	uM	1.03
	1452569	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184244	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	1452572	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(Cl)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186682	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	uM	0.08
	1452573	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(Cl)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186682	=	IC50	nM	1010.0	CHEMBL1913	Homo sapiens	IC50	uM	1.01
	1452574	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(Cl)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186682	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	1452675	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C)nc4Cl)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184392	=	IC50	nM	350.0	CHEMBL1913	Homo sapiens	IC50	uM	0.35
	1452676	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C)nc4Cl)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184392	=	IC50	nM	1150.0	CHEMBL1913	Homo sapiens	IC50	uM	1.15
	1452677	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4Cl)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183987	=	IC50	nM	1400.0	CHEMBL1913	Homo sapiens	IC50	uM	1.4
	1452678	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4Cl)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183987	=	IC50	nM	1130.0	CHEMBL1913	Homo sapiens	IC50	uM	1.13
	1452679	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(C(F)(F)F)nc4Cl)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183987	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1452682	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(N)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL187144	=	IC50	nM	2930.0	CHEMBL1913	Homo sapiens	IC50	uM	2.93
	1452683	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccc(N)nc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL187144	=	IC50	nM	5810.0	CHEMBL1913	Homo sapiens	IC50	uM	5.81
	1452684	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccncc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL363085	=	IC50	nM	3590.0	CHEMBL1913	Homo sapiens	IC50	uM	3.59
	1452685	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccncc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL363085	=	IC50	nM	12100.0	CHEMBL1913	Homo sapiens	IC50	uM	12.1
	1452686	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cccnc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186658	=	IC50	nM	710.0	CHEMBL1913	Homo sapiens	IC50	uM	0.71
	1452687	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4cccnc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186658	=	IC50	nM	2110.0	CHEMBL1913	Homo sapiens	IC50	uM	2.11
	1452688	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccccn4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL363723	=	IC50	nM	4090.0	CHEMBL1913	Homo sapiens	IC50	uM	4.09
Not Determined	1452689	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccccn4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL363723		IC50			CHEMBL1913	Homo sapiens	IC50		
	1452690	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccnc(Cl)c4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184575	=	IC50	nM	770.0	CHEMBL1913	Homo sapiens	IC50	uM	0.77
	1452691	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\Cc4ccnc(Cl)c4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL184575	=	IC50	nM	1790.0	CHEMBL1913	Homo sapiens	IC50	uM	1.79
	1452710	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccn5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186851	=	IC50	nM	180.0	CHEMBL1913	Homo sapiens	IC50	uM	0.18
	1452711	CHEMBL874567	Inhibition of Platelet derived growth factor receptor beta autophosphorylation in CHO cells	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5ccccn5)cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186851	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	uM	0.07
	1452718	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5cccc[n+]5[O-])cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186645	=	IC50	nM	430.0	CHEMBL1913	Homo sapiens	IC50	uM	0.43
	1452719	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccc(-c5cccc[n+]5[O-])cc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186645	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	1452720	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4nccs4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186767	=	IC50	nM	5040.0	CHEMBL1913	Homo sapiens	IC50	uM	5.04
	1452721	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4nccs4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL186767	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	1452722	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccsc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183923	=	IC50	nM	740.0	CHEMBL1913	Homo sapiens	IC50	uM	0.74
	1452723	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(S)=N\c4ccsc4)CC3)ncnc2cc1OCCN1CCCCC1		CHEMBL183923	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	1452724	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(=N\c4ccncc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184231	=	IC50	nM	17100.0	CHEMBL1913	Homo sapiens	IC50	uM	17.1
	1452725	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(=N\c4ccncc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184231	=	IC50	nM	31700.0	CHEMBL1913	Homo sapiens	IC50	uM	31.7
	1452726	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(=N\c4ccc(-c5ccccn5)cc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184913	=	IC50	nM	370.0	CHEMBL1913	Homo sapiens	IC50	uM	0.37
	1452727	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(=N\c4ccc(-c5ccccn5)cc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184913	=	IC50	nM	420.0	CHEMBL1913	Homo sapiens	IC50	uM	0.42
	1452728	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(=N\c4ccc(C(C)(C)C)cc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL363922	=	IC50	nM	1550.0	CHEMBL1913	Homo sapiens	IC50	uM	1.55
	1452729	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(=N\c4ccc(C(C)(C)C)cc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL363922	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	1452730	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(=N\Cc4ccc5c(c4)OCO5)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186850	=	IC50	nM	590.0	CHEMBL1913	Homo sapiens	IC50	uM	0.59
	1452832	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(=N\Cc4ccc5c(c4)OCO5)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186850	=	IC50	nM	320.0	CHEMBL1913	Homo sapiens	IC50	uM	0.32
	1452833	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(=N\Cc4ccc(C(F)(F)F)nc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184906	=	IC50	nM	2180.0	CHEMBL1913	Homo sapiens	IC50	uM	2.18
	1452834	CHEMBL832268	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma	B	COc1cc2c(N3CCN(/C(=N\Cc4ccc(C(F)(F)F)nc4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL184906	=	IC50	nM	3420.0	CHEMBL1913	Homo sapiens	IC50	uM	3.42
	1452835	CHEMBL831532	In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells with 45% human plasma	B	COc1cc2c(N3CCN(/C(=N\Cc4cc(C)on4)NC#N)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL186698	=	IC50	nM	2370.0	CHEMBL1913	Homo sapiens	IC50	uM	2.37
	1481537	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COc1cc2nc(-c3cccs3)c(-c3cccs3)nc2cc1OC		CHEMBL373367	=	Inhibition	%	7.0	CHEMBL1913	Homo sapiens	Inhibition	%	7.0
	1481664	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	Oc1cc2nc(-c3cccs3)c(-c3cccs3)nc2cc1O	Outside typical range	CHEMBL190039	=	Inhibition	%	-11.0	CHEMBL1913	Homo sapiens	Inhibition	%	-11.0
	1481793	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCO4)c1		CHEMBL189940	=	Inhibition	%	54.0	CHEMBL1913	Homo sapiens	Inhibition	%	54.0
	1481814	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCCO4)c1		CHEMBL192489	=	Inhibition	%	61.0	CHEMBL1913	Homo sapiens	Inhibition	%	61.0
	1481935	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)C1COc2cc3nc(-c4cccs4)c(-c4cccs4)nc3cc2O1		CHEMBL193232	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	Inhibition	%	5.0
	1482067	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCCCO4)c1		CHEMBL191410	=	Inhibition	%	24.0	CHEMBL1913	Homo sapiens	Inhibition	%	24.0
	1482713	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4ccccc4cc3nc2-c2cccs2)c1		CHEMBL364499	=	Inhibition	%	15.0	CHEMBL1913	Homo sapiens	Inhibition	%	15.0
	1482842	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)Cc1csc(-c2nc3cc4ccccc4cc3nc2-c2cc(CC(=O)OC)cs2)c1		CHEMBL192974	=	Inhibition	%	9.0	CHEMBL1913	Homo sapiens	Inhibition	%	9.0
	1482863	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)CCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCC(=O)OC)s2)s1		CHEMBL190143	=	Inhibition	%	13.0	CHEMBL1913	Homo sapiens	Inhibition	%	13.0
	1482994	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)CCCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCCC(=O)OC)s2)s1		CHEMBL189104	=	Inhibition	%	47.0	CHEMBL1913	Homo sapiens	Inhibition	%	47.0
	1483124	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)Cc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CC(=O)O)s2)s1		CHEMBL193162	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	Inhibition	%	10.0
	1483145	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)Cc1csc(-c2nc3cc4ccccc4cc3nc2-c2cc(CC(=O)O)cs2)c1		CHEMBL192909	=	Inhibition	%	22.0	CHEMBL1913	Homo sapiens	Inhibition	%	22.0
	1483276	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)CCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCC(=O)O)s2)s1		CHEMBL366201	=	Inhibition	%	49.0	CHEMBL1913	Homo sapiens	Inhibition	%	49.0
	1483392	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)CCCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCCC(=O)O)s2)s1		CHEMBL190057	=	Inhibition	%	37.0	CHEMBL1913	Homo sapiens	Inhibition	%	37.0
	1483512	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)c1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(C(=O)O)s2)s1		CHEMBL366185	=	Inhibition	%	23.0	CHEMBL1913	Homo sapiens	Inhibition	%	23.0
	1483533	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)c1ccc2cc3nc(-c4cccs4)c(-c4cccs4)nc3cc2c1		CHEMBL426445	=	Inhibition	%	68.0	CHEMBL1913	Homo sapiens	Inhibition	%	68.0
	1484959	CHEMBL834955	In vitro percent inhibition of Platelet-derived growth factor receptor, beta polypeptide at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COc1cc2nc3nc(-c4cccs4)c(-c4cccs4)nc3nc2cc1OC		CHEMBL193172	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	Inhibition	%	5.0
	1512376	CHEMBL833545	Inhibition of human platelet-derived growth factor receptor beta	B	CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCCCS(C)(=O)=O)c(C(C)C)c23)c(F)cc1F		CHEMBL195218	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	1512388	CHEMBL833545	Inhibition of human platelet-derived growth factor receptor beta	B	CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCC4CCCO4)c(C(C)C)c23)c(F)cc1F		CHEMBL370266	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	1512527	CHEMBL833545	Inhibition of human platelet-derived growth factor receptor beta	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL365318	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	1512671	CHEMBL833545	Inhibition of human platelet-derived growth factor receptor beta	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)F)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL194498	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	1512824	CHEMBL833545	Inhibition of human platelet-derived growth factor receptor beta	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)(F)S(C)(=O)=O)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL195903	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	1516907	CHEMBL830765	Selectivity for Platelet-derived growth factor receptor beta by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1		CHEMBL194176	=	Selectivity	uM	1.6	CHEMBL1913	Homo sapiens	Selectivity	uM	1.6
	1517046	CHEMBL830765	Selectivity for Platelet-derived growth factor receptor beta by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Selectivity	uM	0.42	CHEMBL1913	Homo sapiens	Selectivity	uM	0.42
	1517064	CHEMBL830765	Selectivity for Platelet-derived growth factor receptor beta by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4Cl)c3)o2)c1		CHEMBL191993	=	Selectivity	uM	0.93	CHEMBL1913	Homo sapiens	Selectivity	uM	0.93
Not Active	1650261	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL1913	Homo sapiens	Kd		
Not Active	1650262	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL1913	Homo sapiens	Kd		
	1650263	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	58.0	CHEMBL1913	Homo sapiens	Kd	uM	0.058
	1650264	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	0.21	CHEMBL1913	Homo sapiens	Kd	uM	0.00021
	1650265	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	7.8	CHEMBL1913	Homo sapiens	Kd	uM	0.0078
	1650266	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	7000.0	CHEMBL1913	Homo sapiens	Kd	uM	7.0
	1650267	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	41.0	CHEMBL1913	Homo sapiens	Kd	uM	0.041
Not Active	1650268	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL1913	Homo sapiens	Kd		
Not Active	1650269	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL1913	Homo sapiens	Kd		
	1651698	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2.7	CHEMBL1913	Homo sapiens	Kd	uM	0.0027
Not Active	1651699	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL1913	Homo sapiens	Kd		
Not Active	1651700	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL1913	Homo sapiens	Kd		
	1651701	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	870.0	CHEMBL1913	Homo sapiens	Kd	uM	0.87
	1651702	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1000.0	CHEMBL1913	Homo sapiens	Kd	uM	1.0
Not Active	1651703	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL1913	Homo sapiens	Kd		
	1651704	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	28.0	CHEMBL1913	Homo sapiens	Kd	uM	0.028
Not Active	1651705	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL1913	Homo sapiens	Kd		
Not Active	1651706	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL1913	Homo sapiens	Kd		
	1651707	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	250.0	CHEMBL1913	Homo sapiens	Kd	uM	0.25
Not Active	1651708	CHEMBL860919	Average Binding Constant for PDGFRB; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL1913	Homo sapiens	Kd		
	1653536	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cc2c(cc1OC)-c1[nH]nc(-c3ccccc3)c1C2		CHEMBL121161	=	IC50	nM	124.0	CHEMBL1913	Homo sapiens	IC50	uM	0.124
	1653537	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1[nH]nc(-c3ccccc3)c1C2		CHEMBL121161	=	IC50	nM	17.0	CHEMBL1913	Homo sapiens	IC50	uM	0.017
	1653538	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccccc3)c1C2		CHEMBL432219	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	uM	0.009
	1653539	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccccc3)c1C2		CHEMBL432219	=	IC50	nM	23.0	CHEMBL1913	Homo sapiens	IC50	uM	0.023
	1653549	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	c1ccc(Nc2n[nH]c3c2Cc2ccccc2-3)cc1		CHEMBL175596	=	IC50	nM	317.0	CHEMBL1913	Homo sapiens	IC50	uM	0.317
	1653550	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1ccc2c(c1)-c1n[nH]c(Nc3ccccc3)c1C2		CHEMBL371949	=	IC50	nM	18.0	CHEMBL1913	Homo sapiens	IC50	uM	0.018
	1653551	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1ccc2c(c1)-c1n[nH]c(Nc3ccccc3)c1C2		CHEMBL371949	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	uM	0.009
	1653561	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1ccc2c(c1)Cc1c-2n[nH]c1Nc1ccccc1		CHEMBL200726	=	IC50	nM	217.0	CHEMBL1913	Homo sapiens	IC50	uM	0.217
	1653562	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cccc2c1Cc1c-2n[nH]c1Nc1ccccc1		CHEMBL371910	=	IC50	nM	54.0	CHEMBL1913	Homo sapiens	IC50	uM	0.054
	1653563	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cccc2c1Cc1c-2n[nH]c1Nc1ccccc1		CHEMBL371910	=	IC50	nM	487.0	CHEMBL1913	Homo sapiens	IC50	uM	0.487
	1653573	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccccc3Cl)c1C2		CHEMBL200774	=	IC50	nM	110.0	CHEMBL1913	Homo sapiens	IC50	uM	0.11
	1653574	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(Cl)c3)c1C2		CHEMBL200735	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	1653575	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(Cl)c3)c1C2		CHEMBL200735	=	IC50	nM	268.0	CHEMBL1913	Homo sapiens	IC50	uM	0.268
	1653584	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccc(Cl)cc3)c1C2		CHEMBL425751	=	IC50	nM	659.0	CHEMBL1913	Homo sapiens	IC50	uM	0.659
	1653585	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cc(Cl)ccc3Cl)c1C2		CHEMBL382735	=	IC50	nM	6220.0	CHEMBL1913	Homo sapiens	IC50	uM	6.22
	1653586	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccc(Cl)cc3Cl)c1C2		CHEMBL198642	=	IC50	nM	5420.0	CHEMBL1913	Homo sapiens	IC50	uM	5.42
	1653587	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccc(Cl)c(Cl)c3)c1C2		CHEMBL119910	=	IC50	nM	410.0	CHEMBL1913	Homo sapiens	IC50	uM	0.41
	1653588	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cc(Cl)cc(Cl)c3)c1C2		CHEMBL262249	=	IC50	nM	310.0	CHEMBL1913	Homo sapiens	IC50	uM	0.31
	1653589	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cccc(Nc2[nH]nc3c2Cc2cc(OC)c(OC)cc2-3)c1		CHEMBL120634	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	1653590	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cccc(Nc2[nH]nc3c2Cc2cc(OC)c(OC)cc2-3)c1		CHEMBL120634	=	IC50	nM	16.0	CHEMBL1913	Homo sapiens	IC50	uM	0.016
	1653600	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(C)c3)c1C2		CHEMBL331760	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	uM	0.012
	1653601	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(C)c3)c1C2		CHEMBL331760	=	IC50	nM	188.0	CHEMBL1913	Homo sapiens	IC50	uM	0.188
	1653611	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(Br)c3)c1C2		CHEMBL120862	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	1653612	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(Br)c3)c1C2		CHEMBL120862	=	IC50	nM	32.0	CHEMBL1913	Homo sapiens	IC50	uM	0.032
	1653622	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	4.2	CHEMBL1913	Homo sapiens	IC50	uM	0.0042
	1653623	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	1653656	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(C#N)c3)c1C2		CHEMBL122528	=	IC50	nM	137.0	CHEMBL1913	Homo sapiens	IC50	uM	0.137
	1653657	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COC(=O)c1cccc(Nc2[nH]nc3c2Cc2cc(OC)c(OC)cc2-3)c1		CHEMBL332375	=	IC50	nM	33.0	CHEMBL1913	Homo sapiens	IC50	uM	0.033
	1653658	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COC(=O)c1cccc(Nc2[nH]nc3c2Cc2cc(OC)c(OC)cc2-3)c1		CHEMBL332375	=	IC50	nM	11.0	CHEMBL1913	Homo sapiens	IC50	uM	0.011
	1653659	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(C(F)(F)F)c3)c1C2		CHEMBL184948	=	IC50	nM	38.0	CHEMBL1913	Homo sapiens	IC50	uM	0.038
	1653660	CHEMBL861464	Antiproliferative activity against PDGF-BB stimulated HCASMC	F	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(C(F)(F)F)c3)c1C2		CHEMBL184948	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	1653670	CHEMBL861463	Inhibitory activity against PDGFRbeta kinase	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(C(=O)O)c3)c1C2		CHEMBL185391	>	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	1677768	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(O)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383237	=	Inhibition	%	2.8	CHEMBL1913	Homo sapiens	Inhibition	%	2.8
	1677814	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCc2ccncc2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL370449	=	Inhibition	%	2.9	CHEMBL1913	Homo sapiens	Inhibition	%	2.9
	1677815	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCc2ccc(C(=O)OC(C)(C)C)cc2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL372798	=	Inhibition	%	62.2	CHEMBL1913	Homo sapiens	Inhibition	%	62.2
	1677816	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCc2ccc(C(F)(F)F)cc2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383280	=	Inhibition	%	51.5	CHEMBL1913	Homo sapiens	Inhibition	%	51.5
	1677817	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCc2ccc(OC)cc2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383008	=	Inhibition	%	69.4	CHEMBL1913	Homo sapiens	Inhibition	%	69.4
	1677818	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCCN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201830	=	Inhibition	%	52.0	CHEMBL1913	Homo sapiens	Inhibition	%	52.0
	1677819	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL382462	=	Inhibition	%	68.9	CHEMBL1913	Homo sapiens	Inhibition	%	68.9
	1677820	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCCN2CCOCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201089	=	Inhibition	%	46.2	CHEMBL1913	Homo sapiens	Inhibition	%	46.2
	1677821	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCCN2CCCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL200976	=	Inhibition	%	89.8	CHEMBL1913	Homo sapiens	Inhibition	%	89.8
	1677822	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCCN2CCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL202244	=	Inhibition	%	95.5	CHEMBL1913	Homo sapiens	Inhibition	%	95.5
	1677823	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383030	=	Inhibition	%	57.2	CHEMBL1913	Homo sapiens	Inhibition	%	57.2
	1677824	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	CCN(CC)CCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O		CHEMBL202162	=	Inhibition	%	64.1	CHEMBL1913	Homo sapiens	Inhibition	%	64.1
	1677825	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201865	=	Inhibition	%	56.5	CHEMBL1913	Homo sapiens	Inhibition	%	56.5
	1677826	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OC(C)=O)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL202158	=	Inhibition	%	-0.3	CHEMBL1913	Homo sapiens	Inhibition	%	-0.3
	1677827	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	CCCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O		CHEMBL202216	=	Inhibition	%	5.7	CHEMBL1913	Homo sapiens	Inhibition	%	5.7
	1677828	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	COC(=O)c1c(OC)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201840	=	Inhibition	%	12.7	CHEMBL1913	Homo sapiens	Inhibition	%	12.7
	1677836	CHEMBL862241	Inhibitory activity against PDGFRbeta kinase at 20 uM	B	N#CC(C#N)=C(N)/C(C#N)=C/c1cc(O)c(O)c(O)c1		CHEMBL78257	=	Inhibition	%	82.0	CHEMBL1913	Homo sapiens	Inhibition	%	82.0
	1677861	CHEMBL862245	Inhibitory activity against PDGFRbeta kinase	B	COC(=O)c1c(OC)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201840	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	1677871	CHEMBL862245	Inhibitory activity against PDGFRbeta kinase	B	CCCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O		CHEMBL202216	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	1677874	CHEMBL862245	Inhibitory activity against PDGFRbeta kinase	B	COC(=O)c1c(OCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201865	=	IC50	nM	7600.0	CHEMBL1913	Homo sapiens	IC50	uM	7.6
	1677885	CHEMBL862245	Inhibitory activity against PDGFRbeta kinase	B	N#CC(C#N)=C(N)/C(C#N)=C/c1cc(O)c(O)c(O)c1		CHEMBL78257	=	IC50	nM	2800.0	CHEMBL1913	Homo sapiens	IC50	uM	2.8
	1677886	CHEMBL862245	Inhibitory activity against PDGFRbeta kinase	B	COC(=O)c1c(OCCN2CCCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL200976	=	IC50	nM	5500.0	CHEMBL1913	Homo sapiens	IC50	uM	5.5
	1677887	CHEMBL862245	Inhibitory activity against PDGFRbeta kinase	B	COC(=O)c1c(OCCN2CCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL202244	=	IC50	nM	8700.0	CHEMBL1913	Homo sapiens	IC50	uM	8.7
	1677888	CHEMBL862245	Inhibitory activity against PDGFRbeta kinase	B	COC(=O)c1c(OCCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383030	=	IC50	nM	10200.0	CHEMBL1913	Homo sapiens	IC50	uM	10.2
	1677889	CHEMBL862245	Inhibitory activity against PDGFRbeta kinase	B	CCN(CC)CCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O		CHEMBL202162	=	IC50	nM	15900.0	CHEMBL1913	Homo sapiens	IC50	uM	15.9
	1689332	CHEMBL862345	Inhibition of PDGFRbeta at 10 uM	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	Kd	nM	610.0	CHEMBL1913	Homo sapiens	Kd	uM	0.61
	1699823	CHEMBL859795	Inhibitory activity against PDGFRbeta	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	IC50	nM	6000.0	CHEMBL1913	Homo sapiens	IC50	nM	6000.0
	1718848	CHEMBL854267	Inhibition of human PDGFR beta	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	IC50	nM	171.0	CHEMBL1913	Homo sapiens	IC50	uM	0.171
	1718866	CHEMBL854267	Inhibition of human PDGFR beta	B	Cc1cccc2[nH]c(C(=O)c3cc4cc(O)ccc4[nH]3)cc12		CHEMBL207858	=	IC50	nM	458.0	CHEMBL1913	Homo sapiens	IC50	uM	0.458
	1718880	CHEMBL854267	Inhibition of human PDGFR beta	B	Cc1cccc2[nH]c(C(=O)c3cc4cc(OCCN5CCCCC5)ccc4[nH]3)cc12		CHEMBL210420	=	IC50	nM	1200.0	CHEMBL1913	Homo sapiens	IC50	uM	1.2
	1720130	CHEMBL854267	Inhibition of human PDGFR beta	B	COc1ccc2[nH]c(C(=O)c3cc4ccc(Cl)cc4[nH]3)cc2c1		CHEMBL206915	=	IC50	nM	55.0	CHEMBL1913	Homo sapiens	IC50	uM	0.055
	1734147	CHEMBL854403	Residual activity at human PDGFRbeta at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	96.0	CHEMBL1913	Homo sapiens	Activity	%	96.0
	1744644	CHEMBL866822	Inhibition of PDGFR beta	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	nM	200.0
	1769414	CHEMBL910931	Inhibition of PDGFRbeta	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
Not Determined	1779361	CHEMBL854971	Inhibition of recombinant PDGFRbeta by ELISA	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090		IC50			CHEMBL1913	Homo sapiens	IC50		
	1779383	CHEMBL854971	Inhibition of recombinant PDGFRbeta by ELISA	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	IC50	nM	5000.0	CHEMBL1913	Homo sapiens	IC50	uM	5.0
	1790001	CHEMBL912738	Percentage activity of human PDGFR beta in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	91.0	CHEMBL1913	Homo sapiens	Activity	%	91.0
	1790432	CHEMBL912720	Inhibition of human PDGFR beta	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	680.0	CHEMBL1913	Homo sapiens	IC50	M	6.8E-7
	1807180	CHEMBL908997	Inhibition of PDGFRbeta	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	uM	0.006
	1815200	CHEMBL908509	Inhibition of PDGFR	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	1940.0	CHEMBL1913	Homo sapiens	IC50	nM	1940.0
	1816517	CHEMBL911987	Inhibition of PDGFRbeta at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)Cc1ccccc1-3		CHEMBL148471	<	Inhibition	%	30.0	CHEMBL1913	Homo sapiens	Inhibition	%	30.0
	1816526	CHEMBL911987	Inhibition of PDGFRbeta at 1 uM	B	O=C1NCc2c1c1c3ccccc3sc1c1[nH]c3ccccc3c21		CHEMBL221536	<	Inhibition	%	30.0	CHEMBL1913	Homo sapiens	Inhibition	%	30.0
	1816527	CHEMBL911987	Inhibition of PDGFRbeta at 1 uM	B	O=C1NCc2c1c1c(c3[nH]c4ccccc4c23)Cc2ccccc2-1		CHEMBL357490	<	Inhibition	%	30.0	CHEMBL1913	Homo sapiens	Inhibition	%	30.0
	1816528	CHEMBL911987	Inhibition of PDGFRbeta at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)CCc1ccccc1-3		CHEMBL374581	<	Inhibition	%	30.0	CHEMBL1913	Homo sapiens	Inhibition	%	30.0
	1816529	CHEMBL911987	Inhibition of PDGFRbeta at 1 uM	B	O=C1NC(=O)c2c1c1c(c3[nH]c4ccccc4c23)CCc2ccccc2-1		CHEMBL386636	<	Inhibition	%	30.0	CHEMBL1913	Homo sapiens	Inhibition	%	30.0
	1826432	CHEMBL919910	Inhibition of PDGFRbeta	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	66.0	CHEMBL1913	Homo sapiens	IC50	nM	66.0
	1841814	CHEMBL914499	Inhibition of PDGFRbeta	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	28.0	CHEMBL1913	Homo sapiens	IC50	nM	28.0
	1891429	CHEMBL905853	Inhibition of PDGFRbeta	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	2090.0	CHEMBL1913	Homo sapiens	Ki	nM	2090.0
	1898421	CHEMBL887692	Inhibition of PDGFRB	B	Cc1cc(Nc2ncnc3cnc(N4CCOCC4)cc23)ccc1Oc1ccc(C(=O)NCC(C)(C)C)cc1		CHEMBL375671	>	Activity	uM	10.0	CHEMBL1913	Homo sapiens	Activity	uM	10.0
	1977698	CHEMBL897766	Inhibition of PDGFRbeta	B	CO/N=C/c1c(N)ncnc1N1CCN(C(=O)Nc2ccc(OC(C)C)cc2)CC1		CHEMBL269594	=	IC50	nM	10700.0	CHEMBL1913	Homo sapiens	IC50	uM	10.7
	1986212	CHEMBL899832	Inhibition of PDGFRbeta	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	nM	30000.0
	2015694	CHEMBL885501	Inhibition of PDGFRbeta at 10 uM	B	NC[C@H]1CC[C@H](c2nc(-c3cccc(OCc4ccccc4)c3)c3c(N)nccn32)CC1		CHEMBL392284	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	Inhibition	%	50.0
	2025172	CHEMBL886999	Inhibition of human PDGFRbeta at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	101.0	CHEMBL1913	Homo sapiens	Inhibition	%	101.0
	2025408	CHEMBL886999	Inhibition of human PDGFRbeta at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	147.0	CHEMBL1913	Homo sapiens	Inhibition	%	147.0
	2025409	CHEMBL886999	Inhibition of human PDGFRbeta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	105.0	CHEMBL1913	Homo sapiens	Inhibition	%	105.0
	2025410	CHEMBL886999	Inhibition of human PDGFRbeta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	103.0	CHEMBL1913	Homo sapiens	Inhibition	%	103.0
	2029847	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030089	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2N1		CHEMBL400310	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030090	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccc(F)cc3F)c2-c2ccccc2N1		CHEMBL248954	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030091	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Br)c2-c2ccccc2N1		CHEMBL400113	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030092	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1		CHEMBL399076	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030093	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3cccc(Cl)c3)c2-c2ccccc2N1		CHEMBL248760	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030094	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Cl)c2-c2ccccc2N1		CHEMBL248759	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030095	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	CC(C)(C)c1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL398877	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030096	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1		CHEMBL248758	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030097	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccc(C(F)(F)F)cc3)c2-c2ccccc2N1		CHEMBL398876	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030098	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL400898	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030099	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	COc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL248558	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030100	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2		CHEMBL400897	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030101	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1		CHEMBL248557	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2030102	CHEMBL886313	Inhibition of PDGFRbeta at 10 uM	B	O=C1Cc2cnn(-c3ccc(Br)cc3)c2-c2ccccc2N1		CHEMBL398288	<=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	Inhibition	%	40.0
	2080198	CHEMBL929553	Inhibition of PDGFRbeta	B	CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL253292	=	IC50	nM	1400.0	CHEMBL1913	Homo sapiens	IC50	uM	1.4
	2081486	CHEMBL928671	Inhibition of PDGFRbeta	B	O=C(Cn1cc(Nc2nncc3cc(OCCCN4CCC[C@@H]4CO)ccc23)cn1)Nc1cccc(F)c1F		CHEMBL253968	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	uM	0.006
	2081806	CHEMBL928830	Inhibition of PDGFRbeta at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL1913	Homo sapiens	Inhibition	%	20.0
	2081975	CHEMBL929883	Inhibition of PDGFRbeta at 1 uM	B	CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258015	=	Inhibition	%	92.0	CHEMBL1913	Homo sapiens	Inhibition	%	92.0
	2081976	CHEMBL929883	Inhibition of PDGFRbeta at 1 uM	B	CCO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL401896	=	Inhibition	%	92.0	CHEMBL1913	Homo sapiens	Inhibition	%	92.0
	2109085	CHEMBL947975	Inhibition of PDGFRbeta by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2)c2c(N)noc12		CHEMBL270084	=	IC50	nM	96.0	CHEMBL1913	Homo sapiens	IC50	nM	96.0
Not Active	2109096	CHEMBL947975	Inhibition of PDGFRbeta by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)c2c(N)noc12		CHEMBL269884		Activity			CHEMBL1913	Homo sapiens	Activity		
	2109097	CHEMBL947975	Inhibition of PDGFRbeta by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12		CHEMBL430090	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	nM	130.0
	2114383	CHEMBL951201	Inhibition of PDGFRbeta	B	CCc1ccc(-c2c(-c3cnc(C)[nH]3)c(=O)[nH]c3ccc(Cl)cc23)cc1		CHEMBL403661	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	2114385	CHEMBL951201	Inhibition of PDGFRbeta	B	CCc1ccc(-c2c(-c3cnc(C)[nH]3)c(=O)[nH]c3ccc(C#N)cc23)cc1		CHEMBL273198	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	2121148	CHEMBL933000	Inhibition of PDGFRbeta	B	COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC		CHEMBL429743	<	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	nM	1.0
	2122201	CHEMBL951155	Inhibition of PDGFRbeta	B	CN1CCN(c2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL414001	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	2122208	CHEMBL951155	Inhibition of PDGFRbeta	B	CN1CCN(Cc2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL256893	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	2132661	CHEMBL921285	Inhibition of PDGFRbeta	B	Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL410659	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	2136771	CHEMBL939365	Inhibition of PDGFRbeta	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	4.2	CHEMBL1913	Homo sapiens	IC50	nM	4.2
	2136887	CHEMBL939365	Inhibition of PDGFRbeta	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	IC50	nM	316.23	CHEMBL1913	Homo sapiens	Log IC50		-6.5
	2136976	CHEMBL939365	Inhibition of PDGFRbeta	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	2137049	CHEMBL937669	Inhibition of bPDGFR in human PAC1 cells	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	IC50	nM	4000.0	CHEMBL1913	Homo sapiens	IC50	nM	4000.0
	2137056	CHEMBL937669	Inhibition of bPDGFR in human PAC1 cells	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	IC50	nM	920.0	CHEMBL1913	Homo sapiens	IC50	nM	920.0
	2137131	CHEMBL939365	Inhibition of PDGFRbeta	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C	Potential transcription error	CHEMBL13485	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	nM	3.0
	2137391	CHEMBL939365	Inhibition of PDGFRbeta	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	2147340	CHEMBL922025	Activity of human PDGFRbeta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	98.0	CHEMBL1913	Homo sapiens	Activity	%	98.0
	2164861	CHEMBL929425	Inhibition of PDGFRbeta	B	Cc1nnc(-c2cn3ncnc(Nc4cnc5[nH]ccc5c4)c3c2C(C)C)o1		CHEMBL258694	=	IC50	nM	389.0	CHEMBL1913	Homo sapiens	IC50	nM	389.0
	2164870	CHEMBL929425	Inhibition of PDGFRbeta	B	Cc1cc2cc(Nc3ncnn4cc(-c5nnc(C)o5)c(C(C)C)c34)cnc2[nH]1		CHEMBL261592	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	nM	2000.0
	2182436	CHEMBL941336	Inhibition of PDGFRbeta at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	2.0	CHEMBL1913	Homo sapiens	INH	%	2.0
	2182826	CHEMBL941452	Inhibition of PDGFRbeta at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	-4.0	CHEMBL1913	Homo sapiens	INH	%	-4.0
	2197999	CHEMBL1005541	Inhibition of Tel-fused PDGFRb kinase-mediated mouse BaF3 cell proliferation	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	3220.0	CHEMBL1913	Homo sapiens	IC50	uM	3.22
	2199104	CHEMBL996037	Inhibition of PDGFRbeta	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	IC50	nM	3000.0	CHEMBL1913	Homo sapiens	IC50	uM	3.0
	2206808	CHEMBL973097	Inhibition of PDGFRbeta by cellular assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	0.2	CHEMBL1913	Homo sapiens	Kd	nM	0.2
	2206899	CHEMBL973097	Inhibition of PDGFRbeta by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	6.0	CHEMBL1913	Homo sapiens	EC50	nM	6.0
	2206922	CHEMBL973097	Inhibition of PDGFRbeta by cellular assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	41.0	CHEMBL1913	Homo sapiens	Kd	nM	41.0
	2206950	CHEMBL973097	Inhibition of PDGFRbeta by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL1913	Homo sapiens	EC50	uM	1.0
	2206978	CHEMBL966751	Inhibition of PDGFRbeta	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	2239378	CHEMBL980067	Inhibition of PDGFRbeta assessed as residual enzyme activity at 1 uM	B	Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1		CHEMBL462132	=	Activity	%	45.0	CHEMBL1913	Homo sapiens	Activity	%	45.0
	2250211	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(C(=O)NCc6ccccc6)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL526507	=	IC50	nM	0.1	CHEMBL1913	Homo sapiens	IC50	uM	0.0001
	2250212	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCCC(Oc2cccc3[nH]c(=O)c(-c4nc5ccccc5[nH]4)c(N)c23)C1		CHEMBL495749	=	IC50	nM	0.1	CHEMBL1913	Homo sapiens	IC50	uM	0.0001
	2250213	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CCC1CCN(C)C(Nc2c(-c3nc4ccccc4[nH]3)c(=O)[nH]c3ccccc23)C1		CHEMBL495984	=	IC50	nM	0.2	CHEMBL1913	Homo sapiens	IC50	uM	0.0002
	2250214	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5c(Cl)cccc5[nH]c4=O)nc3c2)CC1		CHEMBL495762	=	IC50	nM	0.3	CHEMBL1913	Homo sapiens	IC50	uM	0.0003
	2250215	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2cccc3[nH]c(=O)c(-c4nc5ccccc5[nH]4)c(N)c23)CC1		CHEMBL498551	=	IC50	nM	0.3	CHEMBL1913	Homo sapiens	IC50	uM	0.0003
	2250216	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5ccc(F)cc5[nH]c4=O)nc3c2)CC1		CHEMBL498013	=	IC50	nM	0.4	CHEMBL1913	Homo sapiens	IC50	uM	0.0004
	2250217	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(NCc6ccccc6)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL495735	=	IC50	nM	0.6	CHEMBL1913	Homo sapiens	IC50	uM	0.0006
	2250218	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Cc1cccc2[nH]c(=O)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(N)c12		CHEMBL495763	=	IC50	nM	0.7	CHEMBL1913	Homo sapiens	IC50	uM	0.0007
	2250219	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	O=c1[nH]c2ccccc2c(NCC2CCNCC2)c1-c1nc2ccccc2[nH]1		CHEMBL526285	=	IC50	nM	0.9	CHEMBL1913	Homo sapiens	IC50	uM	0.0009
	2250220	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(C(=O)c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL498214	=	IC50	nM	0.9	CHEMBL1913	Homo sapiens	IC50	uM	0.0009
	2250221	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN(C)CC(=O)N(C)c1ccc2[nH]c(-c3c(N)c4ccccc4[nH]c3=O)nc2c1		CHEMBL495962	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	2250222	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(F)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL496763	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	2250223	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL204427	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	2250224	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(Cc2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL495961	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	2250225	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CNc1cccc2[nH]c(=O)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(N)c12		CHEMBL496762	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	2250226	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(F)c(F)cc5[nH]c4=O)nc3c2)CC1		CHEMBL522732	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	2250227	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN(C)[C@H]1CCN(c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)C1		CHEMBL496150	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	2250228	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Nc1c(-c2nc3cc(N4CCOCC4)ccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL204426	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	2250229	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCCN(c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL523071	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	2250230	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Nc1c(-c2nc3cc(OCCN4CCOCC4)ccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL526658	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	2250231	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	2250232	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5c(F)cc(F)cc5[nH]c4=O)nc3c2)CC1		CHEMBL498347	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	2250233	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(N)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL496764	=	IC50	nM	7.0	CHEMBL1913	Homo sapiens	IC50	uM	0.007
	2250234	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(N(C)C)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL495529	=	IC50	nM	7.0	CHEMBL1913	Homo sapiens	IC50	uM	0.007
	2250235	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(Cl)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL523745	=	IC50	nM	8.0	CHEMBL1913	Homo sapiens	IC50	uM	0.008
	2250236	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CNc1ccc2c(N)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(=O)[nH]c2c1		CHEMBL449593	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	uM	0.009
	2250237	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Nc1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL383417	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	2250238	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Cc1cc2nc(-c3c(N)c4ccccc4[nH]c3=O)[nH]c2cc1C		CHEMBL498206	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	uM	0.012
	2250239	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cccc(F)c5[nH]c4=O)nc3c2)CC1		CHEMBL526836	=	IC50	nM	14.0	CHEMBL1913	Homo sapiens	IC50	uM	0.014
	2250240	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	O=c1[nH]c2ccccc2c(O)c1-c1nc2ccccc2[nH]1		CHEMBL377345	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	2250241	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CNc1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL521552	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	uM	0.03
	2250242	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Cc1ccc2[nH]c(-c3c(N)c4ccccc4[nH]c3=O)nc2c1		CHEMBL498205	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	uM	0.03
	2250243	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(F)c(N(C)C)cc5[nH]c4=O)nc3c2)CC1		CHEMBL498348	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	uM	0.03
	2250244	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(NC(=O)c6ccccc6)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL495530	=	IC50	nM	39.0	CHEMBL1913	Homo sapiens	IC50	uM	0.039
	2250245	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	O=c1[nH]c2ccccc2cc1-c1nc2ccccc2[nH]1		CHEMBL118440	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	uM	0.07
	2250246	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN(C)c1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL495983	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	uM	0.07
	2250247	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	CN1CCN(c2ccc3[nH]c(=O)c(-c4nc5ccccc5[nH]4)c(N)c3c2)CC1		CHEMBL457985	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	uM	0.13
	2250248	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Cn1c(-c2c(O)c3ccccc3[nH]c2=O)nc2ccccc21		CHEMBL496172	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	2250249	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Cn1c(=O)c(-c2nc3ccccc3[nH]2)c(O)c2ccccc21		CHEMBL523571	=	IC50	nM	19000.0	CHEMBL1913	Homo sapiens	IC50	uM	19.0
	2250250	CHEMBL1011001	Inhibition of human recombinant PDGFRbeta	B	Cn1c(-c2c(O)c3ccccc3n(C)c2=O)nc2ccccc21		CHEMBL496173	>	IC50	nM	25000.0	CHEMBL1913	Homo sapiens	IC50	uM	25.0
	2250291	CHEMBL1011980	Inhibition of PDGFRbeta phosphorylation expressed in human KM12L4A cells Western blot analysis	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	EC50	nM	51.0	CHEMBL1913	Homo sapiens	EC50	uM	0.051
	2270430	CHEMBL964946	Inhibition of PDGFRbeta by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]ccc23)cc(-c2nc3ccccc3s2)c1		CHEMBL490555	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	2270431	CHEMBL964946	Inhibition of PDGFRbeta by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3cccc(-c4nc5ccccc5s4)c3)n2)n[nH]1		CHEMBL491686	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	2270485	CHEMBL964946	Inhibition of PDGFRbeta by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC		CHEMBL301018	=	IC50	nM	3000.0	CHEMBL1913	Homo sapiens	IC50	uM	3.0
	2270527	CHEMBL964946	Inhibition of PDGFRbeta by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3cccc(-c4nc5ccccc5s4)c3)c2cc1OC		CHEMBL522785	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	2270532	CHEMBL964946	Inhibition of PDGFRbeta by virtual HTS assay	B	O=C(NC(=S)Nc1ccc(O)c(-c2nc3ccccc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL460746	=	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
Not Determined	2270580	CHEMBL964946	Inhibition of PDGFRbeta by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]cnc23)cc(-c2nc3ccccc3s2)c1		CHEMBL443906		IC50			CHEMBL1913	Homo sapiens	IC50		
	2273593	CHEMBL960867	Inhibition of human PDGFR1beta	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1615278	=	IC50	nM	110.0	CHEMBL1913	Homo sapiens	IC50	nM	110.0
	2273594	CHEMBL960867	Inhibition of human PDGFR1beta	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	IC50	nM	420.0	CHEMBL1913	Homo sapiens	IC50	nM	420.0
	2280501	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	240.0	CHEMBL1913	Homo sapiens	IC50	uM	0.24
	2280502	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Nc1ccccc1NC(=O)c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)cn3)c2)cc1		CHEMBL473826	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	2280508	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(C(=O)NO)cc2)cc1Nc1ncc(-c2cccnc2)s1		CHEMBL521652	=	IC50	nM	2100.0	CHEMBL1913	Homo sapiens	IC50	uM	2.1
	2280509	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(C(=O)Nc3ccccc3N)cc2)cc1Nc1ncc(-c2cccnc2)cn1		CHEMBL475820	=	IC50	nM	2600.0	CHEMBL1913	Homo sapiens	IC50	uM	2.6
	2280510	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NCc2ccc(C(=O)Nc3ccccc3N)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL475796	=	IC50	nM	2700.0	CHEMBL1913	Homo sapiens	IC50	uM	2.7
	2280511	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(/C=C/C(=O)NO)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1080580	=	IC50	nM	3900.0	CHEMBL1913	Homo sapiens	IC50	uM	3.9
	2280515	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NCc2ccc(/C=C/C(=O)NO)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL514351	=	IC50	nM	4600.0	CHEMBL1913	Homo sapiens	IC50	uM	4.6
	2280517	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(C(=O)Nc3ccccc3N)s2)cc1Nc1ncc(-c2cccnc2)cn1		CHEMBL473825	=	IC50	nM	5200.0	CHEMBL1913	Homo sapiens	IC50	uM	5.2
	2280519	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(/C=C/C(=O)NO)s2)cc1Nc1ncc(-c2cccnc2)s1		CHEMBL493315	=	IC50	nM	6200.0	CHEMBL1913	Homo sapiens	IC50	uM	6.2
	2280522	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	CN(C(=O)c1ccc(C(=O)Nc2ccccc2N)cc1)c1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL514511	=	IC50	nM	7300.0	CHEMBL1913	Homo sapiens	IC50	uM	7.3
	2280524	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(C(=O)Nc3ccccc3N)nc2)cc1Nc1ncc(-c2cccnc2)cn1		CHEMBL515258	=	IC50	nM	7800.0	CHEMBL1913	Homo sapiens	IC50	uM	7.8
	2280528	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(C(=O)Nc3ccccc3N)cc2)cc1Nc1ncc(-c2cccnc2)s1		CHEMBL515432	=	IC50	nM	8700.0	CHEMBL1913	Homo sapiens	IC50	uM	8.7
	2280538	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(C(=O)Nc3ccccc3N)s2)cc1Nc1ncc(-c2cccnc2)s1		CHEMBL515109	=	IC50	nM	11000.0	CHEMBL1913	Homo sapiens	IC50	uM	11.0
	2280540	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	O=C(/C=C/c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)s3)c2)s1)NO		CHEMBL523684	=	IC50	nM	11000.0	CHEMBL1913	Homo sapiens	IC50	uM	11.0
	2280543	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Nc1ccccc1NC(=O)c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)s3)c2)cn1		CHEMBL474863	=	IC50	nM	13000.0	CHEMBL1913	Homo sapiens	IC50	uM	13.0
	2280544	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	O=C(/C=C/c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)s3)c2)cc1)NO		CHEMBL492956	=	IC50	nM	13000.0	CHEMBL1913	Homo sapiens	IC50	uM	13.0
	2280552	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Nc1ccccc1NC(=O)c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)s3)c2)s1		CHEMBL474208	=	IC50	nM	28000.0	CHEMBL1913	Homo sapiens	IC50	uM	28.0
	2280556	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	O=C(NO)c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)s3)c2)cc1		CHEMBL475051	=	IC50	nM	40000.0	CHEMBL1913	Homo sapiens	IC50	uM	40.0
	2280559	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Cc1ccc(NC(=O)c2ccc(C(=O)Nc3ccccc3N)nc2)cc1Nc1ncc(-c2cccnc2)s1		CHEMBL474046	=	IC50	nM	47000.0	CHEMBL1913	Homo sapiens	IC50	uM	47.0
	2280560	CHEMBL1022424	Inhibition of PDGFRbeta by liquid scintillation counting	B	Nc1ccccc1NC(=O)c1ccc(C(=O)Nc2cccc(Nc3ncc(-c4cccnc4)s3)c2)cc1		CHEMBL474015	=	IC50	nM	71000.0	CHEMBL1913	Homo sapiens	IC50	uM	71.0
Not Active	2301936	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	2301960	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	2301984	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	2302008	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	2302032	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	2302056	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	2302080	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	2302104	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	2302136	CHEMBL949893	Inhibition of PDGFRbeta up to 100 uM	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	2339011	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1		CHEMBL485320	=	IC50	nM	11800.0	CHEMBL1913	Homo sapiens	IC50	uM	11.8
	2339051	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2ccc3[nH]ccc3c2)c2cc(CCc3ccccc3)[nH]c2n1		CHEMBL499067	=	IC50	nM	77400.0	CHEMBL1913	Homo sapiens	IC50	uM	77.4
	2339052	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1		CHEMBL482715	=	IC50	nM	90000.0	CHEMBL1913	Homo sapiens	IC50	uM	90.0
	2339053	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2ccc(Cl)cc2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL519147	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	2339054	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483313	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	2339055	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL520803	=	IC50	nM	100400.0	CHEMBL1913	Homo sapiens	IC50	uM	100.4
	2339056	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483312	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	2339057	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL504416	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	2339058	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483108	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	2339059	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	IC50	nM	6200.0	CHEMBL1913	Homo sapiens	IC50	uM	6.2
	2339060	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccc4ccccc4c3)[nH]c2n1		CHEMBL484109	=	IC50	nM	13700.0	CHEMBL1913	Homo sapiens	IC50	uM	13.7
	2339061	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3cccc4ccccc34)[nH]c2n1		CHEMBL484108	=	IC50	nM	11000.0	CHEMBL1913	Homo sapiens	IC50	uM	11.0
	2339062	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3Cl)[nH]c2n1		CHEMBL482489	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	2339063	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	COc1ccc(CCc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)cc1		CHEMBL485321	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	2339105	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc4ccccc4c3)[nH]c2n1		CHEMBL502015	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	2339106	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3cccc4ccccc34)[nH]c2n1		CHEMBL474538	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	2339107	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3Cl)[nH]c2n1		CHEMBL499345	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	2339108	CHEMBL957464	Inhibition of PDGFRbeta expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3)[nH]c2n1		CHEMBL499344	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	2341400	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	2341404	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	1.0	CHEMBL1913	Homo sapiens	INH	%	1.0
	2341444	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	99.0	CHEMBL1913	Homo sapiens	INH	%	99.0
	2341485	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	2341526	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	89.0	CHEMBL1913	Homo sapiens	INH	%	89.0
	2341567	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	2341608	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	2341649	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	14.0	CHEMBL1913	Homo sapiens	INH	%	14.0
	2341690	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	INH	%	8.0
	2341731	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	13.0	CHEMBL1913	Homo sapiens	INH	%	13.0
	2341772	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	48.0	CHEMBL1913	Homo sapiens	INH	%	48.0
	2341813	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	22.0	CHEMBL1913	Homo sapiens	INH	%	22.0
	2341854	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	24.0	CHEMBL1913	Homo sapiens	INH	%	24.0
	2341895	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	85.0	CHEMBL1913	Homo sapiens	INH	%	85.0
	2341936	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	2341977	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	3.0	CHEMBL1913	Homo sapiens	INH	%	3.0
	2342018	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	93.0	CHEMBL1913	Homo sapiens	INH	%	93.0
	2342059	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	2342100	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	26.0	CHEMBL1913	Homo sapiens	INH	%	26.0
	2342141	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	32.0	CHEMBL1913	Homo sapiens	INH	%	32.0
	2342182	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	37.0	CHEMBL1913	Homo sapiens	INH	%	37.0
	2342210	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	23.0	CHEMBL1913	Homo sapiens	INH	%	23.0
	2342266	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	42.0	CHEMBL1913	Homo sapiens	INH	%	42.0
	2342305	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	33.0	CHEMBL1913	Homo sapiens	INH	%	33.0
	2342346	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	91.0	CHEMBL1913	Homo sapiens	INH	%	91.0
	2342387	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	7.0	CHEMBL1913	Homo sapiens	INH	%	7.0
	2342428	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	2342469	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	INH	%	8.0
	2342510	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	30.0	CHEMBL1913	Homo sapiens	INH	%	30.0
	2342783	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	98.0	CHEMBL1913	Homo sapiens	INH	%	98.0
	2342816	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	2343091	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	2343115	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	2343161	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	2343185	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	7.0	CHEMBL1913	Homo sapiens	INH	%	7.0
	2343209	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	13.0	CHEMBL1913	Homo sapiens	INH	%	13.0
	2343233	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	2343257	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	2343281	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	INH	%	8.0
	2343679	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	2343700	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	11.0	CHEMBL1913	Homo sapiens	INH	%	11.0
	2343722	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	2343744	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	2343766	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	2343788	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	7.0	CHEMBL1913	Homo sapiens	INH	%	7.0
	2343808	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	7.0	CHEMBL1913	Homo sapiens	INH	%	7.0
	2343831	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	2343853	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	2343875	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	2343897	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	INH	%	8.0
	2343919	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	2343941	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	2343962	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	9.0	CHEMBL1913	Homo sapiens	INH	%	9.0
	2343984	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	2344007	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	11.0	CHEMBL1913	Homo sapiens	INH	%	11.0
	2344714	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	2344737	CHEMBL965680	Inhibition of PDGFRbeta at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	14.0	CHEMBL1913	Homo sapiens	INH	%	14.0
	2366699	CHEMBL1035802	Inhibition of PDGFRbeta at 1 uM relative to control	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	2366701	CHEMBL1035804	Inhibition of PDGFRbeta	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	IC50	nM	830.0	CHEMBL1913	Homo sapiens	IC50	uM	0.83
	2379762	CHEMBL996168	Inhibition of human PDGFRbeta expressed in baculovirus insect cell system	B	COc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460989	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	2379772	CHEMBL996168	Inhibition of human PDGFRbeta expressed in baculovirus insect cell system	B	CC(C)Oc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460990	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	2389233	CHEMBL944266	Inhibition of PDGFRbeta at 10 uM	B	O=c1cc2oc3cc(O)c(O)cc3c(-c3cccc(Cl)c3Cl)c-2cc1O		CHEMBL473332	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	INH	%	8.0
	2394485	CHEMBL943608	Inhibition of PDGFRbeta by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(C4CCN(C)CC4)cc3)ncc2c1=O		CHEMBL492809	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	2394492	CHEMBL943608	Inhibition of PDGFRbeta by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(CCN4CCN(C)CC4)cc3)ncc2c1=O		CHEMBL505830	=	IC50	nM	5300.0	CHEMBL1913	Homo sapiens	IC50	uM	5.3
	2394502	CHEMBL943608	Inhibition of PDGFRbeta by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(C4CCN(CC(=O)O)CC4)cc3)ncc2c1=O		CHEMBL452965	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	2394503	CHEMBL943608	Inhibition of PDGFRbeta by fluorescence polarization competition immunoassay	B	CN1CCN(CCc2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL403776	>	IC50	nM	42000.0	CHEMBL1913	Homo sapiens	IC50	uM	42.0
	2395460	CHEMBL963588	Binding affinity to PDGFRB at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	2395476	CHEMBL963604	Inhibition of PDGFRbeta by Ambit binding assay	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	500.0	CHEMBL1913	Homo sapiens	IC50	nM	500.0
	2397098	CHEMBL946290	Inhibition of PDGFRbeta	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
	2419143	CHEMBL1019631	Inhibition of PDGFRB at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	32.0	CHEMBL1913	Homo sapiens	INH	%	32.0
	2461801	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	0.89	CHEMBL1913	Homo sapiens	IC50	10'-7g/ml	8.9
	2461866	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	=	IC50	ug.mL-1	7.6	CHEMBL1913	Homo sapiens	IC50	10'-6g/ml	7.6
	2461867	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	>	IC50	ug.mL-1	10.0	CHEMBL1913	Homo sapiens	IC50	10'-5g/ml	1.0
	2461868	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL1913	Homo sapiens	IC50	10'-5g/ml	1.0
	2461869	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL1913	Homo sapiens	IC50	10'-5g/ml	1.0
	2461870	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	=	IC50	ug.mL-1	5.8	CHEMBL1913	Homo sapiens	IC50	10'-6g/ml	5.8
	2461871	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	=	IC50	ug.mL-1	5.9	CHEMBL1913	Homo sapiens	IC50	10'-6g/ml	5.9
	2461872	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	1.8	CHEMBL1913	Homo sapiens	IC50	10'-6g/ml	1.8
	2461873	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	1.8	CHEMBL1913	Homo sapiens	IC50	10'-6g/ml	1.8
	2461874	CHEMBL962877	Inhibition of recombinant PDGFRbeta	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	1.3	CHEMBL1913	Homo sapiens	IC50	10'-6g/ml	1.3
	2465006	CHEMBL957982	Inhibition of human recombinant PDGFRbeta	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	680.0	CHEMBL1913	Homo sapiens	IC50	uM	0.68
	2465117	CHEMBL957982	Inhibition of human recombinant PDGFRbeta	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL509435	=	IC50	nM	45000.0	CHEMBL1913	Homo sapiens	IC50	uM	45.0
	2465118	CHEMBL957982	Inhibition of human recombinant PDGFRbeta	B	COc1cc(C2=C(c3cn(CC(O)CO)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453593	=	IC50	nM	40000.0	CHEMBL1913	Homo sapiens	IC50	uM	40.0
	2465119	CHEMBL957982	Inhibition of human recombinant PDGFRbeta	B	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488646	=	IC50	nM	38000.0	CHEMBL1913	Homo sapiens	IC50	uM	38.0
	2465120	CHEMBL957982	Inhibition of human recombinant PDGFRbeta	B	COc1cc(C2=C(c3c[nH]c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL529663	=	IC50	nM	11000.0	CHEMBL1913	Homo sapiens	IC50	uM	11.0
	2470345	CHEMBL995024	Inhibition of PDGFRB at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	2476631	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	1.4	CHEMBL1913	Homo sapiens	Activity	%	1.4
	2476834	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582	=	Activity	%	19.0	CHEMBL1913	Homo sapiens	Activity	%	19.0
Not Evaluated	2478673	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL1913	Homo sapiens	Activity		
Active	2478876	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL1913	Homo sapiens	Activity		
	2479564	CHEMBL988957	Binding affinity to human PDGFRB	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Kd	nM	42.0	CHEMBL1913	Homo sapiens	Kd	nM	42.0
	2479731	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	3.5	CHEMBL1913	Homo sapiens	Activity	%	3.5
Active	2480730	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL1913	Homo sapiens	Activity		
	2488848	CHEMBL1028055	Inhibition of PDGFRbeta	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	2488853	CHEMBL1028055	Inhibition of PDGFRbeta	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)NNc4ccccc4)cc32)c(C)c1CCC(=O)O		CHEMBL480356	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM	0.04
	2488854	CHEMBL1028055	Inhibition of PDGFRbeta	B	COc1cc(OC)cc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL231526	=	IC50	nM	780.0	CHEMBL1913	Homo sapiens	IC50	uM	0.78
	2505607	CHEMBL941566	Inhibition of PDGFR1beta	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	IC50	nM	160.0	CHEMBL1913	Homo sapiens	IC50	nM	160.0
	2506963	CHEMBL942621	Inhibition of PDGFRbeta at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	2506964	CHEMBL942621	Inhibition of PDGFRbeta at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	2507024	CHEMBL947773	Inhibition of PDGFRb	B	Nc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)cc1Cl		CHEMBL475817	=	IC50	nM	31.0	CHEMBL1913	Homo sapiens	IC50	uM	0.031
	2511945	CHEMBL969685	Inhibition of human PDGFRbeta at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	111.0	CHEMBL1913	Homo sapiens	Activity	%	111.0
	2526385	CHEMBL981418	Binding affinity to PDGFRB	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	41.0	CHEMBL1913	Homo sapiens	Kd	nM	41.0
	2561552	CHEMBL981078	Inhibition of human PDGFRbeta	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	84.0	CHEMBL1913	Homo sapiens	IC50	nM	84.0
	2567270	CHEMBL975457	Inhibition of human PDGFRbeta kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	103.0	CHEMBL1913	Homo sapiens	Activity	%	103.0
Not Evaluated	2577352	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL1913	Homo sapiens	Activity		
Active	2578584	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL1913	Homo sapiens	Activity		
	2582022	CHEMBL962239	Inhibition of human PDGFRbeta	B	N=C(N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL489083	=	IC50	nM	4200.0	CHEMBL1913	Homo sapiens	IC50	uM	4.2
	2582038	CHEMBL962239	Inhibition of human PDGFRbeta	B	CNC(=N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL488271	=	IC50	nM	6700.0	CHEMBL1913	Homo sapiens	IC50	uM	6.7
	2593557	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	4.5	CHEMBL1913	Homo sapiens	Activity	%	4.5
Active	2593760	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL1913	Homo sapiens	Activity		
Active	2594026	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL1913	Homo sapiens	Activity		
	2594969	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Activity	%	30.0	CHEMBL1913	Homo sapiens	Activity	%	30.0
	2595238	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	0.1	CHEMBL1913	Homo sapiens	Activity	%	0.1
	2596166	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275	=	Activity	%	0.1	CHEMBL1913	Homo sapiens	Activity	%	0.1
	2596369	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	0.4	CHEMBL1913	Homo sapiens	Activity	%	0.4
	2597638	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	5.3	CHEMBL1913	Homo sapiens	Activity	%	5.3
Not Evaluated	2597841	CHEMBL1035895	Binding affinity to human PDGFRB at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL1913	Homo sapiens	Activity		
	2603057	CHEMBL1023852	Inhibition of PDGFRbeta	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	=	Kd	nM	2.3	CHEMBL1913	Homo sapiens	Kd	nM	2.3
	2671882	CHEMBL1026237	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	>	IC50	ug.mL-1	10.0	CHEMBL1913	Homo sapiens	IC50	ug ml-1	10.0
	2671883	CHEMBL1026237	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	>	IC50	ug.mL-1	10.0	CHEMBL1913	Homo sapiens	IC50	ug ml-1	10.0
	2671884	CHEMBL1026237	Inhibition of recombinant PDGFRbeta	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	>	IC50	ug.mL-1	10.0	CHEMBL1913	Homo sapiens	IC50	ug ml-1	10.0
	2672250	CHEMBL1026237	Inhibition of recombinant PDGFRbeta	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	=	IC50	ug.mL-1	6.4	CHEMBL1913	Homo sapiens	IC50	ug ml-1	6.4
	2691867	CHEMBL1054691	Inhibition of human PDGFRbeta assessed as remaining activity at 10 uM	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	Activity	%	114.0	CHEMBL1913	Homo sapiens	Activity	%	114.0
Active	2719549	CHEMBL1059999	Inhibition of PDGFRbeta at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	2721680	CHEMBL1054310	Inhibition of PDGFRbeta at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	2897248	CHEMBL1062828	Percent residual PDGFRbeta activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	80.0	CHEMBL1913	Homo sapiens	Activity	%	80.0
	2899063	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1.9	CHEMBL1913	Homo sapiens	Kd	nM	1.9
	2899064	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	9.1	CHEMBL1913	Homo sapiens	Kd	nM	9.1
	2899065	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	8.1	CHEMBL1913	Homo sapiens	Kd	nM	8.1
	2899066	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	41.0	CHEMBL1913	Homo sapiens	Kd	nM	41.0
	2899067	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1100.0	CHEMBL1913	Homo sapiens	Kd	nM	1100.0
	2899068	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899069	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3.8	CHEMBL1913	Homo sapiens	Kd	nM	3.8
	2899070	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	240.0	CHEMBL1913	Homo sapiens	Kd	nM	240.0
	2899071	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	7500.0	CHEMBL1913	Homo sapiens	Kd	nM	7500.0
	2899072	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899073	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899074	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.63	CHEMBL1913	Homo sapiens	Kd	nM	0.63
	2899075	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899076	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1400.0	CHEMBL1913	Homo sapiens	Kd	nM	1400.0
	2899077	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899078	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899079	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899080	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2.0	CHEMBL1913	Homo sapiens	Kd	nM	2.0
	2899081	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	14.0	CHEMBL1913	Homo sapiens	Kd	nM	14.0
	2899082	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	910.0	CHEMBL1913	Homo sapiens	Kd	nM	910.0
	2899083	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899084	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899085	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	4.5	CHEMBL1913	Homo sapiens	Kd	nM	4.5
	2899086	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899087	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899088	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	110.0	CHEMBL1913	Homo sapiens	Kd	nM	110.0
	2899089	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	25.0	CHEMBL1913	Homo sapiens	Kd	nM	25.0
	2899090	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899091	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899092	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899093	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	uM	10.0
	2899094	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	37.0	CHEMBL1913	Homo sapiens	Kd	nM	37.0
	2899095	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.8	CHEMBL1913	Homo sapiens	Kd	nM	1.8
	2899096	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	0.29	CHEMBL1913	Homo sapiens	Kd	nM	0.29
	2899097	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	0.075	CHEMBL1913	Homo sapiens	Kd	nM	0.075
	2899098	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	310.0	CHEMBL1913	Homo sapiens	Kd	nM	310.0
	2899099	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	8400.0	CHEMBL1913	Homo sapiens	Kd	nM	8400.0
	2899100	CHEMBL1051304	Binding constant for PDGFRB kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	88.0	CHEMBL1913	Homo sapiens	Kd	nM	88.0
	2921224	CHEMBL1057579	Inhibition of PDGFRB assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	78.0	CHEMBL1913	Homo sapiens	Activity	%	78.0
	2924058	CHEMBL1041539	Inhibition of PDGFRbeta by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	2924059	CHEMBL1041539	Inhibition of PDGFRbeta by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	2928490	CHEMBL1043882	Binding affinity to PDGFRB assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	53.0	CHEMBL1913	Homo sapiens	Activity	%	53.0
	2930030	CHEMBL1057694	Binding affinity to PDGFRbeta	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	7.7	CHEMBL1913	Homo sapiens	Kd	nM	7.7
	2943693	CHEMBL1044066	Inhibition of PDGFRbeta	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	microM	10.0
	2943705	CHEMBL1044066	Inhibition of PDGFRbeta	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	microM	10.0
	2945997	CHEMBL1054430	Inhibition of PDGFRbeta at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	2947583	CHEMBL1047364	Inhibition of PDGFRbeta at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	2992232	CHEMBL1044532	Inhibition of human PDGFRbeta at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	3052437	CHEMBL1070472	Residual activity of PDGFRbeta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL1913	Homo sapiens	Residual activity	%	95.0
	3052689	CHEMBL1041176	Residual activity of PDGFRbeta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	88.0	CHEMBL1913	Homo sapiens	Residual activity	%	88.0
	3053998	CHEMBL1050329	Residual activity of PDGFRbeta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	33.0	CHEMBL1913	Homo sapiens	Residual activity	%	33.0
	3054250	CHEMBL1070472	Residual activity of PDGFRbeta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	94.0	CHEMBL1913	Homo sapiens	Residual activity	%	94.0
	3055537	CHEMBL1041176	Residual activity of PDGFRbeta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	78.0	CHEMBL1913	Homo sapiens	Residual activity	%	78.0
	3055908	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	2400.0	CHEMBL1913	Homo sapiens	IC50	uM	2.4
	3055928	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	CCC(C)C(Cc1coc2nc(N)nc(N)c12)c1ccccc1OC		CHEMBL594339	=	IC50	nM	17400.0	CHEMBL1913	Homo sapiens	IC50	uM	17.4
	3055929	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	COc1ccccc1/C(C)=C/c1coc2nc(N)nc(N)c12		CHEMBL610181	=	IC50	nM	12800.0	CHEMBL1913	Homo sapiens	IC50	uM	12.8
	3055942	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	CCCC(=Cc1coc2nc(=N)[nH]c(N)c12)c1ccccc1OC		CHEMBL595497	=	IC50	nM	88200.0	CHEMBL1913	Homo sapiens	IC50	uM	88.2
	3055943	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	COc1ccccc1C(Cc1coc2nc(N)nc(N)c12)C(C)C	Outside typical range	CHEMBL595757	=	IC50	nM	118000.0	CHEMBL1913	Homo sapiens	IC50	uM	118.0
	3056842	CHEMBL1050329	Residual activity of PDGFRbeta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	21.0	CHEMBL1913	Homo sapiens	Residual activity	%	21.0
	3057094	CHEMBL1070472	Residual activity of PDGFRbeta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL1913	Homo sapiens	Residual activity	%	95.0
	3057170	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	COc1ccccc1/C(C)=C\c1coc2nc(N)nc(N)c12	Outside typical range	CHEMBL606039	=	IC50	nM	151900.0	CHEMBL1913	Homo sapiens	IC50	uM	151.9
	3057178	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	COc1ccccc1C(=Cc1coc2nc(=N)[nH]c(N)c12)C(C)C	Outside typical range	CHEMBL594810	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3057179	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	COc1ccccc1C(=Cc1coc2nc(=N)[nH]c(N)c12)C1CC1	Outside typical range	CHEMBL594320	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3057180	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	CCCCC(=Cc1coc2nc(=N)[nH]c(N)c12)c1ccccc1OC	Outside typical range	CHEMBL604879	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3057181	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	COc1ccccc1C(=Cc1coc2nc(=N)[nH]c(N)c12)CC(C)C	Outside typical range	CHEMBL593154	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3057182	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	CCC(C)C(=Cc1coc2nc(=N)[nH]c(N)c12)c1ccccc1OC	Outside typical range	CHEMBL603849	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3057183	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	CCCC(Cc1coc2nc(N)nc(N)c12)c1ccccc1OC	Outside typical range	CHEMBL605413	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3057184	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	COc1ccccc1C(Cc1coc2nc(N)nc(N)c12)C1CC1	Outside typical range	CHEMBL603198	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3057185	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	CCCCC(Cc1coc2nc(N)nc(N)c12)c1ccccc1OC	Outside typical range	CHEMBL594790	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3057186	CHEMBL1038899	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine ELISA	B	COc1ccccc1C(Cc1coc2nc(N)nc(N)c12)CC(C)C	Outside typical range	CHEMBL606362	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	3058414	CHEMBL1041176	Residual activity of PDGFRbeta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	78.0	CHEMBL1913	Homo sapiens	Residual activity	%	78.0
	3059698	CHEMBL1050329	Residual activity of PDGFRbeta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	43.0	CHEMBL1913	Homo sapiens	Residual activity	%	43.0
Not Determined	3059801	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059802	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059803	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059804	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059805	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059806	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059807	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059808	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059809	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908		EC50			CHEMBL1913	Homo sapiens	EC50		
Not Determined	3059810	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483		EC50			CHEMBL1913	Homo sapiens	EC50		
	3059811	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	EC50	nM	170.0	CHEMBL1913	Homo sapiens	EC50	uM	0.17
	3059812	CHEMBL1073386	Inhibition of PDGFRbeta in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	EC50	nM	2000.0	CHEMBL1913	Homo sapiens	EC50	uM	2.0
	3062497	CHEMBL1037984	Binding affinity to human PDGFRbeta at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	3.2	CHEMBL1913	Homo sapiens	Activity	%	3.2
	3063632	CHEMBL1068409	Binding affinity to human PDGFRbeta at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	0.05	CHEMBL1913	Homo sapiens	Activity	%	0.05
	3063722	CHEMBL1042484	Binding affinity to human PDGFRbeta at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	23.0	CHEMBL1913	Homo sapiens	Activity	%	23.0
	3066877	CHEMBL1066083	Inhibition of PDGFRB at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	15.0	CHEMBL1913	Homo sapiens	INH	%	15.0
	3066967	CHEMBL1066083	Inhibition of PDGFRB at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	49.0	CHEMBL1913	Homo sapiens	INH	%	49.0
	3072731	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595615	=	IC50	nM	1400.0	CHEMBL1913	Homo sapiens	IC50	uM	1.4
	3072732	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3C)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595406	=	IC50	nM	6700.0	CHEMBL1913	Homo sapiens	IC50	uM	6.7
	3072733	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3O)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595142	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072734	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221	=	IC50	nM	5100.0	CHEMBL1913	Homo sapiens	IC50	uM	5.1
	3072735	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3OC(F)(F)F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593245	=	IC50	nM	9100.0	CHEMBL1913	Homo sapiens	IC50	uM	9.1
	3072736	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228	=	IC50	nM	4400.0	CHEMBL1913	Homo sapiens	IC50	uM	4.4
	3072737	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(C)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596087	=	IC50	nM	7900.0	CHEMBL1913	Homo sapiens	IC50	uM	7.9
	3072738	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466	=	IC50	nM	4500.0	CHEMBL1913	Homo sapiens	IC50	uM	4.5
	3072739	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860	=	IC50	nM	2100.0	CHEMBL1913	Homo sapiens	IC50	uM	2.1
	3072740	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987	=	IC50	nM	2100.0	CHEMBL1913	Homo sapiens	IC50	uM	2.1
	3072741	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274	=	IC50	nM	3600.0	CHEMBL1913	Homo sapiens	IC50	uM	3.6
	3072742	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1ccc2nc(-c3ccc(Nc4ncnc5cc(OCCCN6CCN(C)CC6)c(OC)cc45)cc3)sc2c1		CHEMBL593306	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072743	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992	=	IC50	nM	3400.0	CHEMBL1913	Homo sapiens	IC50	uM	3.4
	3072744	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593275	=	IC50	nM	8000.0	CHEMBL1913	Homo sapiens	IC50	uM	8.0
	3072745	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072746	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908	=	IC50	nM	8200.0	CHEMBL1913	Homo sapiens	IC50	uM	8.2
	3072747	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593909	=	IC50	nM	9200.0	CHEMBL1913	Homo sapiens	IC50	uM	9.2
	3072748	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(N(C)c3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593770	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072749	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	IC50	nM	6100.0	CHEMBL1913	Homo sapiens	IC50	uM	6.1
	3072750	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	IC50	nM	3500.0	CHEMBL1913	Homo sapiens	IC50	uM	3.5
	3072751	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	IC50	nM	7700.0	CHEMBL1913	Homo sapiens	IC50	uM	7.7
	3072828	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593292	=	IC50	nM	3800.0	CHEMBL1913	Homo sapiens	IC50	uM	3.8
	3072829	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OCCCN1CCN(C)CC1		CHEMBL595374	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072830	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OCCCN1CCN(C)CC1		CHEMBL593294	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072831	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OCCCN3CCN(C)CC3)cc12		CHEMBL593910	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072832	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3F)c2cc1OCCCN1CCN(C)CC1		CHEMBL594661	=	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072833	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL604485	=	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3072834	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593911	=	IC50	nM	3800.0	CHEMBL1913	Homo sapiens	IC50	uM	3.8
	3072835	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593760	=	IC50	nM	8700.0	CHEMBL1913	Homo sapiens	IC50	uM	8.7
	3072836	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL604893	=	IC50	nM	7700.0	CHEMBL1913	Homo sapiens	IC50	uM	7.7
	3072837	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593971	=	IC50	nM	9900.0	CHEMBL1913	Homo sapiens	IC50	uM	9.9
	3072838	CHEMBL1073382	Inhibition of PDGFRbeta by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593905	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	3102196	CHEMBL1070751	Inhibition of PDGFRbeta after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(I)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL597492	=	IC50	nM	858.0	CHEMBL1913	Homo sapiens	IC50	nM	858.0
	3102197	CHEMBL1070751	Inhibition of PDGFRbeta after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL605957	=	IC50	nM	900.0	CHEMBL1913	Homo sapiens	IC50	nM	900.0
	3102198	CHEMBL1070751	Inhibition of PDGFRbeta after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	1867.0	CHEMBL1913	Homo sapiens	IC50	nM	1867.0
	3102199	CHEMBL1070751	Inhibition of PDGFRbeta after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(F)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL606168	=	IC50	nM	2667.0	CHEMBL1913	Homo sapiens	IC50	nM	2667.0
	3123999	CHEMBL1067552	Inhibition of PDGFRbeta	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL597592	=	IC50	nM	1550.0	CHEMBL1913	Homo sapiens	IC50	uM	1.55
	3124000	CHEMBL1067552	Inhibition of PDGFRbeta	B	O=C(Nc1cc(Oc2cccc3[nH]c(=O)[nH]c23)c(F)c(F)c1F)c1cccc(OC(F)(F)F)c1		CHEMBL602123	=	IC50	nM	2390.0	CHEMBL1913	Homo sapiens	IC50	uM	2.39
	3124001	CHEMBL1067552	Inhibition of PDGFRbeta	B	CC(C)(C)c1cc(NC(=O)c2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL598626	=	IC50	nM	7490.0	CHEMBL1913	Homo sapiens	IC50	uM	7.49
	3186219	CHEMBL1110565	Inhibition of PDGFRbeta	B	Cc1ccc(NC(=O)c2ccc(/C=C/C(=O)NO)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1080580	=	IC50	nM	3900.0	CHEMBL1913	Homo sapiens	IC50	uM	3.9
	3186258	CHEMBL1110565	Inhibition of PDGFRbeta	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	55.0	CHEMBL1913	Homo sapiens	IC50	nM	55.0
	3186259	CHEMBL1110565	Inhibition of PDGFRbeta	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	57.0	CHEMBL1913	Homo sapiens	IC50	nM	57.0
	3210391	CHEMBL1109434	Inhibition of PDGFRbeta after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	7700.0	CHEMBL1913	Homo sapiens	IC50	uM	7.7
	3213850	CHEMBL1111266	Inhibition of PDGFRbeta at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	102.0	CHEMBL1913	Homo sapiens	INH	%	102.0
	3224915	CHEMBL1100993	Inhibition of PDGFRbeta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3226161	CHEMBL1112291	Binding affinity to PDGFRbeta	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ncccc3O)cc2)no1		CHEMBL1079545	=	Kd	nM	2.6	CHEMBL1913	Homo sapiens	Kd	nM	2.6
	3226162	CHEMBL1112291	Binding affinity to PDGFRbeta	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cc4ccccc4cn3)cc2)no1		CHEMBL1081509	=	Kd	nM	7.0	CHEMBL1913	Homo sapiens	Kd	nM	7.0
	3226163	CHEMBL1112291	Binding affinity to PDGFRbeta	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cn4c(n3)sc3ccccc34)cc2)no1		CHEMBL575925	=	Kd	nM	2.2	CHEMBL1913	Homo sapiens	Kd	nM	2.2
	3226294	CHEMBL1100993	Inhibition of PDGFRbeta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3242700	CHEMBL1115352	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine cell-based ELISA	B	Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccccc3)c12		CHEMBL1093099	=	IC50	nM	2800.0	CHEMBL1913	Homo sapiens	IC50	uM	2.8
	3242707	CHEMBL1115352	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine cell-based ELISA	B	Cc1ccc(Sc2cccc3[nH]c4nc(N)nc(N)c4c23)cc1		CHEMBL1093100	=	IC50	nM	40300.0	CHEMBL1913	Homo sapiens	IC50	uM	40.3
	3242713	CHEMBL1115352	Inhibition of PDGFRbeta in human SF539 cells by phosphotyrosine cell-based ELISA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	IC50	nM	3750.0	CHEMBL1913	Homo sapiens	IC50	uM	3.75
	3295298	CHEMBL1115601	Inhibition of PDGFRbeta	B	Brc1cccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)c1		CHEMBL1094423	=	IC50	nM	8500.0	CHEMBL1913	Homo sapiens	IC50	uM	8.5
	3295299	CHEMBL1115601	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1		CHEMBL485320	=	IC50	nM	11800.0	CHEMBL1913	Homo sapiens	IC50	uM	11.8
	3295300	CHEMBL1115601	Inhibition of PDGFRbeta	B	C#Cc1cccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL1096972	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3295301	CHEMBL1115601	Inhibition of PDGFRbeta	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL520803	=	IC50	nM	100400.0	CHEMBL1913	Homo sapiens	IC50	uM	100.4
	3295302	CHEMBL1115601	Inhibition of PDGFRbeta	B	FC(F)(F)c1cccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL1097743	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3295303	CHEMBL1115601	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483312	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3295304	CHEMBL1115601	Inhibition of PDGFRbeta	B	Fc1ccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)cc1Br	Outside typical range	CHEMBL1096737	=	IC50	nM	192400.0	CHEMBL1913	Homo sapiens	IC50	uM	192.4
	3295305	CHEMBL1115601	Inhibition of PDGFRbeta	B	Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483108	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3295306	CHEMBL1115601	Inhibition of PDGFRbeta	B	Fc1ccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)cc1C(F)(F)F	Outside typical range	CHEMBL1096415	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3295307	CHEMBL1115601	Inhibition of PDGFRbeta	B	Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1		CHEMBL482715	=	IC50	nM	90000.0	CHEMBL1913	Homo sapiens	IC50	uM	90.0
	3295308	CHEMBL1115601	Inhibition of PDGFRbeta	B	Fc1cc(Cl)ccc1Nc1ncnc2[nH]c(CCc3ccccc3)cc12	Outside typical range	CHEMBL1096416	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3295309	CHEMBL1115601	Inhibition of PDGFRbeta	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483313	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3295310	CHEMBL1115601	Inhibition of PDGFRbeta	B	c1ccc(CCc2cc3c(Nc4ccc5[nH]ccc5c4)ncnc3[nH]2)cc1	Outside typical range	CHEMBL1097368	=	IC50	nM	104200.0	CHEMBL1913	Homo sapiens	IC50	uM	104.2
	3295311	CHEMBL1115601	Inhibition of PDGFRbeta	B	Nc1nc(Nc2ccc3[nH]ccc3c2)c2cc(CCc3ccccc3)[nH]c2n1		CHEMBL499067	=	IC50	nM	77400.0	CHEMBL1913	Homo sapiens	IC50	uM	77.4
	3295312	CHEMBL1115601	Inhibition of PDGFRbeta	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	IC50	nM	6500.0	CHEMBL1913	Homo sapiens	IC50	uM	6.5
	3299640	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095761	=	IC50	nM	17000.0	CHEMBL1913	Homo sapiens	IC50	uM	17.0
	3299641	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Nc1nc(Nc2ccc(Br)cc2Cl)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1	Outside typical range	CHEMBL1095762	>	IC50	nM	300000.0	CHEMBL1913	Homo sapiens	IC50	uM	300.0
	3299642	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095130	=	IC50	nM	24600.0	CHEMBL1913	Homo sapiens	IC50	uM	24.6
	3299643	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Nc1nc(Nc2cccc(F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1	Outside typical range	CHEMBL1095131	=	IC50	nM	183100.0	CHEMBL1913	Homo sapiens	IC50	uM	183.1
	3299644	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1	Outside typical range	CHEMBL1095445	>	IC50	nM	300000.0	CHEMBL1913	Homo sapiens	IC50	uM	300.0
	3299645	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)c1	Outside typical range	CHEMBL1094475	>	IC50	nM	300000.0	CHEMBL1913	Homo sapiens	IC50	uM	300.0
	3299646	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Nc1nc(Nc2ccc(C(F)(F)F)c(F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1	Outside typical range	CHEMBL1094808	>	IC50	nM	300000.0	CHEMBL1913	Homo sapiens	IC50	uM	300.0
	3299647	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	CC(C)c1ccc(Nc2nc(N)nc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)cc1	Outside typical range	CHEMBL1095463	=	IC50	nM	174900.0	CHEMBL1913	Homo sapiens	IC50	uM	174.9
	3299648	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	CC(C)c1ccccc1Nc1nc(N)nc2[nH]c(Cc3ccc(Cl)cc3Cl)cc12		CHEMBL1095776	=	IC50	nM	43000.0	CHEMBL1913	Homo sapiens	IC50	uM	43.0
	3299649	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	IC50	nM	3700.0	CHEMBL1913	Homo sapiens	IC50	uM	3.7
	3299650	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	IC50	nM	83100.0	CHEMBL1913	Homo sapiens	IC50	uM	83.1
	3299651	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	12200.0	CHEMBL1913	Homo sapiens	IC50	uM	12.2
	3299665	CHEMBL1112824	Ratio of compound IC50 to DMBI IC50 for PDGFRbeta phosphorylation in human SF539 cells	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095130	=	Ratio IC50		6.5	CHEMBL1913	Homo sapiens	Ratio IC50		6.5
	3299666	CHEMBL1112825	Ratio of compound IC50 to Sunitinib IC50 for PDGFRbeta phosphorylation in human SF539 cells	B	CC(C)c1ccccc1Nc1nc(N)nc2[nH]c(Cc3ccc(Cl)cc3Cl)cc12		CHEMBL1095776	=	Ratio IC50		4.0	CHEMBL1913	Homo sapiens	Ratio IC50		4.0
	3299667	CHEMBL1112825	Ratio of compound IC50 to Sunitinib IC50 for PDGFRbeta phosphorylation in human SF539 cells	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095130	=	Ratio IC50		2.0	CHEMBL1913	Homo sapiens	Ratio IC50		2.0
	3299668	CHEMBL1112824	Ratio of compound IC50 to DMBI IC50 for PDGFRbeta phosphorylation in human SF539 cells	B	CC(C)c1ccccc1Nc1nc(N)nc2[nH]c(Cc3ccc(Cl)cc3Cl)cc12		CHEMBL1095776	=	Ratio IC50		11.5	CHEMBL1913	Homo sapiens	Ratio IC50		11.5
	3299671	CHEMBL1112828	Inhibition of PDGF-stimulated PDGFRbeta phosphorylation expressed in mouse NIH/3T3 cells by chemiluminescence assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	3299706	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1		CHEMBL1095464	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	3299707	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)c1		CHEMBL1095465	=	IC50	nM	8900.0	CHEMBL1913	Homo sapiens	IC50	uM	8.9
	3299708	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)ncnc2[nH]1	Outside typical range	CHEMBL1095466	=	IC50	nM	182000.0	CHEMBL1913	Homo sapiens	IC50	uM	182.0
	3299709	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)ncnc3[nH]2)c1	Outside typical range	CHEMBL1094782	=	IC50	nM	171300.0	CHEMBL1913	Homo sapiens	IC50	uM	171.3
	3299710	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	Clc1ccc(Cc2cc3c(Nc4cccc(Br)c4)ncnc3[nH]2)c(Cl)c1	Outside typical range	CHEMBL1094783	=	IC50	nM	220400.0	CHEMBL1913	Homo sapiens	IC50	uM	220.4
	3299711	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	FC(F)(F)c1cccc(Nc2ncnc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)c1	Outside typical range	CHEMBL1094784	=	IC50	nM	110100.0	CHEMBL1913	Homo sapiens	IC50	uM	110.1
	3299712	CHEMBL1112819	Inhibition of PDGFRbeta phosphorylation in human SF539 cells after 10 mins by FLISA	B	C#Cc1cccc(Nc2ncnc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)c1	Outside typical range	CHEMBL1098440	=	IC50	nM	142200.0	CHEMBL1913	Homo sapiens	IC50	uM	142.2
	3301996	CHEMBL1119050	Inhibition of PDGFRbeta at 1 uM	B	Clc1ccc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)cc1		CHEMBL1083772	=	Inhibition	%	15.0	CHEMBL1913	Homo sapiens	INH	%	15.0
	3308353	CHEMBL1119638	Inhibition of PDGFRbeta at 3 uM	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082829	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
	3308354	CHEMBL1119638	Inhibition of PDGFRbeta at 3 uM	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084337	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
	3326158	CHEMBL1168770	Inhibition of PDGFRbeta at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3332075	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3333490	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3334895	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3336315	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3337609	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3338940	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3339194	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	3340497	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	76.4	CHEMBL1913	Homo sapiens	INH	%	76.4
	3341857	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	92.0	CHEMBL1913	Homo sapiens	INH	%	92.0
	3343304	CHEMBL1166613	Inhibition of PDGFRB at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
Not Active	3352231	CHEMBL1175403	Inhibition of PDGFRbeta at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170191		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	3352232	CHEMBL1175403	Inhibition of PDGFRbeta at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(N)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1172521		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	3352233	CHEMBL1175403	Inhibition of PDGFRbeta at 10 uM	B	CC(=O)c1cc(C(=O)N2CC[C@@H](O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169631		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	3358723	CHEMBL1175189	Inhibition of PDGFRB at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	3359165	CHEMBL1175189	Inhibition of PDGFRB at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	3359783	CHEMBL1177620	Inhibition PDGFRbeta at 10 uM	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	Inhibition	%	17.2	CHEMBL1913	Homo sapiens	INH	%	17.2
	3359784	CHEMBL1177363	Inhibition PDGFRbeta	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
Active	3360866	CHEMBL1176897	Inhibition of recombinant PDGFRbeta by Hotspot assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	3370118	CHEMBL1176630	Inhibition of PDGFRbeta at 10 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	79.6	CHEMBL1913	Homo sapiens	INH	%	79.6
	3370593	CHEMBL1176718	Inhibition of human PDGFRbeta phosphorylation in HUVEC cells after 24 hrs by Western blotting	B	O=C(Nc1ccccc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL1173482	=	IC50	nM	230.0	CHEMBL1913	Homo sapiens	IC50	nM	230.0
	3407718	CHEMBL1219772	Inhibition of PDGFRbeta at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	=	Inhibition	%	47.0	CHEMBL1913	Homo sapiens	INH	%	47.0
	3407719	CHEMBL1219772	Inhibition of PDGFRbeta at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	=	Inhibition	%	70.0	CHEMBL1913	Homo sapiens	INH	%	70.0
	3407742	CHEMBL1219785	Inhibition of PDGFRbeta by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	3407743	CHEMBL1219785	Inhibition of PDGFRbeta by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	<	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	3418609	CHEMBL1226527	Inhibition of PDGFRbeta	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	68.0	CHEMBL1913	Homo sapiens	IC50	nM	68.0
	3418611	CHEMBL1226527	Inhibition of PDGFRbeta	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	490.0	CHEMBL1913	Homo sapiens	IC50	nM	490.0
	3441504	CHEMBL1244087	Inhibition of human PDGFRbeta	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	65.0	CHEMBL1913	Homo sapiens	IC50	nmol/L	65.0
	3443479	CHEMBL1244245	Inhibition of PDGFRbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	82.0	CHEMBL1913	Homo sapiens	INH	%	82.0
	3443696	CHEMBL1244245	Inhibition of PDGFRbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	72.0	CHEMBL1913	Homo sapiens	INH	%	72.0
	3444851	CHEMBL1244245	Inhibition of PDGFRbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	33.0	CHEMBL1913	Homo sapiens	INH	%	33.0
	3445003	CHEMBL1244559	Binding affinity to PDGFRB	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	7.7	CHEMBL1913	Homo sapiens	Kd	nM	7.7
	3445237	CHEMBL1244559	Binding affinity to PDGFRB	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	28.0	CHEMBL1913	Homo sapiens	Kd	nM	28.0
	3445475	CHEMBL1244245	Inhibition of PDGFRbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	14.0	CHEMBL1913	Homo sapiens	INH	%	14.0
	3445692	CHEMBL1244245	Inhibition of PDGFRbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	17.0	CHEMBL1913	Homo sapiens	INH	%	17.0
	3445887	CHEMBL1244245	Inhibition of PDGFRbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	68.0	CHEMBL1913	Homo sapiens	INH	%	68.0
	3446077	CHEMBL1244245	Inhibition of PDGFRbeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	23.0	CHEMBL1913	Homo sapiens	INH	%	23.0
	3447164	CHEMBL1249645	Inhibition of PDGFRbeta kinase	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	57.0	CHEMBL1913	Homo sapiens	IC50	uM	0.057
	3447174	CHEMBL1249645	Inhibition of PDGFRbeta kinase	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	386.0	CHEMBL1913	Homo sapiens	IC50	uM	0.386
	3448045	CHEMBL1249680	Inhibition of human PDGFR-beta activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	18.0	CHEMBL1913	Homo sapiens	INH	%	18.0
	3448121	CHEMBL1249680	Inhibition of human PDGFR-beta activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	43.0	CHEMBL1913	Homo sapiens	INH	%	43.0
	3448869	CHEMBL1244559	Binding affinity to PDGFRB	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	4.5	CHEMBL1913	Homo sapiens	Kd	nM	4.5
	3449002	CHEMBL1244559	Binding affinity to PDGFRB	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	380.0	CHEMBL1913	Homo sapiens	Kd	nM	380.0
	3449299	CHEMBL1244559	Binding affinity to PDGFRB	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	0.075	CHEMBL1913	Homo sapiens	Kd	nM	0.075
	3449300	CHEMBL1244559	Binding affinity to PDGFRB	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	37.0	CHEMBL1913	Homo sapiens	Kd	nM	37.0
	3449301	CHEMBL1244559	Binding affinity to PDGFRB	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	68.0	CHEMBL1913	Homo sapiens	Kd	nM	68.0
	3463312	CHEMBL1252614	Inhibition of PDGFRbeta at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	18.0	CHEMBL1913	Homo sapiens	INH	%	18.0
	3463856	CHEMBL1252614	Inhibition of PDGFRbeta at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	2.0	CHEMBL1913	Homo sapiens	INH	%	2.0
	3464075	CHEMBL1252614	Inhibition of PDGFRbeta at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	84.0	CHEMBL1913	Homo sapiens	INH	%	84.0
	3468987	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3)[nH]c2n1		CHEMBL499344	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	3468988	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1		CHEMBL1095464	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	3468989	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)c1		CHEMBL1095465	=	IC50	nM	8920.0	CHEMBL1913	Homo sapiens	IC50	uM	8.92
	3468990	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	CN(c1cccc(Br)c1)c1nc(N)nc2[nH]c(Cc3ccccc3)cc12	Outside typical range	CHEMBL1254199	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3468991	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	Cn1c(Cc2ccccc2)cc2c(Nc3cccc(Br)c3)nc(N)nc21		CHEMBL1254285	=	IC50	nM	2800.0	CHEMBL1913	Homo sapiens	IC50	uM	2.8
	3468992	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	CN(c1cccc(Br)c1)c1nc(N)nc2c1cc(Cc1ccccc1)n2C		CHEMBL1254286	=	IC50	nM	71700.0	CHEMBL1913	Homo sapiens	IC50	uM	71.7
	3468993	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	Cc1ccccc1Cc1cc2c(N(C)c3cccc(Br)c3)nc(N)nc2[nH]1		CHEMBL1254363	=	IC50	nM	34800.0	CHEMBL1913	Homo sapiens	IC50	uM	34.8
	3468994	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2n1C	Outside typical range	CHEMBL1254364	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3468995	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	Cc1ccccc1Cc1cc2c(N(C)c3cccc(Br)c3)nc(N)nc2n1C	Outside typical range	CHEMBL1254443	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3468996	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	COc1ccc(OC)c(Cc2cc3c(N(C)c4cccc(Br)c4)nc(N)nc3[nH]2)c1		CHEMBL1254444	=	IC50	nM	1300.0	CHEMBL1913	Homo sapiens	IC50	uM	1.3
	3468997	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3n2C)c1	Outside typical range	CHEMBL1254522	=	IC50	nM	348000.0	CHEMBL1913	Homo sapiens	IC50	uM	348.0
	3468998	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	COc1ccc(OC)c(Cc2cc3c(N(C)c4cccc(Br)c4)nc(N)nc3n2C)c1	Outside typical range	CHEMBL1254523	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	3468999	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	IC50	nM	3750.0	CHEMBL1913	Homo sapiens	IC50	uM	3.75
	3469000	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	IC50	nM	83100.0	CHEMBL1913	Homo sapiens	IC50	uM	83.1
	3469001	CHEMBL1252158	Inhibition of PDGFRbeta expressed in human A431 cells	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	12200.0	CHEMBL1913	Homo sapiens	IC50	uM	12.2
	3471359	CHEMBL1251492	Inhibition of PDGFRbeta autophosphorylation in human A31 cells by ELISA	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	72.0	CHEMBL1913	Homo sapiens	IC50	nM	72.0
	3471373	CHEMBL1251492	Inhibition of PDGFRbeta autophosphorylation in human A31 cells by ELISA	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	71.0	CHEMBL1913	Homo sapiens	IC50	nM	71.0
	3471605	CHEMBL1250646	Inhibition of PDGFRbeta	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	=	IC50	nM	96.0	CHEMBL1913	Homo sapiens	IC50	nM	96.0
	3499152	CHEMBL1259896	Inhibition of PDGRB at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171	=	Inhibition	%	11.3	CHEMBL1913	Homo sapiens	INH	%	11.3
	3504687	CHEMBL1261352	Inhibition of PDGFRbeta autophosphorylation by cell based Western blot analysis	B	Cc1cc(C=C2C(=O)Nc3ccc(F)cc32)c2ccccc(OCCN3CCC[C@H]3CO)c1-2		CHEMBL1258603	=	IC50	nM	28.0	CHEMBL1913	Homo sapiens	IC50	nM	28.0
	3504709	CHEMBL1261352	Inhibition of PDGFRbeta autophosphorylation by cell based Western blot analysis	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	17.0	CHEMBL1913	Homo sapiens	IC50	nM	17.0
	3518583	CHEMBL1274260	Inhibition of PDGFRbeta phosphorylation in human MG63 cells	B	CN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cccc2[nH]ncc12		CHEMBL1269858	=	IC50	nM	58.0	CHEMBL1913	Homo sapiens	IC50	nM	58.0
	3526133	CHEMBL1274459	Binding affinity to PDGFRbeta	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	1.6	CHEMBL1913	Homo sapiens	Kd	nM	1.6
	3556534	CHEMBL1285606	Inhibition of PDGFRB at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	9.0	CHEMBL1913	Homo sapiens	INH	%	9.0
	3561700	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O		CHEMBL1278146	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	3561701	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(Cl)cc43)c(C)c2C1=O		CHEMBL1278147	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	3561702	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(Br)cc43)c(C)c2C1=O		CHEMBL1278233	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	3561703	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(CCN(C)C)CC2		CHEMBL1278234	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	3561704	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(CCN1CCCC1)CC2		CHEMBL1276890	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	3561705	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(CCN1CCOCC1)CC2		CHEMBL1276891	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	3561706	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(C[C@H](O)CN1CCOCC1)CC2		CHEMBL1276980	=	IC50	nM	8.0	CHEMBL1913	Homo sapiens	IC50	uM	0.008
	3561707	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	CCN(CC)CCN1CCCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O		CHEMBL1276981	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	3561708	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(CCN1CCOCC1)CCC2		CHEMBL1277071	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	3561709	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	Cc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(C[C@H](O)CN1CCOCC1)CCC2		CHEMBL1277072	=	IC50	nM	11.0	CHEMBL1913	Homo sapiens	IC50	uM	0.011
	3561710	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	CCN(CC)CCN1CCCCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O		CHEMBL1277161	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	uM	0.013
	3561711	CHEMBL1285789	Inhibition of human PDGFRbeta after 30 mins by ELISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	uM	0.009
	3590792	CHEMBL1292133	Inhibition of human PDGFR-beta	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Outside typical range	CHEMBL1290072	>	Ki	nM	1000000.0	CHEMBL1913	Homo sapiens	Ki	uM	1000.0
	3601440	CHEMBL1292414	Inhibition of PDGFR-beta	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	=	IC50	nM	3200.0	CHEMBL1913	Homo sapiens	IC50	uM	3.2
	5112222	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)NO		CHEMBL1630107	=	IC50	nM	3300.0	CHEMBL1913	Homo sapiens	IC50	uM	3.3
	5112223	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1)NO		CHEMBL1630108	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	uM	1.1
	5112224	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	O=C(/C=C/c1cccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)c1)NO		CHEMBL1630109	=	IC50	nM	2500.0	CHEMBL1913	Homo sapiens	IC50	uM	2.5
	5112225	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1)NO		CHEMBL1630110	=	IC50	nM	2300.0	CHEMBL1913	Homo sapiens	IC50	uM	2.3
	5112226	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL1630111	=	IC50	nM	4000.0	CHEMBL1913	Homo sapiens	IC50	uM	4.0
	5112227	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1		CHEMBL1630112	=	IC50	nM	2300.0	CHEMBL1913	Homo sapiens	IC50	uM	2.3
	5112228	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL1630113	=	IC50	nM	3900.0	CHEMBL1913	Homo sapiens	IC50	uM	3.9
	5112229	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)/C=C/c1cccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)c1		CHEMBL1630114	=	IC50	nM	2500.0	CHEMBL1913	Homo sapiens	IC50	uM	2.5
	5112230	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1		CHEMBL1630115	=	IC50	nM	2700.0	CHEMBL1913	Homo sapiens	IC50	uM	2.7
	5112231	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	Nc1ccccc1NC(=O)CCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1		CHEMBL1630116	=	IC50	nM	4700.0	CHEMBL1913	Homo sapiens	IC50	uM	4.7
	5112232	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	O=C(NO)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL1630117	=	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	5112233	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	O=C(NO)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1		CHEMBL1630118	=	IC50	nM	1800.0	CHEMBL1913	Homo sapiens	IC50	uM	1.8
	5112234	CHEMBL1640696	Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	IC50	nM	8500.0	CHEMBL1913	Homo sapiens	IC50	uM	8.5
	5120315	CHEMBL1648667	Inhibition of human PDGFRbeta at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	99.0	CHEMBL1913	Homo sapiens	INH	%	99.0
	5203005	CHEMBL1670766	Inhibition of human recombinant PDGFRbeta expressed in insect cells after 30 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668420	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	5203007	CHEMBL1670766	Inhibition of human recombinant PDGFRbeta expressed in insect cells after 30 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668419	=	IC50	nM	21000.0	CHEMBL1913	Homo sapiens	IC50	uM	21.0
	5203011	CHEMBL1670766	Inhibition of human recombinant PDGFRbeta expressed in insect cells after 30 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668418	=	IC50	nM	9200.0	CHEMBL1913	Homo sapiens	IC50	uM	9.2
	5203015	CHEMBL1670766	Inhibition of human recombinant PDGFRbeta expressed in insect cells after 30 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)C[C@H](Br)C[C@H](C)OC2=O		CHEMBL1668414	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	5203018	CHEMBL1670766	Inhibition of human recombinant PDGFRbeta expressed in insect cells after 30 mins	B	COc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1668411	=	IC50	nM	41.0	CHEMBL1913	Homo sapiens	IC50	uM	0.041
	5203042	CHEMBL1670766	Inhibition of human recombinant PDGFRbeta expressed in insect cells after 30 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	=	IC50	nM	42000.0	CHEMBL1913	Homo sapiens	IC50	uM	42.0
Not Active	5239590	CHEMBL1686876	Inhibition of PDGFRbeta up to 10 uM	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	5243745	CHEMBL1685849	Inhibition of PDGFRbeta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	82.0	CHEMBL1913	Homo sapiens	INH	%	82.0
	5243853	CHEMBL1686065	Inhibition of PDGFRbeta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	42.0	CHEMBL1913	Homo sapiens	INH	%	42.0
	5243966	CHEMBL1685849	Inhibition of PDGFRbeta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	85.0	CHEMBL1913	Homo sapiens	INH	%	85.0
	5244074	CHEMBL1686065	Inhibition of PDGFRbeta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	34.0	CHEMBL1913	Homo sapiens	INH	%	34.0
	5244947	CHEMBL1685849	Inhibition of PDGFRbeta at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	102.0	CHEMBL1913	Homo sapiens	INH	%	102.0
	5245055	CHEMBL1686065	Inhibition of PDGFRbeta at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	77.0	CHEMBL1913	Homo sapiens	INH	%	77.0
	5245206	CHEMBL1685849	Inhibition of PDGFRbeta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	107.0	CHEMBL1913	Homo sapiens	INH	%	107.0
	5246036	CHEMBL1686065	Inhibition of PDGFRbeta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	88.0	CHEMBL1913	Homo sapiens	INH	%	88.0
	5293889	CHEMBL1697123	Inhibition of PDGFR-beta after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	6167571	CHEMBL1769044	Binding affinity to human PDGFRbeta assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	6167587	CHEMBL1769230	Binding affinity to human PDGFRbeta assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	6167613	CHEMBL1768473	Binding affinity to human PDGFRbeta cysteine residue assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	6167634	CHEMBL1768653	Binding affinity to human PDGFRbeta cysteine residue assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	0.15	CHEMBL1913	Homo sapiens	Activity	%	0.15
	6193891	CHEMBL1777650	Inhibition of PDGFRbeta at 10 uM by ELISA based method	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	55.2	CHEMBL1913	Homo sapiens	INH	%	55.2
	6193902	CHEMBL1777650	Inhibition of PDGFRbeta at 10 uM by ELISA based method	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	32.4	CHEMBL1913	Homo sapiens	INH	%	32.4
	6193913	CHEMBL1777650	Inhibition of PDGFRbeta at 10 uM by ELISA based method	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	62.8	CHEMBL1913	Homo sapiens	INH	%	62.8
	6212365	CHEMBL1786064	Inhibition of PDGFRbeta using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	6218843	CHEMBL1787147	Binding affinity to human PDGFRB at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	Activity	%	4.1	CHEMBL1913	Homo sapiens	Activity	%	4.1
Not Determined	6218869	CHEMBL1787532	Binding affinity to human PDGFRB incubated for 1 hr by kinase binding assay	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Kd			CHEMBL1913	Homo sapiens	Kd		
	6219047	CHEMBL1787147	Binding affinity to human PDGFRB at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	>	Activity	%	50.0	CHEMBL1913	Homo sapiens	Activity	%	50.0
	6219907	CHEMBL1785335	Inhibition of human PDGFRbeta using poly[Glu:Tyr] by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	2.6	CHEMBL1913	Homo sapiens	IC50	nM	2.6
	6220396	CHEMBL1787147	Binding affinity to human PDGFRB at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	>	Activity	%	50.0	CHEMBL1913	Homo sapiens	Activity	%	50.0
Not Active	6230342	CHEMBL1785289	Inhibition of human PDGFRbeta	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	6265568	CHEMBL1798277	Inhibition of PDGFR beta at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL1913	Homo sapiens	INH	%	65.0
	6265672	CHEMBL1798277	Inhibition of PDGFR beta at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	=	Inhibition	%	100.0	CHEMBL1913	Homo sapiens	INH	%	100.0
	6286555	CHEMBL1810340	Inhibition of PDGFR beta at 0.1 uM	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL1807483	=	Inhibition	%	18.0	CHEMBL1913	Homo sapiens	INH	%	18.0
	6304885	CHEMBL1816202	Inhibition of PDGFRbeta	B	O=C(Nc1ccc(Oc2ncnc3scc(-c4ccccc4)c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL1813632	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	6315879	CHEMBL1817207	Inhibition of PDGFR-beta at 50 uM after 1 hrs by luminescence assay	B	Cc1ccc(-c2nc3cc(NC(=O)CCl)ccc3[nH]2)cc1		CHEMBL1812374	=	Inhibition	%	52.6	CHEMBL1913	Homo sapiens	INH	%	52.6
	6315880	CHEMBL1817207	Inhibition of PDGFR-beta at 50 uM after 1 hrs by luminescence assay	B	Cc1ccc(-c2nc3cc(NC(=O)CCCl)ccc3[nH]2)cc1		CHEMBL1812379	=	Inhibition	%	24.6	CHEMBL1913	Homo sapiens	INH	%	24.6
	6315881	CHEMBL1817207	Inhibition of PDGFR-beta at 50 uM after 1 hrs by luminescence assay	B	Cn1cccc1-c1nc2cc(NC(=O)CCl)ccc2[nH]1		CHEMBL1812491	=	Inhibition	%	17.8	CHEMBL1913	Homo sapiens	INH	%	17.8
	6315882	CHEMBL1817207	Inhibition of PDGFR-beta at 50 uM after 1 hrs by luminescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	95.8	CHEMBL1913	Homo sapiens	INH	%	95.8
	6315912	CHEMBL1817443	Inhibition of PDGFR-beta at 20 uM after 1 hrs by luminescence assay	B	O=C(Nc1ccc2[nH]c(-c3ccc(F)cc3)nc2c1)c1cnccn1		CHEMBL1812493	=	Inhibition	%	0.27	CHEMBL1913	Homo sapiens	INH	%	0.27
	6315913	CHEMBL1817443	Inhibition of PDGFR-beta at 20 uM after 1 hrs by luminescence assay	B	Cc1cnc(C(=O)Nc2ccc3[nH]c(-c4ccc(F)cc4)nc3c2)cn1		CHEMBL1812494	=	Inhibition	%	0.5	CHEMBL1913	Homo sapiens	INH	%	0.5
	6315914	CHEMBL1817443	Inhibition of PDGFR-beta at 20 uM after 1 hrs by luminescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	94.81	CHEMBL1913	Homo sapiens	INH	%	94.81
	6339912	CHEMBL1826210	Activity of PDGFRB kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	67.0	CHEMBL1913	Homo sapiens	Activity	%	67.0
	6343513	CHEMBL1828097	Inhibition of PDGFRB at 28 uM by luciferase fragment complementation assay	B	CCOc1ccc(OCC(O)CN(C)Cc2c(C)nn(Cc3ccccc3Cl)c2C)cc1		CHEMBL1223751	>	Inhibition	%	27.0	CHEMBL1913	Homo sapiens	INH	%	27.0
	6343514	CHEMBL1828098	Inhibition of PDGFRB at 16 uM by luciferase fragment complementation assay	B	Cc1nn(Cc2ccccc2Cl)c(C)c1CN(C)CC(O)COc1ccc(Cl)cc1		CHEMBL1824695	>	Inhibition	%	27.0	CHEMBL1913	Homo sapiens	INH	%	27.0
	6350175	CHEMBL1825473	Inhibition of PDGFRbeta by cellular potency assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	7567270	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	0.32	CHEMBL1913	Homo sapiens	Kd	nM	0.32
	7567729	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7568200	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	14.0	CHEMBL1913	Homo sapiens	Kd	nM	14.0
	7568658	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	0.29	CHEMBL1913	Homo sapiens	Kd	nM	0.29
	7569243	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7569703	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7570196	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1900.0	CHEMBL1913	Homo sapiens	Kd	nM	1900.0
	7570623	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	0.075	CHEMBL1913	Homo sapiens	Kd	nM	0.075
	7571219	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7571676	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.63	CHEMBL1913	Homo sapiens	Kd	nM	0.63
	7571710	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7572173	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7572589	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	150.0	CHEMBL1913	Homo sapiens	Kd	nM	150.0
	7573200	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	15.0	CHEMBL1913	Homo sapiens	Kd	nM	15.0
	7573691	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	28.0	CHEMBL1913	Homo sapiens	Kd	nM	28.0
	7574160	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	110.0	CHEMBL1913	Homo sapiens	Kd	nM	110.0
	7574568	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7575197	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1400.0	CHEMBL1913	Homo sapiens	Kd	nM	1400.0
	7575668	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	0.29	CHEMBL1913	Homo sapiens	Kd	nM	0.29
	7576133	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	200.0	CHEMBL1913	Homo sapiens	Kd	nM	200.0
	7576541	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	45.0	CHEMBL1913	Homo sapiens	Kd	nM	45.0
	7576710	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7577169	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	0.96	CHEMBL1913	Homo sapiens	Kd	nM	0.96
	7577647	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	30.0	CHEMBL1913	Homo sapiens	Kd	nM	30.0
	7578117	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	78.0	CHEMBL1913	Homo sapiens	Kd	nM	78.0
	7578522	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	88.0	CHEMBL1913	Homo sapiens	Kd	nM	88.0
	7578718	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7579092	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1100.0	CHEMBL1913	Homo sapiens	Kd	nM	1100.0
	7579542	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7580016	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7580485	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	25.0	CHEMBL1913	Homo sapiens	Kd	nM	25.0
	7580888	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	310.0	CHEMBL1913	Homo sapiens	Kd	nM	310.0
	7581076	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	8.4	CHEMBL1913	Homo sapiens	Kd	nM	8.4
	7581461	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7581906	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7582377	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	3300.0	CHEMBL1913	Homo sapiens	Kd	nM	3300.0
	7583422	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1.9	CHEMBL1913	Homo sapiens	Kd	nM	1.9
	7583819	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7584264	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7584735	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7584755	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	3.3	CHEMBL1913	Homo sapiens	Kd	nM	3.3
	7585159	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	8400.0	CHEMBL1913	Homo sapiens	Kd	nM	8400.0
	7585752	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	7.7	CHEMBL1913	Homo sapiens	Kd	nM	7.7
	7586160	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	50.0	CHEMBL1913	Homo sapiens	Kd	nM	50.0
	7586606	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7587089	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7587713	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	0.57	CHEMBL1913	Homo sapiens	Kd	nM	0.57
	7588132	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	29.0	CHEMBL1913	Homo sapiens	Kd	nM	29.0
	7588614	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7589065	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7589678	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	9.1	CHEMBL1913	Homo sapiens	Kd	nM	9.1
	7590127	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7590601	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	4.5	CHEMBL1913	Homo sapiens	Kd	nM	4.5
	7591052	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7591631	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3.8	CHEMBL1913	Homo sapiens	Kd	nM	3.8
	7592103	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	2900.0	CHEMBL1913	Homo sapiens	Kd	nM	2900.0
	7592576	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7593029	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	200.0	CHEMBL1913	Homo sapiens	Kd	nM	200.0
	7593176	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	8.1	CHEMBL1913	Homo sapiens	Kd	nM	8.1
	7593611	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	240.0	CHEMBL1913	Homo sapiens	Kd	nM	240.0
	7594083	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	3900.0	CHEMBL1913	Homo sapiens	Kd	nM	3900.0
	7594556	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	73.0	CHEMBL1913	Homo sapiens	Kd	nM	73.0
	7595008	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	37.0	CHEMBL1913	Homo sapiens	Kd	nM	37.0
	7595144	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7595588	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	7500.0	CHEMBL1913	Homo sapiens	Kd	nM	7500.0
	7596062	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7596533	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2.0	CHEMBL1913	Homo sapiens	Kd	nM	2.0
	7596980	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.8	CHEMBL1913	Homo sapiens	Kd	nM	1.8
	7597116	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	41.0	CHEMBL1913	Homo sapiens	Kd	nM	41.0
	7597569	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Kd	nM	3100.0	CHEMBL1913	Homo sapiens	Kd	nM	3100.0
	7598042	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL1913	Homo sapiens	Kd	nM	10000.0
	7598512	CHEMBL1908572	Binding constant for PDGFRB kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	1.4	CHEMBL1913	Homo sapiens	Kd	nM	1.4
	7922711	CHEMBL1919206	Inhibition of human recombinant PDGFRB at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	7925718	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(O)cc1		CHEMBL1915330	=	Inhibition	%	44.0	CHEMBL1913	Homo sapiens	INH	%	44.0
	7925721	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926611	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926619	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926627	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926635	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926643	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926651	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926659	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926667	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926675	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926683	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926691	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926699	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926707	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926715	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926723	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926731	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926739	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926747	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926755	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926820	CHEMBL1920419	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926832	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	7926834	CHEMBL1920326	Inhibition of PDGFRbeta using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1cnccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915326	=	Inhibition	%	47.0	CHEMBL1913	Homo sapiens	INH	%	47.0
	7931120	CHEMBL1919457	Inhibition of PDGFRbeta relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	2.0	CHEMBL1913	Homo sapiens	INH	%	2.0
	7939948	CHEMBL1919617	Inhibition of human PDGFRbeta	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	7956223	CHEMBL1924886	Inhibition of N-terminus flag-tagged PDGFRbeta expressed in baculovirus infected insect cells using ATP as substrate after 60 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	7961099	CHEMBL1931531	Inhibition of PDGFRbeta	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	7961100	CHEMBL1931531	Inhibition of PDGFRbeta	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	6200.0	CHEMBL1913	Homo sapiens	IC50	uM	6.2
	7968539	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1		CHEMBL1095464	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	7968540	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3cccc4ccccc34)[nH]c2n1	Outside typical range	CHEMBL474538	>	IC50	nM	300000.0	CHEMBL1913	Homo sapiens	IC50	uM	300.0
	7968541	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)c1	Outside typical range	CHEMBL1095465	>	IC50	nM	300000.0	CHEMBL1913	Homo sapiens	IC50	uM	300.0
	7968542	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	Cc1ccccc1Cc1cc2c(Nc3ccc(Cl)cc3F)nc(N)nc2[nH]1		CHEMBL1929552	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	7968543	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	Cc1ccccc1Cc1cc2c(Nc3ccc(Cl)cc3)nc(N)nc2[nH]1	Outside typical range	CHEMBL1929553	=	IC50	nM	193200.0	CHEMBL1913	Homo sapiens	IC50	uM	193.2
	7968544	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3cccc4ccccc34)[nH]c2n1	Outside typical range	CHEMBL1929554	>	IC50	nM	300000.0	CHEMBL1913	Homo sapiens	IC50	uM	300.0
	7968545	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	Nc1nc(Nc2ccc(Cl)cc2)c2cc(Cc3cccc4ccccc34)[nH]c2n1		CHEMBL1929555	=	IC50	nM	8920.0	CHEMBL1913	Homo sapiens	IC50	uM	8.92
	7968546	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4ccc(Cl)cc4F)nc(N)nc3[nH]2)c1	Outside typical range	CHEMBL1929556	=	IC50	nM	145900.0	CHEMBL1913	Homo sapiens	IC50	uM	145.9
	7968547	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4ccc(Cl)cc4)nc(N)nc3[nH]2)c1		CHEMBL1929557	=	IC50	nM	44300.0	CHEMBL1913	Homo sapiens	IC50	uM	44.3
	7968548	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	IC50	nM	3750.0	CHEMBL1913	Homo sapiens	IC50	uM	3.75
	7968549	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	IC50	nM	83100.0	CHEMBL1913	Homo sapiens	IC50	uM	83.1
	7968550	CHEMBL1932342	Inhibition of PDGFRbeta tyrosine kinase activity in PDGF-BB-stimulated human SF-539 cells after 60 mins by ELISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	12200.0	CHEMBL1913	Homo sapiens	IC50	uM	12.2
	7991159	CHEMBL1937311	Inhibition of PDGFRbeta	B	CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)CC1		CHEMBL1934327	=	IC50	nM	2788.0	CHEMBL1913	Homo sapiens	IC50	nM	2788.0
	7991858	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934300	=	Inhibition	%	42.4	CHEMBL1913	Homo sapiens	INH	%	42.4
	7991859	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934301	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	7991860	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	CCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934302	=	Inhibition	%	11.8	CHEMBL1913	Homo sapiens	INH	%	11.8
	7991861	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934303	=	Inhibition	%	5.1	CHEMBL1913	Homo sapiens	INH	%	5.1
	7991862	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	CCCC(CCC)C(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934304	=	Inhibition	%	13.6	CHEMBL1913	Homo sapiens	INH	%	13.6
	7991863	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	C=CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934305	=	Inhibition	%	6.3	CHEMBL1913	Homo sapiens	INH	%	6.3
	7991864	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccco1		CHEMBL1934306	=	Inhibition	%	13.5	CHEMBL1913	Homo sapiens	INH	%	13.5
	7991865	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccncc1		CHEMBL1934307	=	Inhibition	%	34.7	CHEMBL1913	Homo sapiens	INH	%	34.7
	7991866	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	90.6	CHEMBL1913	Homo sapiens	INH	%	90.6
Not Determined	7991867	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Determined	7991868	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Determined	7991869	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Determined	7991870	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1		CHEMBL56393		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Determined	7991871	CHEMBL1937677	Inhibition of PDGFRbeta at 10 uM	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	7992210	CHEMBL1937332	Inhibition of PDGFRB at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	64.0	CHEMBL1913	Homo sapiens	INH	%	64.0
	7995718	CHEMBL1935843	Inhibition of PDGFRbeta	B	Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CN2CCCC2)c(F)c1		CHEMBL1934626	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	8004502	CHEMBL1943934	Inhibition of PDGFRbeta at 1 uM	B	O=c1c2ccccc2[se]n1-c1ccccc1		CHEMBL51085	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	8004546	CHEMBL1943934	Inhibition of PDGFRbeta at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	8005040	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4cccc(F)c4)c3)c2cc1OC		CHEMBL1940103	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	8005041	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Nc3ncnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940104	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	8005042	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4ccc(N(C)C)cc4)c3)c2cc1OC		CHEMBL1940105	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	uM	0.006
	8005043	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4ccc(N(C)C)cn4)c3)c2cc1OC		CHEMBL1940106	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	8005044	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3cnn(CC(=O)Nc4ccc(N(C)C)cn4)c3)c2cc1OC		CHEMBL1940107	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	8005045	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940108	=	IC50	nM	0.8	CHEMBL1913	Homo sapiens	IC50	uM	0.0008
	8005046	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COCCOc1cc2ncnc(Oc3cnn(CC(=O)Nc4cccc(OC)c4)c3)c2cc1OC		CHEMBL1940109	=	IC50	nM	0.3	CHEMBL1913	Homo sapiens	IC50	uM	0.0003
	8005047	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COCCOc1cc2c(Oc3cnn(CC(=O)Nc4cccc(OC)c4)c3)ncnc2cc1OC		CHEMBL1940110	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	8005048	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OCCN5CCCCC5)cc34)cn2)c1		CHEMBL1940111	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	8005049	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OCCN5CCCC5)c(OC)cc34)cn2)c1		CHEMBL1940112	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	8005050	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)cc(OC)c34)cn2)c1		CHEMBL1940113	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	8005051	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ccnc4cc(OC)c(C#N)cc34)cn2)c1		CHEMBL1940114	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	8005052	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ccnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940115	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	8005053	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OC)cc34)cn2)cn1		CHEMBL1940116	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	8005054	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2cc(Oc3ccnc4cc(OC)c(OC)cc34)n[nH]2)cn1		CHEMBL1940117	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	8005055	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4ccc(N(C)C)cn4)cc3)c2cc1OC		CHEMBL1940118	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	8005056	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940259	=	IC50	nM	0.9	CHEMBL1913	Homo sapiens	IC50	uM	0.0009
	8005057	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2ccc(Nc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940260	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	8005058	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)c1		CHEMBL1940261	=	IC50	nM	300.0	CHEMBL1913	Homo sapiens	IC50	uM	0.3
	8005059	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(NC(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940262	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	uM	0.009
	8005060	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(S(=O)(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940263	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	8005061	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(C(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940264	=	IC50	nM	300.0	CHEMBL1913	Homo sapiens	IC50	uM	0.3
	8005062	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(CNC(=O)c2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940265	=	IC50	nM	700.0	CHEMBL1913	Homo sapiens	IC50	uM	0.7
	8005063	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(CC(=O)Nc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940266	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	8005064	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cccc(COc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940267	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	8005065	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	CCc1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)n[nH]1		CHEMBL1940268	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	8005066	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	CCn1ccc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)n1		CHEMBL1940269	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	8005067	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cn[nH]c4)cc3)c2cc1OC		CHEMBL1940270	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	8005068	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C)c4)cc3)c2cc1OC		CHEMBL1940271	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	uM	0.04
	8005069	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)cn1		CHEMBL1940272	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	8005070	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2)cn1		CHEMBL1940273	=	IC50	nM	0.4	CHEMBL1913	Homo sapiens	IC50	uM	0.0004
	8005071	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC		CHEMBL1940274	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	8005072	CHEMBL1942929	Inhibition of PDGFRbeta phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC		CHEMBL1940275	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	8005210	CHEMBL1943934	Inhibition of PDGFRbeta at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	8005253	CHEMBL1943934	Inhibition of PDGFRbeta at 1 uM	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	8020204	CHEMBL1948346	Inhibition of PDGFRb	B	Cc1ncc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2		CHEMBL1945804	=	IC50	nM	49.0	CHEMBL1913	Homo sapiens	IC50	nM	49.0
	8020205	CHEMBL1948346	Inhibition of PDGFRb	B	CN(C)CCCc1cncc(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945803	=	IC50	nM	27.0	CHEMBL1913	Homo sapiens	IC50	nM	27.0
	8020206	CHEMBL1948346	Inhibition of PDGFRb	B	CN(C)CCCc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)ccc1C(F)(F)F		CHEMBL1945801	=	IC50	nM	72.0	CHEMBL1913	Homo sapiens	IC50	nM	72.0
	8020207	CHEMBL1948346	Inhibition of PDGFRb	B	COc1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)cc1CCCN(C)C		CHEMBL1945502	=	IC50	nM	27.0	CHEMBL1913	Homo sapiens	IC50	nM	27.0
	8020208	CHEMBL1948346	Inhibition of PDGFRb	B	CN(C)CCCc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)ccc1F		CHEMBL1945501	=	IC50	nM	23.0	CHEMBL1913	Homo sapiens	IC50	nM	23.0
	8020209	CHEMBL1948346	Inhibition of PDGFRb	B	CC(C)c1ccc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2		CHEMBL1945499	=	IC50	nM	1600.0	CHEMBL1913	Homo sapiens	IC50	nM	1600.0
	8020210	CHEMBL1948346	Inhibition of PDGFRb	B	CN(C)CCCc1ccc(C(F)(F)F)c(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945498	=	IC50	nM	550.0	CHEMBL1913	Homo sapiens	IC50	nM	550.0
	8020211	CHEMBL1948346	Inhibition of PDGFRb	B	CN(C)CCCc1ccc(OC(F)(F)F)c(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945497	=	IC50	nM	1100.0	CHEMBL1913	Homo sapiens	IC50	nM	1100.0
	8020212	CHEMBL1948346	Inhibition of PDGFRb	B	COc1ccc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2		CHEMBL1945173	=	IC50	nM	190.0	CHEMBL1913	Homo sapiens	IC50	nM	190.0
	8020213	CHEMBL1948346	Inhibition of PDGFRb	B	CN(C)CCCc1ccc(Cl)c(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945172	=	IC50	nM	93.0	CHEMBL1913	Homo sapiens	IC50	nM	93.0
	8020214	CHEMBL1948346	Inhibition of PDGFRb	B	Cc1ccc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2		CHEMBL1945171	=	IC50	nM	49.0	CHEMBL1913	Homo sapiens	IC50	nM	49.0
	8020215	CHEMBL1948346	Inhibition of PDGFRb	B	CN(C)CCCc1cccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945170	=	IC50	nM	19.0	CHEMBL1913	Homo sapiens	IC50	nM	19.0
Dose-dependent effect	8045838	CHEMBL1959232	Inhibition of recombinant cytoplasmic domain of PDGFRbeta autophosphorylation expressed in baculovirus infected Sf21 insect cells using [gamma-33P]ATP by SDS-PAGE based scintillation counting	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	8045839	CHEMBL1959232	Inhibition of recombinant cytoplasmic domain of PDGFRbeta autophosphorylation expressed in baculovirus infected Sf21 insect cells using [gamma-33P]ATP by SDS-PAGE based scintillation counting	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	IC50	nM	1800.0	CHEMBL1913	Homo sapiens	IC50	uM	1.8
Not Active	8045840	CHEMBL1959320	Inhibition of recombinant cytoplasmic domain of PDGFRbeta expressed in baculovirus infected Sf21 insect cells using poly(Glu4,Tyr1) and [gamma-33P]ATP at 100 uM by SDS-PAGE based scintillation counting	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	8045841	CHEMBL1959321	Inhibition of recombinant cytoplasmic domain of PDGFRbeta expressed in baculovirus infected Sf21 insect cells using 10 fold less poly(Glu4,Tyr1) and [gamma-33P]ATP at 100 uM by SDS-PAGE based scintillation counting	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Dose-dependent effect	8045842	CHEMBL1959322	Inhibition of recombinant cytoplasmic domain of PDGFRbeta expressed in baculovirus infected Sf21 insect cells assessed as tyrosine phosphorylation treated 30 hrs after infection measured after 48 hrs of post infection by Western blotting	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	8045843	CHEMBL1959322	Inhibition of recombinant cytoplasmic domain of PDGFRbeta expressed in baculovirus infected Sf21 insect cells assessed as tyrosine phosphorylation treated 30 hrs after infection measured after 48 hrs of post infection by Western blotting	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	8045861	CHEMBL1959340	Inhibition of human PDGFR-1b	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	8047154	CHEMBL1959379	Inhibition of PDGFRB at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	8058309	CHEMBL1959295	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(-c4ccccc4)cc3)[nH]c2n1		CHEMBL1956887	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	8058310	CHEMBL1959295	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc4ccccc4c3)[nH]c2n1		CHEMBL502015	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	8058311	CHEMBL1959295	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3cccc4ccccc34)[nH]c2n1		CHEMBL474538	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	8058312	CHEMBL1959295	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)c(Cl)c3)[nH]c2n1		CHEMBL1956886	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	8058313	CHEMBL1959295	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3)[nH]c2n1		CHEMBL1956885	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	8058314	CHEMBL1959295	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3Cl)[nH]c2n1		CHEMBL499345	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	8058315	CHEMBL1959295	Inhibition of PDGFRbeta	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1		CHEMBL1095464	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	8058316	CHEMBL1959295	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3)[nH]c2n1		CHEMBL499344	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	8058317	CHEMBL1959295	Inhibition of PDGFRbeta	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095761	=	IC50	nM	17000.0	CHEMBL1913	Homo sapiens	IC50	uM	17.0
	8058318	CHEMBL1959295	Inhibition of PDGFRbeta	B	COc1cc(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)cc(OC)c1OC		CHEMBL514014	=	IC50	nM	14700.0	CHEMBL1913	Homo sapiens	IC50	uM	14.7
	8058319	CHEMBL1959295	Inhibition of PDGFRbeta	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)c1		CHEMBL1095465	=	IC50	nM	8920.0	CHEMBL1913	Homo sapiens	IC50	uM	8.92
	8058377	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(Cl)cc3)c2n1	Outside typical range	CHEMBL1956891	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	8058378	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccccc3)c2n1	Outside typical range	CHEMBL1956888	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	8058379	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(Cl)c(Cl)c3)c2n1	Outside typical range	CHEMBL1956894	=	IC50	nM	229600.0	CHEMBL1913	Homo sapiens	IC50	uM	229.6
	8058380	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc4ccccc4c3)c2n1	Outside typical range	CHEMBL1956896	=	IC50	nM	212400.0	CHEMBL1913	Homo sapiens	IC50	uM	212.4
	8058381	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Cc1ccccc1Cn1ccc2c(Nc3cccc(Br)c3)nc(N)nc21	Outside typical range	CHEMBL1956889	=	IC50	nM	159600.0	CHEMBL1913	Homo sapiens	IC50	uM	159.6
	8058382	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3cccc4ccccc34)c2n1	Outside typical range	CHEMBL1956895	=	IC50	nM	129300.0	CHEMBL1913	Homo sapiens	IC50	uM	129.3
	8058383	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(-c4ccccc4)cc3)c2n1	Outside typical range	CHEMBL1956897	=	IC50	nM	129100.0	CHEMBL1913	Homo sapiens	IC50	uM	129.1
	8058384	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(Cl)cc3Cl)c2n1		CHEMBL1956893	=	IC50	nM	34200.0	CHEMBL1913	Homo sapiens	IC50	uM	34.2
	8058385	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	IC50	nM	6200.0	CHEMBL1913	Homo sapiens	IC50	uM	6.2
	8058386	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	COc1cc(Cn2ccc3c(Nc4cccc(Br)c4)nc(N)nc32)cc(OC)c1OC		CHEMBL1956898	=	IC50	nM	1800.0	CHEMBL1913	Homo sapiens	IC50	uM	1.8
	8058387	CHEMBL1959283	Inhibition of PDGFBB-induced PDGFRbeta autophosphorylation in human SF539 cells incubated for 60 mins prior to PDGFBB-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccccc3Cl)c2n1		CHEMBL1956890	=	IC50	nM	1500.0	CHEMBL1913	Homo sapiens	IC50	uM	1.5
	8058393	CHEMBL1959300	Ratio of AG1295 IC50 to compound IC50 for PDGFRbeta autophosphorylation in human SF539 cells	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccccc3Cl)c2n1		CHEMBL1956890	=	Ratio IC50		4.0	CHEMBL1913	Homo sapiens	Ratio IC50		4.0
	8058394	CHEMBL1959300	Ratio of AG1295 IC50 to compound IC50 for PDGFRbeta autophosphorylation in human SF539 cells	B	COc1cc(Cn2ccc3c(Nc4cccc(Br)c4)nc(N)nc32)cc(OC)c1OC		CHEMBL1956898	=	Ratio IC50		3.0	CHEMBL1913	Homo sapiens	Ratio IC50		3.0
	8059503	CHEMBL1958981	Inhibition of PDGFR-beta	B	Nc1nc(Nc2ccc([C@H]3CC[C@H](N4CCOCC4)CC3)cc2)nn1-c1ccccn1		CHEMBL1835870	=	Ki	nM	200.0	CHEMBL1913	Homo sapiens	Ki	uM	0.2
	8060131	CHEMBL1961233	Inhibition of human recombinant PDGFRbeta expressed in Sf9 cells using poly(A,E,K,Y)6:2:5:1 as substrate after 80 mins by scintillation counting	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2		CHEMBL1957190	>	IC50	nM	35000.0	CHEMBL1913	Homo sapiens	IC50	uM	35.0
	8060132	CHEMBL1961233	Inhibition of human recombinant PDGFRbeta expressed in Sf9 cells using poly(A,E,K,Y)6:2:5:1 as substrate after 80 mins by scintillation counting	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	1300.0	CHEMBL1913	Homo sapiens	IC50	uM	1.3
	8061590	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	26.45	CHEMBL1913	Homo sapiens	Inhibition	%	26.45
	8061697	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	7.67	CHEMBL1913	Homo sapiens	Inhibition	%	7.67
	8061921	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	44.72	CHEMBL1913	Homo sapiens	Inhibition	%	44.72
	8062112	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	12.46	CHEMBL1913	Homo sapiens	Inhibition	%	12.46
	8062228	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	7.75	CHEMBL1913	Homo sapiens	Inhibition	%	7.75
	8062452	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.55	CHEMBL1913	Homo sapiens	Inhibition	%	1.55
	8062614	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	22.57	CHEMBL1913	Homo sapiens	Inhibition	%	22.57
	8062936	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	5.63	CHEMBL1913	Homo sapiens	Inhibition	%	5.63
	8063068	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	7.07	CHEMBL1913	Homo sapiens	Inhibition	%	7.07
	8063292	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	30.98	CHEMBL1913	Homo sapiens	Inhibition	%	30.98
	8063459	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.18	CHEMBL1913	Homo sapiens	Inhibition	%	2.18
	8063791	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.41	CHEMBL1913	Homo sapiens	Inhibition	%	2.41
	8063973	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	42.0	CHEMBL1913	Homo sapiens	Inhibition	%	42.0
	8064312	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.81	CHEMBL1913	Homo sapiens	Inhibition	%	6.81
	8064522	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.61	CHEMBL1913	Homo sapiens	Inhibition	%	5.61
	8064884	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	25.49	CHEMBL1913	Homo sapiens	Inhibition	%	25.49
	8065050	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	5.76	CHEMBL1913	Homo sapiens	Inhibition	%	5.76
	8065390	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	7.47	CHEMBL1913	Homo sapiens	Inhibition	%	7.47
	8065565	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	6.05	CHEMBL1913	Homo sapiens	Inhibition	%	6.05
	8065904	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.88	CHEMBL1913	Homo sapiens	Inhibition	%	3.88
	8066114	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	9.98	CHEMBL1913	Homo sapiens	Inhibition	%	9.98
	8066474	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	68.01	CHEMBL1913	Homo sapiens	Inhibition	%	68.01
	8066640	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.45	CHEMBL1913	Homo sapiens	Inhibition	%	1.45
	8066988	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	17.42	CHEMBL1913	Homo sapiens	Inhibition	%	17.42
	8067163	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	14.4	CHEMBL1913	Homo sapiens	Inhibition	%	14.4
	8067387	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.73	CHEMBL1913	Homo sapiens	Inhibition	%	5.73
	8067508	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.43	CHEMBL1913	Homo sapiens	Inhibition	%	6.43
	8067718	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.42	CHEMBL1913	Homo sapiens	Inhibition	%	2.42
	8067942	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	14.02	CHEMBL1913	Homo sapiens	Inhibition	%	14.02
	8068077	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	40.25	CHEMBL1913	Homo sapiens	Inhibition	%	40.25
	8068241	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.91	CHEMBL1913	Homo sapiens	Inhibition	%	5.91
	8068465	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	7.37	CHEMBL1913	Homo sapiens	Inhibition	%	7.37
	8068590	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	35.88	CHEMBL1913	Homo sapiens	Inhibition	%	35.88
	8068988	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.49	CHEMBL1913	Homo sapiens	Inhibition	%	4.49
	8069113	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.58	CHEMBL1913	Homo sapiens	Inhibition	%	0.58
	8069337	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	12.67	CHEMBL1913	Homo sapiens	Inhibition	%	12.67
	8069408	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	84.45	CHEMBL1913	Homo sapiens	Inhibition	%	84.45
	8069793	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	26.13	CHEMBL1913	Homo sapiens	Inhibition	%	26.13
	8069919	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.37	CHEMBL1913	Homo sapiens	Inhibition	%	1.37
	8070143	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	5.64	CHEMBL1913	Homo sapiens	Inhibition	%	5.64
	8070315	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.46	CHEMBL1913	Homo sapiens	Inhibition	%	2.46
	8070664	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.19	CHEMBL1913	Homo sapiens	Inhibition	%	3.19
	8070738	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	64.15	CHEMBL1913	Homo sapiens	Inhibition	%	64.15
	8070962	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	90.85	CHEMBL1913	Homo sapiens	Inhibition	%	90.85
	8071119	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.83	CHEMBL1913	Homo sapiens	Inhibition	%	2.83
	8071469	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.42	CHEMBL1913	Homo sapiens	Inhibition	%	2.42
	8071642	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.23	CHEMBL1913	Homo sapiens	Inhibition	%	4.23
	8071991	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	11.36	CHEMBL1913	Homo sapiens	Inhibition	%	11.36
	8072305	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	11.36	CHEMBL1913	Homo sapiens	Inhibition	%	11.36
	8072462	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	6.52	CHEMBL1913	Homo sapiens	Inhibition	%	6.52
	8072811	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	26.53	CHEMBL1913	Homo sapiens	Inhibition	%	26.53
	8072978	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.97	CHEMBL1913	Homo sapiens	Inhibition	%	3.97
	8073202	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.81	CHEMBL1913	Homo sapiens	Inhibition	%	6.81
	8073327	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	20.16	CHEMBL1913	Homo sapiens	Inhibition	%	20.16
	8073670	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	8.12	CHEMBL1913	Homo sapiens	Inhibition	%	8.12
	8073903	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	45.3	CHEMBL1913	Homo sapiens	Inhibition	%	45.3
	8074055	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	7.12	CHEMBL1913	Homo sapiens	Inhibition	%	7.12
	8074279	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	20.8	CHEMBL1913	Homo sapiens	Inhibition	%	20.8
	8074409	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	6.2	CHEMBL1913	Homo sapiens	Inhibition	%	6.2
	8074790	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.93	CHEMBL1913	Homo sapiens	Inhibition	%	3.93
	8074917	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	55.89	CHEMBL1913	Homo sapiens	Inhibition	%	55.89
	8075252	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	31.67	CHEMBL1913	Homo sapiens	Inhibition	%	31.67
	8075489	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.33	CHEMBL1913	Homo sapiens	Inhibition	%	3.33
	8075854	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.55	CHEMBL1913	Homo sapiens	Inhibition	%	1.55
	8075996	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	34.4	CHEMBL1913	Homo sapiens	Inhibition	%	34.4
	8076368	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.76	CHEMBL1913	Homo sapiens	Inhibition	%	5.76
	8076502	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.3	CHEMBL1913	Homo sapiens	Inhibition	%	1.3
	8076726	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	8.9	CHEMBL1913	Homo sapiens	Inhibition	%	8.9
	8076828	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.37	CHEMBL1913	Homo sapiens	Inhibition	%	-0.37
	8077075	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	12.2	CHEMBL1913	Homo sapiens	Inhibition	%	12.2
	8077427	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.9	CHEMBL1913	Homo sapiens	Inhibition	%	8.9
	8077578	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	6.65	CHEMBL1913	Homo sapiens	Inhibition	%	6.65
	8077802	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	37.45	CHEMBL1913	Homo sapiens	Inhibition	%	37.45
	8077945	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	10.78	CHEMBL1913	Homo sapiens	Inhibition	%	10.78
	8078308	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	11.8	CHEMBL1913	Homo sapiens	Inhibition	%	11.8
	8078410	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	6.02	CHEMBL1913	Homo sapiens	Inhibition	%	6.02
	8078634	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	4.22	CHEMBL1913	Homo sapiens	Inhibition	%	4.22
	8078660	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	50.33	CHEMBL1913	Homo sapiens	Inhibition	%	50.33
	8078884	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	79.55	CHEMBL1913	Homo sapiens	Inhibition	%	79.55
	8079000	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	6.49	CHEMBL1913	Homo sapiens	Inhibition	%	6.49
	8079382	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	7.9	CHEMBL1913	Homo sapiens	Inhibition	%	7.9
	8079524	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	49.91	CHEMBL1913	Homo sapiens	Inhibition	%	49.91
	8079887	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	53.42	CHEMBL1913	Homo sapiens	Inhibition	%	53.42
	8080216	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	23.28	CHEMBL1913	Homo sapiens	Inhibition	%	23.28
	8080468	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	66.28	CHEMBL1913	Homo sapiens	Inhibition	%	66.28
	8080583	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	10.93	CHEMBL1913	Homo sapiens	Inhibition	%	10.93
	8080807	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.54	CHEMBL1913	Homo sapiens	Inhibition	%	0.54
	8080971	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	54.56	CHEMBL1913	Homo sapiens	Inhibition	%	54.56
	8081106	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.19	CHEMBL1913	Homo sapiens	Inhibition	%	1.19
	8081330	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.24	CHEMBL1913	Homo sapiens	Inhibition	%	3.24
	8081474	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	10.44	CHEMBL1913	Homo sapiens	Inhibition	%	10.44
	8081801	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.85	CHEMBL1913	Homo sapiens	Inhibition	%	0.85
	8082053	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	85.96	CHEMBL1913	Homo sapiens	Inhibition	%	85.96
	8082390	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	7.02	CHEMBL1913	Homo sapiens	Inhibition	%	7.02
	8082563	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.91	CHEMBL1913	Homo sapiens	Inhibition	%	3.91
	8082910	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.12	CHEMBL1913	Homo sapiens	Inhibition	%	-0.12
	8083066	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	54.51	CHEMBL1913	Homo sapiens	Inhibition	%	54.51
	8083389	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	11.46	CHEMBL1913	Homo sapiens	Inhibition	%	11.46
	8083643	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.64	CHEMBL1913	Homo sapiens	Inhibition	%	4.64
	8083977	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.26	CHEMBL1913	Homo sapiens	Inhibition	%	4.26
	8084162	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	31.97	CHEMBL1913	Homo sapiens	Inhibition	%	31.97
	8084504	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.37	CHEMBL1913	Homo sapiens	Inhibition	%	4.37
	8084665	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	23.09	CHEMBL1913	Homo sapiens	Inhibition	%	23.09
	8084889	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	68.88	CHEMBL1913	Homo sapiens	Inhibition	%	68.88
	8084987	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-2.19	CHEMBL1913	Homo sapiens	Inhibition	%	-2.19
	8085243	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	26.44	CHEMBL1913	Homo sapiens	Inhibition	%	26.44
	8085467	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	6.26	CHEMBL1913	Homo sapiens	Inhibition	%	6.26
	8085575	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	29.62	CHEMBL1913	Homo sapiens	Inhibition	%	29.62
	8085764	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	63.2	CHEMBL1913	Homo sapiens	Inhibition	%	63.2
	8085988	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	82.78	CHEMBL1913	Homo sapiens	Inhibition	%	82.78
	8086103	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-1.0	CHEMBL1913	Homo sapiens	Inhibition	%	-1.0
	8086489	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.32	CHEMBL1913	Homo sapiens	Inhibition	%	7.32
	8086588	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	7.8	CHEMBL1913	Homo sapiens	Inhibition	%	7.8
	8086812	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.36	CHEMBL1913	Homo sapiens	Inhibition	%	0.36
	8087023	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.46	CHEMBL1913	Homo sapiens	Inhibition	%	5.46
	8087181	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	36.03	CHEMBL1913	Homo sapiens	Inhibition	%	36.03
	8087405	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.7	CHEMBL1913	Homo sapiens	Inhibition	%	-0.7
	8087519	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	70.87	CHEMBL1913	Homo sapiens	Inhibition	%	70.87
	8087881	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.41	CHEMBL1913	Homo sapiens	Inhibition	%	6.41
	8088023	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.44	CHEMBL1913	Homo sapiens	Inhibition	%	1.44
	8088395	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	Inhibition	%	4.0
	8088523	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	12.41	CHEMBL1913	Homo sapiens	Inhibition	%	12.41
	8088747	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	29.78	CHEMBL1913	Homo sapiens	Inhibition	%	29.78
	8088840	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.55	CHEMBL1913	Homo sapiens	Inhibition	%	2.55
	8089192	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	4.35	CHEMBL1913	Homo sapiens	Inhibition	%	4.35
	8089340	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	14.05	CHEMBL1913	Homo sapiens	Inhibition	%	14.05
	8089564	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	17.35	CHEMBL1913	Homo sapiens	Inhibition	%	17.35
	8089684	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	8.35	CHEMBL1913	Homo sapiens	Inhibition	%	8.35
	8089864	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.39	CHEMBL1913	Homo sapiens	Inhibition	%	0.39
	8090088	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.13	CHEMBL1913	Homo sapiens	Inhibition	%	2.13
	8090253	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.46	CHEMBL1913	Homo sapiens	Inhibition	%	1.46
	8090420	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	13.76	CHEMBL1913	Homo sapiens	Inhibition	%	13.76
	8090644	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.99	CHEMBL1913	Homo sapiens	Inhibition	%	1.99
	8090783	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	20.48	CHEMBL1913	Homo sapiens	Inhibition	%	20.48
	8090988	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.95	CHEMBL1913	Homo sapiens	Inhibition	%	5.95
	8091212	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.0	CHEMBL1913	Homo sapiens	Inhibition	%	3.0
	8091349	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	17.8	CHEMBL1913	Homo sapiens	Inhibition	%	17.8
	8091728	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.71	CHEMBL1913	Homo sapiens	Inhibition	%	0.71
	8091844	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	11.12	CHEMBL1913	Homo sapiens	Inhibition	%	11.12
	8092205	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	3.81	CHEMBL1913	Homo sapiens	Inhibition	%	3.81
	8092356	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.8	CHEMBL1913	Homo sapiens	Inhibition	%	4.8
	8092580	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.84	CHEMBL1913	Homo sapiens	Inhibition	%	4.84
	8092728	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	9.4	CHEMBL1913	Homo sapiens	Inhibition	%	9.4
	8093081	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	68.24	CHEMBL1913	Homo sapiens	Inhibition	%	68.24
	8093169	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.69	CHEMBL1913	Homo sapiens	Inhibition	%	5.69
	8093393	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.16	CHEMBL1913	Homo sapiens	Inhibition	%	6.16
	8093533	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	8.63	CHEMBL1913	Homo sapiens	Inhibition	%	8.63
	8093896	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	62.57	CHEMBL1913	Homo sapiens	Inhibition	%	62.57
	8094016	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.1	CHEMBL1913	Homo sapiens	Inhibition	%	4.1
	8094240	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	28.02	CHEMBL1913	Homo sapiens	Inhibition	%	28.02
	8094420	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.05	CHEMBL1913	Homo sapiens	Inhibition	%	0.05
	8094595	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.17	CHEMBL1913	Homo sapiens	Inhibition	%	5.17
	8094975	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	5.95	CHEMBL1913	Homo sapiens	Inhibition	%	5.95
	8095115	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	67.46	CHEMBL1913	Homo sapiens	Inhibition	%	67.46
	8095542	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.72	CHEMBL1913	Homo sapiens	Inhibition	%	4.72
	8095683	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.75	CHEMBL1913	Homo sapiens	Inhibition	%	8.75
	8096055	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.39	CHEMBL1913	Homo sapiens	Inhibition	%	3.39
	8096172	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	47.74	CHEMBL1913	Homo sapiens	Inhibition	%	47.74
	8096396	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.23	CHEMBL1913	Homo sapiens	Inhibition	%	2.23
	8096535	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.68	CHEMBL1913	Homo sapiens	Inhibition	%	5.68
	8096915	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	11.15	CHEMBL1913	Homo sapiens	Inhibition	%	11.15
	8097062	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.06	CHEMBL1913	Homo sapiens	Inhibition	%	3.06
	8097373	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	18.73	CHEMBL1913	Homo sapiens	Inhibition	%	18.73
	8097593	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	14.45	CHEMBL1913	Homo sapiens	Inhibition	%	14.45
	8097743	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	7.96	CHEMBL1913	Homo sapiens	Inhibition	%	7.96
	8098100	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	6.26	CHEMBL1913	Homo sapiens	Inhibition	%	6.26
	8098444	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.6	CHEMBL1913	Homo sapiens	Inhibition	%	0.6
	8098624	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.67	CHEMBL1913	Homo sapiens	Inhibition	%	2.67
	8098809	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	5.8	CHEMBL1913	Homo sapiens	Inhibition	%	5.8
	8099033	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	26.93	CHEMBL1913	Homo sapiens	Inhibition	%	26.93
	8099177	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.03	CHEMBL1913	Homo sapiens	Inhibition	%	3.03
	8099319	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	82.09	CHEMBL1913	Homo sapiens	Inhibition	%	82.09
	8099543	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	8.96	CHEMBL1913	Homo sapiens	Inhibition	%	8.96
	8099737	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.34	CHEMBL1913	Homo sapiens	Inhibition	%	2.34
	8099884	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	37.19	CHEMBL1913	Homo sapiens	Inhibition	%	37.19
	8100108	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	7.34	CHEMBL1913	Homo sapiens	Inhibition	%	7.34
	8100254	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.26	CHEMBL1913	Homo sapiens	Inhibition	%	6.26
	8100594	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	9.63	CHEMBL1913	Homo sapiens	Inhibition	%	9.63
	8100734	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.07	CHEMBL1913	Homo sapiens	Inhibition	%	3.07
	8100958	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	4.43	CHEMBL1913	Homo sapiens	Inhibition	%	4.43
	8101118	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.16	CHEMBL1913	Homo sapiens	Inhibition	%	5.16
	8101260	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.24	CHEMBL1913	Homo sapiens	Inhibition	%	4.24
	8101484	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	22.99	CHEMBL1913	Homo sapiens	Inhibition	%	22.99
	8101669	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.46	CHEMBL1913	Homo sapiens	Inhibition	%	5.46
	8101922	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	54.97	CHEMBL1913	Homo sapiens	Inhibition	%	54.97
	8102077	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	50.76	CHEMBL1913	Homo sapiens	Inhibition	%	50.76
	8102301	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	42.11	CHEMBL1913	Homo sapiens	Inhibition	%	42.11
	8102432	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	16.24	CHEMBL1913	Homo sapiens	Inhibition	%	16.24
	8102776	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	8.32	CHEMBL1913	Homo sapiens	Inhibition	%	8.32
	8102954	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.23	CHEMBL1913	Homo sapiens	Inhibition	%	-0.23
	8103374	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	13.02	CHEMBL1913	Homo sapiens	Inhibition	%	13.02
	8103512	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.87	CHEMBL1913	Homo sapiens	Inhibition	%	5.87
	8103886	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	21.5	CHEMBL1913	Homo sapiens	Inhibition	%	21.5
	8104071	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	16.77	CHEMBL1913	Homo sapiens	Inhibition	%	16.77
	8104443	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	21.05	CHEMBL1913	Homo sapiens	Inhibition	%	21.05
	8104589	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	12.08	CHEMBL1913	Homo sapiens	Inhibition	%	12.08
	8104927	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.5	CHEMBL1913	Homo sapiens	Inhibition	%	2.5
	8105291	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.08	CHEMBL1913	Homo sapiens	Inhibition	%	2.08
	8105457	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	11.38	CHEMBL1913	Homo sapiens	Inhibition	%	11.38
	8105819	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	74.18	CHEMBL1913	Homo sapiens	Inhibition	%	74.18
	8106099	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.29	CHEMBL1913	Homo sapiens	Inhibition	%	3.29
	8106264	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	81.13	CHEMBL1913	Homo sapiens	Inhibition	%	81.13
	8106644	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	84.05	CHEMBL1913	Homo sapiens	Inhibition	%	84.05
	8106773	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	19.19	CHEMBL1913	Homo sapiens	Inhibition	%	19.19
	8106997	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	63.8	CHEMBL1913	Homo sapiens	Inhibition	%	63.8
	8107118	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.04	CHEMBL1913	Homo sapiens	Inhibition	%	2.04
	8107290	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.57	CHEMBL1913	Homo sapiens	Inhibition	%	0.57
	8107514	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.03	CHEMBL1913	Homo sapiens	Inhibition	%	3.03
	8107715	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	57.21	CHEMBL1913	Homo sapiens	Inhibition	%	57.21
	8107850	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	11.52	CHEMBL1913	Homo sapiens	Inhibition	%	11.52
	8108074	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	54.2	CHEMBL1913	Homo sapiens	Inhibition	%	54.2
	8108232	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	9.81	CHEMBL1913	Homo sapiens	Inhibition	%	9.81
	8108407	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	12.18	CHEMBL1913	Homo sapiens	Inhibition	%	12.18
	8108631	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	28.69	CHEMBL1913	Homo sapiens	Inhibition	%	28.69
	8108778	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	39.83	CHEMBL1913	Homo sapiens	Inhibition	%	39.83
	8108920	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	50.36	CHEMBL1913	Homo sapiens	Inhibition	%	50.36
	8109144	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.33	CHEMBL1913	Homo sapiens	Inhibition	%	2.33
	8109258	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.37	CHEMBL1913	Homo sapiens	Inhibition	%	5.37
	8109612	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	4.24	CHEMBL1913	Homo sapiens	Inhibition	%	4.24
	8109783	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	26.27	CHEMBL1913	Homo sapiens	Inhibition	%	26.27
	8110139	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	20.46	CHEMBL1913	Homo sapiens	Inhibition	%	20.46
	8110418	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	6.94	CHEMBL1913	Homo sapiens	Inhibition	%	6.94
	8110584	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	6.34	CHEMBL1913	Homo sapiens	Inhibition	%	6.34
	8110808	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	14.1	CHEMBL1913	Homo sapiens	Inhibition	%	14.1
	8110966	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	9.08	CHEMBL1913	Homo sapiens	Inhibition	%	9.08
	8111313	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	40.39	CHEMBL1913	Homo sapiens	Inhibition	%	40.39
	8111440	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.09	CHEMBL1913	Homo sapiens	Inhibition	%	3.09
	8111830	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	5.82	CHEMBL1913	Homo sapiens	Inhibition	%	5.82
	8112035	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.93	CHEMBL1913	Homo sapiens	Inhibition	%	7.93
	8112396	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.11	CHEMBL1913	Homo sapiens	Inhibition	%	3.11
	8112564	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	44.21	CHEMBL1913	Homo sapiens	Inhibition	%	44.21
	8112960	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.39	CHEMBL1913	Homo sapiens	Inhibition	%	0.39
	8113112	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	84.68	CHEMBL1913	Homo sapiens	Inhibition	%	84.68
	8113472	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	7.33	CHEMBL1913	Homo sapiens	Inhibition	%	7.33
	8113596	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.28	CHEMBL1913	Homo sapiens	Inhibition	%	4.28
	8113820	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	7.07	CHEMBL1913	Homo sapiens	Inhibition	%	7.07
	8113936	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.36	CHEMBL1913	Homo sapiens	Inhibition	%	-0.36
	8114112	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	70.77	CHEMBL1913	Homo sapiens	Inhibition	%	70.77
	8114336	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	7.32	CHEMBL1913	Homo sapiens	Inhibition	%	7.32
	8114468	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	62.88	CHEMBL1913	Homo sapiens	Inhibition	%	62.88
	8114744	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	6.66	CHEMBL1913	Homo sapiens	Inhibition	%	6.66
	8115134	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	48.54	CHEMBL1913	Homo sapiens	Inhibition	%	48.54
	8115299	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	25.51	CHEMBL1913	Homo sapiens	Inhibition	%	25.51
	8115643	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	56.33	CHEMBL1913	Homo sapiens	Inhibition	%	56.33
	8115776	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	8.36	CHEMBL1913	Homo sapiens	Inhibition	%	8.36
	8116000	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	47.2	CHEMBL1913	Homo sapiens	Inhibition	%	47.2
	8116159	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	38.74	CHEMBL1913	Homo sapiens	Inhibition	%	38.74
	8116362	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	37.2	CHEMBL1913	Homo sapiens	Inhibition	%	37.2
	8116720	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	5.79	CHEMBL1913	Homo sapiens	Inhibition	%	5.79
	8116892	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	14.79	CHEMBL1913	Homo sapiens	Inhibition	%	14.79
	8117116	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	53.44	CHEMBL1913	Homo sapiens	Inhibition	%	53.44
	8117287	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	5.15	CHEMBL1913	Homo sapiens	Inhibition	%	5.15
	8117445	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.31	CHEMBL1913	Homo sapiens	Inhibition	%	3.31
	8117799	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.08	CHEMBL1913	Homo sapiens	Inhibition	%	2.08
	8118161	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	5.46	CHEMBL1913	Homo sapiens	Inhibition	%	5.46
	8118277	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	3.03	CHEMBL1913	Homo sapiens	Inhibition	%	3.03
	8118673	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	13.56	CHEMBL1913	Homo sapiens	Inhibition	%	13.56
	8118809	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	7.85	CHEMBL1913	Homo sapiens	Inhibition	%	7.85
	8119033	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	15.01	CHEMBL1913	Homo sapiens	Inhibition	%	15.01
	8119080	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	9.04	CHEMBL1913	Homo sapiens	Inhibition	%	9.04
	8119304	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.12	CHEMBL1913	Homo sapiens	Inhibition	%	2.12
	8119463	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	86.67	CHEMBL1913	Homo sapiens	Inhibition	%	86.67
	8119630	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	6.88	CHEMBL1913	Homo sapiens	Inhibition	%	6.88
	8119854	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	9.6	CHEMBL1913	Homo sapiens	Inhibition	%	9.6
	8119973	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.34	CHEMBL1913	Homo sapiens	Inhibition	%	3.34
	8120336	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.08	CHEMBL1913	Homo sapiens	Inhibition	%	2.08
	8120496	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	72.35	CHEMBL1913	Homo sapiens	Inhibition	%	72.35
	8120697	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.33	CHEMBL1913	Homo sapiens	Inhibition	%	5.33
	8120921	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	41.1	CHEMBL1913	Homo sapiens	Inhibition	%	41.1
	8121049	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	4.34	CHEMBL1913	Homo sapiens	Inhibition	%	4.34
	8121445	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.34	CHEMBL1913	Homo sapiens	Inhibition	%	2.34
	8121612	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	29.62	CHEMBL1913	Homo sapiens	Inhibition	%	29.62
	8121775	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	24.17	CHEMBL1913	Homo sapiens	Inhibition	%	24.17
	8121999	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.3	CHEMBL1913	Homo sapiens	Inhibition	%	4.3
	8122120	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	5.7	CHEMBL1913	Homo sapiens	Inhibition	%	5.7
	8122482	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	10.56	CHEMBL1913	Homo sapiens	Inhibition	%	10.56
	8122602	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.5	CHEMBL1913	Homo sapiens	Inhibition	%	2.5
	8122826	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.5	CHEMBL1913	Homo sapiens	Inhibition	%	1.5
	8122993	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	8.14	CHEMBL1913	Homo sapiens	Inhibition	%	8.14
	8123359	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	45.0	CHEMBL1913	Homo sapiens	Inhibition	%	45.0
	8123637	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	14.96	CHEMBL1913	Homo sapiens	Inhibition	%	14.96
	8123787	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	18.11	CHEMBL1913	Homo sapiens	Inhibition	%	18.11
	8124178	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	13.18	CHEMBL1913	Homo sapiens	Inhibition	%	13.18
	8124297	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	9.07	CHEMBL1913	Homo sapiens	Inhibition	%	9.07
	8124660	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	4.63	CHEMBL1913	Homo sapiens	Inhibition	%	4.63
	8124825	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.18	CHEMBL1913	Homo sapiens	Inhibition	%	2.18
	8125049	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	6.66	CHEMBL1913	Homo sapiens	Inhibition	%	6.66
	8125250	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.82	CHEMBL1913	Homo sapiens	Inhibition	%	1.82
	8125380	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	29.8	CHEMBL1913	Homo sapiens	Inhibition	%	29.8
	8125772	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.85	CHEMBL1913	Homo sapiens	Inhibition	%	0.85
	8125936	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	58.5	CHEMBL1913	Homo sapiens	Inhibition	%	58.5
	8126324	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	14.37	CHEMBL1913	Homo sapiens	Inhibition	%	14.37
	8126439	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	28.9	CHEMBL1913	Homo sapiens	Inhibition	%	28.9
	8126663	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	81.43	CHEMBL1913	Homo sapiens	Inhibition	%	81.43
	8126799	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	56.45	CHEMBL1913	Homo sapiens	Inhibition	%	56.45
	8127145	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.57	CHEMBL1913	Homo sapiens	Inhibition	%	2.57
	8127312	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	11.89	CHEMBL1913	Homo sapiens	Inhibition	%	11.89
	8127678	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	83.5	CHEMBL1913	Homo sapiens	Inhibition	%	83.5
	8127966	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.58	CHEMBL1913	Homo sapiens	Inhibition	%	0.58
	8128118	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	68.91	CHEMBL1913	Homo sapiens	Inhibition	%	68.91
	8128509	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	49.91	CHEMBL1913	Homo sapiens	Inhibition	%	49.91
	8128628	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	23.92	CHEMBL1913	Homo sapiens	Inhibition	%	23.92
	8128852	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	70.01	CHEMBL1913	Homo sapiens	Inhibition	%	70.01
	8128989	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.34	CHEMBL1913	Homo sapiens	Inhibition	%	-0.34
	8129384	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.38	CHEMBL1913	Homo sapiens	Inhibition	%	2.38
	8129573	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	13.79	CHEMBL1913	Homo sapiens	Inhibition	%	13.79
	8129712	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.07	CHEMBL1913	Homo sapiens	Inhibition	%	1.07
	8129936	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	4.59	CHEMBL1913	Homo sapiens	Inhibition	%	4.59
	8130097	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.11	CHEMBL1913	Homo sapiens	Inhibition	%	2.11
	8130269	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.08	CHEMBL1913	Homo sapiens	Inhibition	%	3.08
	8130493	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	4.95	CHEMBL1913	Homo sapiens	Inhibition	%	4.95
	8130653	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	29.08	CHEMBL1913	Homo sapiens	Inhibition	%	29.08
	8130993	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.81	CHEMBL1913	Homo sapiens	Inhibition	%	-0.81
	8131132	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	86.76	CHEMBL1913	Homo sapiens	Inhibition	%	86.76
	8131476	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.75	CHEMBL1913	Homo sapiens	Inhibition	%	3.75
	8131643	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	35.71	CHEMBL1913	Homo sapiens	Inhibition	%	35.71
	8131867	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	83.49	CHEMBL1913	Homo sapiens	Inhibition	%	83.49
	8132008	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	69.44	CHEMBL1913	Homo sapiens	Inhibition	%	69.44
	8132294	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	10.39	CHEMBL1913	Homo sapiens	Inhibition	%	10.39
	8132441	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.76	CHEMBL1913	Homo sapiens	Inhibition	%	5.76
	8132665	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	10.04	CHEMBL1913	Homo sapiens	Inhibition	%	10.04
	8132833	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	7.75	CHEMBL1913	Homo sapiens	Inhibition	%	7.75
	8133178	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.92	CHEMBL1913	Homo sapiens	Inhibition	%	3.92
	8133316	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	4.95	CHEMBL1913	Homo sapiens	Inhibition	%	4.95
	8133712	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	9.14	CHEMBL1913	Homo sapiens	Inhibition	%	9.14
	8133892	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	60.28	CHEMBL1913	Homo sapiens	Inhibition	%	60.28
	8134264	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.93	CHEMBL1913	Homo sapiens	Inhibition	%	1.93
	8134424	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.09	CHEMBL1913	Homo sapiens	Inhibition	%	3.09
	8134832	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	6.47	CHEMBL1913	Homo sapiens	Inhibition	%	6.47
	8134992	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	71.78	CHEMBL1913	Homo sapiens	Inhibition	%	71.78
	8135331	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.5	CHEMBL1913	Homo sapiens	Inhibition	%	1.5
	8135472	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.12	CHEMBL1913	Homo sapiens	Inhibition	%	8.12
	8135696	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	Inhibition	%	8.0
	8135817	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.81	CHEMBL1913	Homo sapiens	Inhibition	%	3.81
	8136209	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.05	CHEMBL1913	Homo sapiens	Inhibition	%	4.05
	8136353	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	94.81	CHEMBL1913	Homo sapiens	Inhibition	%	94.81
	8136643	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.52	CHEMBL1913	Homo sapiens	Inhibition	%	0.52
	8137002	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.34	CHEMBL1913	Homo sapiens	Inhibition	%	1.34
	8137165	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	20.0	CHEMBL1913	Homo sapiens	Inhibition	%	20.0
	8137509	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	13.78	CHEMBL1913	Homo sapiens	Inhibition	%	13.78
	8137657	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-0.56	CHEMBL1913	Homo sapiens	Inhibition	%	-0.56
	8137881	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	5.87	CHEMBL1913	Homo sapiens	Inhibition	%	5.87
	8138047	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.07	CHEMBL1913	Homo sapiens	Inhibition	%	1.07
	8138226	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	79.34	CHEMBL1913	Homo sapiens	Inhibition	%	79.34
	8138450	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.68	CHEMBL1913	Homo sapiens	Inhibition	%	6.68
	8138598	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	11.23	CHEMBL1913	Homo sapiens	Inhibition	%	11.23
	8138756	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.42	CHEMBL1913	Homo sapiens	Inhibition	%	1.42
	8138980	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.8	CHEMBL1913	Homo sapiens	Inhibition	%	-0.8
	8139165	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	37.97	CHEMBL1913	Homo sapiens	Inhibition	%	37.97
	8139324	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.53	CHEMBL1913	Homo sapiens	Inhibition	%	4.53
	8139548	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	13.41	CHEMBL1913	Homo sapiens	Inhibition	%	13.41
	8139662	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.55	CHEMBL1913	Homo sapiens	Inhibition	%	1.55
	8140027	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.69	CHEMBL1913	Homo sapiens	Inhibition	%	4.69
	8140150	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.22	CHEMBL1913	Homo sapiens	Inhibition	%	3.22
	8140374	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.49	CHEMBL1913	Homo sapiens	Inhibition	%	4.49
	8140533	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	11.0	CHEMBL1913	Homo sapiens	Inhibition	%	11.0
	8140676	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.36	CHEMBL1913	Homo sapiens	Inhibition	%	7.36
	8140900	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	12.7	CHEMBL1913	Homo sapiens	Inhibition	%	12.7
	8140978	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.38	CHEMBL1913	Homo sapiens	Inhibition	%	2.38
	8141202	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.46	CHEMBL1913	Homo sapiens	Inhibition	%	1.46
	8141332	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	6.02	CHEMBL1913	Homo sapiens	Inhibition	%	6.02
	8141492	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	27.13	CHEMBL1913	Homo sapiens	Inhibition	%	27.13
	8141716	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	78.83	CHEMBL1913	Homo sapiens	Inhibition	%	78.83
	8141835	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	7.03	CHEMBL1913	Homo sapiens	Inhibition	%	7.03
	8142220	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	4.03	CHEMBL1913	Homo sapiens	Inhibition	%	4.03
	8142388	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.62	CHEMBL1913	Homo sapiens	Inhibition	%	3.62
	8142788	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	10.09	CHEMBL1913	Homo sapiens	Inhibition	%	10.09
	8142937	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.76	CHEMBL1913	Homo sapiens	Inhibition	%	0.76
	8143316	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.04	CHEMBL1913	Homo sapiens	Inhibition	%	3.04
	8143503	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.08	CHEMBL1913	Homo sapiens	Inhibition	%	0.08
	8143886	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	35.37	CHEMBL1913	Homo sapiens	Inhibition	%	35.37
	8144000	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.0	CHEMBL1913	Homo sapiens	Inhibition	%	2.0
	8144224	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.75	CHEMBL1913	Homo sapiens	Inhibition	%	3.75
	8144363	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	Inhibition	%	8.0
	8144717	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.24	CHEMBL1913	Homo sapiens	Inhibition	%	5.24
	8144870	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.45	CHEMBL1913	Homo sapiens	Inhibition	%	3.45
	8145231	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.51	CHEMBL1913	Homo sapiens	Inhibition	%	5.51
	8145544	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.27	CHEMBL1913	Homo sapiens	Inhibition	%	3.27
	8145668	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.45	CHEMBL1913	Homo sapiens	Inhibition	%	1.45
	8146053	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	52.41	CHEMBL1913	Homo sapiens	Inhibition	%	52.41
	8146173	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	26.25	CHEMBL1913	Homo sapiens	Inhibition	%	26.25
	8146397	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	4.35	CHEMBL1913	Homo sapiens	Inhibition	%	4.35
	8146557	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	20.62	CHEMBL1913	Homo sapiens	Inhibition	%	20.62
	8146724	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	56.27	CHEMBL1913	Homo sapiens	Inhibition	%	56.27
	8146948	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	81.49	CHEMBL1913	Homo sapiens	Inhibition	%	81.49
	8147117	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	7.22	CHEMBL1913	Homo sapiens	Inhibition	%	7.22
	8147259	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.4	CHEMBL1913	Homo sapiens	Inhibition	%	2.4
	8147483	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	7.48	CHEMBL1913	Homo sapiens	Inhibition	%	7.48
	8147636	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.64	CHEMBL1913	Homo sapiens	Inhibition	%	3.64
	8147823	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.27	CHEMBL1913	Homo sapiens	Inhibition	%	2.27
	8148047	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.55	CHEMBL1913	Homo sapiens	Inhibition	%	1.55
	8148205	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	85.22	CHEMBL1913	Homo sapiens	Inhibition	%	85.22
	8148543	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	7.34	CHEMBL1913	Homo sapiens	Inhibition	%	7.34
	8148682	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.31	CHEMBL1913	Homo sapiens	Inhibition	%	3.31
	8149044	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.31	CHEMBL1913	Homo sapiens	Inhibition	%	4.31
	8149203	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	6.26	CHEMBL1913	Homo sapiens	Inhibition	%	6.26
	8149427	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	4.64	CHEMBL1913	Homo sapiens	Inhibition	%	4.64
	8149561	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	12.18	CHEMBL1913	Homo sapiens	Inhibition	%	12.18
	8149883	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	8.91	CHEMBL1913	Homo sapiens	Inhibition	%	8.91
	8150008	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	5.96	CHEMBL1913	Homo sapiens	Inhibition	%	5.96
	8150232	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	12.06	CHEMBL1913	Homo sapiens	Inhibition	%	12.06
	8150392	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	77.68	CHEMBL1913	Homo sapiens	Inhibition	%	77.68
	8150736	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	16.52	CHEMBL1913	Homo sapiens	Inhibition	%	16.52
	8150901	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	10.44	CHEMBL1913	Homo sapiens	Inhibition	%	10.44
	8151288	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.82	CHEMBL1913	Homo sapiens	Inhibition	%	1.82
	8151465	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	17.31	CHEMBL1913	Homo sapiens	Inhibition	%	17.31
	8151827	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	37.11	CHEMBL1913	Homo sapiens	Inhibition	%	37.11
	8151981	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.23	CHEMBL1913	Homo sapiens	Inhibition	%	-0.23
	8152393	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.26	CHEMBL1913	Homo sapiens	Inhibition	%	6.26
	8152551	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	10.79	CHEMBL1913	Homo sapiens	Inhibition	%	10.79
	8152889	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	20.86	CHEMBL1913	Homo sapiens	Inhibition	%	20.86
	8153028	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	9.17	CHEMBL1913	Homo sapiens	Inhibition	%	9.17
	8153252	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.48	CHEMBL1913	Homo sapiens	Inhibition	%	2.48
	8153389	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.41	CHEMBL1913	Homo sapiens	Inhibition	%	6.41
	8153770	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	6.45	CHEMBL1913	Homo sapiens	Inhibition	%	6.45
	8153903	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	16.22	CHEMBL1913	Homo sapiens	Inhibition	%	16.22
	8154224	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	49.69	CHEMBL1913	Homo sapiens	Inhibition	%	49.69
	8154574	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	58.34	CHEMBL1913	Homo sapiens	Inhibition	%	58.34
	8154733	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.41	CHEMBL1913	Homo sapiens	Inhibition	%	4.41
	8155077	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.39	CHEMBL1913	Homo sapiens	Inhibition	%	3.39
	8155253	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	33.93	CHEMBL1913	Homo sapiens	Inhibition	%	33.93
	8155638	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	6.94	CHEMBL1913	Homo sapiens	Inhibition	%	6.94
	8155816	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.03	CHEMBL1913	Homo sapiens	Inhibition	%	4.03
	8156178	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.67	CHEMBL1913	Homo sapiens	Inhibition	%	7.67
	8156390	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	11.62	CHEMBL1913	Homo sapiens	Inhibition	%	11.62
	8156764	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	84.27	CHEMBL1913	Homo sapiens	Inhibition	%	84.27
	8156907	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	12.02	CHEMBL1913	Homo sapiens	Inhibition	%	12.02
	8157251	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	8.62	CHEMBL1913	Homo sapiens	Inhibition	%	8.62
	8157616	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	10.27	CHEMBL1913	Homo sapiens	Inhibition	%	10.27
	8157746	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	31.14	CHEMBL1913	Homo sapiens	Inhibition	%	31.14
	8158131	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	10.01	CHEMBL1913	Homo sapiens	Inhibition	%	10.01
	8158381	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	13.19	CHEMBL1913	Homo sapiens	Inhibition	%	13.19
	8158539	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.34	CHEMBL1913	Homo sapiens	Inhibition	%	6.34
	8158763	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	13.44	CHEMBL1913	Homo sapiens	Inhibition	%	13.44
	8158932	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.6	CHEMBL1913	Homo sapiens	Inhibition	%	3.6
	8159067	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.33	CHEMBL1913	Homo sapiens	Inhibition	%	5.33
	8159291	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.59	CHEMBL1913	Homo sapiens	Inhibition	%	1.59
	8159411	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.69	CHEMBL1913	Homo sapiens	Inhibition	%	3.69
	8159766	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	26.15	CHEMBL1913	Homo sapiens	Inhibition	%	26.15
	8159907	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.66	CHEMBL1913	Homo sapiens	Inhibition	%	3.66
	8160131	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.62	CHEMBL1913	Homo sapiens	Inhibition	%	4.62
	8160268	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.42	CHEMBL1913	Homo sapiens	Inhibition	%	2.42
	8160418	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	25.55	CHEMBL1913	Homo sapiens	Inhibition	%	25.55
	8160642	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	5.21	CHEMBL1913	Homo sapiens	Inhibition	%	5.21
	8160712	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	8.16	CHEMBL1913	Homo sapiens	Inhibition	%	8.16
	8160936	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	24.53	CHEMBL1913	Homo sapiens	Inhibition	%	24.53
	8161086	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	33.66	CHEMBL1913	Homo sapiens	Inhibition	%	33.66
	8161229	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	46.57	CHEMBL1913	Homo sapiens	Inhibition	%	46.57
	8161453	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	18.43	CHEMBL1913	Homo sapiens	Inhibition	%	18.43
	8161578	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	12.24	CHEMBL1913	Homo sapiens	Inhibition	%	12.24
	8161940	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	38.0	CHEMBL1913	Homo sapiens	Inhibition	%	38.0
	8162070	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.25	CHEMBL1913	Homo sapiens	Inhibition	%	3.25
	8162294	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	9.91	CHEMBL1913	Homo sapiens	Inhibition	%	9.91
	8162454	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	14.13	CHEMBL1913	Homo sapiens	Inhibition	%	14.13
	8162707	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.13	CHEMBL1913	Homo sapiens	Inhibition	%	4.13
	8163079	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	73.23	CHEMBL1913	Homo sapiens	Inhibition	%	73.23
	8163248	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	14.05	CHEMBL1913	Homo sapiens	Inhibition	%	14.05
	8163606	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.35	CHEMBL1913	Homo sapiens	Inhibition	%	5.35
	8163729	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.36	CHEMBL1913	Homo sapiens	Inhibition	%	1.36
	8163953	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	5.75	CHEMBL1913	Homo sapiens	Inhibition	%	5.75
	8164087	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	6.16	CHEMBL1913	Homo sapiens	Inhibition	%	6.16
	8164451	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.64	CHEMBL1913	Homo sapiens	Inhibition	%	5.64
	8164606	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.2	CHEMBL1913	Homo sapiens	Inhibition	%	8.2
	8164974	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	30.31	CHEMBL1913	Homo sapiens	Inhibition	%	30.31
	8165268	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.26	CHEMBL1913	Homo sapiens	Inhibition	%	7.26
	8165409	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	77.1	CHEMBL1913	Homo sapiens	Inhibition	%	77.1
	8165776	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	67.26	CHEMBL1913	Homo sapiens	Inhibition	%	67.26
	8165902	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.9	CHEMBL1913	Homo sapiens	Inhibition	%	4.9
	8166126	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.43	CHEMBL1913	Homo sapiens	Inhibition	%	3.43
	8166264	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	12.7	CHEMBL1913	Homo sapiens	Inhibition	%	12.7
	8166618	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.66	CHEMBL1913	Homo sapiens	Inhibition	%	5.66
	8166719	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	74.37	CHEMBL1913	Homo sapiens	Inhibition	%	74.37
	8166943	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	87.53	CHEMBL1913	Homo sapiens	Inhibition	%	87.53
	8167031	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	10.66	CHEMBL1913	Homo sapiens	Inhibition	%	10.66
	8167396	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	89.79	CHEMBL1913	Homo sapiens	Inhibition	%	89.79
	8167560	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.17	CHEMBL1913	Homo sapiens	Inhibition	%	3.17
	8167917	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.06	CHEMBL1913	Homo sapiens	Inhibition	%	5.06
	8168265	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.65	CHEMBL1913	Homo sapiens	Inhibition	%	3.65
	8168406	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	32.21	CHEMBL1913	Homo sapiens	Inhibition	%	32.21
	8168766	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.35	CHEMBL1913	Homo sapiens	Inhibition	%	5.35
	8168930	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	27.2	CHEMBL1913	Homo sapiens	Inhibition	%	27.2
	8169154	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	65.09	CHEMBL1913	Homo sapiens	Inhibition	%	65.09
	8169296	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.96	CHEMBL1913	Homo sapiens	Inhibition	%	3.96
	8169600	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	27.05	CHEMBL1913	Homo sapiens	Inhibition	%	27.05
	8169734	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	7.6	CHEMBL1913	Homo sapiens	Inhibition	%	7.6
	8169958	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	14.05	CHEMBL1913	Homo sapiens	Inhibition	%	14.05
	8170103	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	67.81	CHEMBL1913	Homo sapiens	Inhibition	%	67.81
	8170452	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.52	CHEMBL1913	Homo sapiens	Inhibition	%	2.52
	8170592	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	38.05	CHEMBL1913	Homo sapiens	Inhibition	%	38.05
	8170951	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	17.06	CHEMBL1913	Homo sapiens	Inhibition	%	17.06
	8171148	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	25.77	CHEMBL1913	Homo sapiens	Inhibition	%	25.77
	8171365	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.12	CHEMBL1913	Homo sapiens	Inhibition	%	2.12
	8171589	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	9.39	CHEMBL1913	Homo sapiens	Inhibition	%	9.39
	8171730	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	15.14	CHEMBL1913	Homo sapiens	Inhibition	%	15.14
	8171883	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	9.27	CHEMBL1913	Homo sapiens	Inhibition	%	9.27
	8172107	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	12.24	CHEMBL1913	Homo sapiens	Inhibition	%	12.24
	8172239	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.28	CHEMBL1913	Homo sapiens	Inhibition	%	4.28
	8172591	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	6.86	CHEMBL1913	Homo sapiens	Inhibition	%	6.86
	8172733	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.83	CHEMBL1913	Homo sapiens	Inhibition	%	4.83
	8172957	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	18.22	CHEMBL1913	Homo sapiens	Inhibition	%	18.22
	8173093	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.91	CHEMBL1913	Homo sapiens	Inhibition	%	0.91
	8173482	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	44.95	CHEMBL1913	Homo sapiens	Inhibition	%	44.95
	8173623	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	8.42	CHEMBL1913	Homo sapiens	Inhibition	%	8.42
	8173934	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	38.61	CHEMBL1913	Homo sapiens	Inhibition	%	38.61
	8174290	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	9.77	CHEMBL1913	Homo sapiens	Inhibition	%	9.77
	8174438	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	81.48	CHEMBL1913	Homo sapiens	Inhibition	%	81.48
	8174784	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	10.2	CHEMBL1913	Homo sapiens	Inhibition	%	10.2
	8174927	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	12.06	CHEMBL1913	Homo sapiens	Inhibition	%	12.06
	8175151	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	44.62	CHEMBL1913	Homo sapiens	Inhibition	%	44.62
	8175287	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	9.63	CHEMBL1913	Homo sapiens	Inhibition	%	9.63
	8175543	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	7.25	CHEMBL1913	Homo sapiens	Inhibition	%	7.25
	8175930	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	18.18	CHEMBL1913	Homo sapiens	Inhibition	%	18.18
	8176083	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	62.66	CHEMBL1913	Homo sapiens	Inhibition	%	62.66
	8176456	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	51.14	CHEMBL1913	Homo sapiens	Inhibition	%	51.14
	8176588	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	19.67	CHEMBL1913	Homo sapiens	Inhibition	%	19.67
	8176812	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	56.74	CHEMBL1913	Homo sapiens	Inhibition	%	56.74
	8176942	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	15.29	CHEMBL1913	Homo sapiens	Inhibition	%	15.29
	8177308	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	9.66	CHEMBL1913	Homo sapiens	Inhibition	%	9.66
	8177446	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	5.08	CHEMBL1913	Homo sapiens	Inhibition	%	5.08
	8177834	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	81.18	CHEMBL1913	Homo sapiens	Inhibition	%	81.18
	8177974	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.45	CHEMBL1913	Homo sapiens	Inhibition	%	1.45
	8178198	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%		CHEMBL1913	Homo sapiens	Inhibition	%	
	8178286	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	82.65	CHEMBL1913	Homo sapiens	Inhibition	%	82.65
	8178637	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	36.73	CHEMBL1913	Homo sapiens	Inhibition	%	36.73
	8178786	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	9.04	CHEMBL1913	Homo sapiens	Inhibition	%	9.04
	8179010	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	8.57	CHEMBL1913	Homo sapiens	Inhibition	%	8.57
	8179133	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.77	CHEMBL1913	Homo sapiens	Inhibition	%	2.77
	8179501	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	45.57	CHEMBL1913	Homo sapiens	Inhibition	%	45.57
	8179638	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	40.77	CHEMBL1913	Homo sapiens	Inhibition	%	40.77
	8179862	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.14	CHEMBL1913	Homo sapiens	Inhibition	%	3.14
	8179895	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	33.35	CHEMBL1913	Homo sapiens	Inhibition	%	33.35
	8180119	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.43	CHEMBL1913	Homo sapiens	Inhibition	%	2.43
	8180273	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	61.61	CHEMBL1913	Homo sapiens	Inhibition	%	61.61
	8180429	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.08	CHEMBL1913	Homo sapiens	Inhibition	%	9.08
	8180653	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	37.26	CHEMBL1913	Homo sapiens	Inhibition	%	37.26
	8180801	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	26.79	CHEMBL1913	Homo sapiens	Inhibition	%	26.79
	8181158	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	63.84	CHEMBL1913	Homo sapiens	Inhibition	%	63.84
	8181289	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	65.58	CHEMBL1913	Homo sapiens	Inhibition	%	65.58
	8181653	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	49.51	CHEMBL1913	Homo sapiens	Inhibition	%	49.51
	8181792	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	78.21	CHEMBL1913	Homo sapiens	Inhibition	%	78.21
	8182016	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	85.09	CHEMBL1913	Homo sapiens	Inhibition	%	85.09
	8182179	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	10.94	CHEMBL1913	Homo sapiens	Inhibition	%	10.94
	8182543	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.15	CHEMBL1913	Homo sapiens	Inhibition	%	2.15
	8182635	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.18	CHEMBL1913	Homo sapiens	Inhibition	%	2.18
	8182859	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	6.43	CHEMBL1913	Homo sapiens	Inhibition	%	6.43
	8182981	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	12.81	CHEMBL1913	Homo sapiens	Inhibition	%	12.81
	8183354	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	43.73	CHEMBL1913	Homo sapiens	Inhibition	%	43.73
	8183483	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.63	CHEMBL1913	Homo sapiens	Inhibition	%	5.63
	8183707	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	9.78	CHEMBL1913	Homo sapiens	Inhibition	%	9.78
	8183849	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	85.26	CHEMBL1913	Homo sapiens	Inhibition	%	85.26
	8184209	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	8.69	CHEMBL1913	Homo sapiens	Inhibition	%	8.69
	8184475	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	7.79	CHEMBL1913	Homo sapiens	Inhibition	%	7.79
	8184622	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.02	CHEMBL1913	Homo sapiens	Inhibition	%	3.02
	8185003	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	29.34	CHEMBL1913	Homo sapiens	Inhibition	%	29.34
	8185152	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	71.29	CHEMBL1913	Homo sapiens	Inhibition	%	71.29
	8185507	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	84.2	CHEMBL1913	Homo sapiens	Inhibition	%	84.2
	8185638	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	9.96	CHEMBL1913	Homo sapiens	Inhibition	%	9.96
	8185862	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	43.06	CHEMBL1913	Homo sapiens	Inhibition	%	43.06
	8186001	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.45	CHEMBL1913	Homo sapiens	Inhibition	%	6.45
	8186366	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	9.04	CHEMBL1913	Homo sapiens	Inhibition	%	9.04
	8186530	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	42.91	CHEMBL1913	Homo sapiens	Inhibition	%	42.91
	8186893	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.62	CHEMBL1913	Homo sapiens	Inhibition	%	3.62
	8187215	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	9.04	CHEMBL1913	Homo sapiens	Inhibition	%	9.04
	8187339	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	45.26	CHEMBL1913	Homo sapiens	Inhibition	%	45.26
	8187563	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.02	CHEMBL1913	Homo sapiens	Inhibition	%	4.02
	8187711	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	74.76	CHEMBL1913	Homo sapiens	Inhibition	%	74.76
	8188064	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	17.43	CHEMBL1913	Homo sapiens	Inhibition	%	17.43
	8188207	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	11.14	CHEMBL1913	Homo sapiens	Inhibition	%	11.14
	8188566	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	52.39	CHEMBL1913	Homo sapiens	Inhibition	%	52.39
	8188840	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.36	CHEMBL1913	Homo sapiens	Inhibition	%	3.36
	8188988	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	8.52	CHEMBL1913	Homo sapiens	Inhibition	%	8.52
	8189212	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	8.52	CHEMBL1913	Homo sapiens	Inhibition	%	8.52
	8189368	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	69.7	CHEMBL1913	Homo sapiens	Inhibition	%	69.7
	8189517	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.9	CHEMBL1913	Homo sapiens	Inhibition	%	0.9
	8189741	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	6.15	CHEMBL1913	Homo sapiens	Inhibition	%	6.15
	8189873	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	9.53	CHEMBL1913	Homo sapiens	Inhibition	%	9.53
	8190229	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.48	CHEMBL1913	Homo sapiens	Inhibition	%	6.48
	8190369	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	13.32	CHEMBL1913	Homo sapiens	Inhibition	%	13.32
	8190593	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	9.7	CHEMBL1913	Homo sapiens	Inhibition	%	9.7
	8190730	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	15.34	CHEMBL1913	Homo sapiens	Inhibition	%	15.34
	8190894	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.31	CHEMBL1913	Homo sapiens	Inhibition	%	5.31
	8191118	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	12.08	CHEMBL1913	Homo sapiens	Inhibition	%	12.08
	8191256	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	28.38	CHEMBL1913	Homo sapiens	Inhibition	%	28.38
	8191576	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	42.0	CHEMBL1913	Homo sapiens	Inhibition	%	42.0
	8191922	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	32.61	CHEMBL1913	Homo sapiens	Inhibition	%	32.61
	8192071	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	7.91	CHEMBL1913	Homo sapiens	Inhibition	%	7.91
	8192424	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	8.68	CHEMBL1913	Homo sapiens	Inhibition	%	8.68
	8192568	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	36.7	CHEMBL1913	Homo sapiens	Inhibition	%	36.7
	8192792	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.6	CHEMBL1913	Homo sapiens	Inhibition	%	6.6
	8192928	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	78.14	CHEMBL1913	Homo sapiens	Inhibition	%	78.14
	8193200	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.01	CHEMBL1913	Homo sapiens	Inhibition	%	13.01
	8193569	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	45.13	CHEMBL1913	Homo sapiens	Inhibition	%	45.13
	8193726	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.88	CHEMBL1913	Homo sapiens	Inhibition	%	4.88
	8194099	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.37	CHEMBL1913	Homo sapiens	Inhibition	%	3.37
	8194230	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	20.53	CHEMBL1913	Homo sapiens	Inhibition	%	20.53
	8194454	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	33.2	CHEMBL1913	Homo sapiens	Inhibition	%	33.2
	8194585	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	11.57	CHEMBL1913	Homo sapiens	Inhibition	%	11.57
	8194952	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	26.04	CHEMBL1913	Homo sapiens	Inhibition	%	26.04
	8195085	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	8.62	CHEMBL1913	Homo sapiens	Inhibition	%	8.62
	8195473	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	7.32	CHEMBL1913	Homo sapiens	Inhibition	%	7.32
	8195612	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	66.77	CHEMBL1913	Homo sapiens	Inhibition	%	66.77
	8195836	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.87	CHEMBL1913	Homo sapiens	Inhibition	%	4.87
	8195934	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.04	CHEMBL1913	Homo sapiens	Inhibition	%	1.04
	8196275	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.81	CHEMBL1913	Homo sapiens	Inhibition	%	4.81
	8196425	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	9.24	CHEMBL1913	Homo sapiens	Inhibition	%	9.24
	8196649	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	22.5	CHEMBL1913	Homo sapiens	Inhibition	%	22.5
	8196777	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	13.04	CHEMBL1913	Homo sapiens	Inhibition	%	13.04
	8197142	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	20.13	CHEMBL1913	Homo sapiens	Inhibition	%	20.13
	8197279	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	7.05	CHEMBL1913	Homo sapiens	Inhibition	%	7.05
	8197554	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.02	CHEMBL1913	Homo sapiens	Inhibition	%	2.02
	8197918	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	40.98	CHEMBL1913	Homo sapiens	Inhibition	%	40.98
	8198075	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	22.26	CHEMBL1913	Homo sapiens	Inhibition	%	22.26
	8198437	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	8.55	CHEMBL1913	Homo sapiens	Inhibition	%	8.55
	8198791	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	76.63	CHEMBL1913	Homo sapiens	Inhibition	%	76.63
	8198922	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%		CHEMBL1913	Homo sapiens	Inhibition	%	
	8199294	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.76	CHEMBL1913	Homo sapiens	Inhibition	%	5.76
	8199428	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	20.72	CHEMBL1913	Homo sapiens	Inhibition	%	20.72
	8199652	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.95	CHEMBL1913	Homo sapiens	Inhibition	%	6.95
	8199815	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	18.53	CHEMBL1913	Homo sapiens	Inhibition	%	18.53
	8200177	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	11.04	CHEMBL1913	Homo sapiens	Inhibition	%	11.04
	8200281	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	5.78	CHEMBL1913	Homo sapiens	Inhibition	%	5.78
	8200505	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	6.84	CHEMBL1913	Homo sapiens	Inhibition	%	6.84
	8200620	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	14.84	CHEMBL1913	Homo sapiens	Inhibition	%	14.84
	8200994	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	68.06	CHEMBL1913	Homo sapiens	Inhibition	%	68.06
	8201124	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	31.25	CHEMBL1913	Homo sapiens	Inhibition	%	31.25
	8201483	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.66	CHEMBL1913	Homo sapiens	Inhibition	%	3.66
	8201616	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	29.29	CHEMBL1913	Homo sapiens	Inhibition	%	29.29
	8201840	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.23	CHEMBL1913	Homo sapiens	Inhibition	%	0.23
	8201895	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.05	CHEMBL1913	Homo sapiens	Inhibition	%	5.05
	8202119	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.33	CHEMBL1913	Homo sapiens	Inhibition	%	-0.33
	8202259	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	86.49	CHEMBL1913	Homo sapiens	Inhibition	%	86.49
	8202426	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.87	CHEMBL1913	Homo sapiens	Inhibition	%	3.87
	8202650	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	8.35	CHEMBL1913	Homo sapiens	Inhibition	%	8.35
	8202775	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.85	CHEMBL1913	Homo sapiens	Inhibition	%	3.85
	8203129	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.86	CHEMBL1913	Homo sapiens	Inhibition	%	4.86
	8203260	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.69	CHEMBL1913	Homo sapiens	Inhibition	%	8.69
	8203484	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	53.85	CHEMBL1913	Homo sapiens	Inhibition	%	53.85
	8203630	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	12.1	CHEMBL1913	Homo sapiens	Inhibition	%	12.1
	8203988	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	8.55	CHEMBL1913	Homo sapiens	Inhibition	%	8.55
	8204154	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	9.17	CHEMBL1913	Homo sapiens	Inhibition	%	9.17
	8204515	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	53.43	CHEMBL1913	Homo sapiens	Inhibition	%	53.43
	8204844	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	39.4	CHEMBL1913	Homo sapiens	Inhibition	%	39.4
	8204959	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	21.9	CHEMBL1913	Homo sapiens	Inhibition	%	21.9
	8205332	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	12.54	CHEMBL1913	Homo sapiens	Inhibition	%	12.54
	8205468	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	72.55	CHEMBL1913	Homo sapiens	Inhibition	%	72.55
	8205692	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	7.89	CHEMBL1913	Homo sapiens	Inhibition	%	7.89
	8205831	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	8.53	CHEMBL1913	Homo sapiens	Inhibition	%	8.53
	8206187	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	5.35	CHEMBL1913	Homo sapiens	Inhibition	%	5.35
	8206463	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.85	CHEMBL1913	Homo sapiens	Inhibition	%	1.85
	8206606	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.75	CHEMBL1913	Homo sapiens	Inhibition	%	1.75
	8207010	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.05	CHEMBL1913	Homo sapiens	Inhibition	%	5.05
	8207136	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	11.83	CHEMBL1913	Homo sapiens	Inhibition	%	11.83
	8207360	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.64	CHEMBL1913	Homo sapiens	Inhibition	%	5.64
	8207490	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	14.45	CHEMBL1913	Homo sapiens	Inhibition	%	14.45
	8207846	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	79.19	CHEMBL1913	Homo sapiens	Inhibition	%	79.19
	8207991	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.52	CHEMBL1913	Homo sapiens	Inhibition	%	0.52
	8208347	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.26	CHEMBL1913	Homo sapiens	Inhibition	%	7.26
	8208513	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	43.31	CHEMBL1913	Homo sapiens	Inhibition	%	43.31
	8208737	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.15	CHEMBL1913	Homo sapiens	Inhibition	%	2.15
	8208870	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	87.01	CHEMBL1913	Homo sapiens	Inhibition	%	87.01
	8209199	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	17.05	CHEMBL1913	Homo sapiens	Inhibition	%	17.05
	8209315	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	66.98	CHEMBL1913	Homo sapiens	Inhibition	%	66.98
	8209539	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	6.46	CHEMBL1913	Homo sapiens	Inhibition	%	6.46
	8209689	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	51.72	CHEMBL1913	Homo sapiens	Inhibition	%	51.72
	8210049	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	20.2	CHEMBL1913	Homo sapiens	Inhibition	%	20.2
	8210190	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.05	CHEMBL1913	Homo sapiens	Inhibition	%	4.05
	8210550	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	4.9	CHEMBL1913	Homo sapiens	Inhibition	%	4.9
	8210809	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.36	CHEMBL1913	Homo sapiens	Inhibition	%	1.36
	8210953	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	7.52	CHEMBL1913	Homo sapiens	Inhibition	%	7.52
	8211177	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	14.88	CHEMBL1913	Homo sapiens	Inhibition	%	14.88
	8211347	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	11.61	CHEMBL1913	Homo sapiens	Inhibition	%	11.61
	8211694	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	15.03	CHEMBL1913	Homo sapiens	Inhibition	%	15.03
	8211823	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.04	CHEMBL1913	Homo sapiens	Inhibition	%	12.04
	8212179	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.66	CHEMBL1913	Homo sapiens	Inhibition	%	7.66
	8212320	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.61	CHEMBL1913	Homo sapiens	Inhibition	%	4.61
	8212544	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.29	CHEMBL1913	Homo sapiens	Inhibition	%	2.29
	8212677	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	31.86	CHEMBL1913	Homo sapiens	Inhibition	%	31.86
	8213071	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	13.71	CHEMBL1913	Homo sapiens	Inhibition	%	13.71
	8213200	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	10.17	CHEMBL1913	Homo sapiens	Inhibition	%	10.17
	8213528	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	63.56	CHEMBL1913	Homo sapiens	Inhibition	%	63.56
	8213865	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	7.71	CHEMBL1913	Homo sapiens	Inhibition	%	7.71
	8214012	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	6.55	CHEMBL1913	Homo sapiens	Inhibition	%	6.55
	8214373	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	59.71	CHEMBL1913	Homo sapiens	Inhibition	%	59.71
	8214507	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	8.86	CHEMBL1913	Homo sapiens	Inhibition	%	8.86
	8214731	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	54.71	CHEMBL1913	Homo sapiens	Inhibition	%	54.71
	8214883	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	14.4	CHEMBL1913	Homo sapiens	Inhibition	%	14.4
	8215134	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.27	CHEMBL1913	Homo sapiens	Inhibition	%	3.27
	8215511	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	54.86	CHEMBL1913	Homo sapiens	Inhibition	%	54.86
	8215675	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.48	CHEMBL1913	Homo sapiens	Inhibition	%	2.48
	8216018	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.36	CHEMBL1913	Homo sapiens	Inhibition	%	1.36
	8216137	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	41.31	CHEMBL1913	Homo sapiens	Inhibition	%	41.31
	8216361	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-1.07	CHEMBL1913	Homo sapiens	Inhibition	%	-1.07
	8216497	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	11.75	CHEMBL1913	Homo sapiens	Inhibition	%	11.75
	8216859	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	7.77	CHEMBL1913	Homo sapiens	Inhibition	%	7.77
	8216993	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.4	CHEMBL1913	Homo sapiens	Inhibition	%	5.4
	8217217	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	8.15	CHEMBL1913	Homo sapiens	Inhibition	%	8.15
	8217391	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.82	CHEMBL1913	Homo sapiens	Inhibition	%	3.82
	8217522	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	26.92	CHEMBL1913	Homo sapiens	Inhibition	%	26.92
	8217746	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	45.27	CHEMBL1913	Homo sapiens	Inhibition	%	45.27
	8217847	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	4.09	CHEMBL1913	Homo sapiens	Inhibition	%	4.09
	8218186	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.84	CHEMBL1913	Homo sapiens	Inhibition	%	4.84
	8218313	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.87	CHEMBL1913	Homo sapiens	Inhibition	%	5.87
	8218537	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	62.44	CHEMBL1913	Homo sapiens	Inhibition	%	62.44
	8218680	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	95.33	CHEMBL1913	Homo sapiens	Inhibition	%	95.33
	8219035	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	79.7	CHEMBL1913	Homo sapiens	Inhibition	%	79.7
	8219195	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	16.22	CHEMBL1913	Homo sapiens	Inhibition	%	16.22
	8219445	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.65	CHEMBL1913	Homo sapiens	Inhibition	%	3.65
	8219669	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	11.75	CHEMBL1913	Homo sapiens	Inhibition	%	11.75
	8219830	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.23	CHEMBL1913	Homo sapiens	Inhibition	%	3.23
	8219999	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	7.68	CHEMBL1913	Homo sapiens	Inhibition	%	7.68
	8220223	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.13	CHEMBL1913	Homo sapiens	Inhibition	%	4.13
	8220352	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.07	CHEMBL1913	Homo sapiens	Inhibition	%	5.07
	8220690	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	7.98	CHEMBL1913	Homo sapiens	Inhibition	%	7.98
	8220828	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	11.32	CHEMBL1913	Homo sapiens	Inhibition	%	11.32
	8221052	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	47.86	CHEMBL1913	Homo sapiens	Inhibition	%	47.86
	8221188	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.99	CHEMBL1913	Homo sapiens	Inhibition	%	2.99
	8221545	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	7.62	CHEMBL1913	Homo sapiens	Inhibition	%	7.62
	8221710	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	10.34	CHEMBL1913	Homo sapiens	Inhibition	%	10.34
	8222065	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	78.06	CHEMBL1913	Homo sapiens	Inhibition	%	78.06
	8222163	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	6.67	CHEMBL1913	Homo sapiens	Inhibition	%	6.67
	8222387	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	53.7	CHEMBL1913	Homo sapiens	Inhibition	%	53.7
	8222521	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	15.65	CHEMBL1913	Homo sapiens	Inhibition	%	15.65
	8222863	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	77.56	CHEMBL1913	Homo sapiens	Inhibition	%	77.56
	8223007	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	20.23	CHEMBL1913	Homo sapiens	Inhibition	%	20.23
	8223231	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	80.38	CHEMBL1913	Homo sapiens	Inhibition	%	80.38
	8223360	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	9.24	CHEMBL1913	Homo sapiens	Inhibition	%	9.24
	8223521	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	52.22	CHEMBL1913	Homo sapiens	Inhibition	%	52.22
	8223745	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	8.68	CHEMBL1913	Homo sapiens	Inhibition	%	8.68
	8223995	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.38	CHEMBL1913	Homo sapiens	Inhibition	%	2.38
	8224157	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	12.08	CHEMBL1913	Homo sapiens	Inhibition	%	12.08
	8224551	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.87	CHEMBL1913	Homo sapiens	Inhibition	%	5.87
	8224686	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.35	CHEMBL1913	Homo sapiens	Inhibition	%	4.35
	8225024	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.58	CHEMBL1913	Homo sapiens	Inhibition	%	0.58
	8225382	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	9.08	CHEMBL1913	Homo sapiens	Inhibition	%	9.08
	8225520	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	22.43	CHEMBL1913	Homo sapiens	Inhibition	%	22.43
	8225879	CHEMBL1962155	GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.82	CHEMBL1913	Homo sapiens	Inhibition	%	6.82
	8226037	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.3	CHEMBL1913	Homo sapiens	Inhibition	%	1.3
	8226386	CHEMBL1962154	GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	7.6	CHEMBL1913	Homo sapiens	Inhibition	%	7.6
active	9588064	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	=	Ki	nM	10.0	CHEMBL1913	Homo sapiens	pKi		8.0
inactive	9588065	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588066	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
inactive	9588067	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588068	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	63095.73	CHEMBL1913	Homo sapiens	pKi		4.2
inactive	9588069	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588070	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
active	9588071	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
active	9588072	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	316.23	CHEMBL1913	Homo sapiens	pKi		6.5
inactive	9588073	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1ccccc1)Nc1ccccn1		CHEMBL143703	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588074	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	3.162	CHEMBL1913	Homo sapiens	pKi		8.5
inactive	9588075	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588076	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	1258.93	CHEMBL1913	Homo sapiens	pKi		5.9
inactive	9588077	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	19952.62	CHEMBL1913	Homo sapiens	pKi		4.7
inactive	9588078	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588079	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588080	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	251.19	CHEMBL1913	Homo sapiens	pKi		6.6
inactive	9588081	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588082	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588083	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	19952.62	CHEMBL1913	Homo sapiens	pKi		4.7
active	9588084	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	1258.93	CHEMBL1913	Homo sapiens	pKi		5.9
inactive	9588085	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9588086	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588087	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	39.81	CHEMBL1913	Homo sapiens	pKi		7.4
inactive	9588088	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588089	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
inactive	9588090	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588091	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588092	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
inactive	9588093	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588094	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588095	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	31.62	CHEMBL1913	Homo sapiens	pKi		7.5
active	9588096	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Ki	nM	50.12	CHEMBL1913	Homo sapiens	pKi		7.3
inactive	9588097	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	39810.72	CHEMBL1913	Homo sapiens	pKi		4.4
inactive	9588098	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588099	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	3.981	CHEMBL1913	Homo sapiens	pKi		8.4
active	9588100	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
active	9588101	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	316.23	CHEMBL1913	Homo sapiens	pKi		6.5
inactive	9588102	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cccc(-c2ccc3c(c2)C(=O)NC3)c1		CHEMBL1968394	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588103	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	1.259	CHEMBL1913	Homo sapiens	pKi		8.9
inactive	9588104	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588105	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588106	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588107	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	6309.57	CHEMBL1913	Homo sapiens	pKi		5.2
active	9588108	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588109	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588110	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1.0	CHEMBL1913	Homo sapiens	pKi		9.0
inactive	9588111	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588112	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588113	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9588114	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588115	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
inactive	9588116	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588117	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	7943.28	CHEMBL1913	Homo sapiens	pKi		5.1
inactive	9588118	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588119	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588120	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	794.33	CHEMBL1913	Homo sapiens	pKi		6.1
inactive	9588121	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588122	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
active	9588123	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	10.0	CHEMBL1913	Homo sapiens	pKi		8.0
inactive	9588124	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588125	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588126	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588127	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	c1ccc(-c2cccc3nccn23)cc1		CHEMBL1992723	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588128	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	1258.93	CHEMBL1913	Homo sapiens	pKi		5.9
active	9588129	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
active	9588130	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
inactive	9588131	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588132	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588133	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	316.23	CHEMBL1913	Homo sapiens	pKi		6.5
active	9588134	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	50.12	CHEMBL1913	Homo sapiens	pKi		7.3
inactive	9588135	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588136	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588137	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	50118.72	CHEMBL1913	Homo sapiens	pKi		4.3
inactive	9588138	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588139	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588140	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588141	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	630.96	CHEMBL1913	Homo sapiens	pKi		6.2
active	9588142	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	501.19	CHEMBL1913	Homo sapiens	pKi		6.3
inactive	9588143	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588144	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	=	Ki	nM	501.19	CHEMBL1913	Homo sapiens	pKi		6.3
inactive	9588145	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588146	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	15.85	CHEMBL1913	Homo sapiens	pKi		7.8
inactive	9588147	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588148	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	6309.57	CHEMBL1913	Homo sapiens	pKi		5.2
inactive	9588149	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588150	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588151	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
active	9588152	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	0.5012	CHEMBL1913	Homo sapiens	pKi		9.3
active	9588153	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	63095.73	CHEMBL1913	Homo sapiens	pKi		4.2
inactive	9588154	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588155	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588156	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	794.33	CHEMBL1913	Homo sapiens	pKi		6.1
active	9588157	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	=	Ki	nM	158.49	CHEMBL1913	Homo sapiens	pKi		6.8
active	9588158	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	50118.72	CHEMBL1913	Homo sapiens	pKi		4.3
active	9588159	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
inactive	9588160	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588161	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588162	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588163	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
inactive	9588164	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588165	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	251.19	CHEMBL1913	Homo sapiens	pKi		6.6
active	9588166	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Ki	nM	3.981	CHEMBL1913	Homo sapiens	pKi		8.4
inactive	9588167	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588168	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588169	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9588170	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588171	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	31622.78	CHEMBL1913	Homo sapiens	pKi		4.5
inactive	9588172	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9588173	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9588174	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Ki	nM	79.43	CHEMBL1913	Homo sapiens	pKi		7.1
inactive	9588175	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9588176	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Ki	nM	50.12	CHEMBL1913	Homo sapiens	pKi		7.3
inactive	9591743	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591744	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	0.7943	CHEMBL1913	Homo sapiens	pKi		9.1
inactive	9591745	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591746	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	12589.25	CHEMBL1913	Homo sapiens	pKi		4.9
active	9591747	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	501.19	CHEMBL1913	Homo sapiens	pKi		6.3
active	9591748	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	251.19	CHEMBL1913	Homo sapiens	pKi		6.6
inactive	9591749	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591750	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	0.3162	CHEMBL1913	Homo sapiens	pKi		9.5
inactive	9591751	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591752	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591753	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591754	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	7943.28	CHEMBL1913	Homo sapiens	pKi		5.1
inactive	9591755	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591756	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	7.943	CHEMBL1913	Homo sapiens	pKi		8.1
inactive	9591757	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591758	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591759	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591760	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591761	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	630.96	CHEMBL1913	Homo sapiens	pKi		6.2
active	9591762	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Ki	nM	316.23	CHEMBL1913	Homo sapiens	pKi		6.5
inactive	9591763	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591764	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	1.995	CHEMBL1913	Homo sapiens	pKi		8.7
active	9591765	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591766	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	501.19	CHEMBL1913	Homo sapiens	pKi		6.3
inactive	9591767	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591768	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591769	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591770	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	3.981	CHEMBL1913	Homo sapiens	pKi		8.4
active	9591771	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	3.981	CHEMBL1913	Homo sapiens	pKi		8.4
inactive	9591772	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591773	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591774	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	25118.86	CHEMBL1913	Homo sapiens	pKi		4.6
inactive	9591775	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591776	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591777	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	1.259	CHEMBL1913	Homo sapiens	pKi		8.9
active	9591778	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	31622.78	CHEMBL1913	Homo sapiens	pKi		4.5
active	9591779	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	=	Ki	nM	6309.57	CHEMBL1913	Homo sapiens	pKi		5.2
active	9591780	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	=	Ki	nM	794.33	CHEMBL1913	Homo sapiens	pKi		6.1
active	9591781	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=c1[nH]n2ccccc2c1Br		CHEMBL2004033	=	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591782	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N		CHEMBL1984402	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9591783	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591784	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	1258.93	CHEMBL1913	Homo sapiens	pKi		5.9
inactive	9591785	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591786	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591787	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9591788	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591789	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591790	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
inactive	9591791	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591792	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591793	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591794	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591795	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	7.943	CHEMBL1913	Homo sapiens	pKi		8.1
inactive	9591796	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)n1ncc2cc(N)ccc21		CHEMBL1972454	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591797	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	50118.72	CHEMBL1913	Homo sapiens	pKi		4.3
active	9591798	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	158.49	CHEMBL1913	Homo sapiens	pKi		6.8
active	9591799	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	=	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591800	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
inactive	9591801	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591802	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591803	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591804	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	=	Ki	nM	19.95	CHEMBL1913	Homo sapiens	pKi		7.7
active	9591805	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	0.7943	CHEMBL1913	Homo sapiens	pKi		9.1
inactive	9591806	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591807	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591808	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591809	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	0.631	CHEMBL1913	Homo sapiens	pKi		9.2
inactive	9591810	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591811	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591812	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	50118.72	CHEMBL1913	Homo sapiens	pKi		4.3
active	9591813	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	0.3981	CHEMBL1913	Homo sapiens	pKi		9.4
inactive	9591814	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591815	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
active	9591816	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	25118.86	CHEMBL1913	Homo sapiens	pKi		4.6
active	9591817	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	1.0	CHEMBL1913	Homo sapiens	pKi		9.0
inactive	9591818	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591819	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	=	Ki	nM	25.12	CHEMBL1913	Homo sapiens	pKi		7.6
active	9591820	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
active	9591821	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
inactive	9591822	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591823	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
active	9591824	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	63.1	CHEMBL1913	Homo sapiens	pKi		7.2
inactive	9591825	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591826	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	199.53	CHEMBL1913	Homo sapiens	pKi		6.7
inactive	9591827	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591828	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	39.81	CHEMBL1913	Homo sapiens	pKi		7.4
inactive	9591829	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591830	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	7.943	CHEMBL1913	Homo sapiens	pKi		8.1
inactive	9591831	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591832	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591833	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	6.31	CHEMBL1913	Homo sapiens	pKi		8.2
inactive	9591834	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591835	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591836	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
inactive	9591837	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	C(=Cc1ccc2nccn2n1)c1ccccc1		CHEMBL1988622	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591838	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	630.96	CHEMBL1913	Homo sapiens	pKi		6.2
inactive	9591839	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591840	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
inactive	9591841	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591842	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)Nc1nccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL2002432	=	Ki	nM	15.85	CHEMBL1913	Homo sapiens	pKi		7.8
inactive	9591843	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591844	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
active	9591845	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	50118.72	CHEMBL1913	Homo sapiens	pKi		4.3
inactive	9591846	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9591847	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	316.23	CHEMBL1913	Homo sapiens	pKi		6.5
inactive	9591848	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1NCc2ccc(-c3ccccc3)cc21		CHEMBL1973795	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9591849	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591850	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
active	9591851	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	=	Ki	nM	501.19	CHEMBL1913	Homo sapiens	pKi		6.3
inactive	9591852	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591853	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591854	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(-c2ccc3c(c2)CNC3=O)ccc1F		CHEMBL1976290	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591855	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	125.89	CHEMBL1913	Homo sapiens	pKi		6.9
active	9591856	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	31622.78	CHEMBL1913	Homo sapiens	pKi		4.5
inactive	9591857	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591858	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	1258.93	CHEMBL1913	Homo sapiens	pKi		5.9
inactive	9591859	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591860	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591861	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	0.7943	CHEMBL1913	Homo sapiens	pKi		9.1
active	9591862	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	63.1	CHEMBL1913	Homo sapiens	pKi		7.2
active	9591863	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	=	Ki	nM	63095.73	CHEMBL1913	Homo sapiens	pKi		4.2
active	9591864	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	794.33	CHEMBL1913	Homo sapiens	pKi		6.1
active	9591865	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	316.23	CHEMBL1913	Homo sapiens	pKi		6.5
active	9591866	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	=	Ki	nM	7.943	CHEMBL1913	Homo sapiens	pKi		8.1
inactive	9591867	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc2c(c1)C(=O)Nc1ccccc1N2		CHEMBL1970873	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591868	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	=	Ki	nM	630.96	CHEMBL1913	Homo sapiens	pKi		6.2
inactive	9591869	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591870	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591871	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591872	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
active	9591873	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	63095.73	CHEMBL1913	Homo sapiens	pKi		4.2
inactive	9591874	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591875	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
active	9591876	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	63.1	CHEMBL1913	Homo sapiens	pKi		7.2
inactive	9591877	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591878	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	=	Ki	nM	630.96	CHEMBL1913	Homo sapiens	pKi		6.2
active	9591879	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
active	9591880	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	7943.28	CHEMBL1913	Homo sapiens	pKi		5.1
inactive	9591881	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591882	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591883	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591884	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591885	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
inactive	9591886	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591887	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9591888	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591889	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591890	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	=	Ki	nM	158.49	CHEMBL1913	Homo sapiens	pKi		6.8
inactive	9591891	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591892	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	12589.25	CHEMBL1913	Homo sapiens	pKi		4.9
inactive	9591893	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591894	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591895	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
active	9591896	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	25118.86	CHEMBL1913	Homo sapiens	pKi		4.6
active	9591897	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	630.96	CHEMBL1913	Homo sapiens	pKi		6.2
inactive	9591898	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591899	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	199.53	CHEMBL1913	Homo sapiens	pKi		6.7
active	9591900	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
inactive	9591901	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591902	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591903	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591904	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
inactive	9591905	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591906	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
inactive	9591907	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591908	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
inactive	9591909	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ccc(-c2cccn3c(=O)[nH]nc23)cc1		CHEMBL1975503	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9591910	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591911	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	630.96	CHEMBL1913	Homo sapiens	pKi		6.2
active	9591912	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	1258.93	CHEMBL1913	Homo sapiens	pKi		5.9
active	9591913	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	=	Ki	nM	398.11	CHEMBL1913	Homo sapiens	pKi		6.4
active	9591914	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	199.53	CHEMBL1913	Homo sapiens	pKi		6.7
active	9591915	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
active	9591916	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1000.0	CHEMBL1913	Homo sapiens	pKi		6.0
active	9591917	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	125.89	CHEMBL1913	Homo sapiens	pKi		6.9
inactive	9591918	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591919	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	0.5012	CHEMBL1913	Homo sapiens	pKi		9.3
inactive	9591920	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	NC(=O)c1csc2c1NCCC2=O		CHEMBL1973399	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591921	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	0.1259	CHEMBL1913	Homo sapiens	pKi		9.9
active	9591922	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	=	Ki	nM	199.53	CHEMBL1913	Homo sapiens	pKi		6.7
inactive	9591923	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
inactive	9591924	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	1995.26	CHEMBL1913	Homo sapiens	pKi		5.7
active	9591925	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1		CHEMBL1968606	=	Ki	nM	1258.93	CHEMBL1913	Homo sapiens	pKi		5.9
active	9591926	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	79.43	CHEMBL1913	Homo sapiens	pKi		7.1
inactive	9591927	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CC1=CN2CC(=O)NN=C2C=C1		CHEMBL1964718	<	Ki	nM	79432.82	CHEMBL1913	Homo sapiens	pKi		4.1
active	9591928	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	3.162	CHEMBL1913	Homo sapiens	pKi		8.5
active	9591929	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	50.12	CHEMBL1913	Homo sapiens	pKi		7.3
active	9591930	CHEMBL1963778	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRB	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	1584.89	CHEMBL1913	Homo sapiens	pKi		5.8
	10838623	CHEMBL2014501	Inhibition of PDGFRb at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	73.0	CHEMBL1913	Homo sapiens	INH	%	73.0
Not Active	10842732	CHEMBL2016352	Inhibition of PDGFRbeta at 10 uM	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	10842733	CHEMBL2016352	Inhibition of PDGFRbeta at 10 uM	B	O=C(NOC[C@@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012904		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	10842734	CHEMBL2016352	Inhibition of PDGFRbeta at 10 uM	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012902		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	10842735	CHEMBL2016352	Inhibition of PDGFRbeta at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CC3)c(F)c1		CHEMBL2012901		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	10842736	CHEMBL2016352	Inhibition of PDGFRbeta at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	10842737	CHEMBL2016352	Inhibition of PDGFRbeta at 10 uM	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012892		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	10849722	CHEMBL2019681	Inhibition of PDGFRB	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL1913	Homo sapiens	IC50	uM	40.0
Active	10861141	CHEMBL2019281	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)]n as substrate at 1 uM after 60 mins by fluorescence assay	B	C#CCNC(=O)Nc1cccc(CCl)c1		CHEMBL2017300		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	10863744	CHEMBL2024899	Inhibition of PDGFRbeta by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	nM	3.0
	10868248	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1CC(=O)Nc1noc(C)c1C		CHEMBL2023477	=	IC50	nM	0.2	CHEMBL1913	Homo sapiens	IC50	uM	0.0002
	10868249	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCc1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2OC)n[nH]1		CHEMBL2023485	=	IC50	nM	0.2	CHEMBL1913	Homo sapiens	IC50	uM	0.0002
	10868250	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4ncc(C)s4)c(OC)c3)ccnc2c1		CHEMBL2023476	=	IC50	nM	0.3	CHEMBL1913	Homo sapiens	IC50	uM	0.0003
	10868251	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCc1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)ccc34)cc2OC)no1		CHEMBL2023482	=	IC50	nM	0.4	CHEMBL1913	Homo sapiens	IC50	uM	0.0004
	10868252	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCc1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)ccc34)cc2OC)n[nH]1		CHEMBL2023486	=	IC50	nM	0.5	CHEMBL1913	Homo sapiens	IC50	uM	0.0005
	10868253	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)ccc34)cc2OC)cn1		CHEMBL2023118	=	IC50	nM	0.7	CHEMBL1913	Homo sapiens	IC50	uM	0.0007
	10868254	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2OC)cn1		CHEMBL2023117	=	IC50	nM	0.9	CHEMBL1913	Homo sapiens	IC50	uM	0.0009
	10868255	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4noc(C)c4C)c(OC)c3)ccnc2c1		CHEMBL2023478	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	10868256	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCc1c[nH]nc1NC(=O)Cc1ccc(Oc2ccnc3cc(OC)ccc23)cc1OC		CHEMBL2023484	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	10868257	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ncc(Oc3ccnc4cc(OC)ccc34)cc2OC)cn1		CHEMBL2023495	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	10868258	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2OC)cn1		CHEMBL2023115	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	10868259	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4ccc(OC)cc34)cc2OC)cn1		CHEMBL2023119	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	10868260	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cn2)cn1		CHEMBL2023800	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	10868261	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCOc1cc2nccc(Oc3cnc(CC(=O)Nc4n[nH]c(CC)c4C)c(OC)c3)c2cc1OC		CHEMBL2023802	=	IC50	nM	3.0	CHEMBL1913	Homo sapiens	IC50	uM	0.003
	10868264	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC		CHEMBL1940274	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	10868265	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4n[nH]c(C)c4C)c(OC)c3)ccnc2c1		CHEMBL2023483	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	10868266	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4cn(C)nc4C)c(OC)c3)ccnc2c1		CHEMBL2023489	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	10868267	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCc1[nH]nc(NC(=O)Cc2ncc(Oc3ccnc4cc(OC)c(OC)cc34)cc2OC)c1C		CHEMBL2023801	=	IC50	nM	4.0	CHEMBL1913	Homo sapiens	IC50	uM	0.004
	10868270	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2nccc(Oc3ccc(CC(=O)Nc4noc(C)c4C)c(OC)c3)c2c1		CHEMBL2023479	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	10868271	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1cc(Oc2ccnc3ccc(F)cc23)ccc1CC(=O)Nc1noc(C)c1C		CHEMBL2023481	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	10868272	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4cnn(C)c4)c(OC)c3)ccnc2c1		CHEMBL2023492	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	10868273	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4cc(C)nn4C)c(OC)c3)ccnc2c1		CHEMBL2023493	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	10868274	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4cc(C)cc(CN(C)C)c4)c(OC)c3)ccnc2c1		CHEMBL2023494	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	uM	0.005
	10868277	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(F)ccc34)cc2OC)cn1		CHEMBL2023474	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	uM	0.006
	10868278	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1cc(Oc2ccnc3cc(F)ccc23)ccc1CC(=O)Nc1noc(C)c1C		CHEMBL2023480	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	uM	0.006
	10868279	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1CC(=O)Nc1cn(C)nc1C		CHEMBL2023488	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	uM	0.006
	10868280	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4ccc(F)cc34)cc2OC)cn1		CHEMBL2023475	=	IC50	nM	7.0	CHEMBL1913	Homo sapiens	IC50	uM	0.007
	10868283	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4cnn(C)c4C)c(OC)c3)ccnc2c1		CHEMBL2023491	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	uM	0.009
	10868285	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1cc2nccc(Oc3ccc(CC(=O)Nc4cn(C)nc4C)cc3)c2cc1OC		CHEMBL2023490	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
	10868287	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1cc2ncnc(Nc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC		CHEMBL1940275	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	10868288	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1ccc2c(Oc3cnc(CC(=O)Nc4cn(C)nc4C)c(OC)c3)ccnc2c1		CHEMBL2023496	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	10868298	CHEMBL2027405	Inhibition of PDGFRbeta	B	CCn1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(OC)c2)cn1		CHEMBL2023116	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
	10868299	CHEMBL2027405	Inhibition of PDGFRbeta	B	COc1cc(Oc2ncnc3cc(OC)c(OC)cc23)ccc1CC(=O)Nc1cn(C)nc1C		CHEMBL2023487	=	IC50	nM	50.0	CHEMBL1913	Homo sapiens	IC50	uM	0.05
Active	10884069	CHEMBL2033678	Binding affinity to PDGFRbeta	B	C=CC(=O)Nc1cccc(N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL2029436		Activity			CHEMBL1913	Homo sapiens	Activity		
	10886518	CHEMBL2033423	Inhibition of PDGFRbeta in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	2.0	CHEMBL1913	Homo sapiens	Kd	nM	2.0
	10889918	CHEMBL2034591	Inhibition of PDGFRB assessed as remaining activity at 1 uM relative to control	B	COCCOc1cnc2ccc([C@H](C)n3nnc4ccn(-c5cc(C)ns5)c(=O)c43)cc2c1		CHEMBL2029678	=	Activity	%	10.0	CHEMBL1913	Homo sapiens	Activity	%	10.0
	10896873	CHEMBL2039247	Inhibition of PDGFRbeta at 3 uM	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	10896891	CHEMBL2039265	Inhibition of PDGFRbeta	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	>	IC50	nM	3000.0	CHEMBL1913	Homo sapiens	IC50	uM	3.0
	10921392	CHEMBL2046196	Inhibition of PDGFRB at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	98.0	CHEMBL1913	Homo sapiens	INH	%	98.0
	10921393	CHEMBL2044775	Inhibition of PDGFRB at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	66.0	CHEMBL1913	Homo sapiens	INH	%	66.0
	10926124	CHEMBL2046211	Inhibition of human PDGFRbeta assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	107.0	CHEMBL1913	Homo sapiens	Activity	%	107.0
	10926125	CHEMBL2046211	Inhibition of human PDGFRbeta assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	105.0	CHEMBL1913	Homo sapiens	Activity	%	105.0
	10936266	CHEMBL2050059	Inhibition of human PDGFRbeta	B	Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4cc(OCCCN5CCOCC5)ccc34)s2)cc1		CHEMBL2046883	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	10944908	CHEMBL2050148	Ratio of SU4312 IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(Cl)cc3)n1)-c1ccccc1C2		CHEMBL2047247	=	Ratio IC50		4.5	CHEMBL1913	Homo sapiens	Ratio IC50		4.5
	10944909	CHEMBL2050147	Ratio of erlotinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(Cl)cc3F)n1)-c1ccccc1C2		CHEMBL2047253	=	Ratio IC50		4.0	CHEMBL1913	Homo sapiens	Ratio IC50		4.0
	10944910	CHEMBL2050147	Ratio of erlotinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(F)c(Cl)c3)n1)-c1ccccc1C2		CHEMBL2047252	=	Ratio IC50		1.5	CHEMBL1913	Homo sapiens	Ratio IC50		1.5
	10944911	CHEMBL2050147	Ratio of erlotinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(Cl)cc3)n1)-c1ccccc1C2		CHEMBL2047247	=	Ratio IC50		15.0	CHEMBL1913	Homo sapiens	Ratio IC50		15.0
	10944912	CHEMBL2050147	Ratio of erlotinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(F)cc3)n1)-c1ccccc1C2		CHEMBL2047241	=	Ratio IC50		1.5	CHEMBL1913	Homo sapiens	Ratio IC50		1.5
	10944913	CHEMBL2050147	Ratio of erlotinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3cccc(F)c3)n1)-c1ccccc1C2		CHEMBL2047246	=	Ratio IC50		1.5	CHEMBL1913	Homo sapiens	Ratio IC50		1.5
	10944914	CHEMBL2050147	Ratio of erlotinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	CC(C)c1ccc(Nc2nc(N)nc3c2-c2ccccc2C3)cc1		CHEMBL2047245	=	Ratio IC50		1.5	CHEMBL1913	Homo sapiens	Ratio IC50		1.5
	10944915	CHEMBL2050146	Ratio of sunitinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(Cl)cc3F)n1)-c1ccccc1C2		CHEMBL2047253	=	Ratio IC50		23.0	CHEMBL1913	Homo sapiens	Ratio IC50		23.0
	10944916	CHEMBL2050146	Ratio of sunitinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(F)c(Cl)c3)n1)-c1ccccc1C2		CHEMBL2047252	=	Ratio IC50		10.0	CHEMBL1913	Homo sapiens	Ratio IC50		10.0
	10944917	CHEMBL2050146	Ratio of sunitinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(Cl)cc3)n1)-c1ccccc1C2		CHEMBL2047247	=	Ratio IC50		100.0	CHEMBL1913	Homo sapiens	Ratio IC50		100.0
	10944918	CHEMBL2050146	Ratio of sunitinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(F)cc3)n1)-c1ccccc1C2		CHEMBL2047241	=	Ratio IC50		10.0	CHEMBL1913	Homo sapiens	Ratio IC50		10.0
	10944919	CHEMBL2050146	Ratio of sunitinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3cccc(F)c3)n1)-c1ccccc1C2		CHEMBL2047246	=	Ratio IC50		10.0	CHEMBL1913	Homo sapiens	Ratio IC50		10.0
	10944920	CHEMBL2050146	Ratio of sunitinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	CC(C)c1ccc(Nc2nc(N)nc3c2-c2ccccc2C3)cc1		CHEMBL2047245	=	Ratio IC50		10.0	CHEMBL1913	Homo sapiens	Ratio IC50		10.0
	10944921	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1	Potential transcription error	CHEMBL553	=	IC50	nM	12200.0	CHEMBL1913	Homo sapiens	IC50	uM	12.2
	10944922	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C	Potential transcription error	CHEMBL535	=	IC50	nM	83100.0	CHEMBL1913	Homo sapiens	IC50	uM	83.1
	10944923	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	IC50	nM	3750.0	CHEMBL1913	Homo sapiens	IC50	uM	3.75
	10944924	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(Cl)cc3F)n1)-c1ccccc1C2		CHEMBL2047253	=	IC50	nM	3600.0	CHEMBL1913	Homo sapiens	IC50	uM	3.6
	10944925	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(F)c(Cl)c3)n1)-c1ccccc1C2		CHEMBL2047252	=	IC50	nM	6400.0	CHEMBL1913	Homo sapiens	IC50	uM	6.4
	10944926	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	COc1cccc(Nc2nc(N)nc3c2-c2ccccc2C3)c1		CHEMBL2047251	=	IC50	nM	75500.0	CHEMBL1913	Homo sapiens	IC50	uM	75.5
	10944927	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(C(F)(F)F)cc3)n1)-c1ccccc1C2		CHEMBL2047250	=	IC50	nM	23100.0	CHEMBL1913	Homo sapiens	IC50	uM	23.1
	10944928	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(Br)cc3)n1)-c1ccccc1C2		CHEMBL2047249	=	IC50	nM	38900.0	CHEMBL1913	Homo sapiens	IC50	uM	38.9
	10944929	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3cccc(Br)c3)n1)-c1ccccc1C2	Outside typical range	CHEMBL2047248	=	IC50	nM	126300.0	CHEMBL1913	Homo sapiens	IC50	uM	126.3
	10944930	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(Cl)cc3)n1)-c1ccccc1C2		CHEMBL2047247	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	10944931	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3cccc(Cl)c3)n1)-c1ccccc1C2	Outside typical range	CHEMBL2047242	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	10944932	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccc(F)cc3)n1)-c1ccccc1C2		CHEMBL2047241	=	IC50	nM	5900.0	CHEMBL1913	Homo sapiens	IC50	uM	5.9
	10944933	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3cccc(F)c3)n1)-c1ccccc1C2		CHEMBL2047246	=	IC50	nM	7100.0	CHEMBL1913	Homo sapiens	IC50	uM	7.1
	10944934	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	CC(C)c1ccc(Nc2nc(N)nc3c2-c2ccccc2C3)cc1		CHEMBL2047245	=	IC50	nM	7800.0	CHEMBL1913	Homo sapiens	IC50	uM	7.8
	10944935	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	CC(C)c1ccccc1Nc1nc(N)nc2c1-c1ccccc1C2		CHEMBL2047244	=	IC50	nM	21700.0	CHEMBL1913	Homo sapiens	IC50	uM	21.7
	10944936	CHEMBL2050145	Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA	B	Nc1nc2c(c(Nc3ccccc3)n1)-c1ccccc1C2		CHEMBL2047243	=	IC50	nM	43100.0	CHEMBL1913	Homo sapiens	IC50	uM	43.1
	10949915	CHEMBL2049407	Inhibition of PDGFRbeta using ATP measured after 60 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	10980274	CHEMBL2065126	Inhibition of PDGFRB at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL1913	Homo sapiens	INH	%	25.0
	10980275	CHEMBL2065126	Inhibition of PDGFRB at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL1913	Homo sapiens	INH	%	15.0
	10980312	CHEMBL2065156	Inhibition of PDGFRB by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	11020075	CHEMBL2089887	Inhibition of PDGFRbeta	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	1.3	CHEMBL1913	Homo sapiens	IC50	nM	1.3
	12036424	CHEMBL2150259	Inhibition of PDGFRbeta after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	12047297	CHEMBL2157322	Inhibition of PDGFRbeta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.8	CHEMBL1913	Homo sapiens	INH	%	4.8
	12060786	CHEMBL2156906	Inhibition of Platelet-derived growth factor subunit B	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152252	>	IC50	nM	3600.0	CHEMBL1913	Homo sapiens	IC50	nM	3600.0
	12060787	CHEMBL2156906	Inhibition of Platelet-derived growth factor subunit B	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N		CHEMBL2152253	>	IC50	nM	3600.0	CHEMBL1913	Homo sapiens	IC50	nM	3600.0
	12074601	CHEMBL2160998	Inhibition of PDGFRB at 0.1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	12074611	CHEMBL2161008	Inhibition of PDGFRB at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	>	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	12081330	CHEMBL2167852	Inhibition of PDGFRbeta	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	37.0	CHEMBL1913	Homo sapiens	IC50	nM	37.0
	12138518	CHEMBL2185928	Inhibition of PDGFRbeta	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCCNCCO		CHEMBL352308	=	IC50	nM	69.0	CHEMBL1913	Homo sapiens	IC50	nM	69.0
	12152500	CHEMBL2182404	Inhibition of PDGFRbeta assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4cnccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180882	=	Activity	%	106.0	CHEMBL1913	Homo sapiens	Activity	%	106.0
	12152515	CHEMBL2182404	Inhibition of PDGFRbeta assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4ncccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180878	=	Activity	%	84.0	CHEMBL1913	Homo sapiens	Activity	%	84.0
	12172294	CHEMBL2215409	Inhibition of PDGFRB assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	52.0	CHEMBL1913	Homo sapiens	Activity	%	52.0
	12175198	CHEMBL2210725	Inhibition of PDGFRbeta	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	=	IC50	nM	91.0	CHEMBL1913	Homo sapiens	IC50	nM	91.0
	12175326	CHEMBL2211562	Inhibition of PDGFRB at 1 uM	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	12177064	CHEMBL2213405	Binding affinity to PDGFRbeta expressed in HEK-293 cells	B	CCN1C(C)(C)CC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1(C)C		CHEMBL2206278	=	Kd	nM	1.0	CHEMBL1913	Homo sapiens	Kd	nM	1.0
	12177071	CHEMBL2213405	Binding affinity to PDGFRbeta expressed in HEK-293 cells	B	CN1C(C)(C)CC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1(C)C		CHEMBL2206277	=	Kd	nM	2.5	CHEMBL1913	Homo sapiens	Kd	nM	2.5
	12177078	CHEMBL2213405	Binding affinity to PDGFRbeta expressed in HEK-293 cells	B	CCN1CCC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1		CHEMBL2203434	=	Kd	nM	1.3	CHEMBL1913	Homo sapiens	Kd	nM	1.3
	12191216	CHEMBL2215710	Inhibition of PDGFRbeta by AlphaScreen analysis	B	O=C(Nc1cccc(Oc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL2206666	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
	12193497	CHEMBL2215277	Inhibition of PDGFRbeta at 100 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	82.1	CHEMBL1913	Homo sapiens	INH	%	82.1
	12193498	CHEMBL2215277	Inhibition of PDGFRbeta at 100 uM	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]	Outside typical range	CHEMBL2207940	=	Inhibition	%	-133.3	CHEMBL1913	Homo sapiens	INH	%	-133.3
	12193801	CHEMBL2212842	Inhibition of PDGFRB	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@H]1CCCN1		CHEMBL2208034	=	IC50	nM	125.4	CHEMBL1913	Homo sapiens	IC50	nM	125.4
	12275476	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12275477	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12275478	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12275479	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	93.0	CHEMBL1913	Homo sapiens	Residual Activity	%	93.0
	12275480	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	109.0	CHEMBL1913	Homo sapiens	Residual Activity	%	109.0
	12275481	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12275482	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12275483	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12275484	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12275485	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12275486	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	105.0	CHEMBL1913	Homo sapiens	Residual Activity	%	105.0
	12275487	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	104.0	CHEMBL1913	Homo sapiens	Residual Activity	%	104.0
	12275488	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12275489	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12275490	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12275491	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	90.0	CHEMBL1913	Homo sapiens	Residual Activity	%	90.0
	12275492	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12275493	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12275494	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	89.0	CHEMBL1913	Homo sapiens	Residual Activity	%	89.0
	12275495	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12275496	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12275497	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	109.0	CHEMBL1913	Homo sapiens	Residual Activity	%	109.0
	12275498	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	94.0	CHEMBL1913	Homo sapiens	Residual Activity	%	94.0
	12275499	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	46.0	CHEMBL1913	Homo sapiens	Residual Activity	%	46.0
	12275500	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	109.0	CHEMBL1913	Homo sapiens	Residual Activity	%	109.0
	12275501	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	89.0	CHEMBL1913	Homo sapiens	Residual Activity	%	89.0
	12275502	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	35.0	CHEMBL1913	Homo sapiens	Residual Activity	%	35.0
	12275503	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	105.0	CHEMBL1913	Homo sapiens	Residual Activity	%	105.0
	12275504	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	40.0	CHEMBL1913	Homo sapiens	Residual Activity	%	40.0
	12275505	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12275506	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12275507	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	13.0	CHEMBL1913	Homo sapiens	Residual Activity	%	13.0
	12275508	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12275509	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12275510	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12275511	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12275512	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	11.0	CHEMBL1913	Homo sapiens	Residual Activity	%	11.0
	12275513	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	116.0	CHEMBL1913	Homo sapiens	Residual Activity	%	116.0
	12275514	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	95.0	CHEMBL1913	Homo sapiens	Residual Activity	%	95.0
	12275515	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	74.0	CHEMBL1913	Homo sapiens	Residual Activity	%	74.0
	12275516	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	119.0	CHEMBL1913	Homo sapiens	Residual Activity	%	119.0
	12275517	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12275518	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	88.0	CHEMBL1913	Homo sapiens	Residual Activity	%	88.0
	12275519	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	71.0	CHEMBL1913	Homo sapiens	Residual Activity	%	71.0
	12275520	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	31.0	CHEMBL1913	Homo sapiens	Residual Activity	%	31.0
	12275521	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	113.0	CHEMBL1913	Homo sapiens	Residual Activity	%	113.0
	12275522	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	114.0	CHEMBL1913	Homo sapiens	Residual Activity	%	114.0
	12275523	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	43.0	CHEMBL1913	Homo sapiens	Residual Activity	%	43.0
	12275524	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	120.0	CHEMBL1913	Homo sapiens	Residual Activity	%	120.0
	12275525	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12275526	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12275527	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	54.0	CHEMBL1913	Homo sapiens	Residual Activity	%	54.0
	12275528	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	79.0	CHEMBL1913	Homo sapiens	Residual Activity	%	79.0
	12275529	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	100.0	CHEMBL1913	Homo sapiens	Residual Activity	%	100.0
	12275530	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12275531	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12275532	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	114.0	CHEMBL1913	Homo sapiens	Residual Activity	%	114.0
	12275533	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12275534	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	50.0	CHEMBL1913	Homo sapiens	Residual Activity	%	50.0
	12275535	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	90.0	CHEMBL1913	Homo sapiens	Residual Activity	%	90.0
	12275536	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL1913	Homo sapiens	Residual Activity	%	75.0
	12275537	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	46.0	CHEMBL1913	Homo sapiens	Residual Activity	%	46.0
	12275538	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12275539	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	116.0	CHEMBL1913	Homo sapiens	Residual Activity	%	116.0
	12275540	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	120.0	CHEMBL1913	Homo sapiens	Residual Activity	%	120.0
	12275541	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	101.0	CHEMBL1913	Homo sapiens	Residual Activity	%	101.0
	12275542	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12275543	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12275544	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12275545	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12275546	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12275547	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12275548	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12275549	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12275550	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	3.0	CHEMBL1913	Homo sapiens	Residual Activity	%	3.0
	12275551	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	83.0	CHEMBL1913	Homo sapiens	Residual Activity	%	83.0
	12275552	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12275553	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL1913	Homo sapiens	Residual Activity	%	1.0
	12275554	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12275555	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	4.0	CHEMBL1913	Homo sapiens	Residual Activity	%	4.0
	12275556	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12275557	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12275558	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	89.0	CHEMBL1913	Homo sapiens	Residual Activity	%	89.0
	12275559	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12275560	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	80.0	CHEMBL1913	Homo sapiens	Residual Activity	%	80.0
	12275561	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12275562	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12277208	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	120.0	CHEMBL1913	Homo sapiens	Residual Activity	%	120.0
	12277209	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	111.0	CHEMBL1913	Homo sapiens	Residual Activity	%	111.0
	12277210	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	84.0	CHEMBL1913	Homo sapiens	Residual Activity	%	84.0
	12277211	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12277212	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12277213	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	79.0	CHEMBL1913	Homo sapiens	Residual Activity	%	79.0
	12277214	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	94.0	CHEMBL1913	Homo sapiens	Residual Activity	%	94.0
	12277215	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	100.0	CHEMBL1913	Homo sapiens	Residual Activity	%	100.0
	12277216	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	116.0	CHEMBL1913	Homo sapiens	Residual Activity	%	116.0
	12277217	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12277218	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	104.0	CHEMBL1913	Homo sapiens	Residual Activity	%	104.0
	12277219	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	93.0	CHEMBL1913	Homo sapiens	Residual Activity	%	93.0
	12277220	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12277221	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	88.0	CHEMBL1913	Homo sapiens	Residual Activity	%	88.0
	12277222	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	46.0	CHEMBL1913	Homo sapiens	Residual Activity	%	46.0
	12277223	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	114.0	CHEMBL1913	Homo sapiens	Residual Activity	%	114.0
	12277224	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	90.0	CHEMBL1913	Homo sapiens	Residual Activity	%	90.0
	12277225	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12277226	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12277227	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	90.0	CHEMBL1913	Homo sapiens	Residual Activity	%	90.0
	12277228	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	110.0	CHEMBL1913	Homo sapiens	Residual Activity	%	110.0
	12277229	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12277230	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12277231	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12277232	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12277233	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	115.0	CHEMBL1913	Homo sapiens	Residual Activity	%	115.0
	12277234	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12277235	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12277236	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	95.0	CHEMBL1913	Homo sapiens	Residual Activity	%	95.0
	12277237	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	89.0	CHEMBL1913	Homo sapiens	Residual Activity	%	89.0
	12277238	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	109.0	CHEMBL1913	Homo sapiens	Residual Activity	%	109.0
	12277239	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	114.0	CHEMBL1913	Homo sapiens	Residual Activity	%	114.0
	12277240	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	123.0	CHEMBL1913	Homo sapiens	Residual Activity	%	123.0
	12277241	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	101.0	CHEMBL1913	Homo sapiens	Residual Activity	%	101.0
	12277242	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12277243	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12277244	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12277245	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	79.0	CHEMBL1913	Homo sapiens	Residual Activity	%	79.0
	12277246	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12277247	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12277248	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	117.0	CHEMBL1913	Homo sapiens	Residual Activity	%	117.0
	12277249	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	104.0	CHEMBL1913	Homo sapiens	Residual Activity	%	104.0
	12277250	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	83.0	CHEMBL1913	Homo sapiens	Residual Activity	%	83.0
	12277251	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	93.0	CHEMBL1913	Homo sapiens	Residual Activity	%	93.0
	12277252	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	101.0	CHEMBL1913	Homo sapiens	Residual Activity	%	101.0
	12277253	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12277254	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	95.0	CHEMBL1913	Homo sapiens	Residual Activity	%	95.0
	12277255	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	48.0	CHEMBL1913	Homo sapiens	Residual Activity	%	48.0
	12277256	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12277257	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12277258	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	63.0	CHEMBL1913	Homo sapiens	Residual Activity	%	63.0
	12277259	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	36.0	CHEMBL1913	Homo sapiens	Residual Activity	%	36.0
	12277260	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	91.0	CHEMBL1913	Homo sapiens	Residual Activity	%	91.0
	12277261	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12277262	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277263	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	111.0	CHEMBL1913	Homo sapiens	Residual Activity	%	111.0
	12277264	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	27.0	CHEMBL1913	Homo sapiens	Residual Activity	%	27.0
	12277265	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	113.0	CHEMBL1913	Homo sapiens	Residual Activity	%	113.0
	12277266	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12277267	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	86.0	CHEMBL1913	Homo sapiens	Residual Activity	%	86.0
	12277268	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	104.0	CHEMBL1913	Homo sapiens	Residual Activity	%	104.0
	12277269	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12277270	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	110.0	CHEMBL1913	Homo sapiens	Residual Activity	%	110.0
	12277271	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	117.0	CHEMBL1913	Homo sapiens	Residual Activity	%	117.0
	12277272	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12277273	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	100.0	CHEMBL1913	Homo sapiens	Residual Activity	%	100.0
	12277274	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12277275	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12277276	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12277277	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	111.0	CHEMBL1913	Homo sapiens	Residual Activity	%	111.0
	12277278	CHEMBL2219386	Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	119.0	CHEMBL1913	Homo sapiens	Residual Activity	%	119.0
	12277279	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12277280	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	83.0	CHEMBL1913	Homo sapiens	Residual Activity	%	83.0
	12277281	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	93.0	CHEMBL1913	Homo sapiens	Residual Activity	%	93.0
	12277282	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	111.0	CHEMBL1913	Homo sapiens	Residual Activity	%	111.0
	12277283	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	113.0	CHEMBL1913	Homo sapiens	Residual Activity	%	113.0
	12277284	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	105.0	CHEMBL1913	Homo sapiens	Residual Activity	%	105.0
	12277285	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	51.0	CHEMBL1913	Homo sapiens	Residual Activity	%	51.0
	12277286	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12277287	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	46.0	CHEMBL1913	Homo sapiens	Residual Activity	%	46.0
	12277288	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	81.0	CHEMBL1913	Homo sapiens	Residual Activity	%	81.0
	12277289	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	86.0	CHEMBL1913	Homo sapiens	Residual Activity	%	86.0
	12277290	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	81.0	CHEMBL1913	Homo sapiens	Residual Activity	%	81.0
	12277291	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277292	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	71.0	CHEMBL1913	Homo sapiens	Residual Activity	%	71.0
	12277293	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	83.0	CHEMBL1913	Homo sapiens	Residual Activity	%	83.0
	12277294	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277295	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	125.0	CHEMBL1913	Homo sapiens	Residual Activity	%	125.0
	12277296	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12277297	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12277298	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	85.0	CHEMBL1913	Homo sapiens	Residual Activity	%	85.0
	12277299	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	93.0	CHEMBL1913	Homo sapiens	Residual Activity	%	93.0
	12277300	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	95.0	CHEMBL1913	Homo sapiens	Residual Activity	%	95.0
	12277301	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12277302	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	4.0	CHEMBL1913	Homo sapiens	Residual Activity	%	4.0
	12277303	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12277304	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	91.0	CHEMBL1913	Homo sapiens	Residual Activity	%	91.0
	12277305	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	6.0	CHEMBL1913	Homo sapiens	Residual Activity	%	6.0
	12277306	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	83.0	CHEMBL1913	Homo sapiens	Residual Activity	%	83.0
	12277307	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	10.0	CHEMBL1913	Homo sapiens	Residual Activity	%	10.0
	12277308	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	60.0	CHEMBL1913	Homo sapiens	Residual Activity	%	60.0
	12277309	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	109.0	CHEMBL1913	Homo sapiens	Residual Activity	%	109.0
	12277310	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	2.0	CHEMBL1913	Homo sapiens	Residual Activity	%	2.0
	12277311	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12277312	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	113.0	CHEMBL1913	Homo sapiens	Residual Activity	%	113.0
	12277313	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277314	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	101.0	CHEMBL1913	Homo sapiens	Residual Activity	%	101.0
	12277315	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	1.0	CHEMBL1913	Homo sapiens	Residual Activity	%	1.0
	12277316	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	114.0	CHEMBL1913	Homo sapiens	Residual Activity	%	114.0
	12277317	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	112.0	CHEMBL1913	Homo sapiens	Residual Activity	%	112.0
	12277318	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	51.0	CHEMBL1913	Homo sapiens	Residual Activity	%	51.0
	12277319	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12277320	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	105.0	CHEMBL1913	Homo sapiens	Residual Activity	%	105.0
	12277321	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	68.0	CHEMBL1913	Homo sapiens	Residual Activity	%	68.0
	12277322	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	24.0	CHEMBL1913	Homo sapiens	Residual Activity	%	24.0
	12277323	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	9.0	CHEMBL1913	Homo sapiens	Residual Activity	%	9.0
	12277324	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	109.0	CHEMBL1913	Homo sapiens	Residual Activity	%	109.0
	12277325	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	113.0	CHEMBL1913	Homo sapiens	Residual Activity	%	113.0
	12277326	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	23.0	CHEMBL1913	Homo sapiens	Residual Activity	%	23.0
	12277327	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	111.0	CHEMBL1913	Homo sapiens	Residual Activity	%	111.0
	12277328	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12277329	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	63.0	CHEMBL1913	Homo sapiens	Residual Activity	%	63.0
	12277330	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	6.0	CHEMBL1913	Homo sapiens	Residual Activity	%	6.0
	12277331	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	29.0	CHEMBL1913	Homo sapiens	Residual Activity	%	29.0
	12277332	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12277333	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	104.0	CHEMBL1913	Homo sapiens	Residual Activity	%	104.0
	12277334	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	86.0	CHEMBL1913	Homo sapiens	Residual Activity	%	86.0
	12277335	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12277336	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	85.0	CHEMBL1913	Homo sapiens	Residual Activity	%	85.0
	12277337	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	9.0	CHEMBL1913	Homo sapiens	Residual Activity	%	9.0
	12277338	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	82.0	CHEMBL1913	Homo sapiens	Residual Activity	%	82.0
	12277339	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	25.0	CHEMBL1913	Homo sapiens	Residual Activity	%	25.0
	12277340	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	25.0	CHEMBL1913	Homo sapiens	Residual Activity	%	25.0
	12277341	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	77.0	CHEMBL1913	Homo sapiens	Residual Activity	%	77.0
	12277342	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12277343	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12277344	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	30.0	CHEMBL1913	Homo sapiens	Residual Activity	%	30.0
	12277345	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	80.0	CHEMBL1913	Homo sapiens	Residual Activity	%	80.0
	12277346	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	88.0	CHEMBL1913	Homo sapiens	Residual Activity	%	88.0
	12277347	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12277348	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	83.0	CHEMBL1913	Homo sapiens	Residual Activity	%	83.0
	12277349	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12277350	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	70.0	CHEMBL1913	Homo sapiens	Residual Activity	%	70.0
	12277351	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	65.0	CHEMBL1913	Homo sapiens	Residual Activity	%	65.0
	12277352	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	89.0	CHEMBL1913	Homo sapiens	Residual Activity	%	89.0
	12277353	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	0.0	CHEMBL1913	Homo sapiens	Residual Activity	%	0.0
	12277354	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	55.0	CHEMBL1913	Homo sapiens	Residual Activity	%	55.0
	12277355	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	116.0	CHEMBL1913	Homo sapiens	Residual Activity	%	116.0
	12277356	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL1913	Homo sapiens	Residual Activity	%	1.0
	12277357	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	73.0	CHEMBL1913	Homo sapiens	Residual Activity	%	73.0
	12277358	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL1913	Homo sapiens	Residual Activity	%	1.0
	12277359	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12277360	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	82.0	CHEMBL1913	Homo sapiens	Residual Activity	%	82.0
	12277361	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	76.0	CHEMBL1913	Homo sapiens	Residual Activity	%	76.0
	12277362	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12277363	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	90.0	CHEMBL1913	Homo sapiens	Residual Activity	%	90.0
	12277364	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	125.0	CHEMBL1913	Homo sapiens	Residual Activity	%	125.0
	12277365	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	110.0	CHEMBL1913	Homo sapiens	Residual Activity	%	110.0
	12277366	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	120.0	CHEMBL1913	Homo sapiens	Residual Activity	%	120.0
	12277367	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277368	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	26.0	CHEMBL1913	Homo sapiens	Residual Activity	%	26.0
	12277369	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12277370	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12277371	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	28.0	CHEMBL1913	Homo sapiens	Residual Activity	%	28.0
	12277372	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	110.0	CHEMBL1913	Homo sapiens	Residual Activity	%	110.0
	12277373	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	99.0	CHEMBL1913	Homo sapiens	Residual Activity	%	99.0
	12277374	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	109.0	CHEMBL1913	Homo sapiens	Residual Activity	%	109.0
	12277375	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12277376	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	107.0	CHEMBL1913	Homo sapiens	Residual Activity	%	107.0
	12277377	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277378	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	110.0	CHEMBL1913	Homo sapiens	Residual Activity	%	110.0
	12277379	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277380	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	8.0	CHEMBL1913	Homo sapiens	Residual Activity	%	8.0
	12277381	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12277382	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	86.0	CHEMBL1913	Homo sapiens	Residual Activity	%	86.0
	12277383	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	100.0	CHEMBL1913	Homo sapiens	Residual Activity	%	100.0
	12277384	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	94.0	CHEMBL1913	Homo sapiens	Residual Activity	%	94.0
	12277385	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	80.0	CHEMBL1913	Homo sapiens	Residual Activity	%	80.0
	12277386	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12277387	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	115.0	CHEMBL1913	Homo sapiens	Residual Activity	%	115.0
	12277388	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12277389	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	111.0	CHEMBL1913	Homo sapiens	Residual Activity	%	111.0
	12277390	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277391	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	83.0	CHEMBL1913	Homo sapiens	Residual Activity	%	83.0
	12277392	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	106.0	CHEMBL1913	Homo sapiens	Residual Activity	%	106.0
	12277393	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	128.0	CHEMBL1913	Homo sapiens	Residual Activity	%	128.0
	12277394	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	103.0	CHEMBL1913	Homo sapiens	Residual Activity	%	103.0
	12277395	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	55.0	CHEMBL1913	Homo sapiens	Residual Activity	%	55.0
	12277396	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	104.0	CHEMBL1913	Homo sapiens	Residual Activity	%	104.0
	12277397	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	85.0	CHEMBL1913	Homo sapiens	Residual Activity	%	85.0
	12277398	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	128.0	CHEMBL1913	Homo sapiens	Residual Activity	%	128.0
	12277399	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	113.0	CHEMBL1913	Homo sapiens	Residual Activity	%	113.0
	12277400	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	76.0	CHEMBL1913	Homo sapiens	Residual Activity	%	76.0
	12277401	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	113.0	CHEMBL1913	Homo sapiens	Residual Activity	%	113.0
	12277402	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12277403	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	24.0	CHEMBL1913	Homo sapiens	Residual Activity	%	24.0
	12277404	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	121.0	CHEMBL1913	Homo sapiens	Residual Activity	%	121.0
	12277405	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	111.0	CHEMBL1913	Homo sapiens	Residual Activity	%	111.0
	12277406	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	137.0	CHEMBL1913	Homo sapiens	Residual Activity	%	137.0
	12277407	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	105.0	CHEMBL1913	Homo sapiens	Residual Activity	%	105.0
	12277408	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	24.0	CHEMBL1913	Homo sapiens	Residual Activity	%	24.0
	12277409	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	100.0	CHEMBL1913	Homo sapiens	Residual Activity	%	100.0
	12277410	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	100.0	CHEMBL1913	Homo sapiens	Residual Activity	%	100.0
	12277411	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12277412	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	93.0	CHEMBL1913	Homo sapiens	Residual Activity	%	93.0
	12277413	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	8.0	CHEMBL1913	Homo sapiens	Residual Activity	%	8.0
	12277414	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277415	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	98.0	CHEMBL1913	Homo sapiens	Residual Activity	%	98.0
	12277416	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	14.0	CHEMBL1913	Homo sapiens	Residual Activity	%	14.0
	12277417	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	11.0	CHEMBL1913	Homo sapiens	Residual Activity	%	11.0
	12277418	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	88.0	CHEMBL1913	Homo sapiens	Residual Activity	%	88.0
	12277419	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	102.0	CHEMBL1913	Homo sapiens	Residual Activity	%	102.0
	12277420	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	82.0	CHEMBL1913	Homo sapiens	Residual Activity	%	82.0
	12277421	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12277422	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	4.0	CHEMBL1913	Homo sapiens	Residual Activity	%	4.0
	12277423	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	75.0	CHEMBL1913	Homo sapiens	Residual Activity	%	75.0
	12277424	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	105.0	CHEMBL1913	Homo sapiens	Residual Activity	%	105.0
	12277425	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	52.0	CHEMBL1913	Homo sapiens	Residual Activity	%	52.0
	12277426	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277427	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	109.0	CHEMBL1913	Homo sapiens	Residual Activity	%	109.0
	12277428	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	108.0	CHEMBL1913	Homo sapiens	Residual Activity	%	108.0
	12277429	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	79.0	CHEMBL1913	Homo sapiens	Residual Activity	%	79.0
	12277430	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12277431	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	60.0	CHEMBL1913	Homo sapiens	Residual Activity	%	60.0
	12277432	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	96.0	CHEMBL1913	Homo sapiens	Residual Activity	%	96.0
	12277433	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL1913	Homo sapiens	Residual Activity	%	92.0
	12277434	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	95.0	CHEMBL1913	Homo sapiens	Residual Activity	%	95.0
	12277435	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	97.0	CHEMBL1913	Homo sapiens	Residual Activity	%	97.0
	12277436	CHEMBL2219387	Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	88.0	CHEMBL1913	Homo sapiens	Residual Activity	%	88.0
	12617263	CHEMBL2319221	Binding affinity to human PDGFRbeata	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL2311806	=	Kd	nM	12.0	CHEMBL1913	Homo sapiens	Kd	nM	12.0
	12617269	CHEMBL2319226	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL2311806	=	IC50	nM	768.4	CHEMBL1913	Homo sapiens	IC50	nM	768.4
	12617282	CHEMBL2319221	Binding affinity to human PDGFRbeata	B	Cc1cn(-c2cc(F)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311807	=	Kd	nM	8.5	CHEMBL1913	Homo sapiens	Kd	nM	8.5
	12617288	CHEMBL2319226	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cc(F)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311807	>	IC50	nM	5000.0	CHEMBL1913	Homo sapiens	IC50	nM	5000.0
	12617301	CHEMBL2319221	Binding affinity to human PDGFRbeata	B	Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311808	=	Kd	nM	7.2	CHEMBL1913	Homo sapiens	Kd	nM	7.2
	12617307	CHEMBL2319226	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311808	=	IC50	nM	35400.0	CHEMBL1913	Homo sapiens	IC50	nM	35400.0
	12617320	CHEMBL2319221	Binding affinity to human PDGFRbeata	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	16.0	CHEMBL1913	Homo sapiens	Kd	nM	16.0
	12617326	CHEMBL2319226	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	60.11	CHEMBL1913	Homo sapiens	IC50	nM	60.11
Not Active	12623298	CHEMBL2318778	Binding affinity to PDGFRbeta (unknown origin) at 10 nM after 2 hrs by FRET assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1		CHEMBL2316582		Activity			CHEMBL1913	Homo sapiens	Activity		
	12626703	CHEMBL2316980	Inhibition of PDGFRbeta (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL1913	Homo sapiens	INH	%	80.0
	12670830	CHEMBL2346202	Inhibition of PDGFRbeta (unknown origin) at 100 uM after 60 mins by ELISA relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	82.1	CHEMBL1913	Homo sapiens	INH	%	82.1
	12670831	CHEMBL2346202	Inhibition of PDGFRbeta (unknown origin) at 100 uM after 60 mins by ELISA relative to control	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]	Outside typical range	CHEMBL2334795	=	Inhibition	%	-81.8	CHEMBL1913	Homo sapiens	INH	%	-81.8
	12674091	CHEMBL2345558	Inhibition of PDGFR-beta (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O		CHEMBL2333163	=	IC50	nM	4000.0	CHEMBL1913	Homo sapiens	IC50	uM	4.0
	12674092	CHEMBL2345558	Inhibition of PDGFR-beta (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O		CHEMBL505637	=	IC50	nM	3300.0	CHEMBL1913	Homo sapiens	IC50	uM	3.3
	12674093	CHEMBL2345558	Inhibition of PDGFR-beta (unknown origin)	B	O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O		CHEMBL360190	=	IC50	nM	10200.0	CHEMBL1913	Homo sapiens	IC50	uM	10.2
	12675486	CHEMBL2344408	Inhibition of PDGFRbeta (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ncc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2332840	=	IC50	nM	408.0	CHEMBL1913	Homo sapiens	IC50	uM	0.408
	12684809	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1	Potential transcription error	CHEMBL553	=	IC50	nM	12200.0	CHEMBL1913	Homo sapiens	IC50	uM	12.2
	12684810	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C	Potential transcription error	CHEMBL535	=	IC50	nM	83100.0	CHEMBL1913	Homo sapiens	IC50	uM	83.1
	12684811	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	IC50	nM	3700.0	CHEMBL1913	Homo sapiens	IC50	uM	3.7
	12684812	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	COc1cccc(Nc2nc(NC(=O)C(C)(C)C)nc3[nH]c4cccc(Cl)c4c23)c1	Outside typical range	CHEMBL2337372	=	IC50	nM	196200.0	CHEMBL1913	Homo sapiens	IC50	uM	196.2
	12684813	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	CC(C)(C)C(=O)Nc1nc(Nc2cccc(F)c2)c2c(n1)[nH]c1cccc(Cl)c12	Outside typical range	CHEMBL2337371	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	12684814	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(Cl)cc2F)c2c(n1)[nH]c1cccc(Cl)c12	Outside typical range	CHEMBL2337370	=	IC50	nM	170800.0	CHEMBL1913	Homo sapiens	IC50	uM	170.8
	12684815	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(Cl)cc2)c2c(n1)[nH]c1cccc(Cl)c12	Outside typical range	CHEMBL2337369	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	12684816	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	CC(C)c1ccc(Nc2nc(NC(=O)C(C)(C)C)nc3[nH]c4cccc(Cl)c4c23)cc1	Outside typical range	CHEMBL2337368	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	12684817	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	CC(C)(C)C(=O)Nc1nc(Nc2ccccc2)c2c(n1)[nH]c1cccc(Cl)c12		CHEMBL2337367	=	IC50	nM	70600.0	CHEMBL1913	Homo sapiens	IC50	uM	70.6
	12684818	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	COc1cccc(Nc2nc(N)nc3[nH]c4cccc(Cl)c4c23)c1		CHEMBL2337366	=	IC50	nM	50500.0	CHEMBL1913	Homo sapiens	IC50	uM	50.5
	12684819	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	Nc1nc(Nc2cccc(F)c2)c2c(n1)[nH]c1cccc(Cl)c12	Outside typical range	CHEMBL2337365	=	IC50	nM	172200.0	CHEMBL1913	Homo sapiens	IC50	uM	172.2
	12684820	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	Nc1nc(Nc2ccc(Cl)cc2F)c2c(n1)[nH]c1cccc(Cl)c12	Outside typical range	CHEMBL2337364	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	12684821	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	Nc1nc(Nc2ccc(Cl)cc2)c2c(n1)[nH]c1cccc(Cl)c12	Outside typical range	CHEMBL2337363	=	IC50	nM	196200.0	CHEMBL1913	Homo sapiens	IC50	uM	196.2
	12684822	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	CC(C)c1ccc(Nc2nc(N)nc3[nH]c4cccc(Cl)c4c23)cc1	Outside typical range	CHEMBL2337362	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	12684823	CHEMBL2344595	Inhibition of PDGFRbeta in human SF539 cells assessed as inhibition of PDGFR-BB-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA	B	Nc1nc(Nc2ccccc2)c2c(n1)[nH]c1cccc(Cl)c12	Outside typical range	CHEMBL2337374	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	12685257	CHEMBL2342046	Inhibition of PDGFRbeta (unknown origin) assessed as residual activity at 100 nM after 1 hr by competitive binding assay relative to control	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	Activity	%	31.0	CHEMBL1913	Homo sapiens	Activity	%	31.0
	12692741	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335019	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	12692742	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335018	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	12692743	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335016	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	12692744	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335014	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	12692745	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335013	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	12692746	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335378	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	12692747	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335377	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	uM	500.0
	12692757	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	C#Cc1cccc(Nc2nc(NC(=O)C(C)(C)C)nc3[nH]c(CCc4ccccn4)cc23)c1	Outside typical range	CHEMBL2335017	=	IC50	nM	430100.0	CHEMBL1913	Homo sapiens	IC50	uM	430.1
	12692758	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccn4)cc23)c1	Outside typical range	CHEMBL2335379	=	IC50	nM	331500.0	CHEMBL1913	Homo sapiens	IC50	uM	331.5
	12692770	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335015	=	IC50	nM	89700.0	CHEMBL1913	Homo sapiens	IC50	uM	89.7
	12692773	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C	Potential transcription error	CHEMBL535	=	IC50	nM	83100.0	CHEMBL1913	Homo sapiens	IC50	uM	83.1
	12692791	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335376	=	IC50	nM	13400.0	CHEMBL1913	Homo sapiens	IC50	uM	13.4
	12692795	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1	Potential transcription error	CHEMBL553	=	IC50	nM	12200.0	CHEMBL1913	Homo sapiens	IC50	uM	12.2
	12692803	CHEMBL2343566	Inhibition of PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta pretreated for 60 mins prior to PDGF-BB addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	IC50	nM	6200.0	CHEMBL1913	Homo sapiens	IC50	uM	6.2
	12692804	CHEMBL2343080	Ratio of sunitinib IC50 to compound IC50 for PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335376	=	Ratio IC50		6.0	CHEMBL1913	Homo sapiens	Ratio IC50		6.0
	12692814	CHEMBL2343079	Ratio of compound IC50 to AG1295 IC50 for PDGF-BB-induced PDGFR beta phosphorylation in human SF539 cells overexpressing PDGFR beta by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335376	=	Ratio IC50		2.0	CHEMBL1913	Homo sapiens	Ratio IC50		2.0
	12693280	CHEMBL2343957	Inhibition of PDGFRbeta (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	3500.0	CHEMBL1913	Homo sapiens	IC50	nM	3500.0
	12697473	CHEMBL2343161	Inhibition of PDGFR-beta (unknown origin) after 20 mins by scintillation counting	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	400.0	CHEMBL1913	Homo sapiens	IC50	uM	0.4
	12697485	CHEMBL2343161	Inhibition of PDGFR-beta (unknown origin) after 20 mins by scintillation counting	B	NC(=O)C1=C(N)C(=O)C=C(Nc2ccccc2O)C1=O		CHEMBL2332119	=	IC50	nM	480.0	CHEMBL1913	Homo sapiens	IC50	uM	0.48
	12718788	CHEMBL2350672	Inhibition of PDGFRbeta (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	0.4	CHEMBL1913	Homo sapiens	IC50	nM	0.4
	12718810	CHEMBL2350694	Inhibition of PDGFRbeta (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	41.0	CHEMBL1913	Homo sapiens	INH	%	41.0
	12718833	CHEMBL2350986	Inhibition of PDGFRbeta (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	70.0	CHEMBL1913	Homo sapiens	INH	%	70.0
	12721804	CHEMBL2353788	Inhibition of PDGFRB (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	16.0	CHEMBL1913	Homo sapiens	INH	%	16.0
	12727697	CHEMBL2350875	Inhibition of PDGFR beta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	91.0	CHEMBL1913	Homo sapiens	Activity	%	91.0
	12728075	CHEMBL2351290	Inhibition of PDGFRbeta (unknown origin) incubated for 5 mins prior to ATP addition measured after 60 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	12728985	CHEMBL2350162	Inhibition of PDGFR beta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL1913	Homo sapiens	Activity	%	94.0
	12729864	CHEMBL2354080	Inhibition of PDGFRb (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	81.0	CHEMBL1913	Homo sapiens	Activity	%	81.0
	12730128	CHEMBL2350875	Inhibition of PDGFR beta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	97.0	CHEMBL1913	Homo sapiens	Activity	%	97.0
	12730626	CHEMBL2353585	Inhibition of PDGFRbeta (unknown origin) by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
Active	12732578	CHEMBL2352080	Inhibition of PDGFRbeta in human HASMC assessed as decrease in PDGF-induced ERK1/2 phosphorylation at 1 to 4 uM after 5 to 15 mins by Western blot analysis	B	CCCCCCCC/C=C\CCCCCCC[C@H](O)[C@@H](O)[C@H](O)C#CC#CCO		CHEMBL2349065		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Active	12732579	CHEMBL2352081	Inhibition of PDGFRbeta in human HASMC assessed as decrease in PDGF-induced Akt phosphorylation at 1 to 4 uM after 5 to 15 mins by Western blot analysis	B	CCCCCCCC/C=C\CCCCCCC[C@H](O)[C@@H](O)[C@H](O)C#CC#CCO		CHEMBL2349065		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Active	12732580	CHEMBL2352082	Inhibition of PDGFRbeta in human HASMC assessed as decrease in PDGF-induced PLC-gamma1 phosphorylation at 1 to 4 uM after 5 to 15 mins by Western blot analysis	B	CCCCCCCC/C=C\CCCCCCC[C@H](O)[C@@H](O)[C@H](O)C#CC#CCO		CHEMBL2349065		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Dose-dependent effect	12732581	CHEMBL2352083	Inhibition of PDGF-induced PDGFRbeta phosphorylation in human HASMC after 5 to 15 mins by Western blot analysis	B	CCCCCCCC/C=C\CCCCCCC[C@H](O)[C@@H](O)[C@H](O)C#CC#CCO		CHEMBL2349065		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307666	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	C#CCNC(=O)Nc1cccc(CCl)c1		CHEMBL2017300		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307667	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	NS(=O)(=O)c1cccc(-n2cc(CNC(=O)Nc3cccc(CCl)c3)nn2)c1		CHEMBL2381856		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307668	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	NS(=O)(=O)c1ccc(-n2cc(CNC(=O)Nc3cccc(CCl)c3)nn2)cc1		CHEMBL2381855		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307669	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	O=C(NCc1cn(-c2ccc3ncsc3c2)nn1)Nc1cccc(CCl)c1		CHEMBL2381854		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307670	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	O=C(NCc1cn(Cc2cc(=O)[nH]c3ccccc23)nn1)Nc1cccc(CCl)c1		CHEMBL2381853		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307671	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	CC(=O)N1CCc2ccc(-n3cc(CNC(=O)Nc4cccc(CCl)c4)nn3)cc21		CHEMBL2381852		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307672	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	O=C(NCc1cn(CCN2C(=O)c3ccccc3C2=O)nn1)Nc1cccc(CCl)c1		CHEMBL2381851		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307673	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	O=C(NCc1cn(-c2ccc(S(=O)(=O)N3CCOCC3)cc2)nn1)Nc1cccc(CCl)c1		CHEMBL2381861		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307674	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	O=C(NCc1cn(-c2ccc3scnc3c2)nn1)Nc1cccc(CCl)c1		CHEMBL2381860		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307675	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	O=C(NCc1cn(-c2ccc3[nH]ncc3c2)nn1)Nc1cccc(CCl)c1		CHEMBL2381859		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307676	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	O=C(NCc1cn(-c2ccc3cn[nH]c3c2)nn1)Nc1cccc(CCl)c1		CHEMBL2381858		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13307677	CHEMBL2382762	Inhibition of human recombinant PDGFR-beta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)] as substrate at 1 uM after 15 to 60 mins by fluorescence assay	B	COC(=O)c1ccc(-n2cc(CNC(=O)Nc3cccc(CCl)c3)nn2)cc1		CHEMBL2381857		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	13327009	CHEMBL2389798	Inhibition of PDGFRB (unknown origin) at 1 uM by kinase Glo assay	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	97.0	CHEMBL1913	Homo sapiens	INH	%	97.0
	13327010	CHEMBL2389798	Inhibition of PDGFRB (unknown origin) at 1 uM by kinase Glo assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	99.0	CHEMBL1913	Homo sapiens	INH	%	99.0
	13327642	CHEMBL2389814	Inhibition of PDGFRB (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	87.0	CHEMBL1913	Homo sapiens	INH	%	87.0
	13330065	CHEMBL2389575	Inhibition of PDGFR (unknown origin)	B	CC(C)n1cc(C(=O)c2cccc(NC(=O)Nc3ccc(Cl)cc3)c2)c2c(N)ncnc21		CHEMBL2387002	=	IC50	nM	1400.0	CHEMBL1913	Homo sapiens	IC50	nM	1400.0
	13330066	CHEMBL2389575	Inhibition of PDGFR (unknown origin)	B	Nc1ncnc2c1c(C(=O)c1cccc(NC(=O)Nc3c(F)cccc3F)c1)cn2C1CCCC1		CHEMBL2386994	>	IC50	nM	5000.0	CHEMBL1913	Homo sapiens	IC50	nM	5000.0
	13340738	CHEMBL2394290	Inhibition of PDGFR-beta (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12)c1ccccc1[N+](=O)[O-]		CHEMBL2391406	=	Inhibition	%	37.93	CHEMBL1913	Homo sapiens	INH	%	37.93
Not Active	13349224	CHEMBL2399724	Inhibition of recombinant PDGFRbeta (unknown origin) at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL2397148		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	13349225	CHEMBL2399724	Inhibition of recombinant PDGFRbeta (unknown origin) at 10 uM	B	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL242459		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	13371350	CHEMBL2403996	Inhibition of PDGFR beta (unknown origin) at 10 uM by Z'-LYTE kinase assay	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	Inhibition	%	9.63	CHEMBL1913	Homo sapiens	INH	%	9.63
	13374404	CHEMBL2406535	Inhibition of PDGFRbeta (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	13389892	CHEMBL2410838	Inhibition of PDGFRbeta (unknown origin) using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	=	IC50	nM	14.0	CHEMBL1913	Homo sapiens	IC50	nM	14.0
	13389956	CHEMBL2410838	Inhibition of PDGFRbeta (unknown origin) using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)c2)n(C)n1		CHEMBL2409790	=	IC50	nM	21.0	CHEMBL1913	Homo sapiens	IC50	nM	21.0
	13389957	CHEMBL2410838	Inhibition of PDGFRbeta (unknown origin) using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4n3)c2)n(C)n1		CHEMBL2409781	=	IC50	nM	8.3	CHEMBL1913	Homo sapiens	IC50	nM	8.3
	13389958	CHEMBL2410838	Inhibition of PDGFRbeta (unknown origin) using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c2)n(C)n1		CHEMBL2409779	=	IC50	nM	5.9	CHEMBL1913	Homo sapiens	IC50	nM	5.9
	13389959	CHEMBL2410838	Inhibition of PDGFRbeta (unknown origin) using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)c2)n(C)n1		CHEMBL2409775	=	IC50	nM	19.0	CHEMBL1913	Homo sapiens	IC50	nM	19.0
	13389960	CHEMBL2410838	Inhibition of PDGFRbeta (unknown origin) using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c2)n(C)n1		CHEMBL2348996	=	IC50	nM	5.5	CHEMBL1913	Homo sapiens	IC50	nM	5.5
	13392443	CHEMBL2411324	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	uM	0.002
	13392444	CHEMBL2411324	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCCCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407635	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	13392445	CHEMBL2411324	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598022	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	13392446	CHEMBL2411324	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598852	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	uM	50.0
	13392447	CHEMBL2411324	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407519	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	13392448	CHEMBL2411324	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407518	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	13392449	CHEMBL2411324	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407517	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	13392450	CHEMBL2411324	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CN(C)CCNCCNc1ccc2c3c(cccc13)C(=O)N(C)C2=O		CHEMBL2407516	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	13414478	CHEMBL2422318	Inhibition of PDGFRbeta (unknown origin) at 1 uM	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1		CHEMBL2419762	=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	13414488	CHEMBL2422324	Inhibition of PDGFRbeta (unknown origin)	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCO5)c2)cc1		CHEMBL2419761	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	13414489	CHEMBL2422324	Inhibition of PDGFRbeta (unknown origin)	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCO5)c2)cc1		CHEMBL2419760	=	IC50	nM	243.0	CHEMBL1913	Homo sapiens	IC50	uM	0.243
	13442318	CHEMBL2429486	Competitive binding affinity to PDGFRB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	67.0	CHEMBL1913	Homo sapiens	INH	%	67.0
	13442439	CHEMBL2429486	Competitive binding affinity to PDGFRB (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL1913	Homo sapiens	INH	%	85.0
	13442479	CHEMBL2429171	Binding affinity to PDGFRB (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	6800.0	CHEMBL1913	Homo sapiens	Kd	uM	6.8
	13445453	CHEMBL2429486	Competitive binding affinity to PDGFRB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	98.0	CHEMBL1913	Homo sapiens	INH	%	98.0
	13448508	CHEMBL2429486	Competitive binding affinity to PDGFRB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
	13448644	CHEMBL2429486	Competitive binding affinity to PDGFRB (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	70.0	CHEMBL1913	Homo sapiens	INH	%	70.0
	13451439	CHEMBL2429486	Competitive binding affinity to PDGFRB (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	95.0	CHEMBL1913	Homo sapiens	INH	%	95.0
	13454624	CHEMBL2429486	Competitive binding affinity to PDGFRB (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	91.0	CHEMBL1913	Homo sapiens	INH	%	91.0
	13461915	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	10.6	CHEMBL1913	Homo sapiens	IC50	nM	10.6
	13461916	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)N1CCC[C@H]1CN1CCCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430253	=	IC50	nM	118.4	CHEMBL1913	Homo sapiens	IC50	nM	118.4
	13461917	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)N1CCC(N3CCCCC3)CC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430252	=	IC50	nM	40.7	CHEMBL1913	Homo sapiens	IC50	nM	40.7
	13461918	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)N1CCOCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430251	=	IC50	nM	40.1	CHEMBL1913	Homo sapiens	IC50	nM	40.1
	13461919	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CC(O)CNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430250	=	IC50	nM	19.3	CHEMBL1913	Homo sapiens	IC50	nM	19.3
	13461920	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)NCCCN1CCCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430249	=	IC50	nM	64.8	CHEMBL1913	Homo sapiens	IC50	nM	64.8
	13461921	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)NCCCN1CCOCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430248	=	IC50	nM	18.0	CHEMBL1913	Homo sapiens	IC50	nM	18.0
	13461922	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430247	=	IC50	nM	21.3	CHEMBL1913	Homo sapiens	IC50	nM	21.3
	13461923	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)NCCc1ccccn1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430198	=	IC50	nM	160.6	CHEMBL1913	Homo sapiens	IC50	nM	160.6
	13461924	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)NCCO)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430262	=	IC50	nM	12.7	CHEMBL1913	Homo sapiens	IC50	nM	12.7
	13461925	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)NCCN(C)C)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430261	=	IC50	nM	22.7	CHEMBL1913	Homo sapiens	IC50	nM	22.7
	13461926	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)NCCN1CCCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430260	=	IC50	nM	41.6	CHEMBL1913	Homo sapiens	IC50	nM	41.6
	13461927	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)NCCN1CCCCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430259	=	IC50	nM	19.4	CHEMBL1913	Homo sapiens	IC50	nM	19.4
	13461928	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	Cc1[nH]c2c(c1C(=O)NCCN1CCOCC1)CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2430258	=	IC50	nM	13.2	CHEMBL1913	Homo sapiens	IC50	nM	13.2
	13461929	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2c(F)cccc21		CHEMBL2430257	=	IC50	nM	260.3	CHEMBL1913	Homo sapiens	IC50	nM	260.3
	13461930	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2cccc(F)c21		CHEMBL2430256	=	IC50	nM	62.1	CHEMBL1913	Homo sapiens	IC50	nM	62.1
	13461931	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(S(=O)(=O)N(CC)CC)cc21		CHEMBL2429872	=	IC50	nM	395.7	CHEMBL1913	Homo sapiens	IC50	nM	395.7
	13461932	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(C(=O)OC)cc21		CHEMBL2430255	=	IC50	nM	70.3	CHEMBL1913	Homo sapiens	IC50	nM	70.3
	13461933	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc([N+](=O)[O-])cc21		CHEMBL2430254	=	IC50	nM	13.3	CHEMBL1913	Homo sapiens	IC50	nM	13.3
	13461934	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(OC)cc21		CHEMBL2430267	=	IC50	nM	101.4	CHEMBL1913	Homo sapiens	IC50	nM	101.4
	13461935	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(C)cc21		CHEMBL2430266	=	IC50	nM	15.6	CHEMBL1913	Homo sapiens	IC50	nM	15.6
	13461936	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(Br)cc21		CHEMBL2430265	=	IC50	nM	7.6	CHEMBL1913	Homo sapiens	IC50	nM	7.6
	13461937	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(Cl)cc21		CHEMBL2430264	=	IC50	nM	12.1	CHEMBL1913	Homo sapiens	IC50	nM	12.1
	13461938	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2180602	=	IC50	nM	10.1	CHEMBL1913	Homo sapiens	IC50	nM	10.1
	13461939	CHEMBL2434541	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccccc21		CHEMBL2430263	=	IC50	nM	89.9	CHEMBL1913	Homo sapiens	IC50	nM	89.9
	13476407	CHEMBL2439131	Inhibition of human wild type PDGFRB at 1 uM by qPCR analysis relative to control	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
	13484281	CHEMBL2437780	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) (4:1) as substrate after 30 mins by spectrophotometric analysis	B	COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL2435999	=	IC50	nM	1.42	CHEMBL1913	Homo sapiens	IC50	nM	1.42
	13499587	CHEMBL2447152	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	13506649	CHEMBL2443986	Inhibition of PDGFRbeta (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
	13506650	CHEMBL2443986	Inhibition of PDGFRbeta (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
	13506651	CHEMBL2443986	Inhibition of PDGFRbeta (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
	13506652	CHEMBL2443986	Inhibition of PDGFRbeta (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
Active	13826420	CHEMBL3088488	Binding affinity to PDGFRbeta (unknown origin)	B	C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1		CHEMBL3086102		Activity			CHEMBL1913	Homo sapiens	Activity		
	13851889	CHEMBL3095042	Inhibition of recombinant PDGFR-beta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCN(CC)CCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092314	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	13851890	CHEMBL3095042	Inhibition of recombinant PDGFR-beta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C(NCCN1CCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092308	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	13871790	CHEMBL3101251	Inhibition of human PDGFRbeta assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	160.0	CHEMBL1913	Homo sapiens	Activity	%	160.0
Not Active	13898463	CHEMBL3110508	Inhibition of PDGFRB (unknown origin) at 10 uM by qPCR analysis	B	CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL3108909		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	13898464	CHEMBL3110509	Inhibition of PDGFRB (unknown origin) expressed in HEK293 cells at 500 nM preincubated for 1 hr followed by compound washout measured after 30 mins by qPCR analysis relative to control	B	CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F		CHEMBL3108909	=	Inhibition	%	35.0	CHEMBL1913	Homo sapiens	INH	%	35.0
	13899601	CHEMBL3112008	Inhibition of human recombinant PDGFRbeta expressed in insect cells using ATP/Ulight-PolyGAT[EAY(1:1:1)]n as substrate at 1 uM after 30 mins by LANCE assay	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144	=	Inhibition	%	13.7	CHEMBL1913	Homo sapiens	INH	%	13.7
	13902309	CHEMBL3117949	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL3116440	=	IC50	nM	530.6	CHEMBL1913	Homo sapiens	IC50	nM	530.6
	13906553	CHEMBL3117483	Inhibition of PDGFRbeta (unknown origin) at 10 uM after 30 mins relative to control	B	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC		CHEMBL3113284	=	Inhibition	%	-0.8	CHEMBL1913	Homo sapiens	INH	%	-0.8
Not Active	13907183	CHEMBL3118659	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	CCCCCCCCCC(NC(=O)CNC(=O)OCc1ccccc1)C(=O)NCCc1ccccc1		CHEMBL3113587		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	13917426	CHEMBL3117355	Inhibition of PDGFRbeta (unknown origin)	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	13917463	CHEMBL3117355	Inhibition of PDGFRbeta (unknown origin)	B	CN1CCN(c2ccc(Nc3ncc4cc(C#N)c(=O)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL3115681	=	IC50	nM	26.0	CHEMBL1913	Homo sapiens	IC50	nM	26.0
	13948211	CHEMBL3132618	Inhibition of PDGFR beta (unknown origin) using biotinylated poly-Glu-Tyr (4:1) as substrate preincubated for 5 mins measured after 12 hrs	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	IC50	nM	120.0	CHEMBL1913	Homo sapiens	IC50	nmol/L	120.0
	13954561	CHEMBL3130930	Inhibition of human PDGFRbeta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	70.0	CHEMBL1913	Homo sapiens	Activity	%	70.0
	13954722	CHEMBL3130930	Inhibition of human PDGFRbeta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	82.0	CHEMBL1913	Homo sapiens	Activity	%	82.0
	13954758	CHEMBL3130930	Inhibition of human PDGFRbeta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	64.0	CHEMBL1913	Homo sapiens	Activity	%	64.0
	14543403	CHEMBL3226015	Inhibition of recombinant PDGFRbeta (unknown origin) using poly-Glu-Tyr peptide as substrate	B	Nc1ccccc1NC(=O)c1ccc(COc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1		CHEMBL3217993	=	IC50	nM	28000.0	CHEMBL1913	Homo sapiens	IC50	uM	28.0
	14543404	CHEMBL3226015	Inhibition of recombinant PDGFRbeta (unknown origin) using poly-Glu-Tyr peptide as substrate	B	C#Cc1cccc(Nc2ncnc3ccc(OCc4ccc(C(=O)Nc5ccccc5N)cc4)cc23)c1		CHEMBL3218000	=	IC50	nM	7200.0	CHEMBL1913	Homo sapiens	IC50	uM	7.2
	14543405	CHEMBL3226015	Inhibition of recombinant PDGFRbeta (unknown origin) using poly-Glu-Tyr peptide as substrate	B	C#Cc1cccc(Nc2ncnc3ccc(S(=O)(=O)n4ccc(/C=C/C(=O)Nc5ccccc5N)c4)cc23)c1		CHEMBL3218001	=	IC50	nM	16000.0	CHEMBL1913	Homo sapiens	IC50	uM	16.0
	14543406	CHEMBL3226015	Inhibition of recombinant PDGFRbeta (unknown origin) using poly-Glu-Tyr peptide as substrate	B	C#Cc1cccc(Nc2ncnc3ccc(S(=O)(=O)n4ccc(/C=C/C(=O)NO)c4)cc23)c1		CHEMBL3218002	=	IC50	nM	70000.0	CHEMBL1913	Homo sapiens	IC50	uM	70.0
	14543407	CHEMBL3226015	Inhibition of recombinant PDGFRbeta (unknown origin) using poly-Glu-Tyr peptide as substrate	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	IC50	nM	2300.0	CHEMBL1913	Homo sapiens	IC50	uM	2.3
	14553642	CHEMBL3225782	Inhibition of PDGFRbeta (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	96.3	CHEMBL1913	Homo sapiens	Activity	%	96.3
	14565386	CHEMBL3240908	Inhibition of PDGFR-beta (unknown origin) at 1 uM relative to control	B	Cc1ccc(Nc2cc(N[C@@H]3CCCC[C@@H]3N)nnc2C(N)=O)nc1C		CHEMBL3237561	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
Active	14571530	CHEMBL3240263	Inhibition of PDGFRbeta (unknown origin) at 1 uM by KINOMEscan assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc2[nH]ccc2c1		CHEMBL3234752		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Active	14577999	CHEMBL3239327	Inhibition of PDGFRB (unknown origin) at 10 uM by KinomeScan analysis	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235538		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Active	14578000	CHEMBL3239327	Inhibition of PDGFRB (unknown origin) at 10 uM by KinomeScan analysis	B	O=C(Cc1ccccc1Cl)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235542		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	14582580	CHEMBL3241644	Inhibition of human PDGFRbeta assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	114.5	CHEMBL1913	Homo sapiens	Activity	%	114.5
	14589539	CHEMBL3239038	Inhibition of recombinant PDGFRbeta (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233767	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	14589540	CHEMBL3239038	Inhibition of recombinant PDGFRbeta (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	O=C(/C=C/CN1CC2CCC1C(=O)C2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233785	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
Not Active	14652724	CHEMBL3269414	Inhibition of human PDGFRbeta kinase at 1 uM	B	CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1		CHEMBL3261905		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	14652725	CHEMBL3269415	Inhibition of human PDGFRbeta kinase at 10 uM	B	CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1		CHEMBL3261905		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	14659375	CHEMBL3267953	Inhibition of PDGFRb (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	18.0	CHEMBL1913	Homo sapiens	INH	%	18.0
	14659376	CHEMBL3267953	Inhibition of PDGFRb (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	2.0	CHEMBL1913	Homo sapiens	INH	%	2.0
	14664275	CHEMBL3271251	Inhibition of PDGFRB (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	89.0	CHEMBL1913	Homo sapiens	INH	%	89.0
	14664276	CHEMBL3271251	Inhibition of PDGFRB (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	52.0	CHEMBL1913	Homo sapiens	INH	%	52.0
	14664277	CHEMBL3271251	Inhibition of PDGFRB (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	62.0	CHEMBL1913	Homo sapiens	INH	%	62.0
	14666348	CHEMBL3270467	Inhibition of PDGFR-beta (unknown origin) assessed as [33P] incorporation in substrate by TopCount microplate scintillation counting analysis	B	COc1ccc(Oc2cc(C)c(-c3csc(NC(=O)c4ccnc(F)c4)n3)c(C)c2)cc1		CHEMBL3263869	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	14712159	CHEMBL3293745	Inhibition of PDGFR beta (unknown origin)	B	COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL3290931	=	IC50	nM	92.3	CHEMBL1913	Homo sapiens	IC50	nM	92.3
	14713689	CHEMBL3296759	Binding affinity to PDGFR-beta (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Ki	nM	8.0	CHEMBL1913	Homo sapiens	Ki	uM	0.008
	14713694	CHEMBL3296759	Binding affinity to PDGFR-beta (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	19.0	CHEMBL1913	Homo sapiens	Ki	uM	0.019
	14713739	CHEMBL3296848	Inhibition of PDGFR-beta (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	79.0	CHEMBL1913	Homo sapiens	INH	%	79.0
	14746915	CHEMBL3295615	Inhibition of recombinant PDGFR-beta (unknown origin) using poly (4 Glu, Tyr) as substrate after 60 mins by ELISA	B	Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12		CHEMBL3288526	=	IC50	nM	4.6	CHEMBL1913	Homo sapiens	IC50	nM	4.6
Not Determined	14751454	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	Cc1nc(Nc2ccccc2)c2cc(C)oc2n1		CHEMBL3297816		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	14751455	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	Cc1nc(Nc2cccc3ccccc23)c2cc(C)oc2n1		CHEMBL3297891		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	14751456	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	Cc1nc(Nc2ccc(F)c(Cl)c2)c2cc(C)oc2n1		CHEMBL3297894		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	14751457	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	Cc1nc(Nc2ccc(Cl)cc2)c2cc(C)oc2n1		CHEMBL3297895		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	14751458	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	14751459	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	14751460	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		IC50			CHEMBL1913	Homo sapiens	IC50		
	14752111	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	C#Cc1cccc(Nc2nc(C)nc3oc(C)cc23)c1		CHEMBL3297892	=	IC50	nM	16.2	CHEMBL1913	Homo sapiens	IC50	nM	16.2
	14752119	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1.Cl		CHEMBL3298000	=	IC50	nM	21.9	CHEMBL1913	Homo sapiens	IC50	nM	21.9
	14752124	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	COc1ccc(N(c2nc(C)nc3oc(C)cc23)C(C)C)cc1		CHEMBL3297999	=	IC50	nM	23.1	CHEMBL1913	Homo sapiens	IC50	nM	23.1
	14752126	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	CCN(c1ccc(OC)cc1)c1nc(C)nc2oc(C)cc12		CHEMBL3297899	=	IC50	nM	27.1	CHEMBL1913	Homo sapiens	IC50	nM	27.1
	14752128	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	Cc1nc(Nc2cccc3[nH]ccc23)c2cc(C)oc2n1		CHEMBL3297896	=	IC50	nM	28.3	CHEMBL1913	Homo sapiens	IC50	nM	28.3
	14752132	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	CCCN(c1ccc(OC)cc1)c1nc(C)nc2oc(C)cc12		CHEMBL3297900	=	IC50	nM	29.9	CHEMBL1913	Homo sapiens	IC50	nM	29.9
	14752134	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1		CHEMBL3297898	=	IC50	nM	22.8	CHEMBL1913	Homo sapiens	IC50	nM	22.8
	14752139	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	CCCCN(c1ccc(OC)cc1)c1nc(C)nc2oc(C)cc12		CHEMBL3297998	=	IC50	nM	56.5	CHEMBL1913	Homo sapiens	IC50	nM	56.5
	14752146	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	Cc1nc(Nc2ccc(C(F)(F)F)cc2)c2cc(C)oc2n1		CHEMBL3297893	=	IC50	nM	66.1	CHEMBL1913	Homo sapiens	IC50	nM	66.1
	14752158	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	83.1	CHEMBL1913	Homo sapiens	IC50	nM	83.1
	14752175	CHEMBL3299342	Inhibition of PDGFRbeta in human SH-SY5Y cells by phosphotyrosine ELISA assay	B	COc1ccc(Nc2nc(C)nc3oc(C)cc23)cc1		CHEMBL3297897	=	IC50	nM	63.5	CHEMBL1913	Homo sapiens	IC50	nM	63.5
	14983178	CHEMBL3385021	Inhibition of PDGFR beta (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	78.0	CHEMBL1913	Homo sapiens	INH	%	78.0
	14983212	CHEMBL3383537	Inhibition of recombinant PDGFRb (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL3356289	=	Inhibition	%	61.8	CHEMBL1913	Homo sapiens	INH	%	61.8
	14983218	CHEMBL3383543	Inhibition of recombinant PDGFRb (unknown origin) at 1 uM after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL3356289	=	Inhibition	%	26.2	CHEMBL1913	Homo sapiens	INH	%	26.2
	14983224	CHEMBL3383549	Inhibition of recombinant PDGFRb (unknown origin) at 0.1 uM after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL3356289	=	Inhibition	%	0.4	CHEMBL1913	Homo sapiens	INH	%	0.4
	14983253	CHEMBL3383537	Inhibition of recombinant PDGFRb (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356290	=	Inhibition	%	76.0	CHEMBL1913	Homo sapiens	INH	%	76.0
	14983259	CHEMBL3383543	Inhibition of recombinant PDGFRb (unknown origin) at 1 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356290	=	Inhibition	%	46.7	CHEMBL1913	Homo sapiens	INH	%	46.7
	14983265	CHEMBL3383549	Inhibition of recombinant PDGFRb (unknown origin) at 0.1 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356290	=	Inhibition	%	13.6	CHEMBL1913	Homo sapiens	INH	%	13.6
	14984420	CHEMBL3384371	Inhibition of PDGFR beta (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	51.0	CHEMBL1913	Homo sapiens	INH	%	51.0
	14992041	CHEMBL3374158	Inhibition of PDGFRbeta (unknown origin) at 1 uM by ELISA method	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	80.2	CHEMBL1913	Homo sapiens	INH	%	80.2
	14992042	CHEMBL3374158	Inhibition of PDGFRbeta (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	14994881	CHEMBL3372475	Inhibition of PDGFRbeta (unknown origin) at 100 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	70.6	CHEMBL1913	Homo sapiens	INH	%	70.6
	14994882	CHEMBL3372475	Inhibition of PDGFRbeta (unknown origin) at 100 uM	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(Cc2ccccc2)C1=O		CHEMBL3358803	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	15005100	CHEMBL3366508	Inhibition of PDGFR-beta (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	15008072	CHEMBL3369101	Inhibition of human PDGFRbeta at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1	Outside typical range	CHEMBL3330255	=	Inhibition	%	-16.0	CHEMBL1913	Homo sapiens	INH	%	-16.0
	15008073	CHEMBL3369101	Inhibition of human PDGFRbeta at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	-6.0	CHEMBL1913	Homo sapiens	INH	%	-6.0
	15008074	CHEMBL3369101	Inhibition of human PDGFRbeta at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1	Outside typical range	CHEMBL3330410	=	Inhibition	%	-34.0	CHEMBL1913	Homo sapiens	INH	%	-34.0
	15022503	CHEMBL3374442	Inhibition of PDGFRbeta (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329652	=	Inhibition	%	35.0	CHEMBL1913	Homo sapiens	INH	%	35.0
	15022504	CHEMBL3374442	Inhibition of PDGFRbeta (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	74.0	CHEMBL1913	Homo sapiens	INH	%	74.0
	15025270	CHEMBL3362107	Inhibition of PDGFRbeta (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	O=C(CC(=O)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1)Nc1ccc(F)cc1		CHEMBL3322563	=	IC50	nM	86.9	CHEMBL1913	Homo sapiens	IC50	nM	86.9
	15025271	CHEMBL3362107	Inhibition of PDGFRbeta (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3322564	=	IC50	nM	176.7	CHEMBL1913	Homo sapiens	IC50	nM	176.7
	15025272	CHEMBL3362107	Inhibition of PDGFRbeta (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)cc1		CHEMBL3322565	=	IC50	nM	8.1	CHEMBL1913	Homo sapiens	IC50	nM	8.1
	15025273	CHEMBL3362107	Inhibition of PDGFRbeta (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)cc1		CHEMBL3322566	=	IC50	nM	1.54	CHEMBL1913	Homo sapiens	IC50	nM	1.54
Not Determined	15025274	CHEMBL3362107	Inhibition of PDGFRbeta (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322567		IC50			CHEMBL1913	Homo sapiens	IC50		
	15025275	CHEMBL3362108	Inhibition of PDGFRbeta (unknown origin) using EAIYAAPFAKKK substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)C2(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)CC2)cc1		CHEMBL3322568	=	Inhibition	%	39.0	CHEMBL1913	Homo sapiens	INH	%	39.0
	15036903	CHEMBL3381096	Inhibition of PDGFR (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	15036904	CHEMBL3381096	Inhibition of PDGFR (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	15036905	CHEMBL3381096	Inhibition of PDGFR (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	15036906	CHEMBL3381096	Inhibition of PDGFR (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	15036907	CHEMBL3381096	Inhibition of PDGFR (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	15055303	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccccc3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3359000	=	IC50	nM	8000.0	CHEMBL1913	Homo sapiens	IC50	uM	8.0
	15055304	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	15055305	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1ccc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)c(F)c1		CHEMBL3358998	=	IC50	nM	19000.0	CHEMBL1913	Homo sapiens	IC50	uM	19.0
	15055306	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccccc3O)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358997	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	15055307	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccc(O)cc3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358996	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	15055308	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccccc3Cl)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358995	=	IC50	nM	5000.0	CHEMBL1913	Homo sapiens	IC50	uM	5.0
	15055309	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3cccc(Cl)c3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358994	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	uM	0.8
	15055310	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccc(Cl)cc3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358993	=	IC50	nM	31000.0	CHEMBL1913	Homo sapiens	IC50	uM	31.0
	15055311	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cccc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)c1		CHEMBL3358992	=	IC50	nM	1400.0	CHEMBL1913	Homo sapiens	IC50	uM	1.4
	15055312	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1ccc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)cc1		CHEMBL3358991	=	IC50	nM	22000.0	CHEMBL1913	Homo sapiens	IC50	uM	22.0
	15055313	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccc[nH]3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358990	=	IC50	nM	7000.0	CHEMBL1913	Homo sapiens	IC50	uM	7.0
	15055314	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3cccnc3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358989	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	15055315	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccsc3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358988	=	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	15055316	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccoc3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358987	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	15055317	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3ccc4ccccc4c3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358986	=	IC50	nM	8000.0	CHEMBL1913	Homo sapiens	IC50	uM	8.0
	15055318	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3cccc4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358985	=	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	15055319	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3cnc4ccccc4c3)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358984	=	IC50	nM	26000.0	CHEMBL1913	Homo sapiens	IC50	uM	26.0
	15055320	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3coc4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358983	=	IC50	nM	3000.0	CHEMBL1913	Homo sapiens	IC50	uM	3.0
	15055321	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COC(=O)c1ccc2c(-c3c[nH]c(=O)c(-c4cc(OC)c(OC)c(OC)c4)n3)c[nH]c2c1		CHEMBL3358982	=	IC50	nM	9000.0	CHEMBL1913	Homo sapiens	IC50	uM	9.0
	15055322	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1ccc2c(-c3c[nH]c(=O)c(-c4cc(OC)c(OC)c(OC)c4)n3)c[nH]c2c1		CHEMBL3358981	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	15055323	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4cc(F)ccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358980	=	IC50	nM	56000.0	CHEMBL1913	Homo sapiens	IC50	uM	56.0
	15055324	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3cn(C)c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358979	=	IC50	nM	14000.0	CHEMBL1913	Homo sapiens	IC50	uM	14.0
	15055325	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccc(C)cc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358978	=	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	15055326	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccc(O)cc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358977	=	IC50	nM	300.0	CHEMBL1913	Homo sapiens	IC50	uM	0.3
	15055327	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	O=c1[nH]cc(-c2c[nH]c3ccccc23)nc1-c1c[nH]c2ccccc12		CHEMBL1986478	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	15055328	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	CCc1ccc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc1		CHEMBL3358976	=	IC50	nM	32000.0	CHEMBL1913	Homo sapiens	IC50	uM	32.0
	15055329	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	O=c1[nH]cc(-c2c[nH]c3ccccc23)nc1-c1ccc(F)cc1		CHEMBL3358975	=	IC50	nM	12000.0	CHEMBL1913	Homo sapiens	IC50	uM	12.0
	15055330	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	O=c1[nH]cc(-c2c[nH]c3ccccc23)nc1-c1ccc(N2CCOCC2)cc1		CHEMBL3358974	=	IC50	nM	13000.0	CHEMBL1913	Homo sapiens	IC50	uM	13.0
	15055331	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	O=c1[nH]cc(-c2c[nH]c3ccccc23)nc1-c1ccc2c(c1)OCO2		CHEMBL3358973	=	IC50	nM	13000.0	CHEMBL1913	Homo sapiens	IC50	uM	13.0
	15055332	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	CCOc1ccc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc1OC		CHEMBL3358972	=	IC50	nM	5000.0	CHEMBL1913	Homo sapiens	IC50	uM	5.0
	15055333	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1ccc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)c(OC)c1OC		CHEMBL3358971	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	15055334	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(OC)c(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)c(OC)c1		CHEMBL3358970	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	15055335	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(OC)cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)c1		CHEMBL3358969	=	IC50	nM	4000.0	CHEMBL1913	Homo sapiens	IC50	uM	4.0
	15055336	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1ccc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc1		CHEMBL3358968	=	IC50	nM	19000.0	CHEMBL1913	Homo sapiens	IC50	uM	19.0
	15055337	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1ccc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc1OC		CHEMBL3358967	=	IC50	nM	1500.0	CHEMBL1913	Homo sapiens	IC50	uM	1.5
	15055338	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358966	=	IC50	nM	500.0	CHEMBL1913	Homo sapiens	IC50	uM	0.5
	15055350	CHEMBL3380482	Inhibition of PDGFRbeta (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	1.0	CHEMBL1913	Homo sapiens	Activity	%	1.0
	15056636	CHEMBL3371134	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	CCN(CC)CCCNc1nc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)nc2ccsc12		CHEMBL3326099	=	IC50	nM	5800.0	CHEMBL1913	Homo sapiens	IC50	uM	5.8
Not Determined	15056637	CHEMBL3371134	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	15056638	CHEMBL3371134	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		IC50			CHEMBL1913	Homo sapiens	IC50		
Dose-dependent effect	15058867	CHEMBL3374475	Inhibition of PDGFRbeta in human U87 cells assessed as inhibition of PDGF-BB-induced Akt phosphorylation	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Dose-dependent effect	15058868	CHEMBL3374476	Inhibition of PDGFRbeta in human U87 cells assessed as inhibition of PDGF-BB-induced ERK phosphorylation	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Active	15058869	CHEMBL3374477	Inhibition of PDGFRbeta in human U87 cells assessed as inhibition of PDGF-BB-induced Akt phosphorylation at 3 uM	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	15058872	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c(C)[nH]c2=O)cc(OC)c1OC		CHEMBL3359001	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	15058873	CHEMBL3376848	Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate	B	COc1cc(-c2c[nH]c(=O)c(-c3c[nH]c4ccccc34)n2)cc(OC)c1OC		CHEMBL3359002	=	IC50	nM	12000.0	CHEMBL1913	Homo sapiens	IC50	uM	12.0
Not Active	15071574	CHEMBL3381565	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	CCN(CC)CCO/N=C(\c1ccc(SC)cc1)c1cccc2ccccc12.O=C(O)C(=O)O		CHEMBL3356484		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	15085845	CHEMBL3383509	Inhibition of purified PDGFRbeta (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	Inhibition	%	5.6	CHEMBL1913	Homo sapiens	INH	%	5.6
	15107871	CHEMBL3385199	Inhibition of wild type PDGFRbeta (unknown origin) incubated for 5 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C		CHEMBL3357634	=	IC50	nM	2102.0	CHEMBL1913	Homo sapiens	IC50	nM	2102.0
	15112615	CHEMBL3381426	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL3343366	=	IC50	nM	16.3	CHEMBL1913	Homo sapiens	IC50	nM	16.3
	15130243	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL554	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130244	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CN(C)[C@@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344221	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130245	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CS(=O)(=O)C[C@H](N)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344220	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130246	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CCCCCCC(=O)ON[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344219	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130247	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CCCCC(=O)ON[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344218	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130248	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CCC(=O)ON[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344217	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130249	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CN(C)[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344216	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130250	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CS(=O)(=O)C[C@@H](N)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344215	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130251	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CS(=O)(=O)CCNC(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344214	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130252	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CC(C)NC(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344213	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130253	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CS(=O)(=O)CC(NC1CCCCC1)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344212	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130254	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CCNC(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344211	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130255	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CN(C)C(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344208	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130256	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CNC(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344210	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
	15130257	CHEMBL3385741	Inhibition of PDGFRbeta (unknown origin) by ELISA method	B	CS(=O)(=O)CC(N)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL3344209	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	nM	200000.0
Not Active	15130293	CHEMBL3386310	Inhibition of PDGFRbeta phosphorylation (unknown origin) expressed in human U87MG cells at 0.001 to 1 uM incubated for 2 hrs by Western blot method	B	CN(C)[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL3344216		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	15130297	CHEMBL3386314	Inhibition of PDGFRbeta phosphorylation (unknown origin) expressed in human U87MG cells at 0.001 to 10 uM incubated for 2 hrs by Western blot method	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	15136044	CHEMBL3387489	Inhibition of purified PDGFRbeta (unknown origin) after 30 mins by homogeneous time-resolved fluorescence assay	B	Cc1cc(/C=N/NC(=O)Nc2ccc(-c3nc(N4CCOCC4)c4sccc4n3)cc2)cc(C)c1O		CHEMBL3343621	=	IC50	nM	7000.0	CHEMBL1913	Homo sapiens	IC50	uM	7.0
	15141921	CHEMBL3395906	Inhibition of PDGFRbeta (unknown origin)	B	Cc1ccc(-c2ncn(-c3ccc(Nc4nccc(-c5cccc(N6CCOCC6)c5)n4)cc3)n2)cn1		CHEMBL2144409	<	Kd	nM	1000.0	CHEMBL1913	Homo sapiens	Kd	uM	1.0
	15143826	CHEMBL3396212	Inhibition of purified PDGFRbeta (unknown origin) at 1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	59.3	CHEMBL1913	Homo sapiens	INH	%	59.3
Not Determined	15143841	CHEMBL3396227	Inhibition of purified PDGFRbeta (unknown origin) at 0.1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Determined	15143856	CHEMBL3396242	Inhibition of purified PDGFRbeta (unknown origin) at 0.01 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	15175177	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1		CHEMBL3297898	=	IC50	nM	22.8	CHEMBL1913	Homo sapiens	IC50	nM	22.8
	15175188	CHEMBL3404076	Ratio of sunitinib IC50 to compound IC50 for PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	Cc1nc(N(C)c2ccc3c(c2)CCO3)c2cc(C)oc2n1		CHEMBL3403513	=	Ratio IC50		4.0	CHEMBL1913	Homo sapiens	Ratio IC50		4.0
	15175201	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	Cc1nc(N(C)c2ccc3c(c2)CCO3)c2cc(C)oc2n1		CHEMBL3403513	=	IC50	nM	24.6	CHEMBL1913	Homo sapiens	IC50	nM	24.6
	15175215	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	Cc1nc(N(C)c2ccc3c(c2)OCO3)c2cc(C)oc2n1		CHEMBL3403512	=	IC50	nM	50.1	CHEMBL1913	Homo sapiens	IC50	nM	50.1
	15175229	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	COc1cc(N(C)c2nc(C)nc3oc(C)cc23)cc(OC)c1OC		CHEMBL3403511	=	IC50	nM	166.3	CHEMBL1913	Homo sapiens	IC50	nM	166.3
	15175243	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1OC		CHEMBL3403510	=	IC50	nM	66.1	CHEMBL1913	Homo sapiens	IC50	nM	66.1
	15175257	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)c(OC)c1		CHEMBL3403509	=	IC50	nM	40.4	CHEMBL1913	Homo sapiens	IC50	nM	40.4
	15176260	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	Cc1nc(N(C)c2ccc3occc3c2)c2cc(C)oc2n1		CHEMBL3403514	=	IC50	nM	25.0	CHEMBL1913	Homo sapiens	IC50	nM	25.0
	15176273	CHEMBL3404076	Ratio of sunitinib IC50 to compound IC50 for PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	Cc1nc(N(C)c2ccc3occc3c2)c2cc(C)oc2n1		CHEMBL3403514	=	Ratio IC50		4.0	CHEMBL1913	Homo sapiens	Ratio IC50		4.0
	15176334	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	COc1ccc2c(c1)CCN2c1nc(C)nc2oc(C)cc12		CHEMBL3403515	=	IC50	nM	73.2	CHEMBL1913	Homo sapiens	IC50	nM	73.2
	15176348	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	COc1ccc2c(ccn2-c2nc(C)nc3oc(C)cc23)c1		CHEMBL3403516	=	IC50	nM	198.0	CHEMBL1913	Homo sapiens	IC50	nM	198.0
	15176362	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	COc1ccc2c(c1)CCCN2c1nc(C)nc2oc(C)cc12		CHEMBL3403517	=	IC50	nM	58.2	CHEMBL1913	Homo sapiens	IC50	nM	58.2
	15176437	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	Cc1nc(N(C)c2ccc(OC(C)C)cc2)c2cc(C)oc2n1		CHEMBL3403518	=	IC50	nM	84.0	CHEMBL1913	Homo sapiens	IC50	nM	84.0
	15176451	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	CCOc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1		CHEMBL3403519	=	IC50	nM	132.0	CHEMBL1913	Homo sapiens	IC50	nM	132.0
Not Determined	15176477	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	15176491	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711		IC50			CHEMBL1913	Homo sapiens	IC50		
	15176496	CHEMBL3404063	Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min before PDGF-BB stimulation for 10 mins by phosphotyrosine ELISA cytoblot method	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	83.1	CHEMBL1913	Homo sapiens	IC50	nM	83.1
	15193443	CHEMBL3411889	Inhibition of human PDGFRbeta	B	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL3039504	=	IC50	nM	65.0	CHEMBL1913	Homo sapiens	IC50	nM	65.0
	15216310	CHEMBL3420460	Inhibition of PDGFR-beta (unknown origin) at 10 uM after 30 mins by HTRF method	B	CN(C)Cc1ccc2nc(NC(=O)N/N=C3\C(=O)Nc4ccc(F)cc43)sc2c1		CHEMBL3415260	=	Inhibition	%	2.2	CHEMBL1913	Homo sapiens	INH	%	2.2
	15216311	CHEMBL3420460	Inhibition of PDGFR-beta (unknown origin) at 10 uM after 30 mins by HTRF method	B	CN(C)Cc1ccc2nc(NC(=O)N/N=C/c3cn(Cc4ccc(Cl)cc4)c4ccccc34)sc2c1		CHEMBL3415268	=	Inhibition	%	12.8	CHEMBL1913	Homo sapiens	INH	%	12.8
	15216312	CHEMBL3420460	Inhibition of PDGFR-beta (unknown origin) at 10 uM after 30 mins by HTRF method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	99.8	CHEMBL1913	Homo sapiens	INH	%	99.8
	15223348	CHEMBL3420304	Inhibition of PDGFRbeta (unknown origin)	B	O=c1ccc(-n2ccc3ccc(F)cc32)nn1CCOc1ccnc2cc(OCCCN3CCOCC3)ccc12		CHEMBL3417489	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	15250389	CHEMBL3430293	Binding affinity to human PDGFRbeta at 10 uM relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	<	Activity	%	10.0	CHEMBL1913	Homo sapiens	Activity	%	10.0
	15250396	CHEMBL3430300	Binding affinity to human PDGFRbeta	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Kd	nM	70.0	CHEMBL1913	Homo sapiens	Kd	nM	70.0
	15600629	CHEMBL3578480	Inhibition of N-terminal GST fusion protein human PDGFR-beta cytoplasmic domain expressed in baculovirus using CSKtide as substrate at 10 uM after 1 hr by off-chip Mobility Shift Assay	B	COC(=O)c1cccc(Nc2n[nH]c3c2Cc2cc(OC)ccc2-3)c1		CHEMBL3578239	>	Inhibition	%	82.0	CHEMBL1913	Homo sapiens	INH	%	82.0
Not Active	15600633	CHEMBL3578484	Inhibition of N-terminal GST fusion protein human PDGFR-beta cytoplasmic domain expressed in baculovirus using CSKtide as substrate at 0.1 uM after 1 hr by off-chip Mobility Shift Assay	B	COC(=O)c1cccc(Nc2n[nH]c3c2Cc2cc(OC)ccc2-3)c1		CHEMBL3578239		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	15609950	CHEMBL3580044	Inhibition of human PDGFRbeta assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	51.0	CHEMBL1913	Homo sapiens	Activity	%	51.0
	15616220	CHEMBL3583138	Inhibition of Tel-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	4600.0	CHEMBL1913	Homo sapiens	IC50	uM	4.6
	15616221	CHEMBL3583138	Inhibition of Tel-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	2200.0	CHEMBL1913	Homo sapiens	IC50	uM	2.2
	15616222	CHEMBL3583138	Inhibition of Tel-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	uM	2.0
	15649716	CHEMBL3595389	Inhibition of human PDGFRbeta at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	91.0	CHEMBL1913	Homo sapiens	INH	%	91.0
	15667029	CHEMBL3603308	Inhibition of PDGFRB (unknown origin) assessed as residual enzyme activity at 1 uM by Z'-Lyte assay relative to control	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223	=	Activity	%	9.6	CHEMBL1913	Homo sapiens	Activity	%	9.6
	15685908	CHEMBL3608087	Inhibition of human PDGFRb	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
Not Active	15723466	CHEMBL3620319	Inhibition of PDGFRbeta (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	15731000	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	O=C1Nc2ccc(O)cc2/C1=C/c1ccc[nH]1		CHEMBL393636	=	IC50	nM	637.0	CHEMBL1913	Homo sapiens	IC50	nM	637.0
	15731001	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	68.0	CHEMBL1913	Homo sapiens	IC50	nM	68.0
Not Active	15731002	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	CSCCCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)cc1C		CHEMBL3621300		IC50			CHEMBL1913	Homo sapiens	IC50		
	15731003	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	CSCCCNC(=O)c1ccc2c(c1)/C(=C/c1[nH]c(C)cc1C)C(=O)N2		CHEMBL3621299	=	IC50	nM	8.0	CHEMBL1913	Homo sapiens	IC50	nM	8.0
Not Active	15731004	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	Nc1ccccc1NC(=O)CCCCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3621298		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Active	15731005	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	Nc1ccccc1NC(=O)CCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3621297		IC50			CHEMBL1913	Homo sapiens	IC50		
	15731006	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	O=C(CCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2)NO		CHEMBL3621296	=	IC50	nM	518.0	CHEMBL1913	Homo sapiens	IC50	nM	518.0
Not Active	15731007	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc32)[nH]1		CHEMBL3621295		IC50			CHEMBL1913	Homo sapiens	IC50		
	15731008	CHEMBL3626705	Inhibition of PDGFRb (unknown origin)	B	O=C(CCCCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2)NO		CHEMBL3621294	=	IC50	nM	185.0	CHEMBL1913	Homo sapiens	IC50	nM	185.0
	15736635	CHEMBL3625816	Inhibition of human recombinant PDGFRbeta	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	=	IC50	nM	1982.0	CHEMBL1913	Homo sapiens	IC50	uM	1.982
	15753825	CHEMBL3630462	Inhibition of human PDGFRbeta at 10 uM by kinase inhibition assay	B	COc1ccc2c(c1)SCc1cnc(-c3ccccc3)nc1-2		CHEMBL481789	=	Inhibition	%	-6.0	CHEMBL1913	Homo sapiens	INH	%	-6.0
	15753885	CHEMBL3630462	Inhibition of human PDGFRbeta at 10 uM by kinase inhibition assay	B	Clc1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2SC3)cc1		CHEMBL3628818	=	Inhibition	%	2.5	CHEMBL1913	Homo sapiens	INH	%	2.5
	15753960	CHEMBL3630462	Inhibition of human PDGFRbeta at 10 uM by kinase inhibition assay	B	COc1ccc(Nc2ncc3c(n2)-c2ccccc2SC3)cc1		CHEMBL3628537	=	Inhibition	%	42.0	CHEMBL1913	Homo sapiens	INH	%	42.0
	15753981	CHEMBL3630472	Inhibition of human PDGFRbeta by kinase inhibition assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.3	CHEMBL1913	Homo sapiens	IC50	10'-8M	0.43
	15754258	CHEMBL3631183	Inhibition of PDGFRbeta (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	23.8	CHEMBL1913	Homo sapiens	INH	%	23.8
	15755913	CHEMBL3631433	Inhibition of PDGFRB (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	45.0	CHEMBL1913	Homo sapiens	Activity	%	45.0
	15756867	CHEMBL3630916	Inhibition of PDGFRbeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	99.45	CHEMBL1913	Homo sapiens	INH	%	99.45
	15757856	CHEMBL3630916	Inhibition of PDGFRbeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	91.05	CHEMBL1913	Homo sapiens	INH	%	91.05
	15758835	CHEMBL3630916	Inhibition of PDGFRbeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	11.11	CHEMBL1913	Homo sapiens	INH	%	11.11
Not Determined	15760039	CHEMBL3631062	Inhibition of PDGFR-beta (unknown origin) by radiometric protein kinase assay	B	COc1cc2ncnc(Nc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC		CHEMBL3628796		IC50			CHEMBL1913	Homo sapiens	IC50		
	15760040	CHEMBL3631062	Inhibition of PDGFR-beta (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628797	=	IC50	nM	850.0	CHEMBL1913	Homo sapiens	IC50	nM	850.0
	15760041	CHEMBL3631062	Inhibition of PDGFR-beta (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3sccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628798	=	IC50	nM	2120.0	CHEMBL1913	Homo sapiens	IC50	nM	2120.0
	15760042	CHEMBL3631062	Inhibition of PDGFR-beta (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1		CHEMBL3628799	=	IC50	nM	2820.0	CHEMBL1913	Homo sapiens	IC50	nM	2820.0
	15760043	CHEMBL3631062	Inhibition of PDGFR-beta (unknown origin) by radiometric protein kinase assay	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC		CHEMBL2018882	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	nM	5.0
	15760044	CHEMBL3631062	Inhibition of PDGFR-beta (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628807	=	IC50	nM	320.0	CHEMBL1913	Homo sapiens	IC50	nM	320.0
	15760045	CHEMBL3631062	Inhibition of PDGFR-beta (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3sccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628808	=	IC50	nM	570.0	CHEMBL1913	Homo sapiens	IC50	nM	570.0
	15760046	CHEMBL3631062	Inhibition of PDGFR-beta (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1		CHEMBL3628811	=	IC50	nM	2300.0	CHEMBL1913	Homo sapiens	IC50	nM	2300.0
	15770707	CHEMBL3636904	Inhibition of PDGFRbeta (unknown origin)	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	uM	0.006
	15770708	CHEMBL3636904	Inhibition of PDGFRbeta (unknown origin)	B	Cn1c(Nc2cccc(C(C)(C)C)c2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL3632719	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	15770709	CHEMBL3636904	Inhibition of PDGFRbeta (unknown origin)	B	Cn1c(Nc2cccc(C(C)(C)C)c2)nc2cc(Oc3ccnc(-c4ncc[nH]4)c3)ccc21		CHEMBL3632717	=	IC50	nM	310.0	CHEMBL1913	Homo sapiens	IC50	uM	0.31
	15770710	CHEMBL3636904	Inhibition of PDGFRbeta (unknown origin)	B	CC(=O)Nc1cc(Oc2ccc3c(c2)nc(Nc2cccc(C(C)(C)C)c2)n3C)ccn1		CHEMBL3335371	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	uM	0.001
	15770711	CHEMBL3636904	Inhibition of PDGFRbeta (unknown origin)	B	CNC(=O)c1cc(Oc2ccc3c(c2)nc(Nc2cccc(C(C)(C)C)c2)n3C)ccn1		CHEMBL470808	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	uM	0.01
248446	16259360	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	CCN1CCN(C2CCc3cc(C(=O)Nc4ccc(C)c(Nc5nccc(-c6cccnc6)n5)c4)ccc32)CC1		CHEMBL3690075	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
213911	16259706	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231218	=	IC50	nM	9.3	CHEMBL1913	Homo sapiens	IC50	nM	9.3
213907	16260047	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL230615	=	IC50	nM	69.1	CHEMBL1913	Homo sapiens	IC50	nM	69.1
248451	16261870	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCC(N(C)C)C2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690080	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
213905	16262417	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
248457	16270668	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(C)CC2)cc1Nc1nccc(-c2ccncc2)n1		CHEMBL3690083	=	IC50	nM	24.0	CHEMBL1913	Homo sapiens	IC50	nM	24.0
248453	16276497	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CC[C@@H]3N2CCN(C)CC2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690082	=	IC50	nM	9.6	CHEMBL1913	Homo sapiens	IC50	nM	9.6
248445	16277476	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCNCC2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690074	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	nM	12.0
248455	16277637	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(C)CC2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL3690079	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
213935	16278644	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(N4CCOCC4)nc3)nc12		CHEMBL3651249	=	IC50	nM	2.1	CHEMBL1913	Homo sapiens	IC50	nM	2.1
248456	16279782	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(C)CC2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL3690079	=	IC50	nM	65.0	CHEMBL1913	Homo sapiens	IC50	nM	65.0
213932	16283694	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(N(C)C)c3)nc12		CHEMBL3651236	=	IC50	nM	20.8	CHEMBL1913	Homo sapiens	IC50	nM	20.8
213933	16283795	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL250214	=	IC50	nM	1.2	CHEMBL1913	Homo sapiens	IC50	nM	1.2
213937	16285963	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651257	=	IC50	nM	5.7	CHEMBL1913	Homo sapiens	IC50	nM	5.7
213931	16290426	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(C(=O)NCCN(C)C)c3)nc12		CHEMBL3651228	=	IC50	nM	5.3	CHEMBL1913	Homo sapiens	IC50	nM	5.3
213923	16290949	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(F)cc1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651212	=	IC50	nM	26.1	CHEMBL1913	Homo sapiens	IC50	nM	26.1
248444	16293354	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(C(=O)OC(C)(C)C)CC2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690073	=	IC50	nM	233.0	CHEMBL1913	Homo sapiens	IC50	nM	233.0
213908	16295307	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL3648036	=	IC50	nM	76.3	CHEMBL1913	Homo sapiens	IC50	nM	76.3
213909	16296334	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648037	=	IC50	nM	50.3	CHEMBL1913	Homo sapiens	IC50	nM	50.3
213930	16298753	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C		CHEMBL3651227	=	IC50	nM	39.3	CHEMBL1913	Homo sapiens	IC50	nM	39.3
213904	16299130	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCC4CCCC4)cc3)nnc2c1		CHEMBL3651296	=	IC50	nM	5.9	CHEMBL1913	Homo sapiens	IC50	nM	5.9
248447	16299372	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(C(C)C)CC2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690076	=	IC50	nM	18.0	CHEMBL1913	Homo sapiens	IC50	nM	18.0
213927	16302900	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651220	=	IC50	nM	1850.0	CHEMBL1913	Homo sapiens	IC50	nM	1850.0
213916	16306841	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL231237	=	IC50	nM	24.3	CHEMBL1913	Homo sapiens	IC50	nM	24.3
213906	16312166	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(O)cc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL3648035	=	IC50	nM	41.1	CHEMBL1913	Homo sapiens	IC50	nM	41.1
213903	16312898	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL374248	=	IC50	nM	628.0	CHEMBL1913	Homo sapiens	IC50	nM	628.0
248443	16313367	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(C)CC2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690072	=	IC50	nM	17.0	CHEMBL1913	Homo sapiens	IC50	nM	17.0
213940	16314978	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL400303	=	IC50	nM	8.0	CHEMBL1913	Homo sapiens	IC50	nM	8.0
248448	16315212	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(CCO)CC2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690077	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	nM	20.0
213917	16315646	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL231251	=	IC50	nM	11.5	CHEMBL1913	Homo sapiens	IC50	nM	11.5
213925	16316972	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccnc3)nc12		CHEMBL3651219	=	IC50	nM	23.5	CHEMBL1913	Homo sapiens	IC50	nM	23.5
213912	16316987	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nnc2c1		CHEMBL3648058	=	IC50	nM	117.0	CHEMBL1913	Homo sapiens	IC50	nM	117.0
213928	16317690	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL249821	=	IC50	nM	1.7	CHEMBL1913	Homo sapiens	IC50	nM	1.7
213936	16317797	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL250019	=	IC50	nM	3.1	CHEMBL1913	Homo sapiens	IC50	nM	3.1
213918	16323087	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	COc1ccc(Cl)c(-c2cc3nnc(Nc4ccc(C(=O)N5CCN(C)CC5)cc4)nc3cc2C)c1		CHEMBL3651202	=	IC50	nM	3.5	CHEMBL1913	Homo sapiens	IC50	nM	3.5
248450	16325270	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(C)CC2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL3690079	=	IC50	nM	22.0	CHEMBL1913	Homo sapiens	IC50	nM	22.0
213938	16330889	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL399268	=	IC50	nM	2.9	CHEMBL1913	Homo sapiens	IC50	nM	2.9
213919	16333232	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(NS(C)(=O)=O)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL390479	=	IC50	nM	15.7	CHEMBL1913	Homo sapiens	IC50	nM	15.7
248454	16333298	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CCN(C)CC2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690072	=	IC50	nM	53.0	CHEMBL1913	Homo sapiens	IC50	nM	53.0
213921	16334477	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651210	=	IC50	nM	3.7	CHEMBL1913	Homo sapiens	IC50	nM	3.7
213920	16338756	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1ccc(Cl)cc1-c1cc2nnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc2cc1C		CHEMBL3651206	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	nM	6.0
213929	16345165	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nc12		CHEMBL3651225	=	IC50	nM	14.4	CHEMBL1913	Homo sapiens	IC50	nM	14.4
213914	16346177	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3nc(C(=O)NCCN4CCCC4)cs3)nnc2c1		CHEMBL3648061	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	nM	60.0
248449	16346631	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	CC(=O)N1CCN(C2CCc3cc(C(=O)Nc4ccc(C)c(Nc5nccc(-c6cccnc6)n5)c4)ccc32)CC1		CHEMBL3690078	=	IC50	nM	41.0	CHEMBL1913	Homo sapiens	IC50	nM	41.0
213915	16346984	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1c(C)cccc1C		CHEMBL230816	=	IC50	nM	48.1	CHEMBL1913	Homo sapiens	IC50	nM	48.1
213939	16347306	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)C4CCNCC4)cc3)nc12		CHEMBL250625	=	IC50	nM	2.8	CHEMBL1913	Homo sapiens	IC50	nM	2.8
213922	16349821	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	IC50	nM	1.1	CHEMBL1913	Homo sapiens	IC50	nM	1.1
213913	16351766	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1ccc2nc(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3)nnc2c1		CHEMBL3651298	=	IC50	nM	81.3	CHEMBL1913	Homo sapiens	IC50	nM	81.3
213924	16352541	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cccc(O)c1		CHEMBL3651217	=	IC50	nM	7.4	CHEMBL1913	Homo sapiens	IC50	nM	7.4
213934	16353118	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651246	=	IC50	nM	1.9	CHEMBL1913	Homo sapiens	IC50	nM	1.9
213926	16354879	CHEMBL3707813	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL397691	=	IC50	nM	73.7	CHEMBL1913	Homo sapiens	IC50	nM	73.7
248452	16356776	CHEMBL3707918	Enzyme Assay: The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPES, pH 7.5; 0.001875% Brij-35; 12.5 mM MgCl2; 2.5 mM DTT. Stop buffer: 100 mM HEPES, pH 7.5; 0.015% Brij-35; 0.2% coating agent 3; 50 mM EDTA. Preparation of kinase solution: Kinase solution was obtained by dissolving kinases in the kinase buffer mentioned above. With regard to c-Kit kinase, the pre-activation treatments should be carried out as follows. 700 nM c-Kit, 2 mM ATP, 4 mM DTT and 10 mM MgCl2 were dissolved in kinase buffer. After being incubated at 28° C. for 15 minutes, the solution was added to the kinase buffer.	B	Cc1ccc(NC(=O)c2ccc3c(c2)CCC3N2CC[C@@H](N(C)C)C2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3690081	=	IC50	nM	21.0	CHEMBL1913	Homo sapiens	IC50	nM	21.0
	16395329	CHEMBL3744146	Inhibition of PDGFR-beta (unknown origin) at 1 uM by ELISA	B	CC[C@@H](C)/C=C/CCCC/C=C/C=C/C=C/C(=O)N[C@@H]1CO[C@@]2(O)C=C[C@@H](Cl)[C@H](O)[C@@]2(O)C1		CHEMBL3740961	=	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	16396080	CHEMBL3742728	Inhibition of human recombinant PDGFRbeta using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1		CHEMBL3740721	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	16396081	CHEMBL3742728	Inhibition of human recombinant PDGFRbeta using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccc(F)c5)cccc4c3)n2)c1		CHEMBL3740487	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	16396082	CHEMBL3742728	Inhibition of human recombinant PDGFRbeta using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccnc5)cccc4c3)n2)c1		CHEMBL3739732	=	IC50	nM	223.9	CHEMBL1913	Homo sapiens	IC50	nM	223.9
	16417259	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	12.0	CHEMBL1913	Homo sapiens	INH	%	12.0
	16417260	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	100.0	CHEMBL1913	Homo sapiens	INH	%	100.0
	16417261	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	29.0	CHEMBL1913	Homo sapiens	INH	%	29.0
	16417262	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	100.0	CHEMBL1913	Homo sapiens	INH	%	100.0
	16417263	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	16417264	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	41.0	CHEMBL1913	Homo sapiens	INH	%	41.0
	16417265	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	16417266	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	39.0	CHEMBL1913	Homo sapiens	INH	%	39.0
	16417267	CHEMBL3751445	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	16425358	CHEMBL3751234	Inhibition of PDGFR_beta (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	INH	%	8.0
	16425944	CHEMBL3748760	Inhibition of PDGFRB (unknown origin) expressed in BaF3 cells assessed as inhibition of cell proliferation after 72 hrs by CelltiterGlo assay	B	CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3745919	=	GI50	nM	680.0	CHEMBL1913	Homo sapiens	GI50	uM	0.68
	16425967	CHEMBL3749075	Inhibition of PDGFRB (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3745919	=	Activity	%	0.35	CHEMBL1913	Homo sapiens	Activity	%	0.35
	16429066	CHEMBL3750804	Inhibition of PDGFRbeta (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	13.0	CHEMBL1913	Homo sapiens	INH	%	13.0
	16431951	CHEMBL3748044	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	16433849	CHEMBL3756761	Inhibition of human PDGFRbeta using srctide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	Inhibition	%	75.7	CHEMBL1913	Homo sapiens	INH	%	75.7
	16433850	CHEMBL3756761	Inhibition of human PDGFRbeta using srctide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1		CHEMBL3752265	=	Inhibition	%	13.8	CHEMBL1913	Homo sapiens	INH	%	13.8
	16451556	CHEMBL3760853	Inhibition of PDGFRbeta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	35.2	CHEMBL1913	Homo sapiens	INH	%	35.2
	16451744	CHEMBL3760853	Inhibition of PDGFRbeta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	10.8	CHEMBL1913	Homo sapiens	INH	%	10.8
	16458548	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	16458549	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	16458550	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	-5.0	CHEMBL1913	Homo sapiens	INH	%	-5.0
	16458551	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	INH	%	8.0
	16458552	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	16458553	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	3.0	CHEMBL1913	Homo sapiens	INH	%	3.0
	16458554	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	1.0	CHEMBL1913	Homo sapiens	INH	%	1.0
	16458555	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	-3.0	CHEMBL1913	Homo sapiens	INH	%	-3.0
	16458556	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	13.0	CHEMBL1913	Homo sapiens	INH	%	13.0
	16458557	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	-3.0	CHEMBL1913	Homo sapiens	INH	%	-3.0
	16458558	CHEMBL3761594	Inhibition of PDGFRB (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-5.0	CHEMBL1913	Homo sapiens	INH	%	-5.0
	16461604	CHEMBL3762058	Inhibition of recombinant human PDGFR-beta using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1		CHEMBL3759079	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	16461605	CHEMBL3762058	Inhibition of recombinant human PDGFR-beta using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	16486372	CHEMBL3771606	Inhibition of human recombinant PDGFRB assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	95.0	CHEMBL1913	Homo sapiens	Activity	%	95.0
	16495163	CHEMBL3777742	Inhibition of N-terminal His6-tagged recombinant human PDGFRbeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	14.0	CHEMBL1913	Homo sapiens	Activity	%	14.0
	16496082	CHEMBL3777742	Inhibition of N-terminal His6-tagged recombinant human PDGFRbeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-12.0	CHEMBL1913	Homo sapiens	Activity	%	-12.0
	16496305	CHEMBL3779156	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1nnn(-c2ccc(F)cc2)c1C(F)(F)F		CHEMBL3774451	=	IC50	nM	4.57	CHEMBL1913	Homo sapiens	IC50	nM	4.57
	16508269	CHEMBL3777742	Inhibition of N-terminal His6-tagged recombinant human PDGFRbeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-2.0	CHEMBL1913	Homo sapiens	Activity	%	-2.0
Not Active	16514157	CHEMBL3782378	Inhibition of partial length human PDGFRbeta expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	16518590	CHEMBL3782292	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL3780676	=	IC50	nM	526.5	CHEMBL1913	Homo sapiens	IC50	nM	526.5
	16547764	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccnc3Br)c(=O)c2cc1OC		CHEMBL3792855	=	Inhibition	%	37.0	CHEMBL1913	Homo sapiens	INH	%	37.0
	16547765	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccc(-c4ccccc4)c3)c(=O)c2cc1OC		CHEMBL3793594	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	16547766	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccc(Br)c3)c(=O)c2cc1OC		CHEMBL3793760	=	Inhibition	%	22.0	CHEMBL1913	Homo sapiens	INH	%	22.0
	16547767	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3793678	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	16547768	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(CC(=O)c3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3793297	=	Inhibition	%	1.0	CHEMBL1913	Homo sapiens	INH	%	1.0
	16547769	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(CC(O)c3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3792891	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	16547770	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(-c2ccccc2)cc1)OCCO3		CHEMBL3794032	=	Inhibition	%	13.0	CHEMBL1913	Homo sapiens	INH	%	13.0
	16547771	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1cccc(Br)c1)OCCO3		CHEMBL3793623	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	16547772	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(Br)cc1)OCCO3		CHEMBL3792773	=	Inhibition	%	1.0	CHEMBL1913	Homo sapiens	INH	%	1.0
	16547773	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=C(Cn1cnc2cc3c(cc2c1=O)OCCO3)c1ccc(Br)cc1		CHEMBL3793356	=	Inhibition	%	1.0	CHEMBL1913	Homo sapiens	INH	%	1.0
	16547774	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=C(Cn1cnc2cc3c(cc2c1=O)OCCO3)c1cccc(Br)c1		CHEMBL3792910	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	16547775	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1CC(O)c1cccc(Cl)c1)OCCO3		CHEMBL3793972	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	16547776	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(Br)cc1)OCO3		CHEMBL3793896	=	Inhibition	%	45.0	CHEMBL1913	Homo sapiens	INH	%	45.0
	16547777	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1cccc(-c2ccccc2)c1)OCO3		CHEMBL3794041	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	16547778	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(-c2ccccc2)cc1)OCO3		CHEMBL3794304	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	16547779	CHEMBL3796158	Inhibition of human PDGFR-beta at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Inhibition	%	72.0	CHEMBL1913	Homo sapiens	INH	%	72.0
	16563787	CHEMBL3802294	Inhibition of PDGFRbeta (unknown origin) by Z-LYTE assay	B	CC(NC(=O)c1ccc2[nH]nc(-c3ccncc3)c2c1)c1cccc(Cl)c1		CHEMBL3798631	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	16563788	CHEMBL3802294	Inhibition of PDGFRbeta (unknown origin) by Z-LYTE assay	B	Cc1cc(-c2n[nH]c3ccc(C(=O)NC(C)c4c(Cl)cncc4Cl)cc23)ccn1		CHEMBL3798257	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	16574814	CHEMBL3801257	Inhibition of recombinant PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	19.6	CHEMBL1913	Homo sapiens	INH	%	19.6
	16578403	CHEMBL3802275	Inhibition of partial length wild type human PDGFRbeta expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	73.0	CHEMBL1913	Homo sapiens	Activity	%	73.0
	16587038	CHEMBL3807849	Inhibition of PDGFRbeta (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	16588222	CHEMBL3806825	Inhibition of human recombinant PDGFRbeta expressed in sf21 cells using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	=	IC50	nM	1083.0	CHEMBL1913	Homo sapiens	IC50	uM	1.083
	16588223	CHEMBL3806825	Inhibition of human recombinant PDGFRbeta expressed in sf21 cells using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	=	IC50	nM	1055.0	CHEMBL1913	Homo sapiens	IC50	uM	1.055
	16588283	CHEMBL3806850	Inhibition of human recombinant PDGFRbeta expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	>	Inhibition	%	99.0	CHEMBL1913	Homo sapiens	INH	%	99.0
	16588284	CHEMBL3806850	Inhibition of human recombinant PDGFRbeta expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	>	Inhibition	%	99.0	CHEMBL1913	Homo sapiens	INH	%	99.0
	16593511	CHEMBL3812363	Inhibition of His-tagged human recombinant PDGFRbeta (558 to 1106 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	16593744	CHEMBL3812308	Inhibition of human wild type partial length PDGFRbeta expressed in bacterial expression system assessed as residual activity at 1 uM by KinomeScan method	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2ccncc2)CC1		CHEMBL3809935	=	Activity	%	0.2	CHEMBL1913	Homo sapiens	Activity	%	0.2
	16593748	CHEMBL3812311	Inhibition of N-terminal GST-tagged recombinant human PDGFRbeta (amino acids 557-end) expressed in baculovirus infected insect Sf9 cells using Poly(4:1 Glu, Tyr) peptide as substrate after 1 hr by promega ADP-glo assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2ccncc2)CC1		CHEMBL3809935	=	IC50	nM	120.0	CHEMBL1913	Homo sapiens	IC50	nM	120.0
Active	16593914	CHEMBL3811486	Inhibition of PDGFRbeta phosphorylation at Y857 in human GISTT1 cells up to 10 uM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2ccncc2)CC1		CHEMBL3809935		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Active	16593915	CHEMBL3811487	Inhibition of PDGFRbeta phosphorylation at Y857 in human GIST882 cells up to 10 uM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2ccncc2)CC1		CHEMBL3809935		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Active	16593916	CHEMBL3811488	Inhibition of PDGFRbeta phosphorylation at Y857 in human GIST48B cells up to 10 uM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2ccncc2)CC1		CHEMBL3809935		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	16594857	CHEMBL3812880	Inhibition of human PDGFRB (582 to 1009 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL1913	Homo sapiens	Activity	%	100.0
	16614583	CHEMBL3817614	Inhibition of human PDGFRbeta at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	84.0	CHEMBL1913	Homo sapiens	INH	%	84.0
	16618097	CHEMBL3816380	Inhibition of recombinant human His-tagged cytoplasmic PDGFRB (558 to 1106 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	16621526	CHEMBL3820665	Inhibition of PDGFRbeta (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	nM	30000.0
	16622233	CHEMBL3820665	Inhibition of PDGFRbeta (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.6	CHEMBL1913	Homo sapiens	IC50	nM	0.6
	16627550	CHEMBL3820351	Inhibition of recombinant human N-terminal His6-tagged PDGFRB (557-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	16627551	CHEMBL3820351	Inhibition of recombinant human N-terminal His6-tagged PDGFRB (557-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	16640435	CHEMBL3824975	Inhibition of partial-length human wild type PDGFR-beta expressed in bacterial expression system at 1 uM by KINOMEscan assay	B	CN1CCN(c2ccc(-n3cc(-c4ccncc4OCC4CCNCC4)cn3)cc2)CC1		CHEMBL3824068	=	Inhibition	%	57.0	CHEMBL1913	Homo sapiens	INH	%	57.0
	16653342	CHEMBL3830178	Inhibition of recombinant human PDGFRbeta using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	16655118	CHEMBL3830419	Inhibition of N-terminal His6-tagged recombinant human PDGFRbeta (557 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	64.2	CHEMBL1913	Homo sapiens	IC50	nM	64.2
	16737962	CHEMBL3856679	Inhibition of recombinant human PDGFR-beta expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	88.0	CHEMBL1913	Homo sapiens	Activity	%	88.0
	16739433	CHEMBL3857069	Inhibition of His tagged recombinant human PDGFRB cytoplasmic domain (558 to 1106 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	16739434	CHEMBL3857069	Inhibition of His tagged recombinant human PDGFRB cytoplasmic domain (558 to 1106 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	16739435	CHEMBL3857069	Inhibition of His tagged recombinant human PDGFRB cytoplasmic domain (558 to 1106 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-5.0	CHEMBL1913	Homo sapiens	INH	%	-5.0
	16742586	CHEMBL3857924	Inhibition of PDGFR-beta (unknown origin) preincubated for 60 mins followed by poly (Glu, Tyr) 4:1 substrate addition for 2 to 4 hrs by luciferase-coupled chemiluminescence assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	9.6	CHEMBL1913	Homo sapiens	IC50	nM	9.6
	16777248	CHEMBL3864905	Inhibition of recombinant PDGFR-beta (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	16810289	CHEMBL3870609	Inhibition of PDGFRbeta (unknown origin) using poly(Glu, Tyr)4:1 as substrate preincubated for 60 mins followed by substrate addition measured after 2 to 4 hrs by coupled luciferase reporter gene assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	9.6	CHEMBL1913	Homo sapiens	IC50	nM	9.6
	16815463	CHEMBL3871624	Inhibition of human recombinant His-tagged PDGFRbeta cytoplasmic domain (558 to 1106 residues) expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	-2.0	CHEMBL1913	Homo sapiens	INH	%	-2.0
	16854243	CHEMBL3879001	Inhibition of Tel-fused PDGFR-beta (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150	=	GI50	nM	14.0	CHEMBL1913	Homo sapiens	GI50	uM	0.014
	16854244	CHEMBL3879001	Inhibition of Tel-fused PDGFR-beta (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	19.0	CHEMBL1913	Homo sapiens	GI50	uM	0.019
	16854257	CHEMBL3878994	Inhibition of recombinant His-tagged human PDGFR-beta cytoplasmic domain (558 to 1106 residues) expressed in baculovirus expression system measured after 1 hr by FRET based Z'Lyte assay	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	nM	80.0
	16854258	CHEMBL3878993	Inhibition of recombinant His-tagged human PDGFR-beta cytoplasmic domain (558 to 1106 residues) expressed in baculovirus expression system assessed as residual activity at 1 uM measured after 1 hr by FRET based Z'Lyte assay relative to control	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150	=	Activity	%	0.3	CHEMBL1913	Homo sapiens	Activity	%	0.3
	16894653	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCC(=O)NO		CHEMBL3980861	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894654	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCCC(=O)NO		CHEMBL3940740	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894655	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCCCCC(=O)NO		CHEMBL3943406	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894656	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCCCCCC(=O)NO		CHEMBL3956652	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894657	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCCCCCCC(=O)NO		CHEMBL3909619	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894869	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CC(=O)NO)CC2)n1		CHEMBL3945209	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894870	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCC(=O)NO)CC2)n1		CHEMBL3947855	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894871	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCCC(=O)NO)CC2)n1		CHEMBL3907624	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894872	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCCCC(=O)NO)CC2)n1		CHEMBL3901629	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894873	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCCCCC(=O)NO)CC2)n1		CHEMBL3904339	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894874	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(NCCNCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3965755	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894875	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(NCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3984972	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894876	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	Cc1nc(NCCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3889939	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894929	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	O=C(CCCCCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1)NO		CHEMBL3934468	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894930	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	O=C(CCCCCCCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1)NO		CHEMBL3973966	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894931	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	O=C(CCCCCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1)NO		CHEMBL3946124	<=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894932	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	O=C(CCCCC(=O)NCc1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1)NO		CHEMBL3984522	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16894933	CHEMBL3882089	Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human PDGFRbeta (Arg561 to Leu1106 residues) assessed as decrease in biotinylated FLT3 phosphorylation at Tyr589 preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA method	B	O=C(CCCCCCC(=O)NCc1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1)NO		CHEMBL3949983	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	16908208	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccccc3)nnc2c1		CHEMBL374248	=	IC50	nM	628.0	CHEMBL1913	Homo sapiens	IC50	nM	628.0
	16908209	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	5.9	CHEMBL1913	Homo sapiens	IC50	nM	5.9
	16908210	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
	16908211	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(O)cc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL3648035	=	IC50	nM	41.1	CHEMBL1913	Homo sapiens	IC50	nM	41.1
	16908212	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL230615	=	IC50	nM	69.1	CHEMBL1913	Homo sapiens	IC50	nM	69.1
	16908213	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(OCCCN4CCN(C)CC4)c3)nnc2c1		CHEMBL3648036	=	IC50	nM	76.3	CHEMBL1913	Homo sapiens	IC50	nM	76.3
	16908214	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCCN4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648037	=	IC50	nM	50.3	CHEMBL1913	Homo sapiens	IC50	nM	50.3
	16908215	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(N)(=O)=O)c3)nnc2c1		CHEMBL218597	=	IC50	nM	16.3	CHEMBL1913	Homo sapiens	IC50	nM	16.3
	16908216	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231218	=	IC50	nM	9.3	CHEMBL1913	Homo sapiens	IC50	nM	9.3
	16908217	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nnc2c1		CHEMBL3648058	=	IC50	nM	117.0	CHEMBL1913	Homo sapiens	IC50	nM	117.0
	16908218	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3)nnc2c1		CHEMBL436516	=	IC50	nM	81.3	CHEMBL1913	Homo sapiens	IC50	nM	81.3
	16908219	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3nc(C(=O)NCCN4CCCC4)cs3)nnc2c1		CHEMBL3648061	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	nM	60.0
	16908220	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1c(C)cccc1C		CHEMBL230816	=	IC50	nM	48.1	CHEMBL1913	Homo sapiens	IC50	nM	48.1
	16908221	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1ccccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL231237	=	IC50	nM	24.3	CHEMBL1913	Homo sapiens	IC50	nM	24.3
	16908222	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL231251	=	IC50	nM	11.5	CHEMBL1913	Homo sapiens	IC50	nM	11.5
	16908223	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	COc1ccc(Cl)c(-c2cc3nnc(Nc4ccc(C(=O)N5CCN(C)CC5)cc4)nc3cc2C)c1		CHEMBL3651202	=	IC50	nM	3.5	CHEMBL1913	Homo sapiens	IC50	nM	3.5
	16908224	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(NS(C)(=O)=O)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL390479	=	IC50	nM	15.7	CHEMBL1913	Homo sapiens	IC50	nM	15.7
	16908225	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1ccc(Cl)cc1-c1cc2nnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nc2cc1C		CHEMBL3651206	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	nM	6.0
	16908226	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651210	=	IC50	nM	3.7	CHEMBL1913	Homo sapiens	IC50	nM	3.7
	16908227	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	IC50	nM	1.1	CHEMBL1913	Homo sapiens	IC50	nM	1.1
	16908228	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1ccc(F)cc1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C		CHEMBL3651212	=	IC50	nM	26.1	CHEMBL1913	Homo sapiens	IC50	nM	26.1
	16908229	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cccc(O)c1		CHEMBL3651217	=	IC50	nM	7.4	CHEMBL1913	Homo sapiens	IC50	nM	7.4
	16908230	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccnc3)nc12		CHEMBL3651219	=	IC50	nM	23.5	CHEMBL1913	Homo sapiens	IC50	nM	23.5
	16908231	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(F)ccc1-c1cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc2cc1C		CHEMBL397691	=	IC50	nM	73.7	CHEMBL1913	Homo sapiens	IC50	nM	73.7
	16908232	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	CC(=O)Nc1cc(-c2c(C)cccc2C)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL3651220	=	IC50	nM	1850.0	CHEMBL1913	Homo sapiens	IC50	nM	1850.0
	16908233	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL249821	=	IC50	nM	1.7	CHEMBL1913	Homo sapiens	IC50	nM	1.7
	16908234	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nc12		CHEMBL3651225	=	IC50	nM	14.4	CHEMBL1913	Homo sapiens	IC50	nM	14.4
	16908235	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	COc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1ccccc1C		CHEMBL3651227	=	IC50	nM	39.3	CHEMBL1913	Homo sapiens	IC50	nM	39.3
	16908236	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(C(=O)NCCN(C)C)c3)nc12		CHEMBL3651228	=	IC50	nM	5.3	CHEMBL1913	Homo sapiens	IC50	nM	5.3
	16908237	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3cccc(N(C)C)c3)nc12		CHEMBL3651236	=	IC50	nM	20.8	CHEMBL1913	Homo sapiens	IC50	nM	20.8
	16908238	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL250214	=	IC50	nM	1.2	CHEMBL1913	Homo sapiens	IC50	nM	1.2
	16908239	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651246	=	IC50	nM	1.9	CHEMBL1913	Homo sapiens	IC50	nM	1.9
	16908240	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(N4CCOCC4)nc3)nc12		CHEMBL3651249	=	IC50	nM	2.1	CHEMBL1913	Homo sapiens	IC50	nM	2.1
	16908241	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)N(C)CCN4CCCC4)cc3)nc12		CHEMBL250019	=	IC50	nM	3.1	CHEMBL1913	Homo sapiens	IC50	nM	3.1
	16908242	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2cc1-c1cc(O)ccc1Cl		CHEMBL3651257	=	IC50	nM	5.7	CHEMBL1913	Homo sapiens	IC50	nM	5.7
	16908243	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)CCCN4CCCC4)cc3)nc12		CHEMBL399268	=	IC50	nM	2.9	CHEMBL1913	Homo sapiens	IC50	nM	2.9
	16908244	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)C4CCNCC4)cc3)nc12		CHEMBL250625	=	IC50	nM	2.8	CHEMBL1913	Homo sapiens	IC50	nM	2.8
	16908245	CHEMBL3883089	Inhibition of human recombinant Yes using PTK2 peptide substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)ccc(O)c2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL400303	=	IC50	nM	8.0	CHEMBL1913	Homo sapiens	IC50	nM	8.0
269292	17651611	CHEMBL3705727	Kinase Assay: Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in the presence of a test compound. Briefly, a reaction mixture of 25 uL final volume containing 55 ng of PDGFR-beta kinase (obtained by purifying recombinant N-terminal 6xHis-tagged PDGFR-beta kinase domain construct expressed by baculovirus), 2.5 ug of the substrate [Poly (Glu-Tyr, 4:1), Sigma], kinase reaction buffer (20 mM MOPS pH 7.0, 1 mM EDTA, 5% glycerol, 0.01% Brij-35, 0.1% beta-mercaptoethanol, 1 mg/mL BSA, 2 mM MnCl2, 30 nM ATP, 0.1 uCi per well [33P]-gamma-ATP (2,500-3,000 Ci/mmol)), and a test compound (diluted from 9 uM to the desired final concentration by 4% DMSO) or DMSO (as the control) was incubated at 30C. for 30 minutes. The reaction was stopped by adding 5 uL of 3% phosphoric acid solution. The resultant solution (30 uL) was later harvested by a UniFilter Plate GF/B (PerkinElmer).	B	Nc1ccc(-c2n[nH]c3c2Cc2sccc2-3)cc1		CHEMBL3644445	=	IC50	nM	858.9	CHEMBL1913	Homo sapiens	IC50	nM	858.9
269293	17651612	CHEMBL3705727	Kinase Assay: Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in the presence of a test compound. Briefly, a reaction mixture of 25 uL final volume containing 55 ng of PDGFR-beta kinase (obtained by purifying recombinant N-terminal 6xHis-tagged PDGFR-beta kinase domain construct expressed by baculovirus), 2.5 ug of the substrate [Poly (Glu-Tyr, 4:1), Sigma], kinase reaction buffer (20 mM MOPS pH 7.0, 1 mM EDTA, 5% glycerol, 0.01% Brij-35, 0.1% beta-mercaptoethanol, 1 mg/mL BSA, 2 mM MnCl2, 30 nM ATP, 0.1 uCi per well [33P]-gamma-ATP (2,500-3,000 Ci/mmol)), and a test compound (diluted from 9 uM to the desired final concentration by 4% DMSO) or DMSO (as the control) was incubated at 30C. for 30 minutes. The reaction was stopped by adding 5 uL of 3% phosphoric acid solution. The resultant solution (30 uL) was later harvested by a UniFilter Plate GF/B (PerkinElmer).	B	Oc1cccc(Cc2ccc(-c3n[nH]c4c3Cc3sccc3-4)cc2)c1		CHEMBL3644446	=	IC50	nM	118.2	CHEMBL1913	Homo sapiens	IC50	nM	118.2
269294	17651613	CHEMBL3705727	Kinase Assay: Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in the presence of a test compound. Briefly, a reaction mixture of 25 uL final volume containing 55 ng of PDGFR-beta kinase (obtained by purifying recombinant N-terminal 6xHis-tagged PDGFR-beta kinase domain construct expressed by baculovirus), 2.5 ug of the substrate [Poly (Glu-Tyr, 4:1), Sigma], kinase reaction buffer (20 mM MOPS pH 7.0, 1 mM EDTA, 5% glycerol, 0.01% Brij-35, 0.1% beta-mercaptoethanol, 1 mg/mL BSA, 2 mM MnCl2, 30 nM ATP, 0.1 uCi per well [33P]-gamma-ATP (2,500-3,000 Ci/mmol)), and a test compound (diluted from 9 uM to the desired final concentration by 4% DMSO) or DMSO (as the control) was incubated at 30C. for 30 minutes. The reaction was stopped by adding 5 uL of 3% phosphoric acid solution. The resultant solution (30 uL) was later harvested by a UniFilter Plate GF/B (PerkinElmer).	B	COc1ccc(-c2cc3c(s2)Cc2c(-c4ccc(OC)cc4)n[nH]c2-3)cc1		CHEMBL3644447	=	IC50	nM	316.4	CHEMBL1913	Homo sapiens	IC50	nM	316.4
269295	17651614	CHEMBL3705727	Kinase Assay: Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in the presence of a test compound. Briefly, a reaction mixture of 25 uL final volume containing 55 ng of PDGFR-beta kinase (obtained by purifying recombinant N-terminal 6xHis-tagged PDGFR-beta kinase domain construct expressed by baculovirus), 2.5 ug of the substrate [Poly (Glu-Tyr, 4:1), Sigma], kinase reaction buffer (20 mM MOPS pH 7.0, 1 mM EDTA, 5% glycerol, 0.01% Brij-35, 0.1% beta-mercaptoethanol, 1 mg/mL BSA, 2 mM MnCl2, 30 nM ATP, 0.1 uCi per well [33P]-gamma-ATP (2,500-3,000 Ci/mmol)), and a test compound (diluted from 9 uM to the desired final concentration by 4% DMSO) or DMSO (as the control) was incubated at 30C. for 30 minutes. The reaction was stopped by adding 5 uL of 3% phosphoric acid solution. The resultant solution (30 uL) was later harvested by a UniFilter Plate GF/B (PerkinElmer).	B	COc1ccc(-c2n[nH]c3c2Cc2sc(-c4cccnc4)cc2-3)cc1		CHEMBL3644448	=	IC50	nM	479.4	CHEMBL1913	Homo sapiens	IC50	nM	479.4
269296	17651615	CHEMBL3705727	Kinase Assay: Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in the presence of a test compound. Briefly, a reaction mixture of 25 uL final volume containing 55 ng of PDGFR-beta kinase (obtained by purifying recombinant N-terminal 6xHis-tagged PDGFR-beta kinase domain construct expressed by baculovirus), 2.5 ug of the substrate [Poly (Glu-Tyr, 4:1), Sigma], kinase reaction buffer (20 mM MOPS pH 7.0, 1 mM EDTA, 5% glycerol, 0.01% Brij-35, 0.1% beta-mercaptoethanol, 1 mg/mL BSA, 2 mM MnCl2, 30 nM ATP, 0.1 uCi per well [33P]-gamma-ATP (2,500-3,000 Ci/mmol)), and a test compound (diluted from 9 uM to the desired final concentration by 4% DMSO) or DMSO (as the control) was incubated at 30C. for 30 minutes. The reaction was stopped by adding 5 uL of 3% phosphoric acid solution. The resultant solution (30 uL) was later harvested by a UniFilter Plate GF/B (PerkinElmer).	B	COc1ccc(-c2n[nH]c3c2Cc2sc(-c4ccc(N)nc4)cc2-3)cc1		CHEMBL3644449	=	IC50	nM	362.8	CHEMBL1913	Homo sapiens	IC50	nM	362.8
269297	17651616	CHEMBL3705727	Kinase Assay: Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in the presence of a test compound. Briefly, a reaction mixture of 25 uL final volume containing 55 ng of PDGFR-beta kinase (obtained by purifying recombinant N-terminal 6xHis-tagged PDGFR-beta kinase domain construct expressed by baculovirus), 2.5 ug of the substrate [Poly (Glu-Tyr, 4:1), Sigma], kinase reaction buffer (20 mM MOPS pH 7.0, 1 mM EDTA, 5% glycerol, 0.01% Brij-35, 0.1% beta-mercaptoethanol, 1 mg/mL BSA, 2 mM MnCl2, 30 nM ATP, 0.1 uCi per well [33P]-gamma-ATP (2,500-3,000 Ci/mmol)), and a test compound (diluted from 9 uM to the desired final concentration by 4% DMSO) or DMSO (as the control) was incubated at 30C. for 30 minutes. The reaction was stopped by adding 5 uL of 3% phosphoric acid solution. The resultant solution (30 uL) was later harvested by a UniFilter Plate GF/B (PerkinElmer).	B	COc1ccc(-c2n[nH]c3c2Cc2sc(-c4ccc(NC(=O)CN5CCCC5)nc4)cc2-3)cc1		CHEMBL3644450	=	IC50	nM	175.5	CHEMBL1913	Homo sapiens	IC50	nM	175.5
273989	17656289	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	CC(C)c1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)c1		CHEMBL3702602	=	IC50	nM	54.0	CHEMBL1913	Homo sapiens	IC50	nM	54.0
273990	17656290	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)c1		CHEMBL3702603	=	IC50	nM	116.0	CHEMBL1913	Homo sapiens	IC50	nM	116.0
273991	17656291	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	CC(C)(C)c1ccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)cc1		CHEMBL3702604	=	IC50	nM	109.0	CHEMBL1913	Homo sapiens	IC50	nM	109.0
273992	17656292	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Nc1ncc2c(n1)CCN(c1cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c1)C2		CHEMBL3702605	=	IC50	nM	47.0	CHEMBL1913	Homo sapiens	IC50	nM	47.0
273993	17656293	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1ccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)cc1		CHEMBL3702606	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	nM	90.0
273994	17656294	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	CCCCNC(=O)c1cccc(N2CCc3nc(N)ncc3C2)c1		CHEMBL3702616	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
273995	17656295	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	CC(C)(C)C1CCC(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)CC1		CHEMBL3702617	=	IC50	nM	246.0	CHEMBL1913	Homo sapiens	IC50	nM	246.0
273996	17656296	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Nc1ncc2c(n1)CCN(c1cccc(C(=O)NCC3CCCCC3)c1)C2		CHEMBL3702618	=	IC50	nM	602.0	CHEMBL1913	Homo sapiens	IC50	nM	602.0
273997	17656297	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Nc1ncc2c(n1)CCN(c1cccc(C(=O)NC3CCCC3)c1)C2		CHEMBL3702619	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
273998	17656298	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)n2)c1		CHEMBL3702628	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
273999	17656299	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1N1CCc2nc(N)ncc2C1		CHEMBL3702661	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	nM	20.0
274000	17656300	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc(N2CCc3nc(N)ncc3C2)c1		CHEMBL3702662	=	IC50	nM	273.0	CHEMBL1913	Homo sapiens	IC50	nM	273.0
274001	17656301	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1N1CCc2nc(N)ncc2C1		CHEMBL3702663	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	nM	30.0
274002	17656302	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1cc(C(=O)Nc2cccc(C(C)C)c2)cc(N2CCc3nc(N)ncc3C2)c1		CHEMBL3702664	=	IC50	nM	59.0	CHEMBL1913	Homo sapiens	IC50	nM	59.0
274003	17656303	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	O=C(Nc1ccc(N2CCc3ccncc3C2)cc1)c1cccc(C(F)(F)F)c1		CHEMBL3644546	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
274004	17656304	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1cccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)cc2)c1		CHEMBL3644547	=	IC50	nM	1560.0	CHEMBL1913	Homo sapiens	IC50	nM	1560.0
274005	17656305	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	O=C(Nc1ccccc1)Nc1ccc(N2CCc3ccncc3C2)cc1		CHEMBL3644548	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
274006	17656306	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1ccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)cc2)cc1		CHEMBL3644549	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
274007	17656307	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1cccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)c(C)c2)c1		CHEMBL3644550	=	IC50	nM	36.0	CHEMBL1913	Homo sapiens	IC50	nM	36.0
274008	17656308	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Cc1cccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)cc2C)c1		CHEMBL3644551	=	IC50	nM	1050.0	CHEMBL1913	Homo sapiens	IC50	nM	1050.0
274009	17656309	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	CC(C)c1cccc(NC(=O)c2cccc(N3CCc4ccncc4C3)c2)c1		CHEMBL3644552	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	nM	40.0
274010	17656310	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	COC(=O)c1cncc2c1CCN(c1cccc(C(=O)Nc3cccc(C(C)C)c3)c1)C2		CHEMBL3644553	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
274011	17656311	CHEMBL3706175	Kinase Assay: Biochemical PDGFR.beta. kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 .mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mLs per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mLs per well PBS-T prior to starting the reaction. Reactions were carried out in 100 .mu.L reaction volumes containing 36 .mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore).	B	Nc1ncc2c(n1)CCN(c1cccc(C(=O)Nc3ccc(F)c(C(F)(F)F)c3)c1)C2		CHEMBL3644560	=	IC50	nM	61.0	CHEMBL1913	Homo sapiens	IC50	nM	61.0
280982	17663327	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc([NH2+][O-])cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696070	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
280983	17663328	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc(N)cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696071	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
280984	17663329	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696072	=	IC50	nM	21.0	CHEMBL1913	Homo sapiens	IC50	nM	21.0
280985	17663330	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCN4CCOCC4)c3C(N)=O)cc2)c1		CHEMBL3696073	=	IC50	nM	47.0	CHEMBL1913	Homo sapiens	IC50	nM	47.0
280986	17663331	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1cccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCN4CCOCC4)c3C(N)=O)cc2)c1		CHEMBL3696074	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
280987	17663332	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696075	=	IC50	nM	24.0	CHEMBL1913	Homo sapiens	IC50	nM	24.0
280988	17663333	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCN4CCOCC4)c3C(N)=O)cc2)cc1		CHEMBL3696076	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	nM	12.0
280989	17663334	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	COCCCNC(=O)Nc1snc(-c2ccc(N)cc2)c1C(N)=O		CHEMBL3696077	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
280990	17663335	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696079	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
280991	17663336	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCC(=O)O)c3C(N)=O)cc2)cc1		CHEMBL3696083	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
280992	17663337	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCO)c3C(N)=O)cc2)cc1		CHEMBL3696084	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
280993	17663338	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(NC(=O)Nc2ccc(-c3nsc(N)c3C(N)=O)cc2)cc1		CHEMBL3696087	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	nM	60.0
280994	17663339	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc(N)c3C(N)=O)cc2)c1		CHEMBL3696088	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	nM	70.0
280995	17663340	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)nsc1N		CHEMBL3696092	=	IC50	nM	844.0	CHEMBL1913	Homo sapiens	IC50	nM	844.0
280996	17663341	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2cccc(NC(=O)Nc3ccccc3)c2)nsc1N		CHEMBL3696093	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
280997	17663342	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCN4CCCC4)c3C(N)=O)cc2)cc1		CHEMBL3696095	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	nM	12.0
280998	17663343	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3snc(N)c3C(N)=O)cc2)c1		CHEMBL3696096	=	IC50	nM	48.0	CHEMBL1913	Homo sapiens	IC50	nM	48.0
280999	17663344	CHEMBL3705992	Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3snc(NCCCN4CCOCC4)c3C(N)=O)cc2)c1		CHEMBL3696097	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	nM	70.0
342803	17720194	CHEMBL3887559	Kinase Inhibition Assay: This example shows that the inhibitory activity of the compound, N1'-[3-fluoro-4-[[7-[4-(hydroxyamino)-4-oxobutoxy]-6-methoxy-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide prepared in Example 9 in cells against kinases including ALK, AXL, FLT3, VEGFR2, c-KIT, c-MET, PDGFR-beta, RET and SRC (tested by Advanced Cellular Dynamics, 3550 General Atomics Court, Building 2, Room 639, San Diego, CA 92121. www.advancedcelldynamics.com and Carna Biosciences, Inc.(www.carnabio.com)) measured according to the method described in the literature (Reference: Daley, G. Q.; Baltimore, D. Proc. Natl. Acd. Sci. USA 1988, 85(23), 9312). Specific steps were as follows: The compound of the present invention was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution of 2 mM, then the stock solution was diluted with DMSO following a 7 half-log series to concentrations ranging from 2 uM to 600 pM.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCC(=O)NO		CHEMBL3981567	=	IC50	nM	172.0	CHEMBL1913	Homo sapiens	IC50	nM	172.0
357161	17732824	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1cccc(NC(=O)Nc2ccc(C#Cc3ccc4nc(N)cn4n3)cc2)c1		CHEMBL3961214	=	IC50	nM	34.0	CHEMBL1913	Homo sapiens	IC50	nM	34.0
357162	17732825	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1ccc(C#Cc2ccc3nccn3n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL3939257	=	IC50	nM	32.0	CHEMBL1913	Homo sapiens	IC50	nM	32.0
357163	17732826	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1cccc(NC(=O)Nc2ccc(C#Cc3ccc4nccn4n3)cc2)c1		CHEMBL3972326	=	IC50	nM	80.0	CHEMBL1913	Homo sapiens	IC50	nM	80.0
357164	17732827	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Nc1cn2nc(C#Cc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2n1		CHEMBL3948032	=	IC50	nM	55.0	CHEMBL1913	Homo sapiens	IC50	nM	55.0
357165	17732828	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1ccc(C#Cc2ccc3nccn3n2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL3985362	=	IC50	nM	43.0	CHEMBL1913	Homo sapiens	IC50	nM	43.0
357166	17732829	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1ccccc1)Nc1ccc(C#Cc2ccc3nccn3n2)cc1		CHEMBL3968883	=	IC50	nM	185.0	CHEMBL1913	Homo sapiens	IC50	nM	185.0
357167	17732830	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1ccc(C#Cc2ccc3nccn3n2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3897714	=	IC50	nM	93.0	CHEMBL1913	Homo sapiens	IC50	nM	93.0
357168	17732831	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1ccc(C#Cc2ccc3nc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cn3n2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3919314	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357169	17732832	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(NC(=O)Nc2ccc(C#Cc3ccc4nccn4n3)cc2)cc1		CHEMBL3980495	=	IC50	nM	67.0	CHEMBL1913	Homo sapiens	IC50	nM	67.0
357170	17732833	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Nc1ccc(C#Cc2ccc3nc(NC(=O)Nc4ccc(F)c(Cl)c4)cn3n2)cc1		CHEMBL3904823	=	IC50	nM	6574.0	CHEMBL1913	Homo sapiens	IC50	nM	6574.0
357171	17732834	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1ccc(C#Cc2ccc3nc(NC(=O)Nc4ccc(F)c(Cl)c4)cn3n2)cc1)Nc1ccc(F)c(Cl)c1		CHEMBL3972455	=	IC50	nM	3610.0	CHEMBL1913	Homo sapiens	IC50	nM	3610.0
357172	17732835	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Nc1cn2nc(C#Cc3ccc(NC(=O)c4ccccc4)cc3)ccc2n1		CHEMBL3895870	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357173	17732836	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(C(=O)Nc2ccc(C#Cc3ccc4nc(N)cn4n3)cc2)c1		CHEMBL3967141	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357174	17732837	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(C(=O)Nc2cccc(C#Cc3ccc4nc(N)cn4n3)c2)c1		CHEMBL3981416	=	IC50	nM	767.0	CHEMBL1913	Homo sapiens	IC50	nM	767.0
357175	17732838	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL3956039	=	IC50	nM	628.0	CHEMBL1913	Homo sapiens	IC50	nM	628.0
357176	17732839	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1cccc(C(=O)Nc2cccc(C#Cc3ccc4nccn4n3)c2)c1		CHEMBL3903593	=	IC50	nM	1531.0	CHEMBL1913	Homo sapiens	IC50	nM	1531.0
357177	17732840	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1ccc(F)c(Cl)c1		CHEMBL3932553	=	IC50	nM	938.0	CHEMBL1913	Homo sapiens	IC50	nM	938.0
357178	17732841	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1cc2ccccc2o1		CHEMBL3952283	=	IC50	nM	2715.0	CHEMBL1913	Homo sapiens	IC50	nM	2715.0
357179	17732842	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(C(=O)Nc2cccc(C#Cc3ccc4nccn4n3)c2)c1		CHEMBL3895469	=	IC50	nM	6083.0	CHEMBL1913	Homo sapiens	IC50	nM	6083.0
357180	17732843	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1ccccc1		CHEMBL3955638	=	IC50	nM	27.0	CHEMBL1913	Homo sapiens	IC50	nM	27.0
357181	17732844	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(C(=O)Nc2cccc(C#Cc3ccc4nccn4n3)c2)cc1		CHEMBL3890006	=	IC50	nM	4313.0	CHEMBL1913	Homo sapiens	IC50	nM	4313.0
357182	17732845	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2cccc(C#Cc3ccc4nccn4n3)c2)c1		CHEMBL3950335	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357183	17732846	CHEMBL3887845	PDGFRbeta Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2ccccc2C#Cc2ccc3nccn3n2)c1		CHEMBL3979359	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357210	17732873	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1cccc(NC(=O)Nc2ccc(C#Cc3ccc4nc(N)cn4n3)cc2)c1		CHEMBL3961214	=	IC50	nM	227.0	CHEMBL1913	Homo sapiens	IC50	nM	227.0
357211	17732874	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	O=C(Nc1ccc(C#Cc2ccc3nccn3n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL3939257	=	IC50	nM	457.0	CHEMBL1913	Homo sapiens	IC50	nM	457.0
357212	17732875	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1cccc(NC(=O)Nc2ccc(C#Cc3ccc4nccn4n3)cc2)c1		CHEMBL3972326	=	IC50	nM	70.0	CHEMBL1913	Homo sapiens	IC50	nM	70.0
357213	17732876	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Nc1cn2nc(C#Cc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)ccc2n1		CHEMBL3948032	=	IC50	nM	516.0	CHEMBL1913	Homo sapiens	IC50	nM	516.0
357214	17732877	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	O=C(Nc1ccc(C#Cc2ccc3nc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cn3n2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL3919314	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357215	17732878	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	CC(=O)Nc1cn2nc(C#Cc3ccc(NC(=O)Nc4cccc(C)c4)cc3)ccc2n1		CHEMBL3894814	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357216	17732879	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1cccc(NC(=O)Nc2ccc(C#Cc3ccc4nc(NC(=O)C5CC5)cn4n3)cc2)c1		CHEMBL3910382	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357217	17732880	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Nc1ccc(C#Cc2ccc3nc(NC(=O)Nc4ccc(F)c(Cl)c4)cn3n2)cc1		CHEMBL3904823	=	IC50	nM	10490.0	CHEMBL1913	Homo sapiens	IC50	nM	10490.0
357218	17732881	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	O=C(Nc1ccc(C#Cc2ccc3nc(NC(=O)Nc4ccc(F)c(Cl)c4)cn3n2)cc1)Nc1ccc(F)c(Cl)c1		CHEMBL3972455	=	IC50	nM	3634.0	CHEMBL1913	Homo sapiens	IC50	nM	3634.0
357219	17732882	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Nc1cn2nc(C#Cc3ccc(NC(=O)c4ccccc4)cc3)ccc2n1		CHEMBL3895870	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357220	17732883	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccc(F)c(C(=O)Nc2ccc(C#Cc3ccc4nc(N)cn4n3)cc2)c1		CHEMBL3967141	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357221	17732884	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccc(F)c(C(=O)Nc2cccc(C#Cc3ccc4nc(N)cn4n3)c2)c1		CHEMBL3981416	=	IC50	nM	371.0	CHEMBL1913	Homo sapiens	IC50	nM	371.0
357222	17732885	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL3956039	=	IC50	nM	1628.0	CHEMBL1913	Homo sapiens	IC50	nM	1628.0
357223	17732886	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1ccc(F)c(Cl)c1		CHEMBL3932553	=	IC50	nM	2684.0	CHEMBL1913	Homo sapiens	IC50	nM	2684.0
357224	17732887	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1cc2ccccc2o1		CHEMBL3952283	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357225	17732888	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccc(F)c(C(=O)Nc2cccc(C#Cc3ccc4nccn4n3)c2)c1		CHEMBL3895469	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
357226	17732889	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	O=C(Nc1cccc(C#Cc2ccc3nccn3n2)c1)c1ccccc1		CHEMBL3955638	=	IC50	nM	17766.0	CHEMBL1913	Homo sapiens	IC50	nM	17766.0
357227	17732890	CHEMBL3887847	PDGFRbeta: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. HUVEC (human umbilical vein endothelial cells) (Clonetics) were seeded in 384-well fibronectin coated black-walled plates overnight at 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by VEGF165 stimulation (10 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccc(C(=O)Nc2cccc(C#Cc3ccc4nccn4n3)c2)cc1		CHEMBL3890006	=	IC50	nM	26893.0	CHEMBL1913	Homo sapiens	IC50	nM	26893.0
364056	17739249	CHEMBL3887933	Competitive Binding Assay (KINOMEscan): For the competitive binding assay, test compounds were screened at 10 uM against 70 diverse kinase targets for competitive binding using the KINOMEscan technology (Ambit Biosciences) (Karaman, et al. (2008) Nature biotechnology 26:127-132). 11-point Kd curves were determined for hits identified during the initial screen.	B	CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cccc(C(F)(F)F)c4)[nH]3)cc2)n1		CHEMBL3932957	=	Kd	nM	520.0	CHEMBL1913	Homo sapiens	Kd	nM	520.0
364629	17739772	CHEMBL3887951	PDGFRbeta Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	Cc1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccccc45)C3)c2)c1		CHEMBL3895520	=	IC50	nM	16.0	CHEMBL1913	Homo sapiens	IC50	nM	16.0
364630	17739773	CHEMBL3887951	PDGFRbeta Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	CCc1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccccc45)C3)c2)c1		CHEMBL3911073	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
364631	17739774	CHEMBL3887951	PDGFRbeta Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	CC(C)c1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccccc45)C3)c2)c1		CHEMBL3984316	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
364632	17739775	CHEMBL3887951	PDGFRbeta Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	CC(C)c1ccc(NC(=O)c2cccc(N3CCc4c(cnc5ccccc45)C3)c2)cc1		CHEMBL3950471	=	IC50	nM	16.0	CHEMBL1913	Homo sapiens	IC50	nM	16.0
364633	17739776	CHEMBL3887951	PDGFRbeta Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(N2CCc3c(cnc4ccccc34)C2)c1		CHEMBL3937330	=	IC50	nM	14.0	CHEMBL1913	Homo sapiens	IC50	nM	14.0
364634	17739777	CHEMBL3887951	PDGFRbeta Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	CC(C)c1cccc(NC(=O)c2cccc(N3CCc4c(cnc5cc(CO)c(CO)cc45)C3)c2)c1		CHEMBL3899614	=	IC50	nM	11.0	CHEMBL1913	Homo sapiens	IC50	nM	11.0
364635	17739778	CHEMBL3887951	PDGFRbeta Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	CC(C)c1ccc(NC(=O)c2cccc(N3CCc4c(cnc5cc(CO)c(CO)cc45)C3)c2)cc1		CHEMBL3890120	=	IC50	nM	18.0	CHEMBL1913	Homo sapiens	IC50	nM	18.0
364636	17739779	CHEMBL3887951	PDGFRbeta Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	CCc1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccsc45)C3)c2)c1		CHEMBL3966912	=	IC50	nM	7.0	CHEMBL1913	Homo sapiens	IC50	nM	7.0
364637	17739780	CHEMBL3887952	PDGFRbeta: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	CCc1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccccc45)C3)c2)c1		CHEMBL3911073	=	IC50	nM	58.0	CHEMBL1913	Homo sapiens	IC50	nM	58.0
364638	17739781	CHEMBL3887952	PDGFRbeta: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	CC(C)c1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccccc45)C3)c2)c1		CHEMBL3984316	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	nM	200.0
364639	17739782	CHEMBL3887952	PDGFRbeta: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase.	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(N2CCc3c(cnc4ccccc34)C2)c1		CHEMBL3937330	=	IC50	nM	103.0	CHEMBL1913	Homo sapiens	IC50	nM	103.0
368425	17743291	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cc(C(=O)N=S(C)(C)=O)cnc2N)c1		CHEMBL3978649	=	IC50	nM	16.0	CHEMBL1913	Homo sapiens	IC50	nM	16.0
368426	17743292	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=S(C)(C)=O)c2)c1		CHEMBL3917187	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	nM	6.0
368427	17743293	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=S3(=O)CCCC3)c2)c1		CHEMBL3986945	=	IC50	nM	34.0	CHEMBL1913	Homo sapiens	IC50	nM	34.0
368428	17743294	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cc(C(=O)N=S3(=O)CCCC3)cnc2N)c1		CHEMBL3914411	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	nM	30.0
368429	17743295	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3ccc(Cl)cc3)c2)c1		CHEMBL3901672	=	IC50	nM	22.0	CHEMBL1913	Homo sapiens	IC50	nM	22.0
368430	17743296	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(C(=O)Nc2cccc(C#Cc3cc(C(=O)N=S(C)(C)=O)cnc3N)c2)c1		CHEMBL3938643	=	IC50	nM	7.0	CHEMBL1913	Homo sapiens	IC50	nM	7.0
368431	17743297	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)Nc2cccc(C#Cc3cncc(C(=O)N=S(C)(C)=O)c3)c2)c1		CHEMBL3980266	=	IC50	nM	19.0	CHEMBL1913	Homo sapiens	IC50	nM	19.0
368432	17743298	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(NC(=O)Nc2cccc(C#Cc3cncc(C(=O)N=S(C)(C)=O)c3)c2)cc1		CHEMBL3910155	=	IC50	nM	19.0	CHEMBL1913	Homo sapiens	IC50	nM	19.0
368433	17743299	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=S(=O)(CCCO)CCCO)c2)c1		CHEMBL3896486	=	IC50	nM	26.0	CHEMBL1913	Homo sapiens	IC50	nM	26.0
368434	17743300	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cc(C(=O)N=S(=O)(CCCO)CCCO)cnc2N)c1		CHEMBL3924505	=	IC50	nM	16.0	CHEMBL1913	Homo sapiens	IC50	nM	16.0
368435	17743301	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(C(=O)Nc2cccc(C#Cc3cncc(C(=O)N=S(=O)(CCCO)CCCO)c3)c2)c1		CHEMBL3983308	=	IC50	nM	6.0	CHEMBL1913	Homo sapiens	IC50	nM	6.0
368436	17743302	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)c2cccc(C#Cc3cc(C(=O)N=S(=O)(CCCO)CCCO)cnc3N)c2)c1		CHEMBL3900571	=	IC50	nM	8.0	CHEMBL1913	Homo sapiens	IC50	nM	8.0
368437	17743303	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3occc3C)c2)c1		CHEMBL3974963	=	IC50	nM	54.0	CHEMBL1913	Homo sapiens	IC50	nM	54.0
368438	17743304	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cc(C)ccc3F)c2)c1		CHEMBL3960598	=	IC50	nM	45.0	CHEMBL1913	Homo sapiens	IC50	nM	45.0
368439	17743305	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cccc(C)c3)c2)c1		CHEMBL3970053	=	IC50	nM	11.0	CHEMBL1913	Homo sapiens	IC50	nM	11.0
368440	17743306	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cc(C(F)(F)F)ccc3F)c2)c1		CHEMBL3918345	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	nM	40.0
368441	17743307	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c1		CHEMBL3920861	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	nM	9.0
368442	17743308	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)c1		CHEMBL3963696	=	IC50	nM	25.0	CHEMBL1913	Homo sapiens	IC50	nM	25.0
368443	17743309	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cccc(OC)c3)c2)c1		CHEMBL3933295	=	IC50	nM	14.0	CHEMBL1913	Homo sapiens	IC50	nM	14.0
368444	17743310	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3ccc(OC)c(OC)c3)c2)c1		CHEMBL3957336	=	IC50	nM	38.0	CHEMBL1913	Homo sapiens	IC50	nM	38.0
368445	17743311	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCC[S@](C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3occc3C)c2)c1		CHEMBL3906392	=	IC50	nM	31.0	CHEMBL1913	Homo sapiens	IC50	nM	31.0
368446	17743312	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCC[S@@](C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3occc3C)c2)c1		CHEMBL4112857	=	IC50	nM	27.0	CHEMBL1913	Homo sapiens	IC50	nM	27.0
368447	17743313	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(C(=O)Nc3cccc(C)c3)c2)c1		CHEMBL3911919	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
368448	17743314	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)Nc3cc(C)ccc3F)c2)c1		CHEMBL3915272	=	IC50	nM	14.0	CHEMBL1913	Homo sapiens	IC50	nM	14.0
368449	17743315	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)Nc3cccc(C)c3)c2)c1		CHEMBL3925180	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
368450	17743316	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=S(C)(=O)CCCO)c2)c1		CHEMBL3897137	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
368451	17743317	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=[S@@](C)(=O)CCCO)c2)c1		CHEMBL3909723	=	IC50	nM	18.0	CHEMBL1913	Homo sapiens	IC50	nM	18.0
368452	17743318	CHEMBL3888029	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per wellPBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=[S@](C)(=O)CCCO)c2)c1		CHEMBL4107561	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
368453	17743319	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cc(C(=O)N=S(C)(C)=O)cnc2N)c1		CHEMBL3978649	=	IC50	nM	11.0	CHEMBL1913	Homo sapiens	IC50	nM	11.0
368454	17743320	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=S3(=O)CCCC3)c2)c1		CHEMBL3986945	=	IC50	nM	66.0	CHEMBL1913	Homo sapiens	IC50	nM	66.0
368455	17743321	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cc(C(=O)N=S3(=O)CCCC3)cnc2N)c1		CHEMBL3914411	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
368456	17743322	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccc(F)c(C(=O)Nc2cccc(C#Cc3cc(C(=O)N=S(C)(C)=O)cnc3N)c2)c1		CHEMBL3938643	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
368457	17743323	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccc(F)c(NC(=O)Nc2cccc(C#Cc3cncc(C(=O)N=S(C)(C)=O)c3)c2)c1		CHEMBL3985264	=	IC50	nM	28.0	CHEMBL1913	Homo sapiens	IC50	nM	28.0
368458	17743324	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3occc3C)c2)c1		CHEMBL3974963	=	IC50	nM	31.0	CHEMBL1913	Homo sapiens	IC50	nM	31.0
368459	17743325	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cc(C)ccc3F)c2)c1		CHEMBL3960598	=	IC50	nM	27.0	CHEMBL1913	Homo sapiens	IC50	nM	27.0
368460	17743326	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cccc(C)c3)c2)c1		CHEMBL3970053	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
368461	17743327	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cc(C(F)(F)F)ccc3F)c2)c1		CHEMBL3918345	=	IC50	nM	19.0	CHEMBL1913	Homo sapiens	IC50	nM	19.0
368462	17743328	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c1		CHEMBL3920861	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	nM	12.0
368463	17743329	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)c1		CHEMBL3963696	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
368464	17743330	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3cccc(OC)c3)c2)c1		CHEMBL3933295	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	nM	9.0
368465	17743331	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3ccc(OC)c(OC)c3)c2)c1		CHEMBL3957336	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
368466	17743332	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCC[S@](C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3occc3C)c2)c1		CHEMBL3906392	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	nM	60.0
368467	17743333	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCC[S@@](C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)c3occc3C)c2)c1		CHEMBL4112857	=	IC50	nM	86.0	CHEMBL1913	Homo sapiens	IC50	nM	86.0
368468	17743334	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(C(=O)Nc3cccc(C)c3)c2)c1		CHEMBL3911919	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
368469	17743335	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(C(=O)Nc3cc(C)ccc3F)c2)c1		CHEMBL3943327	=	IC50	nM	43.0	CHEMBL1913	Homo sapiens	IC50	nM	43.0
368470	17743336	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(C(=O)Nc3cc(C(C)(C)C)on3)c2)c1		CHEMBL3985051	=	IC50	nM	18.0	CHEMBL1913	Homo sapiens	IC50	nM	18.0
368471	17743337	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)Nc3cc(C)ccc3F)c2)c1		CHEMBL3915272	=	IC50	nM	44.0	CHEMBL1913	Homo sapiens	IC50	nM	44.0
368472	17743338	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	COC(=O)CCCCS(C)(=O)=NC(=O)c1cnc(N)c(C#Cc2cccc(NC(=O)Nc3cccc(C)c3)c2)c1		CHEMBL3925180	=	IC50	nM	25.0	CHEMBL1913	Homo sapiens	IC50	nM	25.0
368473	17743339	CHEMBL3888030	PDGFRbeta : Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 uM) or at concentrations ranging from 0.0001 to 10.0 uM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera. Data were generated by determining max-min fluorescence levels for unstimulated, stimulated, and drug treated samples.	B	Cc1ccoc1C(=O)Nc1cccc(C#Cc2cncc(C(=O)N=S(C)(=O)CCCO)c2)c1		CHEMBL3897137	=	IC50	nM	31.0	CHEMBL1913	Homo sapiens	IC50	nM	31.0
377150	17751211	CHEMBL3888174	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COc1ccc(Nc2ncc3c(n2)CCN(C(=O)c2cccnc2)C3)cc1		CHEMBL3952249	=	IC50	nM	17.0	CHEMBL1913	Homo sapiens	IC50	nM	17.0
377151	17751212	CHEMBL3888174	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COc1ccccc1Nc1ncc2c(n1)CCN(C(=O)c1cccnc1)C2		CHEMBL3895612	=	IC50	nM	244.0	CHEMBL1913	Homo sapiens	IC50	nM	244.0
377152	17751213	CHEMBL3888174	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cn1nccc1Nc1ncc2c(n1)CCN(C(=O)c1cccnc1)C2		CHEMBL3920116	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	nM	130.0
377153	17751214	CHEMBL3888174	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	O=C(c1cccnc1)N1CCc2nc(Nc3cccc(F)c3)ncc2C1		CHEMBL3967722	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
377154	17751215	CHEMBL3888174	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COc1cc(Nc2ncc3c(n2)CCN(C(=O)c2occc2C)C3)cc(OC)c1OC		CHEMBL3943535	=	IC50	nM	239.0	CHEMBL1913	Homo sapiens	IC50	nM	239.0
377155	17751216	CHEMBL3888174	PDGFRbeta Kinase Assay: Biochemical PDGFRbeta kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 36 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 ul of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 ul of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 ul of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COc1cc(Nc2ncc3c(n2)CCN(C(=O)c2cc(C)nn2C)C3)cc(OC)c1OC		CHEMBL3976229	=	IC50	nM	19.0	CHEMBL1913	Homo sapiens	IC50	nM	19.0
377156	17751217	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	COc1cc(Nc2ncc3c(n2)CCN(C(=O)c2ccccc2)C3)cc(OC)c1OC		CHEMBL3916154	=	IC50	nM	810.0	CHEMBL1913	Homo sapiens	IC50	nM	810.0
377157	17751218	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	COc1cc(Nc2ncc3c(n2)CCN(C(=O)c2cccnc2)C3)cc(OC)c1OC		CHEMBL3985924	=	IC50	nM	89.0	CHEMBL1913	Homo sapiens	IC50	nM	89.0
377158	17751219	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	O=C(Nc1cccnc1)N1CCc2nc(Nc3ccccc3)ncc2C1		CHEMBL3944186	=	IC50	nM	282.0	CHEMBL1913	Homo sapiens	IC50	nM	282.0
377159	17751220	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	O=C(c1cccnc1)N1CCc2nc(Nc3ccccc3)ncc2C1		CHEMBL3912751	=	IC50	nM	1934.0	CHEMBL1913	Homo sapiens	IC50	nM	1934.0
377160	17751221	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	COc1ccc(Nc2ncc3c(n2)CCN(C(=O)c2cccnc2)C3)cc1		CHEMBL3952249	>	IC50	nM	40000.0	CHEMBL1913	Homo sapiens	IC50	nM	40000.0
377161	17751222	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	COc1cccc(Nc2ncc3c(n2)CCN(C(=O)c2cccnc2)C3)c1		CHEMBL3981059	>	IC50	nM	40000.0	CHEMBL1913	Homo sapiens	IC50	nM	40000.0
377162	17751223	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	COc1cc(Nc2ncc3c(n2)CCN(C(=O)c2ccccn2)C3)cc(OC)c1OC		CHEMBL3946852	=	IC50	nM	2820.0	CHEMBL1913	Homo sapiens	IC50	nM	2820.0
377163	17751224	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	COc1ccc(Nc2ncc3c(n2)CCN(C(=O)c2cccnc2)C3)cc1OC		CHEMBL3981517	=	IC50	nM	176.0	CHEMBL1913	Homo sapiens	IC50	nM	176.0
377164	17751225	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	COc1cc(Nc2ncc3c(n2)CCN(C(=O)c2cccnc2)C3)cc(OC)c1		CHEMBL3952783	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	nM	130.0
377165	17751226	CHEMBL3888175	PKR KinaseGlo Assay: Commercially available recombinant human GST-PKR (SignalChem, Canada; 1.5 uM-2 uM stock) is diluted to 500 nM in assay buffer (20 mM Tris-HCl, pH 7.2, 10 mM KCl, 10 mM MgCl2, 10% glycerol). Preactivated PKR is dispensed to 384/96-well black plates at 3.125/12.5 uls/well using the liquid handler Janus. Appropriate dilutions of inhibitors are added to 384/96-well plate followed by 6.6 uM ATP (final) and incubated for 10 minutes at room temperature. The remaining ATP/well is determined by adding 6.25/25 uls/well Kinase-Glo assay mix (Promega) and luminescence is measured on EnVision luminescence plate reader (integration time, 0.2 sec; Perkin-Elmer, Massachusetts, USA).	B	COC(=O)N1CCc2nc(Nc3cc(OC)c(OC)c(OC)c3)ncc2C1		CHEMBL3892475	=	IC50	nM	749.0	CHEMBL1913	Homo sapiens	IC50	nM	749.0
390876	17762986	CHEMBL3888350	PDGFRβ Kinase Assay: Biochemical PDGFR3 kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 °C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CC(C)(C)c1ccc(-n2cccc(N3CCc4nc(N)ncc4C3)c2=O)cc1		CHEMBL3898974	=	IC50	nM	655.0	CHEMBL1913	Homo sapiens	IC50	nM	655.0
390877	17762987	CHEMBL3888350	PDGFRβ Kinase Assay: Biochemical PDGFR3 kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 °C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cc[nH]c(=O)c1N1CCc2nc(N)ncc2C1		CHEMBL3921600	=	IC50	nM	3887.0	CHEMBL1913	Homo sapiens	IC50	nM	3887.0
390878	17762988	CHEMBL3888350	PDGFRβ Kinase Assay: Biochemical PDGFR3 kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 °C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccn(-c2ccc(C(C)(C)C)cc2)c(=O)c1N1CCc2nc(N)ncc2C1		CHEMBL3893580	=	IC50	nM	381.0	CHEMBL1913	Homo sapiens	IC50	nM	381.0
390879	17762989	CHEMBL3888350	PDGFRβ Kinase Assay: Biochemical PDGFR3 kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 °C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccn(-c2cccc(N(C)C)c2)c(=O)c1N1CCc2nc(N)ncc2C1		CHEMBL3911476	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
390880	17762990	CHEMBL3888350	PDGFRβ Kinase Assay: Biochemical PDGFR3 kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30 °C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1ccc(-n2ccc(C)c(N3CCc4nc(N)ncc4C3)c2=O)cc1		CHEMBL3984713	=	IC50	nM	33.0	CHEMBL1913	Homo sapiens	IC50	nM	33.0
409032	17774391	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	CCc1cccc(NC(=O)Nc2ccc(-c3cc4ccccc4n3C(N)=O)cc2)c1		CHEMBL3895384	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
409033	17774392	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	COC(=O)c1ccc2cc(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)n(C(N)=O)c2c1		CHEMBL3893131	=	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
409034	17774393	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1cccc(NC(=O)Nc2ccc(-c3cc4ccccc4n3C(N)=O)cc2)c1		CHEMBL3944202	=	IC50	nM	14.0	CHEMBL1913	Homo sapiens	IC50	nM	14.0
409035	17774394	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	CC(C)c1cccc(NC(=O)Nc2ccc(-c3cc4ccccc4n3C(N)=O)cc2)c1		CHEMBL3968343	=	IC50	nM	16.0	CHEMBL1913	Homo sapiens	IC50	nM	16.0
409036	17774395	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2ccc(NC(=O)Nc3ccc(F)c(Cl)c3)cc2)cc2ccccc21		CHEMBL3938792	=	IC50	nM	19.0	CHEMBL1913	Homo sapiens	IC50	nM	19.0
409037	17774396	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cc2ccccc21		CHEMBL3920784	=	IC50	nM	28.0	CHEMBL1913	Homo sapiens	IC50	nM	28.0
409038	17774397	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cc4ccccc4n3C(N)=O)cc2)c1		CHEMBL3896265	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	nM	20.0
409039	17774398	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	COc1cccc(NC(=O)Nc2ccc(-c3cc4ccccc4n3C(N)=O)cc2)c1		CHEMBL3911854	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	nM	12.0
409040	17774399	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc2ccccc21		CHEMBL3981808	=	IC50	nM	55.0	CHEMBL1913	Homo sapiens	IC50	nM	55.0
409041	17774400	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)cc2ccccc21		CHEMBL3939918	=	IC50	nM	23.0	CHEMBL1913	Homo sapiens	IC50	nM	23.0
409042	17774401	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(NC(=O)Nc2ccc(-c3cc4ccccc4n3C(N)=O)cc2)cc1		CHEMBL3908397	=	IC50	nM	11.0	CHEMBL1913	Homo sapiens	IC50	nM	11.0
409043	17774402	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccccc1NC(=O)Nc1ccc(-c2cc3ccccc3n2C(N)=O)cc1		CHEMBL3979836	=	IC50	nM	118.0	CHEMBL1913	Homo sapiens	IC50	nM	118.0
409044	17774403	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2cccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c2)cc2ccccc21		CHEMBL3918574	=	IC50	nM	3310.0	CHEMBL1913	Homo sapiens	IC50	nM	3310.0
409045	17774404	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2cccc(NC(=O)Nc3ccc(F)c(Cl)c3)c2)cc2ccccc21		CHEMBL3966485	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
409046	17774405	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2cccc(-c3cc4ccccc4n3C(N)=O)c2)c1		CHEMBL3895175	=	IC50	nM	3030.0	CHEMBL1913	Homo sapiens	IC50	nM	3030.0
409047	17774406	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1cccc(NC(=O)Nc2csc(-c3cc4ccccc4n3C(N)=O)c2)c1		CHEMBL3904099	=	IC50	nM	1141.0	CHEMBL1913	Homo sapiens	IC50	nM	1141.0
409048	17774407	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cs2)cc2ccccc21		CHEMBL3945521	=	IC50	nM	152.0	CHEMBL1913	Homo sapiens	IC50	nM	152.0
409049	17774408	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	CCc1cccc(NC(=O)Nc2csc(-c3cc4ccccc4n3C(N)=O)c2)c1		CHEMBL3974900	=	IC50	nM	264.0	CHEMBL1913	Homo sapiens	IC50	nM	264.0
409050	17774409	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2csc(-c3cc4ccccc4n3C(N)=O)c2)c1		CHEMBL3918687	=	IC50	nM	4608.0	CHEMBL1913	Homo sapiens	IC50	nM	4608.0
409051	17774410	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2cc(NC(=O)Nc3ccc(F)c(Cl)c3)cs2)cc2ccccc21		CHEMBL3985195	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
409052	17774411	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)n1c(-c2cc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cs2)cc2ccccc21		CHEMBL3965529	=	IC50	nM	151.0	CHEMBL1913	Homo sapiens	IC50	nM	151.0
409053	17774412	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccoc1C(=O)Nc1csc(-c2cc3ccccc3n2C(N)=O)c1		CHEMBL3904259	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
409054	17774413	CHEMBL3888560	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(C(=O)Nc2csc(-c3cc4ccccc4n3C(N)=O)c2)c1		CHEMBL3894545	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
412041	17776756	CHEMBL3888684	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
412755	17777470	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CC(C)c1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)c1		CHEMBL3702602	=	IC50	nM	21.0	CHEMBL1913	Homo sapiens	IC50	nM	21.0
412756	17777471	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)c1		CHEMBL3702603	=	IC50	nM	116.0	CHEMBL1913	Homo sapiens	IC50	nM	116.0
412757	17777472	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CC(C)(C)c1ccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)cc1		CHEMBL3702604	=	IC50	nM	109.0	CHEMBL1913	Homo sapiens	IC50	nM	109.0
412758	17777473	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Nc1ncc2c(n1)CCN(c1cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c1)C2		CHEMBL3702605	=	IC50	nM	26.0	CHEMBL1913	Homo sapiens	IC50	nM	26.0
412759	17777474	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)cc1		CHEMBL3702606	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	nM	90.0
412760	17777475	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COc1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)c1		CHEMBL3702607	=	IC50	nM	1240.0	CHEMBL1913	Homo sapiens	IC50	nM	1240.0
412761	17777476	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCc1ccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)cc1		CHEMBL3702608	=	IC50	nM	134.0	CHEMBL1913	Homo sapiens	IC50	nM	134.0
412762	17777477	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCc1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)c1		CHEMBL3702609	=	IC50	nM	52.0	CHEMBL1913	Homo sapiens	IC50	nM	52.0
412763	17777478	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCCc1ccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)cc1		CHEMBL3702610	=	IC50	nM	32.0	CHEMBL1913	Homo sapiens	IC50	nM	32.0
412764	17777479	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CN1CCC(Oc2ccc(NC(=O)c3cccc(N4CCc5nc(N)ncc5C4)c3)cc2)CC1		CHEMBL3702611	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
412765	17777480	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CC(C)c1ccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)cc1		CHEMBL3702612	=	IC50	nM	24.0	CHEMBL1913	Homo sapiens	IC50	nM	24.0
412766	17777481	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCCCNC(=O)c1cccc(N2CCc3nc(N)ncc3C2)c1		CHEMBL3702616	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
412767	17777482	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CC(C)(C)C1CCC(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)c2)CC1		CHEMBL3702617	=	IC50	nM	246.0	CHEMBL1913	Homo sapiens	IC50	nM	246.0
412768	17777483	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Nc1ncc2c(n1)CCN(c1cccc(C(=O)NCC3CCCCC3)c1)C2		CHEMBL3702618	=	IC50	nM	602.0	CHEMBL1913	Homo sapiens	IC50	nM	602.0
412769	17777484	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Nc1ncc2c(n1)CCN(c1cccc(C(=O)NC3CCCC3)c1)C2		CHEMBL3702619	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
412770	17777485	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CC(C)(C)CCNC(=O)c1cccc(N2CCc3nc(N)ncc3C2)c1		CHEMBL3702620	=	IC50	nM	164.0	CHEMBL1913	Homo sapiens	IC50	nM	164.0
412771	17777486	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCN(CC)C(=O)c1cccc(N2CCc3nc(N)ncc3C2)c1		CHEMBL3702621	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
412772	17777487	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)c2cccc(N3CCc4nc(N)ncc4C3)n2)c1		CHEMBL3702628	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
412773	17777488	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CSc1ncc2c(n1)CCN(c1cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc1C)C2		CHEMBL3920210	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	nM	20.0
412774	17777489	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc(N2CCc3nc(N)ncc3C2)c1		CHEMBL3702662	=	IC50	nM	273.0	CHEMBL1913	Homo sapiens	IC50	nM	273.0
412775	17777490	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1N1CCc2nc(N)ncc2C1		CHEMBL3702663	=	IC50	nM	30.0	CHEMBL1913	Homo sapiens	IC50	nM	30.0
412776	17777491	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cc(C(=O)Nc2cccc(C(C)C)c2)cc(N2CCc3nc(N)ncc3C2)c1		CHEMBL3702664	=	IC50	nM	59.0	CHEMBL1913	Homo sapiens	IC50	nM	59.0
412777	17777492	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	O=C(Nc1ccc(N2CCc3ccncc3C2)cc1)c1cccc(C(F)(F)F)c1		CHEMBL3644546	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
412778	17777493	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)cc2)c1		CHEMBL3644547	=	IC50	nM	1560.0	CHEMBL1913	Homo sapiens	IC50	nM	1560.0
412779	17777494	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	O=C(Nc1ccccc1)Nc1ccc(N2CCc3ccncc3C2)cc1		CHEMBL3644548	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
412780	17777495	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)cc2)cc1		CHEMBL3644549	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
412781	17777496	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)c(C)c2)c1		CHEMBL3644550	=	IC50	nM	36.0	CHEMBL1913	Homo sapiens	IC50	nM	36.0
412782	17777497	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)Nc2ccc(N3CCc4ccncc4C3)cc2C)c1		CHEMBL3644551	=	IC50	nM	1050.0	CHEMBL1913	Homo sapiens	IC50	nM	1050.0
412783	17777498	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CC(C)c1cccc(NC(=O)c2cccc(N3CCc4ccncc4C3)c2)c1		CHEMBL3644552	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	nM	40.0
412784	17777499	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)c1cncc2c1CCN(c1cccc(C(=O)Nc3cccc(C(C)C)c3)c1)C2		CHEMBL3644553	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
412785	17777500	CHEMBL3888725	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microliter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-β protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Nc1ncc2c(n1)CCN(c1cccc(C(=O)Nc3ccc(F)c(C(F)(F)F)c3)c1)C2		CHEMBL3644560	=	IC50	nM	61.0	CHEMBL1913	Homo sapiens	IC50	nM	61.0
412795	17777510	CHEMBL3888728	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFRβ protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mis per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CC(C)c1cccc(NC(=O)c2cccc(N3CCc4c(cnc5ccnn45)C3)c2)c1		CHEMBL3978214	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	nM	20.0
412796	17777511	CHEMBL3888728	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFRβ protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mis per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(N2CCc3c(cnc4ccnn34)C2)c1		CHEMBL3940300	=	IC50	nM	27.0	CHEMBL1913	Homo sapiens	IC50	nM	27.0
412797	17777512	CHEMBL3888728	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFRβ protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mis per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	O=C(Nc1cccc(N2CCc3c(cnc4ccnn34)C2)c1)c1ccccc1		CHEMBL3894122	=	IC50	nM	202.0	CHEMBL1913	Homo sapiens	IC50	nM	202.0
412798	17777513	CHEMBL3888728	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFRβ protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mis per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	O=C(Nc1cccc(N2CCc3c(cnc4ccnn34)C2)c1)c1cccc(C(F)(F)F)c1		CHEMBL3954328	=	IC50	nM	21.0	CHEMBL1913	Homo sapiens	IC50	nM	21.0
412799	17777514	CHEMBL3888728	PDGFRβ Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFRβ protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mis per well wash with PBS-Tween-20, 100 μl of 0-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)Nc2cccc(N3CCc4c(cnc5ccnn45)C3)c2)c1		CHEMBL3982995	=	IC50	nM	32.0	CHEMBL1913	Homo sapiens	IC50	nM	32.0
412800	17777515	CHEMBL3888729	PDGFRβ Cellular Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF-induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal Human Dermal Fibroblasts, Adult; Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight @ 37° C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37° C. Cells were washed 2 times (Elx405, Biotek Instruments) to remove extracellular dye. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 μM) or at concentrations ranging from 0.0001 to 10.0 μM followed by PDGF-BB stimulation (30 ng/mL). Changes in fluorescence at 516 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(N2CCc3c(cnc4ccnn34)C2)c1		CHEMBL3940300	=	IC50	nM	192.0	CHEMBL1913	Homo sapiens	IC50	nM	192.0
415925	17779506	CHEMBL3888789	Inhibition Assay: In a similar manner to Experimental Example 1, the % inhibitory activity (concentration of the compound 1.0 μM) and the IC50 values of the inventive compound of Example 1 against various kinases were obtained by using Kinase Profiling Service (Invitrogen) according to the manufacturer's instructions.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cccc2c(N)nccc12		CHEMBL3967980	=	IC50	nM	66.0	CHEMBL1913	Homo sapiens	IC50	nM	66.0
416971	17780482	CHEMBL3888804	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1cccc(NC(=O)Nc2ccc(-c3[nH]c4ccccc4c3C(N)=O)cc2)c1		CHEMBL3950267	=	IC50	nM	140.0	CHEMBL1913	Homo sapiens	IC50	nM	140.0
416972	17780483	CHEMBL3888804	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	NC(=O)c1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)[nH]c2ccccc12		CHEMBL3913556	=	IC50	nM	61.0	CHEMBL1913	Homo sapiens	IC50	nM	61.0
416973	17780484	CHEMBL3888804	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3[nH]c4ccccc4c3C(N)=O)cc2)c1		CHEMBL3941533	=	IC50	nM	267.0	CHEMBL1913	Homo sapiens	IC50	nM	267.0
416974	17780485	CHEMBL3888804	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCc1cccc(NC(=O)Nc2ccc(-c3[nH]c4ccccc4c3C(N)=O)cc2)c1		CHEMBL3975267	=	IC50	nM	37.0	CHEMBL1913	Homo sapiens	IC50	nM	37.0
416975	17780486	CHEMBL3888804	Kinase Assay: Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 μL reaction volumes containing 36 μM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 μl per well of kinase buffer containing 200-300 ng purified cytoplasmic domain PDGFR-b protein (Millipore). Following a 60 minute incubation at 30° C., the reactions were washed 2 mls per well PBS-T. 100 μl of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate diluted 1:10,000 in PBS-T was added to the wells for 30 minutes. Following a 2 mls per well wash with PBS-Tween-20, 100 μl of O-Phenylenediamine Dihydrochloride in phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7-10 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 μl of 2.5N H2SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccoc1C(=O)Nc1cccc(-c2[nH]c3ccccc3c2C(N)=O)c1		CHEMBL3984270	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
423188	17786104	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccccc3)c12		CHEMBL1093099	=	IC50	nM	2800.0	CHEMBL1913	Homo sapiens	IC50	nM	2800.0
423222	17786138	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	CC(C)c1ccccc1Nc1nc(N)nc2c1-c1ccccc1C2		CHEMBL2047244	=	IC50	nM	21700.0	CHEMBL1913	Homo sapiens	IC50	nM	21700.0
423223	17786139	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	CC(C)c1ccc(Nc2nc(N)nc3c2-c2ccccc2C3)cc1		CHEMBL2047245	=	IC50	nM	7800.0	CHEMBL1913	Homo sapiens	IC50	nM	7800.0
423224	17786140	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	Nc1nc2c(c(Nc3cccc(Br)c3)n1)-c1ccccc1C2	Outside typical range	CHEMBL2047248	=	IC50	nM	126300.0	CHEMBL1913	Homo sapiens	IC50	nM	126300.0
423225	17786141	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	Nc1nc2c(c(Nc3ccc(Cl)cc3F)n1)-c1ccccc1C2		CHEMBL2047253	=	IC50	nM	3600.0	CHEMBL1913	Homo sapiens	IC50	nM	3600.0
423226	17786142	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	Nc1nc2c(c(Nc3ccc(Cl)cc3)n1)-c1ccccc1C2		CHEMBL2047247	=	IC50	nM	800.0	CHEMBL1913	Homo sapiens	IC50	nM	800.0
423227	17786143	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	Nc1nc2c(c(Nc3cccc(Cl)c3)n1)-c1ccccc1C2	Outside typical range	CHEMBL2047242	>	IC50	nM	500000.0	CHEMBL1913	Homo sapiens	IC50	nM	500000.0
423228	17786144	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	CN(C)c1ccc(/C=C2/C(=O)Nc3ccccc32)cc1		CHEMBL296455	=	IC50	nM	3750.0	CHEMBL1913	Homo sapiens	IC50	nM	3750.0
423229	17786145	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	Nc1nc2c(c(Nc3ccccc3)n1)-c1ccccc1C2		CHEMBL2047243	=	IC50	nM	43100.0	CHEMBL1913	Homo sapiens	IC50	nM	43100.0
423230	17786146	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	COc1cccc(Nc2nc(N)nc3c2-c2ccccc2C3)c1		CHEMBL2047251	=	IC50	nM	75500.0	CHEMBL1913	Homo sapiens	IC50	nM	75500.0
423231	17786147	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	Nc1nc2c(c(Nc3cccc(F)c3)n1)-c1ccccc1C2		CHEMBL2047246	=	IC50	nM	7100.0	CHEMBL1913	Homo sapiens	IC50	nM	7100.0
423232	17786148	CHEMBL3888923	Inhibition Assay: Inhibition of various kinase enzyme.	B	Nc1nc2c(c(Nc3ccc(F)c(Cl)c3)n1)-c1ccccc1C2		CHEMBL2047252	=	IC50	nM	6400.0	CHEMBL1913	Homo sapiens	IC50	nM	6400.0
431423	17791531	CHEMBL3889033	Inhibition Assay: Inhibition of recombinant PDGFR tyrosine kinase using exogenous substrate.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	2636.67	CHEMBL1913	Homo sapiens	IC50	nM	2636.67
431438	17791546	CHEMBL3889048	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	1860.0	CHEMBL1913	Homo sapiens	IC50	nM	1860.0
436756	17796721	CHEMBL3889149	Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 Î¼g/ml with potassium ion-free PBS, and enzyme labeled plate was coated by the substrate, reacted at 37° C. for 12-16 h, and then the liquid in holes was removed.(2) Enzyme labeled plate was washed with T-PBS for three times, 10 min each time.(3) Enzyme labeled plate was dried at 37° C. in a dryer.(4) The tested samples were added into holes of the coated enzyme labeled plate:The tested samples were firstly formulated to be a 10â¿¿2 M stock solution with DMSO, and then diluted to required concentration with reaction buffer before use, added into the experiment holes to reach corresponding final concentration in a 100 uL reaction system. Meanwhile, positive control holes were created, and compound Sorafenib was added. The rest of the stock solutions was storaged at â¿¿20° C. after subpackage.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)c3ccccc23)c1		CHEMBL3951451	=	IC50	nM	25.4	CHEMBL1913	Homo sapiens	IC50	nM	25.4
436757	17796722	CHEMBL3889149	Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 Î¼g/ml with potassium ion-free PBS, and enzyme labeled plate was coated by the substrate, reacted at 37° C. for 12-16 h, and then the liquid in holes was removed.(2) Enzyme labeled plate was washed with T-PBS for three times, 10 min each time.(3) Enzyme labeled plate was dried at 37° C. in a dryer.(4) The tested samples were added into holes of the coated enzyme labeled plate:The tested samples were firstly formulated to be a 10â¿¿2 M stock solution with DMSO, and then diluted to required concentration with reaction buffer before use, added into the experiment holes to reach corresponding final concentration in a 100 uL reaction system. Meanwhile, positive control holes were created, and compound Sorafenib was added. The rest of the stock solutions was storaged at â¿¿20° C. after subpackage.	B	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)c3ccccc23)c1		CHEMBL3920239	=	IC50	nM	6.7	CHEMBL1913	Homo sapiens	IC50	nM	6.7
436758	17796723	CHEMBL3889149	Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 Î¼g/ml with potassium ion-free PBS, and enzyme labeled plate was coated by the substrate, reacted at 37° C. for 12-16 h, and then the liquid in holes was removed.(2) Enzyme labeled plate was washed with T-PBS for three times, 10 min each time.(3) Enzyme labeled plate was dried at 37° C. in a dryer.(4) The tested samples were added into holes of the coated enzyme labeled plate:The tested samples were firstly formulated to be a 10â¿¿2 M stock solution with DMSO, and then diluted to required concentration with reaction buffer before use, added into the experiment holes to reach corresponding final concentration in a 100 uL reaction system. Meanwhile, positive control holes were created, and compound Sorafenib was added. The rest of the stock solutions was storaged at â¿¿20° C. after subpackage.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCN4CCCC4)c4[nH]nc(N)c34)c3ccccc23)c1		CHEMBL3892076	=	IC50	nM	16.3	CHEMBL1913	Homo sapiens	IC50	nM	16.3
436759	17796724	CHEMBL3889149	Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 Î¼g/ml with potassium ion-free PBS, and enzyme labeled plate was coated by the substrate, reacted at 37° C. for 12-16 h, and then the liquid in holes was removed.(2) Enzyme labeled plate was washed with T-PBS for three times, 10 min each time.(3) Enzyme labeled plate was dried at 37° C. in a dryer.(4) The tested samples were added into holes of the coated enzyme labeled plate:The tested samples were firstly formulated to be a 10â¿¿2 M stock solution with DMSO, and then diluted to required concentration with reaction buffer before use, added into the experiment holes to reach corresponding final concentration in a 100 uL reaction system. Meanwhile, positive control holes were created, and compound Sorafenib was added. The rest of the stock solutions was storaged at â¿¿20° C. after subpackage.	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccc(OCCCN4CCCC4)c4[nH]nc(N)c34)c3ccccc23)c1		CHEMBL3914717	=	IC50	nM	45.4	CHEMBL1913	Homo sapiens	IC50	nM	45.4
436760	17796725	CHEMBL3889149	Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 Î¼g/ml with potassium ion-free PBS, and enzyme labeled plate was coated by the substrate, reacted at 37° C. for 12-16 h, and then the liquid in holes was removed.(2) Enzyme labeled plate was washed with T-PBS for three times, 10 min each time.(3) Enzyme labeled plate was dried at 37° C. in a dryer.(4) The tested samples were added into holes of the coated enzyme labeled plate:The tested samples were firstly formulated to be a 10â¿¿2 M stock solution with DMSO, and then diluted to required concentration with reaction buffer before use, added into the experiment holes to reach corresponding final concentration in a 100 uL reaction system. Meanwhile, positive control holes were created, and compound Sorafenib was added. The rest of the stock solutions was storaged at â¿¿20° C. after subpackage.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCC(C)(C)N)c4[nH]nc(N)c34)c3ccccc23)c1		CHEMBL3916527	=	IC50	nM	105.9	CHEMBL1913	Homo sapiens	IC50	nM	105.9
436761	17796726	CHEMBL3889149	Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 Î¼g/ml with potassium ion-free PBS, and enzyme labeled plate was coated by the substrate, reacted at 37° C. for 12-16 h, and then the liquid in holes was removed.(2) Enzyme labeled plate was washed with T-PBS for three times, 10 min each time.(3) Enzyme labeled plate was dried at 37° C. in a dryer.(4) The tested samples were added into holes of the coated enzyme labeled plate:The tested samples were firstly formulated to be a 10â¿¿2 M stock solution with DMSO, and then diluted to required concentration with reaction buffer before use, added into the experiment holes to reach corresponding final concentration in a 100 uL reaction system. Meanwhile, positive control holes were created, and compound Sorafenib was added. The rest of the stock solutions was storaged at â¿¿20° C. after subpackage.	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccc(OCCC(C)(C)N)c4[nH]nc(N)c34)c3ccccc23)c1		CHEMBL3963292	=	IC50	nM	154.8	CHEMBL1913	Homo sapiens	IC50	nM	154.8
436762	17796727	CHEMBL3889149	Enzyme-Linked Immunosorbent Assay: Experimental Procedures(1) Kinase reaction substrate Poly(Glu, Tyr, 4:1) was diluted to 20 Î¼g/ml with potassium ion-free PBS, and enzyme labeled plate was coated by the substrate, reacted at 37° C. for 12-16 h, and then the liquid in holes was removed.(2) Enzyme labeled plate was washed with T-PBS for three times, 10 min each time.(3) Enzyme labeled plate was dried at 37° C. in a dryer.(4) The tested samples were added into holes of the coated enzyme labeled plate:The tested samples were firstly formulated to be a 10â¿¿2 M stock solution with DMSO, and then diluted to required concentration with reaction buffer before use, added into the experiment holes to reach corresponding final concentration in a 100 uL reaction system. Meanwhile, positive control holes were created, and compound Sorafenib was added. The rest of the stock solutions was storaged at â¿¿20° C. after subpackage.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	18.4	CHEMBL1913	Homo sapiens	IC50	nM	18.4
Inactive	17924451	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924452	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924453	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924454	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924455	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17924456	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	Kd	nM	278.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	278.0
Inactive	17924457	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924458	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924459	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924460	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924461	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924462	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924463	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924464	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924465	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924466	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	292.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	292.0
Inactive	17924467	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924468	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924469	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	203.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	203.0
Inactive	17924470	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924471	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924472	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	1146.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1146.0
Inactive	17924473	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924474	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924475	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924476	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17924477	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	2550.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	2550.0
Inactive	17924478	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924479	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	4592.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	4592.0
Inactive	17924480	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924481	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	1118.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1118.0
Inactive	17924482	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924483	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924484	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924485	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924486	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	Kd	nM	91.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	91.0
Active	17924487	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	288.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	288.0
Inactive	17924488	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924489	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924490	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924491	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924492	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924493	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924494	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	404.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	404.0
Active	17924495	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1551.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1551.0
Inactive	17924496	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924497	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1795.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1795.0
Active	17924498	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	2776.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	2776.0
Active	17924499	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	9383.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	9383.0
Inactive	17924500	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924501	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	512.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	512.0
Inactive	17924502	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924503	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924504	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924505	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924506	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924507	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924508	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924509	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924510	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924511	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924512	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924513	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	510.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	510.0
Inactive	17924514	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924515	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924516	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924517	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	11107.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	11107.0
Inactive	17924518	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924519	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924520	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924521	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924522	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1735.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1735.0
Active	17924523	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	109.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	109.0
Inactive	17924524	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924525	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924526	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924527	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924528	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924529	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924530	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924531	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	316.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	316.0
Active	17924532	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	3132.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	3132.0
Inactive	17924533	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924534	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924535	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924536	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924537	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924538	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924539	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924540	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	4.0
Inactive	17924541	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924542	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924543	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924544	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	3285.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	3285.0
Inactive	17924545	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924546	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924547	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924548	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924549	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924550	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924551	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924552	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924553	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924554	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924555	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924556	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924557	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924558	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924559	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924560	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924561	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924562	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	=	Kd	nM	555.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	555.0
Inactive	17924563	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924564	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924565	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	430.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	430.0
Inactive	17924566	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924567	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924568	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924569	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924570	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924571	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924572	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	35.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	35.0
Inactive	17924573	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924574	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924575	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	744.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	744.0
Inactive	17924576	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924577	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924578	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	31.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	31.0
Inactive	17924579	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924580	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924581	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924582	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924583	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	2666.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	2666.0
Inactive	17924584	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924585	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924586	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924587	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924588	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	103.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	103.0
Inactive	17924589	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924590	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924591	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924592	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924593	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924594	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924595	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	552.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	552.0
Inactive	17924596	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924597	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	2537.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	2537.0
Inactive	17924598	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924599	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924600	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924601	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924602	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924603	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	3609.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	3609.0
Active	17924604	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	19.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	19.0
Inactive	17924605	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924606	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924607	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924608	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924609	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924610	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924611	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924612	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924613	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17924614	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	Kd	nM	543.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	543.0
Inactive	17924615	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924616	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924617	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	=	Kd	nM	1607.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1607.0
Inactive	17924618	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924619	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	631.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	631.0
Inactive	17924620	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924621	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924622	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924623	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924624	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924625	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924626	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924627	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924628	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924629	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924630	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924631	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924632	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924633	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	106.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	106.0
Active	17924634	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	1006.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1006.0
Inactive	17924635	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924636	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924637	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924638	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924639	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	2692.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	2692.0
Inactive	17924640	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924641	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924642	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924643	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	=	Kd	nM	3988.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	3988.0
Inactive	17924644	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924645	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	4.0
Inactive	17924646	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924647	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924648	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924649	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924650	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	100.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	100.0
Inactive	17924651	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924652	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924653	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	4393.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	4393.0
Inactive	17924654	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924655	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924656	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924657	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924658	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924659	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924660	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924661	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17924662	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	1364.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1364.0
Inactive	17924663	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924664	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924665	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924666	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924667	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924668	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	=	Kd	nM	1892.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1892.0
Uncertain	17924669	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	29725.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	29725.0
Inactive	17924670	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924671	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924672	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924673	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924674	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924675	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	4743.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	4743.0
Inactive	17924676	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17924677	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	907.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	907.0
Inactive	17924678	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924679	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924680	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924681	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924682	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	2409.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	2409.0
Inactive	17924683	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924684	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	1107.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	1107.0
Inactive	17924685	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924686	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924687	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Active	17924688	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	436.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	436.0
Inactive	17924689	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924690	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924691	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17924692	CHEMBL3991817	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd apparent	nM	30000.0
	17957958	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)cc1)c1ccccc1		CHEMBL4069394	=	IC50	nM	14.3	CHEMBL1913	Homo sapiens	IC50	nM	14.3
	17957959	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	CCN(CC)Cc1cccn1-c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)OC)ccc32)c2ccccc2)cc1		CHEMBL4070403	=	IC50	nM	31.36	CHEMBL1913	Homo sapiens	IC50	nM	31.36
	17957960	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCCC2)cc1)c1ccccc1		CHEMBL4091341	=	IC50	nM	27.11	CHEMBL1913	Homo sapiens	IC50	nM	27.11
	17957961	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCCCC2)cc1)c1ccccc1		CHEMBL4059568	=	IC50	nM	45.52	CHEMBL1913	Homo sapiens	IC50	nM	45.52
Not Determined	17957962	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCC(C)CC2)cc1)c1ccccc1		CHEMBL4087886		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	17957963	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCOCC2)cc1)c1ccccc1		CHEMBL4068213		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	17957964	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCSCC2)cc1)c1ccccc1		CHEMBL4095586		IC50			CHEMBL1913	Homo sapiens	IC50		
	17957965	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4079087	=	IC50	nM	83.17	CHEMBL1913	Homo sapiens	IC50	nM	83.17
Not Determined	17957966	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(C(=O)OC(C)(C)C)CC2)cc1)c1ccccc1		CHEMBL4103336		IC50			CHEMBL1913	Homo sapiens	IC50		
	17957967	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(Cn2cccc2CN(C)C)cc1)c1ccccc1		CHEMBL4086939	=	IC50	nM	29.79	CHEMBL1913	Homo sapiens	IC50	nM	29.79
Not Determined	17957968	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(Cn2cccc2CN2CCC(C)CC2)cc1)c1ccccc1		CHEMBL4065508		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	17957969	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(Cn2cccc2CN2CCOCC2)cc1)c1ccccc1		CHEMBL4071990		IC50			CHEMBL1913	Homo sapiens	IC50		
	17957970	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(Cn2cccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4098962	=	IC50	nM	67.85	CHEMBL1913	Homo sapiens	IC50	nM	67.85
	17957971	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCNCC2)cc1)c1ccccc1		CHEMBL4061361	=	IC50	nM	65.24	CHEMBL1913	Homo sapiens	IC50	nM	65.24
Not Determined	17957972	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(C(C)=O)CC2)cc1)c1ccccc1		CHEMBL4083218		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	17957973	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(S(C)(=O)=O)CC2)cc1)c1ccccc1		CHEMBL4099641		IC50			CHEMBL1913	Homo sapiens	IC50		
	17957974	CHEMBL3993993	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	3.7	CHEMBL1913	Homo sapiens	IC50	nM	3.7
	17964934	CHEMBL3995043	Inhibition of human PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	22.0	CHEMBL1913	Homo sapiens	Activity	%	22.0
	17971061	CHEMBL3995864	Inhibition of human PDGFRbeta at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [33P]ATP by Hotspot assay relative to control	B	COc1cc2cc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c(C)nc2cc1OC		CHEMBL4100501	=	Inhibition	%	29.48	CHEMBL1913	Homo sapiens	INH	%	29.48
	17979265	CHEMBL3998069	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain (558 to 1106 residues) expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	-1.0	CHEMBL1913	Homo sapiens	INH	%	-1.0
	17979749	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1ccc2c(c1)CCN2c1nc(C)nc2c(Cc3ccccc3)c[nH]c12.Cl		CHEMBL4098409	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	nM	200.0
	17979750	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1ccc2c(c1)CCCN2c1nc(C)nc2c(Cc3ccccc3)c[nH]c12.Cl		CHEMBL4069672	=	IC50	nM	90.3	CHEMBL1913	Homo sapiens	IC50	nM	90.3
	17979751	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1ccc(Nc2nc(C)nc3c(Cc4ccccc4)cn(C)c23)cc1.Cl		CHEMBL4099682	=	IC50	nM	7.2	CHEMBL1913	Homo sapiens	IC50	nM	7.2
	17979752	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1ccc(N(C)c2nc(C)nc3c(Cc4ccccc4)cn(C)c23)cc1.Cl		CHEMBL4060996	=	IC50	nM	10.3	CHEMBL1913	Homo sapiens	IC50	nM	10.3
	17979753	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1ccc2c(c1)CCCN2c1nc(C)nc2c(Cc3ccccc3)cn(C)c12.Cl		CHEMBL4104515	=	IC50	nM	30.2	CHEMBL1913	Homo sapiens	IC50	nM	30.2
	17979754	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1ccc(N(C)c2nc(N)nc3c(Cc4ccccc4)c[nH]c23)cc1		CHEMBL4099329	=	IC50	nM	8.1	CHEMBL1913	Homo sapiens	IC50	nM	8.1
	17979755	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1ccc2c(c1)CCCN2c1nc(N)nc2c(Cc3ccccc3)c[nH]c12		CHEMBL4072383	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	nM	200.0
Not Determined	17979756	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O		CHEMBL67		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	17979757	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711		IC50			CHEMBL1913	Homo sapiens	IC50		
	17979758	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	83.1	CHEMBL1913	Homo sapiens	IC50	nM	83.1
Not Determined	17979759	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	17979760	CHEMBL3998245	Inhibition of PDGFR-beta in human SF539 cells assessed as reduction in PDGF-BB induced phosphorylation preincubated for 60 mins followed by PDGF-BB addition measured after 10 mins by ELISA method	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		IC50			CHEMBL1913	Homo sapiens	IC50		
	17979951	CHEMBL3998345	Inhibition of recombinant PDGFRbeta (unknown origin) expressed in baculovirus infected insect cells using biotinylated peptide substrate GGLFDDPSYVNVQNL in presence of ATP incubated for 1 to 4 hrs by time resolved fluorescence assay	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	nM	1.0
	17982178	CHEMBL3998821	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	Inhibition	%	80.0	CHEMBL1913	Homo sapiens	INH	%	80.0
	17994969	CHEMBL4001103	Inhibition of PDGFRbeta (unknown origin) phosphorylation	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	2.0	CHEMBL1913	Homo sapiens	IC50	nM	2.0
	17995004	CHEMBL4001114	Inhibition of recombinant human PDGFRbeta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)]n as substrate measured after 30 mins by LANCE method	B	CCN(CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C)CCOCCOCCNC(=O)c1cc(OCc2cn(CCCCN3C[C@@H]4C[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N4)nn2)cc(OCc2cn(CCCCN3C[C@@H]4C[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N4)nn2)c1		CHEMBL4066412	=	IC50	nM	9.0	CHEMBL1913	Homo sapiens	IC50	nM	9.0
	17995630	CHEMBL4001275	Inhibition of human recombinant His tagged PDGFRB cytoplasmic domain (556 to 1108 residues) expressed in baculovirus expression system using Tyr 04 as substrate after 1 hr by Z'-Lyte assay	B	Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1		CHEMBL4070633	<	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	pIC50		5.0
	17995631	CHEMBL4001275	Inhibition of human recombinant His tagged PDGFRB cytoplasmic domain (556 to 1108 residues) expressed in baculovirus expression system using Tyr 04 as substrate after 1 hr by Z'-Lyte assay	B	Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1		CHEMBL4070633	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	17995746	CHEMBL4001307	Inhibition of human recombinant PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 1 uM by KINOMEScan assay relative to control	B	Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1		CHEMBL4070633	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
Not Active	17996198	CHEMBL4001363	Inhibition of recombinant human GST-tagged PDGFR-beta (557-end residues) transphosphorylation activity expressed in baculovirus infected Sf9 cells using poly[Glu:Tyr] (4:1) as substrate after 60 mins	B	Cc1nc2nc(Oc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4085696		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	17996199	CHEMBL4001363	Inhibition of recombinant human GST-tagged PDGFR-beta (557-end residues) transphosphorylation activity expressed in baculovirus infected Sf9 cells using poly[Glu:Tyr] (4:1) as substrate after 60 mins	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)c1ccccc1		CHEMBL4094680		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	17996200	CHEMBL4001363	Inhibition of recombinant human GST-tagged PDGFR-beta (557-end residues) transphosphorylation activity expressed in baculovirus infected Sf9 cells using poly[Glu:Tyr] (4:1) as substrate after 60 mins	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4083528		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	17996269	CHEMBL4001418	Inhibition of human wild type partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 10 uM by KinomeScan method relative to control	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4083528	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	18002362	CHEMBL4002773	Inhibition of recombinant PDGFRbeta (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628	=	IC50	nM	5.5	CHEMBL1913	Homo sapiens	IC50	nM	5.5
	18002380	CHEMBL4002773	Inhibition of recombinant PDGFRbeta (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	1.2	CHEMBL1913	Homo sapiens	IC50	nM	1.2
	18029902	CHEMBL4007194	Inhibition of PDGF-BB-induced PDGFR-beta phosphorylation in human SF-539 cells preincubated for 60 mins followed by PDGF-BB induction measured after 10 mins by ELISA	B	Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccc4ccccc4c3)c12		CHEMBL4060383	=	IC50	nM	90100.0	CHEMBL1913	Homo sapiens	IC50	uM	90.1
	18029903	CHEMBL4007194	Inhibition of PDGF-BB-induced PDGFR-beta phosphorylation in human SF-539 cells preincubated for 60 mins followed by PDGF-BB induction measured after 10 mins by ELISA	B	Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3cccc4ccccc34)c12		CHEMBL4088617	=	IC50	nM	58200.0	CHEMBL1913	Homo sapiens	IC50	uM	58.2
	18029904	CHEMBL4007194	Inhibition of PDGF-BB-induced PDGFR-beta phosphorylation in human SF-539 cells preincubated for 60 mins followed by PDGF-BB induction measured after 10 mins by ELISA	B	COc1ccc(OC)c(Sc2cccc3[nH]c4nc(N)nc(N)c4c23)c1	Outside typical range	CHEMBL4069070	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	18029905	CHEMBL4007194	Inhibition of PDGF-BB-induced PDGFR-beta phosphorylation in human SF-539 cells preincubated for 60 mins followed by PDGF-BB induction measured after 10 mins by ELISA	B	COc1ccc(Sc2cccc3[nH]c4nc(N)nc(N)c4c23)cc1		CHEMBL4096329	=	IC50	nM	60500.0	CHEMBL1913	Homo sapiens	IC50	uM	60.5
	18029906	CHEMBL4007194	Inhibition of PDGF-BB-induced PDGFR-beta phosphorylation in human SF-539 cells preincubated for 60 mins followed by PDGF-BB induction measured after 10 mins by ELISA	B	Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccc(Cl)cc3)c12	Outside typical range	CHEMBL4079829	>	IC50	nM	200000.0	CHEMBL1913	Homo sapiens	IC50	uM	200.0
	18029907	CHEMBL4007194	Inhibition of PDGF-BB-induced PDGFR-beta phosphorylation in human SF-539 cells preincubated for 60 mins followed by PDGF-BB induction measured after 10 mins by ELISA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	IC50	nM	3700.0	CHEMBL1913	Homo sapiens	IC50	uM	3.7
	18031818	CHEMBL4007733	Inhibition of PDGFRB (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	5270.0	CHEMBL1913	Homo sapiens	IC50	uM	5.27
	18031819	CHEMBL4007733	Inhibition of PDGFRB (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	18031820	CHEMBL4007733	Inhibition of PDGFRB (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	18031821	CHEMBL4007733	Inhibition of PDGFRB (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	5190.0	CHEMBL1913	Homo sapiens	IC50	uM	5.19
	18031822	CHEMBL4007733	Inhibition of PDGFRB (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	18033094	CHEMBL4007910	Inhibition of human PDGFRbeta at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	48.0	CHEMBL1913	Homo sapiens	INH	%	48.0
	18034703	CHEMBL4008323	Inhibition of recombinant TEL-fused PDGFR-beta (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4064566	=	GI50	nM	130.0	CHEMBL1913	Homo sapiens	GI50	uM	0.13
	18034704	CHEMBL4008323	Inhibition of recombinant TEL-fused PDGFR-beta (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4093840	=	GI50	nM	59.0	CHEMBL1913	Homo sapiens	GI50	uM	0.059
	18034705	CHEMBL4008323	Inhibition of recombinant TEL-fused PDGFR-beta (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4066104	=	GI50	nM	910.0	CHEMBL1913	Homo sapiens	GI50	uM	0.91
	18034706	CHEMBL4008323	Inhibition of recombinant TEL-fused PDGFR-beta (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4087478	=	GI50	nM	790.0	CHEMBL1913	Homo sapiens	GI50	uM	0.79
	18053037	CHEMBL4011884	Inhibition of PDGFRbeta (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.8	CHEMBL1913	Homo sapiens	INH	%	1.8
	18057693	CHEMBL4012651	Inhibition of human PDGFRbeta (582 to 1009 residues) expressed in bacterial expression system assessed as activity remaining at 1 uM by KINOMEscan assay relative to control	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	18057742	CHEMBL4012660	Inhibition of human His-tagged PDGFRbeta (558 to 1106 residues) expressed in baculovirus by ELISA	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	<	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	nM	1.0
	18057861	CHEMBL4012623	Inhibition of PDGFRbeta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4103605	=	IC50	nM	197.0	CHEMBL1913	Homo sapiens	IC50	nM	197.0
	18057931	CHEMBL4012659	Inhibition of human His-tagged PDGFRbeta (558 to 1106 residues) expressed in baculovirus assessed as activity remaining at 1 uM by ELISA relative to control	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	18085985	CHEMBL4018641	Inhibition of recombinant PDGFR-beta (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	>	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	nM	100.0
	18085986	CHEMBL4018641	Inhibition of recombinant PDGFR-beta (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	nM	1.0
	18085987	CHEMBL4018641	Inhibition of recombinant PDGFR-beta (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	>	IC50	nM	10.0	CHEMBL1913	Homo sapiens	IC50	nM	10.0
	18085988	CHEMBL4018641	Inhibition of recombinant PDGFR-beta (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	=	IC50	nM	1.0	CHEMBL1913	Homo sapiens	IC50	nM	1.0
	18096340	CHEMBL4021227	Inhibition of PDGFRbeta (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	nM	30000.0
	18114766	CHEMBL4025296	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	92.0	CHEMBL1913	Homo sapiens	Activity	%	92.0
	18141790	CHEMBL4031405	Inhibition of human PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	18141799	CHEMBL4031413	Inhibition of PDGFRbeta (unknown origin) using poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo kinase assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	IC50	nM	606.0	CHEMBL1913	Homo sapiens	IC50	nM	606.0
	18141848	CHEMBL4031446	Binding affinity to PDGFRbeta (unknown origin) by KinomeSCan assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	7.7	CHEMBL1913	Homo sapiens	Kd	nM	7.7
	18152581	CHEMBL4034166	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1		CHEMBL4066684	=	IC50	nM	3.26	CHEMBL1913	Homo sapiens	IC50	nM	3.26
	18172310	CHEMBL4038028	Inhibition of recombinant human PDGFRbeta expressed in baculovirus using poly (4:1 Glu, Tyr) peptide as substrate after 1 hr by ADP-Glo assay	B	CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1		CHEMBL4066141	=	IC50	nM	106.2	CHEMBL1913	Homo sapiens	IC50	nM	106.2
	18203820	CHEMBL4044107	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	A	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	1.5	CHEMBL1913	Homo sapiens	Activity	%	1.5
	18225259	CHEMBL4048653	Inhibition of PDGFRB (unknown origin) at 1 uM relative to control	B	CC1(c2cccc(Cl)c2)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21		CHEMBL4064839	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	18225272	CHEMBL4048653	Inhibition of PDGFRB (unknown origin) at 1 uM relative to control	B	N[C@H]1C[C@H](Oc2ccc3ncc(-c4ccc5cnccc5c4)n3n2)C1		CHEMBL4094080	=	Inhibition	%	17.0	CHEMBL1913	Homo sapiens	INH	%	17.0
	18250444	CHEMBL4054261	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	19.6	CHEMBL1913	Homo sapiens	INH	%	19.6
	18250446	CHEMBL4054263	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1 uM after 1 hr by ELISA relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	97.0	CHEMBL1913	Homo sapiens	INH	%	97.0
	18253255	CHEMBL4054911	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	19.0	CHEMBL1913	Homo sapiens	Activity	%	19.0
	18253256	CHEMBL4054911	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	64.0	CHEMBL1913	Homo sapiens	Activity	%	64.0
	18265889	CHEMBL4057339	Inhibition of PDGFR beta (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	78.3	CHEMBL1913	Homo sapiens	INH	%	78.3
	18266145	CHEMBL4057595	Inhibition of PDGFR beta (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	20.0	CHEMBL1913	Homo sapiens	INH	%	20.0
	18274424	CHEMBL4059356	Inhibition of human PDGFRbeta assessed as remaining activity at 1 uM after 30 mins by qPCR method	B	CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(F)(F)F)n(C)n3)c2)ncn1		CHEMBL4076112	<=	Activity	%	10.0	CHEMBL1913	Homo sapiens	Activity	%	10.0
	18274896	CHEMBL4118344	Inhibition of PDGFRb in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKMLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	33.7	CHEMBL1913	Homo sapiens	INH	%	33.7
	18274897	CHEMBL4118344	Inhibition of PDGFRb in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKMLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	7.6	CHEMBL1913	Homo sapiens	INH	%	7.6
	18274898	CHEMBL4118344	Inhibition of PDGFRb in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKMLK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	18.4	CHEMBL1913	Homo sapiens	INH	%	18.4
	18275370	CHEMBL4118504	Inhibition of human PDGFRB (582 to 1009 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	1.5	CHEMBL1913	Homo sapiens	Activity	%	1.5
	18276142	CHEMBL4119072	Inhibition of human PDGFRB (582 to 1009 residues) expressed in bacterial expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	0.05	CHEMBL1913	Homo sapiens	Activity	%	0.05
	18282789	CHEMBL4120374	Inhibition of PDGFR beta (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	78.3	CHEMBL1913	Homo sapiens	INH	%	78.3
	18283016	CHEMBL4120601	Inhibition of PDGFR beta (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	97.0	CHEMBL1913	Homo sapiens	INH	%	97.0
	18283240	CHEMBL4120825	Inhibition of PDGFR beta (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	21.0	CHEMBL1913	Homo sapiens	INH	%	21.0
	18286320	CHEMBL4121555	Inhibition of recombinant His-tagged human PDGFRbeta (558 to 1106 residues) cytoplasmic domain expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-4.0	CHEMBL1913	Homo sapiens	INH	%	-4.0
	18314101	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2nc(CN(C)C)oc2c1)c1ccccc1		CHEMBL4163106	>	IC50	nM	500.0	CHEMBL1913	Homo sapiens	IC50	nM	500.0
	18314102	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2nc(CN3CCN(C)CC3)oc2c1)c1ccccc1		CHEMBL4173817	=	IC50	nM	116.2	CHEMBL1913	Homo sapiens	IC50	nM	116.2
	18314103	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)nc(CN(C)C)n2C)c1ccccc1		CHEMBL4169257	=	IC50	nM	45.5	CHEMBL1913	Homo sapiens	IC50	nM	45.5
	18314104	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)nc(CN1CCN(C)CC1)n2C)c1ccccc1		CHEMBL4177112	=	IC50	nM	61.0	CHEMBL1913	Homo sapiens	IC50	nM	61.0
Not Determined	18314105	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(CN(C)C)cc2c1)c1ccccc1		CHEMBL4165827		IC50			CHEMBL1913	Homo sapiens	IC50		
	18314106	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(CN3CCN(C)CC3)cc2c1)c1ccccc1		CHEMBL4173756	=	IC50	nM	92.7	CHEMBL1913	Homo sapiens	IC50	nM	92.7
Not Determined	18314107	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(C(=O)N(C)C)cc2c1)c1ccccc1		CHEMBL4176039		IC50			CHEMBL1913	Homo sapiens	IC50		
	18314108	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(C(=O)N3CCN(C)CC3)cc2c1)c1ccccc1		CHEMBL4165429	=	IC50	nM	22.0	CHEMBL1913	Homo sapiens	IC50	nM	22.0
	18314109	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)cc(C(=O)N1CCN(C)CC1)n2C)c1ccccc1		CHEMBL4166696	=	IC50	nM	44.2	CHEMBL1913	Homo sapiens	IC50	nM	44.2
	18314110	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	CCn1c(C(=O)N2CCN(C)CC2)cc2cc(N/C(=C3\C(=O)Nc4cc(C(=O)OC)ccc43)c3ccccc3)ccc21		CHEMBL4161991	=	IC50	nM	39.0	CHEMBL1913	Homo sapiens	IC50	nM	39.0
	18314111	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]cc(CN(C)C)c2c1)c1ccccc1		CHEMBL4164318	=	IC50	nM	60.7	CHEMBL1913	Homo sapiens	IC50	nM	60.7
	18314112	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)c(CN(C)C)cn2C)c1ccccc1		CHEMBL4172205	=	IC50	nM	64.6	CHEMBL1913	Homo sapiens	IC50	nM	64.6
	18314113	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	CCn1cc(CN(C)C)c2cc(N/C(=C3\C(=O)Nc4cc(C(=O)OC)ccc43)c3ccccc3)ccc21		CHEMBL4173078	=	IC50	nM	34.3	CHEMBL1913	Homo sapiens	IC50	nM	34.3
	18314114	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)c(CN(C)C)cn2C(C)C)c1ccccc1		CHEMBL4162400	=	IC50	nM	49.2	CHEMBL1913	Homo sapiens	IC50	nM	49.2
	18314115	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]cc(CN3CCN(C)CC3)c2c1)c1ccccc1		CHEMBL4176458	=	IC50	nM	135.1	CHEMBL1913	Homo sapiens	IC50	nM	135.1
	18314116	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)c(CN1CCN(C)CC1)cn2C)c1ccccc1		CHEMBL4165850	=	IC50	nM	91.7	CHEMBL1913	Homo sapiens	IC50	nM	91.7
	18314117	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]cc(CN3CCOCC3)c2c1)c1ccccc1		CHEMBL4161351	=	IC50	nM	241.6	CHEMBL1913	Homo sapiens	IC50	nM	241.6
	18314118	CHEMBL4132766	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	3.5	CHEMBL1913	Homo sapiens	IC50	nM	3.5
	18318842	CHEMBL4133760	Inhibition of PDGFRbeta (unknown origin) using ATP and enzyme substrate by kinase-glo Plus luminescence kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	204.7	CHEMBL1913	Homo sapiens	IC50	nM	204.7
	18318843	CHEMBL4133760	Inhibition of PDGFRbeta (unknown origin) using ATP and enzyme substrate by kinase-glo Plus luminescence kinase assay	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	IC50	nM	7800.0	CHEMBL1913	Homo sapiens	IC50	uM	7.8
	18318896	CHEMBL4133779	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as PDGFRbeta Tyr740 phosphorylation level at 2.5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		1.2	CHEMBL1913	Homo sapiens	FC		1.2
	18318897	CHEMBL4133780	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as PDGFRbeta Tyr740 phosphorylation level at 5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.78	CHEMBL1913	Homo sapiens	FC		0.78
	18318898	CHEMBL4133781	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as PDGFRbeta Tyr740 phosphorylation level at 10 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.61	CHEMBL1913	Homo sapiens	FC		0.61
	18318899	CHEMBL4133782	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Thr305 phosphorylation level at 2.5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.95	CHEMBL1913	Homo sapiens	FC		0.95
	18318900	CHEMBL4133783	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Thr305 phosphorylation level at 5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.75	CHEMBL1913	Homo sapiens	FC		0.75
	18318901	CHEMBL4133784	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Thr305 phosphorylation level at 10 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.12	CHEMBL1913	Homo sapiens	FC		0.12
	18318902	CHEMBL4133785	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Ser473 phosphorylation level at 2.5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.45	CHEMBL1913	Homo sapiens	FC		0.45
	18318903	CHEMBL4133786	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Ser473 phosphorylation level at 5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.23	CHEMBL1913	Homo sapiens	FC		0.23
	18318904	CHEMBL4133787	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Ser473 phosphorylation level at 10 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.18	CHEMBL1913	Homo sapiens	FC		0.18
	18318905	CHEMBL4133788	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as mTOR Ser2448 phosphorylation level at 2.5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.74	CHEMBL1913	Homo sapiens	FC		0.74
	18318906	CHEMBL4133789	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as mTOR Ser2448 phosphorylation level at 5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.23	CHEMBL1913	Homo sapiens	FC		0.23
	18318907	CHEMBL4133790	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as mTOR Ser2448 phosphorylation level at 10 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.16	CHEMBL1913	Homo sapiens	FC		0.16
	18318908	CHEMBL4133791	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser317 phosphorylation level at 2.5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		1.5	CHEMBL1913	Homo sapiens	FC		1.5
	18318909	CHEMBL4133792	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser317 phosphorylation level at 5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		2.1	CHEMBL1913	Homo sapiens	FC		2.1
	18318910	CHEMBL4133793	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser317 phosphorylation level at 10 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		3.2	CHEMBL1913	Homo sapiens	FC		3.2
	18318911	CHEMBL4133794	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser555 phosphorylation level at 2.5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		4.5	CHEMBL1913	Homo sapiens	FC		4.5
	18318912	CHEMBL4133795	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser555 phosphorylation level at 5 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		4.2	CHEMBL1913	Homo sapiens	FC		4.2
	18318913	CHEMBL4133796	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser555 phosphorylation level at 10 uM incubated for 24 hrs by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		5.6	CHEMBL1913	Homo sapiens	FC		5.6
	18318935	CHEMBL4133819	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as PDGFRbeta Tyr740 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of control siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.08	CHEMBL1913	Homo sapiens	FC		0.08
	18318936	CHEMBL4133820	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Thr305 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of control siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.1	CHEMBL1913	Homo sapiens	FC		0.1
	18318937	CHEMBL4133821	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Thr305 phosphorylation level at 2.5 uM incubated for 24 hrs in absence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.05	CHEMBL1913	Homo sapiens	FC		0.05
	18318938	CHEMBL4133822	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Thr305 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.04	CHEMBL1913	Homo sapiens	FC		0.04
	18318939	CHEMBL4133823	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Ser473 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of control siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.88	CHEMBL1913	Homo sapiens	FC		0.88
	18318940	CHEMBL4133824	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Ser473 phosphorylation level at 2.5 uM incubated for 24 hrs in absence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.48	CHEMBL1913	Homo sapiens	FC		0.48
	18318941	CHEMBL4133825	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as Akt Ser473 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.52	CHEMBL1913	Homo sapiens	FC		0.52
	18318942	CHEMBL4133826	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as mTOR Ser2448 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of control siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.26	CHEMBL1913	Homo sapiens	FC		0.26
	18318943	CHEMBL4133827	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as mTOR Ser2448 phosphorylation level at 2.5 uM incubated for 24 hrs in absence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.21	CHEMBL1913	Homo sapiens	FC		0.21
	18318944	CHEMBL4133828	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as mTOR Ser2448 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.16	CHEMBL1913	Homo sapiens	FC		0.16
	18318945	CHEMBL4133829	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser317 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of control siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		3.21	CHEMBL1913	Homo sapiens	FC		3.21
	18318946	CHEMBL4133830	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser317 phosphorylation level at 2.5 uM incubated for 24 hrs in absence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		3.67	CHEMBL1913	Homo sapiens	FC		3.67
	18318947	CHEMBL4133831	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser317 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		3.46	CHEMBL1913	Homo sapiens	FC		3.46
	18318948	CHEMBL4133832	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser555 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of control siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		3.21	CHEMBL1913	Homo sapiens	FC		3.21
	18318949	CHEMBL4133833	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser555 phosphorylation level at 2.5 uM incubated for 24 hrs in absence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		3.67	CHEMBL1913	Homo sapiens	FC		3.67
	18318950	CHEMBL4133834	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as ULK Ser555 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		3.69	CHEMBL1913	Homo sapiens	FC		3.69
	18318965	CHEMBL4133849	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as C-Raf Ser259 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.95	CHEMBL1913	Homo sapiens	FC		0.95
	18318966	CHEMBL4133850	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as C-Raf Ser259 phosphorylation level at 5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		1.06	CHEMBL1913	Homo sapiens	FC		1.06
	18318967	CHEMBL4133851	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as C-Raf Ser259 phosphorylation level at 10 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.95	CHEMBL1913	Homo sapiens	FC		0.95
	18318968	CHEMBL4133852	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as C-Raf Ser338 phosphorylation level at 2.5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.85	CHEMBL1913	Homo sapiens	FC		0.85
	18318969	CHEMBL4133853	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as C-Raf Ser338 phosphorylation level at 5 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.78	CHEMBL1913	Homo sapiens	FC		0.78
	18318970	CHEMBL4133854	Inhibition of PDGFRbeta in human MDA-MB-231 cells assessed as C-Raf Ser338 phosphorylation level at 10 uM incubated for 24 hrs in presence of PDGFRbeta siRNA by Western blot relative to untreated control	B	COc1cccc(Nc2cc(N3CCN(C(=O)Nc4ccc(C(F)(F)F)cc4)CC3)ncn2)c1		CHEMBL4169916	=	FC		0.66	CHEMBL1913	Homo sapiens	FC		0.66
	18328497	CHEMBL4135867	Inhibition of PDGFRbeta (unknown origin)	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cn1		CHEMBL4171543	=	IC50	nM	180.0	CHEMBL1913	Homo sapiens	IC50	nM	180.0
	18330875	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-n5nccn5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4177014	=	IC50	nM	1.5	CHEMBL1913	Homo sapiens	IC50	nM	1.5
	18330876	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5ccco5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4172546	=	IC50	nM	12.0	CHEMBL1913	Homo sapiens	IC50	nM	12.0
	18330877	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5cnco5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4161897	=	IC50	nM	34.0	CHEMBL1913	Homo sapiens	IC50	nM	34.0
	18330878	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5nnn(C)n5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4175951	=	IC50	nM	13.0	CHEMBL1913	Homo sapiens	IC50	nM	13.0
	18330879	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5ncon5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4165331	=	IC50	nM	5.3	CHEMBL1913	Homo sapiens	IC50	nM	5.3
	18330880	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5nnco5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4160821	=	IC50	nM	4.5	CHEMBL1913	Homo sapiens	IC50	nM	4.5
	18330881	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(OC(F)(F)F)ccc43)c3ccccc3)cc2)CC1		CHEMBL4169611	=	IC50	nM	27.0	CHEMBL1913	Homo sapiens	IC50	nM	27.0
	18330882	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2CCC(CN3CCN(C)CC3)C2=O)cc1)c1ccccc1		CHEMBL4166187	=	IC50	nM	45.0	CHEMBL1913	Homo sapiens	IC50	nM	45.0
	18330883	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2C(=O)CC[C@@H]2CN(C)C)cc1)c1ccccc1		CHEMBL4162743	=	IC50	nM	14.0	CHEMBL1913	Homo sapiens	IC50	nM	14.0
	18330884	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2C(=O)CC[C@@H]2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4170680	=	IC50	nM	3.2	CHEMBL1913	Homo sapiens	IC50	nM	3.2
	18330885	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2C(=O)CC[C@H]2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4171244	=	IC50	nM	4.3	CHEMBL1913	Homo sapiens	IC50	nM	4.3
	18330886	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	1.8	CHEMBL1913	Homo sapiens	IC50	nM	1.8
	18330887	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCOCC1)CC2)c1ccccc1		CHEMBL4168811	=	IC50	nM	25.0	CHEMBL1913	Homo sapiens	IC50	nM	25.0
	18330888	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)Cn1cccn1)CC2)c1ccccc1		CHEMBL4161551	=	IC50	nM	24.0	CHEMBL1913	Homo sapiens	IC50	nM	24.0
	18330889	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)Cn1cncn1)CC2)c1ccccc1		CHEMBL4172155	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
	18330890	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCCC1=O)CC2)c1ccccc1		CHEMBL4165455	=	IC50	nM	19.0	CHEMBL1913	Homo sapiens	IC50	nM	19.0
	18330891	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CC(C)OC(C)C1)CC2)c1ccccc1		CHEMBL4173370	=	IC50	nM	91.0	CHEMBL1913	Homo sapiens	IC50	nM	91.0
	18330892	CHEMBL4136261	Inhibition of recombinant PDGFRbeta (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN(C)C)CC2)c1ccccc1		CHEMBL4166319	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
	18356037	CHEMBL4140588	Inhibition of PDGFRbeta (unknown origin)	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12		CHEMBL4160854	=	IC50	nM	177.0	CHEMBL1913	Homo sapiens	IC50	nM	177.0
	18379249	CHEMBL4145359	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 10 uM by ATP-site competition binding assay based KinomeScan assay relative to control	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1N		CHEMBL4172550	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
Active	18410237	CHEMBL4151865	Inhibition of human PDGFRbeta expressed in bacterial expression system at 10 uM	B	O=C(NCCN1CCOCC1)Nc1cccc(-c2ccc3nc(NC(=O)C4CC4)sc3n2)c1		CHEMBL4171209		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	18431076	CHEMBL4155757	Inhibition of recombinant His-tagged human PDGFRbeta expressed in baculovirus expression system at 1 uM by Z'-Lyte relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	82.0	CHEMBL1913	Homo sapiens	INH	%	82.0
	18431329	CHEMBL4155781	Inhibition of PDGFRbeta (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21		CHEMBL4170025	=	Inhibition	%	35.6	CHEMBL1913	Homo sapiens	INH	%	35.6
	18434137	CHEMBL4156119	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	1.0	CHEMBL1913	Homo sapiens	INH	%	1.0
	18434207	CHEMBL4156119	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	18434267	CHEMBL4156119	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	5.0	CHEMBL1913	Homo sapiens	INH	%	5.0
	18434339	CHEMBL4156119	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	7.0	CHEMBL1913	Homo sapiens	INH	%	7.0
	18440362	CHEMBL4157186	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	88.0	CHEMBL1913	Homo sapiens	Activity	%	88.0
	18450288	CHEMBL4178290	Inhibition of recombinant human full length N-terminal GST-tagged PDGFRbeta (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	2.0	CHEMBL1913	Homo sapiens	Activity	%	2.0
	18450338	CHEMBL4178290	Inhibition of recombinant human full length N-terminal GST-tagged PDGFRbeta (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-3.0	CHEMBL1913	Homo sapiens	Activity	%	-3.0
	18463778	CHEMBL4181194	Inhibition of recombinant human N-terminal His6-tagged PDGFRbeta (557 to end residue) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-8.0	CHEMBL1913	Homo sapiens	INH	%	-8.0
	18477346	CHEMBL4183782	Inhibition of human N-terminal GST-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 10 nM relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
	18481855	CHEMBL4185097	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins in presence of ATP by HTRF assay	B	CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1		CHEMBL4204920	=	IC50	nM	482.1	CHEMBL1913	Homo sapiens	IC50	nM	482.1
	18484318	CHEMBL4185965	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	94.0	CHEMBL1913	Homo sapiens	Activity	%	94.0
	18484802	CHEMBL4185965	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	84.0	CHEMBL1913	Homo sapiens	Activity	%	84.0
	18489546	CHEMBL4187287	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	56.0	CHEMBL1913	Homo sapiens	Activity	%	56.0
	18501937	CHEMBL4189530	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)nn23)cc1		CHEMBL4203889	>	Inhibition	%	65.0	CHEMBL1913	Homo sapiens	INH	%	65.0
	18502861	CHEMBL4189700	Inhibition of recombinant human PDGFR-beta using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	18502862	CHEMBL4189700	Inhibition of recombinant human PDGFR-beta using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C		CHEMBL4211949	=	IC50	nM	214.5	CHEMBL1913	Homo sapiens	IC50	nM	214.5
Active	18504080	CHEMBL4189911	Inhibition of DNA-tagged human partial length PDGFRB expressed in mammalian expression system at 100 nM by qPCR method	B	CN1CCN(c2cc(Nc3cc(-c4cccc(F)c4)[nH]n3)nc(Sc3ccccc3)n2)CC1		CHEMBL4216563		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Not Active	18504081	CHEMBL4189911	Inhibition of DNA-tagged human partial length PDGFRB expressed in mammalian expression system at 100 nM by qPCR method	B	Cc1ccc(CSc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4217093		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	18506018	CHEMBL4190478	Inhibition of recombinant human GST-tagged PDGFRbeta expressed in baculovirus infected Sf9 insect cells using Poly(Ala,Glu,Lys,Tyr)6:2:5:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Non standard unit for type	CHEMBL1290072	>	INH	uM	100.0	CHEMBL1913	Homo sapiens	INH	uM	100.0
	18507982	CHEMBL4191102	Inhibition of recombinant human PDGFRbeta (557 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-7.0	CHEMBL1913	Homo sapiens	INH	%	-7.0
	18528593	CHEMBL4194930	Binding affinity to PDGFRbeta (unknown origin)	B	COCCOc1cc2ncnc(N3CCN(c4ncc(Cc5ccccc5)cn4)CC3)c2cc1OCCOC		CHEMBL4205999	=	Kd	nM	8.0	CHEMBL1913	Homo sapiens	Kd	nM	8.0
	18531084	CHEMBL4195392	Inhibition of PDGFRbeta (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCCCC(=O)NO)cc4)n3)cc2nn1C		CHEMBL4212117	=	IC50	nM	111.0	CHEMBL1913	Homo sapiens	IC50	uM	0.111
	18531085	CHEMBL4195392	Inhibition of PDGFRbeta (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)Nc5ccccc5N)cc4)n3)cc2nn1C		CHEMBL4213341	=	IC50	nM	88.0	CHEMBL1913	Homo sapiens	IC50	uM	0.088
	18531086	CHEMBL4195392	Inhibition of PDGFRbeta (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	83.0	CHEMBL1913	Homo sapiens	IC50	uM	0.083
	18558663	CHEMBL4201055	Inhibition of human PDGFRbeta at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	98.1	CHEMBL1913	Homo sapiens	INH	%	98.1
	18561774	CHEMBL4201726	Inhibition of TEL-fused PDGFRbeta (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	102.0	CHEMBL1913	Homo sapiens	GI50	uM	0.102
	18561775	CHEMBL4201726	Inhibition of TEL-fused PDGFRbeta (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	GI50	nM	114.0	CHEMBL1913	Homo sapiens	GI50	uM	0.114
	18561776	CHEMBL4201726	Inhibition of TEL-fused PDGFRbeta (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	GI50	nM	29.0	CHEMBL1913	Homo sapiens	GI50	uM	0.029
	18561777	CHEMBL4201726	Inhibition of TEL-fused PDGFRbeta (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21		CHEMBL4216467	=	GI50	nM	45.0	CHEMBL1913	Homo sapiens	GI50	uM	0.045
	18561778	CHEMBL4201726	Inhibition of TEL-fused PDGFRbeta (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1		CHEMBL4204794	=	GI50	nM	22.0	CHEMBL1913	Homo sapiens	GI50	uM	0.022
	18561779	CHEMBL4201726	Inhibition of TEL-fused PDGFRbeta (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1		CHEMBL4216473	=	GI50	nM	8.0	CHEMBL1913	Homo sapiens	GI50	uM	0.008
	18568751	CHEMBL4220257	Inhibition of PDGFRbeta (unknown origin)	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	66.0	CHEMBL1913	Homo sapiens	IC50	nM	66.0
	18571115	CHEMBL4221046	Inhibition of PDGFRb (unknown origin) after 40 mins in presence of [gamma-33P]-ATP by liquid scintillation counting method	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(C4=Nc5cscc5NC(=O)C4)cc3)cc2C(F)(F)F)CC1		CHEMBL4228601	=	IC50	nM	63.4	CHEMBL1913	Homo sapiens	IC50	nM	63.4
Active	18571119	CHEMBL4221043	Inhibition of human PDGFRb using poly[Glu:Tyr] (4:1) as substrate at 10 uM after 40 mins in presence of [gamma-33P]-ATP by liquid scintillation counting method	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(C4=Nc5cscc5NC(=O)C4)cc3)cc2C(F)(F)F)CC1		CHEMBL4228601		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	18577624	CHEMBL4222210	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain (558 to 1106 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	21.7	CHEMBL1913	Homo sapiens	INH	%	21.7
	18577648	CHEMBL4222210	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain (558 to 1106 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	53.1	CHEMBL1913	Homo sapiens	INH	%	53.1
	18577672	CHEMBL4222210	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain (558 to 1106 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	-4.7	CHEMBL1913	Homo sapiens	INH	%	-4.7
	18653451	CHEMBL4230178	Inhibition of PDGFR-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	100.0	CHEMBL1913	Homo sapiens	INH	%	100.0
	18653452	CHEMBL4230178	Inhibition of PDGFR-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	71.0	CHEMBL1913	Homo sapiens	INH	%	71.0
	18655110	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCO)C(=O)CN(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4248828	=	GI50	nM	3880.0	CHEMBL1913	Homo sapiens	GI50	uM	3.88
	18655111	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCO)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4244561	=	GI50	nM	3020.0	CHEMBL1913	Homo sapiens	GI50	uM	3.02
	18655112	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)N(CCC(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4245029	=	GI50	nM	230.0	CHEMBL1913	Homo sapiens	GI50	uM	0.23
	18655113	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN3CCCC3)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4240820	=	GI50	nM	934.0	CHEMBL1913	Homo sapiens	GI50	uM	0.934
	18655114	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCN(CC)CCN(Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1)C(=O)c1cccnc1		CHEMBL4243958	=	GI50	nM	699.0	CHEMBL1913	Homo sapiens	GI50	uM	0.699
	18655115	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)N(CCN(CC)CC)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4238377	=	GI50	nM	1100.0	CHEMBL1913	Homo sapiens	GI50	uM	1.1
	18655116	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(C(=O)N(CCN(C)C)Cc2ccc(C(=O)Nc3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc2)cc1		CHEMBL4247752	=	GI50	nM	240.0	CHEMBL1913	Homo sapiens	GI50	uM	0.24
	18655117	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccs3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4243521	=	GI50	nM	207.0	CHEMBL1913	Homo sapiens	GI50	uM	0.207
	18655118	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccno3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4237277	=	GI50	nM	787.0	CHEMBL1913	Homo sapiens	GI50	uM	0.787
	18655119	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	GI50	nM	2900.0	CHEMBL1913	Homo sapiens	GI50	uM	2.9
	18655120	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)CN(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4245919	=	GI50	nM	9200.0	CHEMBL1913	Homo sapiens	GI50	uM	9.2
	18655121	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)C(C)(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4251137	=	GI50	nM	61.0	CHEMBL1913	Homo sapiens	GI50	uM	0.061
	18655122	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCCC(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4244760	=	GI50	nM	90.0	CHEMBL1913	Homo sapiens	GI50	uM	0.09
	18655123	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)C(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4240563	=	GI50	nM	123.0	CHEMBL1913	Homo sapiens	GI50	uM	0.123
	18655124	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)C3CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4239175	=	GI50	nM	437.0	CHEMBL1913	Homo sapiens	GI50	uM	0.437
	18655125	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C/C=C/C(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4243399	=	GI50	nM	219.0	CHEMBL1913	Homo sapiens	GI50	uM	0.219
	18655126	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4250559	=	GI50	nM	504.0	CHEMBL1913	Homo sapiens	GI50	uM	0.504
	18655127	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4242508	=	GI50	nM	350.0	CHEMBL1913	Homo sapiens	GI50	uM	0.35
	18655128	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CNCCN(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4237427	=	GI50	nM	125.0	CHEMBL1913	Homo sapiens	GI50	uM	0.125
	18655129	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1cc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(C(F)(F)F)c1		CHEMBL4251023	=	GI50	nM	231.0	CHEMBL1913	Homo sapiens	GI50	uM	0.231
	18655130	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(C(F)(F)F)c1		CHEMBL4243753	=	GI50	nM	98.0	CHEMBL1913	Homo sapiens	GI50	uM	0.098
	18655131	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)c1		CHEMBL4247977	=	GI50	nM	173.0	CHEMBL1913	Homo sapiens	GI50	uM	0.173
	18655132	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(NC(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4239972	=	GI50	nM	583.0	CHEMBL1913	Homo sapiens	GI50	uM	0.583
	18655133	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL3642842	=	GI50	nM	757.0	CHEMBL1913	Homo sapiens	GI50	uM	0.757
	18655134	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4242986	=	GI50	nM	888.0	CHEMBL1913	Homo sapiens	GI50	uM	0.888
	18655135	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)c3cccnc3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4238799	=	GI50	nM	82.0	CHEMBL1913	Homo sapiens	GI50	uM	0.082
	18655136	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1C(F)(F)F		CHEMBL4239216	=	GI50	nM	161.0	CHEMBL1913	Homo sapiens	GI50	uM	0.161
	18655137	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)NCc1cccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)c1		CHEMBL4249299	=	GI50	nM	244.0	CHEMBL1913	Homo sapiens	GI50	uM	0.244
	18655138	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)NCc1cccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)c1		CHEMBL4247213	=	GI50	nM	221.0	CHEMBL1913	Homo sapiens	GI50	uM	0.221
	18655139	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4245489	=	GI50	nM	341.0	CHEMBL1913	Homo sapiens	GI50	uM	0.341
	18655140	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CS(=O)(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4245969	=	GI50	nM	48.0	CHEMBL1913	Homo sapiens	GI50	uM	0.048
	18655141	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL3642838	=	GI50	nM	155.0	CHEMBL1913	Homo sapiens	GI50	uM	0.155
	18655142	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4238660	=	GI50	nM	201.0	CHEMBL1913	Homo sapiens	GI50	uM	0.201
	18655143	CHEMBL4231028	Inhibition of TEL-fused PDGFRbeta (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	19.0	CHEMBL1913	Homo sapiens	GI50	uM	0.019
	18655215	CHEMBL4231020	Inhibition of PDGFRbeta (unknown origin) using poly(4:1 Glu,Tyr) peptide as substrate preincubated for 1 hr followed by addition of ATP and measured after 30 mins by ADP-Glo bioluminescence assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	IC50	nM	6115.0	CHEMBL1913	Homo sapiens	IC50	nM	6115.0
	18655370	CHEMBL4230865	Binding affinity to wild-type human partial length PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	0.7	CHEMBL1913	Homo sapiens	Activity	%	0.7
	18656116	CHEMBL4231154	Inhibition of recombinant human PDGFRbeta using Ulight-Poly GAT[EAY(1:1:1)]n as substrate measured after 30 mins by LANCE assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.7	CHEMBL1913	Homo sapiens	IC50	10'-9M	4.7
	18656122	CHEMBL4231150	Inhibition of recombinant human PDGFRbeta at 10'-5 M using Ulight-Poly GAT[EAY(1:1:1)]n as substrate measured after 30 mins by LANCE assay relative to control	B	COc1ccc(Nc2ncc3c(n2)-c2ccccc2SC3)cc1OC		CHEMBL4240970	=	Inhibition	%	39.9	CHEMBL1913	Homo sapiens	INH	%	39.9
	18656509	CHEMBL4231217	Inhibition of recombinant human PDGFRbeta expressed in insect cells using Ulight-Poly GAT[EAY(1:1:1)]n as substrate after 30 mins by LANCE method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.76	CHEMBL1913	Homo sapiens	IC50	10'-10M	7.6
	18663942	CHEMBL4232926	Inhibition of human PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL1913	Homo sapiens	Activity	%	100.0
	18664039	CHEMBL4233023	Binding affinity to human PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL1913	Homo sapiens	Kd	uM	5.0
	18674979	CHEMBL4235482	Binding affinity to partial length human PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system by KdELECT assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382	=	Kd	nM	250.0	CHEMBL1913	Homo sapiens	Kd	nM	250.0
Active	18675002	CHEMBL4235465	Inhibition of partial length human PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 1 uM by scanEDGE assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	18676654	CHEMBL4235840	Potency index, ratio of sunitinib IC50 to test compound IC50 for PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells	B	COc1ccc(N(C)c2ncnc3occ(C)c23)cc1		CHEMBL4250191	=	Ratio IC50		7.0	CHEMBL1913	Homo sapiens	Ratio IC50		7.0
Not Determined	18676690	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711		IC50			CHEMBL1913	Homo sapiens	IC50		
	18676691	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	Cc1coc2ncnc(Nc3ccc(N(C)C)cc3)c12		CHEMBL4237915	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	nM	200.0
	18676692	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	CNc1ccc(Nc2ncnc3occ(C)c23)cc1		CHEMBL4247926	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	nM	200.0
	18676693	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	Cc1coc2ncnc(Nc3ccc([N+](=O)[O-])cc3)c12		CHEMBL4240844	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	nM	200.0
	18676694	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	Cc1coc2ncnc(N(C)c3ccc([N+](=O)[O-])cc3)c12		CHEMBL4243157	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	nM	200.0
	18676695	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	Cc1coc2ncnc(N(C)c3ccc(N(C)C)cc3)c12		CHEMBL4245415	=	IC50	nM	63.0	CHEMBL1913	Homo sapiens	IC50	nM	63.0
	18676696	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	CNc1ccc(N(C)c2ncnc3occ(C)c23)cc1		CHEMBL4250210	=	IC50	nM	57.8	CHEMBL1913	Homo sapiens	IC50	nM	57.8
	18676697	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	CSc1ccc(N(C)c2ncnc3occ(C)c23)cc1		CHEMBL4239716	=	IC50	nM	62.2	CHEMBL1913	Homo sapiens	IC50	nM	62.2
	18676698	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	CCc1ccc(N(C)c2ncnc3occ(C)c23)cc1		CHEMBL4242522	=	IC50	nM	28.9	CHEMBL1913	Homo sapiens	IC50	nM	28.9
	18676699	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	CCCN(c1ccc(OC)cc1)c1ncnc2occ(C)c12		CHEMBL4237916	=	IC50	nM	38.9	CHEMBL1913	Homo sapiens	IC50	nM	38.9
	18676700	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	COc1ccc(N(c2ncnc3occ(C)c23)C(C)C)cc1		CHEMBL4250273	=	IC50	nM	42.6	CHEMBL1913	Homo sapiens	IC50	nM	42.6
	18676701	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	CCN(c1ccc(OC)cc1)c1ncnc2occ(C)c12		CHEMBL4241638	=	IC50	nM	51.4	CHEMBL1913	Homo sapiens	IC50	nM	51.4
	18676702	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	COc1ccc(Nc2ncnc3occ(C)c23)cc1		CHEMBL4245874	=	IC50	nM	57.3	CHEMBL1913	Homo sapiens	IC50	nM	57.3
Not Determined	18676703	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		IC50			CHEMBL1913	Homo sapiens	IC50		
	18676704	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	83.1	CHEMBL1913	Homo sapiens	IC50	nM	83.1
Not Determined	18676705	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		IC50			CHEMBL1913	Homo sapiens	IC50		
	18676706	CHEMBL4235836	Inhibition of PDGF-BB-induced PDGFRbeta activation in human SH-SY5Y cells pretreated for 60 mins followed by PDGF-BB addition and measured after 10 mins by ELISA	B	COc1ccc(N(C)c2ncnc3occ(C)c23)cc1		CHEMBL4250191	=	IC50	nM	12.3	CHEMBL1913	Homo sapiens	IC50	nM	12.3
	18679007	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	nM	60.0
	18679008	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	C=C(CN1CCOCC1)C(=O)Nc1ccc(NC(=O)Nc2ccc(-c3cc(C)nc4noc(N)c34)cc2)cc1C		CHEMBL4238294	=	IC50	nM	510.0	CHEMBL1913	Homo sapiens	IC50	nM	510.0
Not Active	18679009	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	C/C=C\C(=O)Nc1ccc(NC(=O)Nc2ccc(-c3cc(C)nc4noc(N)c34)cc2)cc1C		CHEMBL4240512		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Active	18679010	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	C/C=C\C(=O)Nc1ccc(NC(=O)Nc2ccc(-c3cc(C)nc4noc(N)c34)cc2)cc1		CHEMBL4244708		IC50			CHEMBL1913	Homo sapiens	IC50		
	18679011	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Cc1cc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)c2c(N)onc2n1		CHEMBL4251080	=	IC50	nM	820.0	CHEMBL1913	Homo sapiens	IC50	nM	820.0
	18679012	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Cc1cc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)onc2n1		CHEMBL4240969	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	nM	20.0
	18679013	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Cc1cc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c2c(N)onc2n1		CHEMBL4247248	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	nM	20.0
	18679014	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Cc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)c2c(N)onc2n1		CHEMBL4237289	=	IC50	nM	40.0	CHEMBL1913	Homo sapiens	IC50	nM	40.0
	18679015	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3cc(C)nc4noc(N)c34)cc2)c1		CHEMBL4243470	=	IC50	nM	8.0	CHEMBL1913	Homo sapiens	IC50	nM	8.0
Not Active	18679016	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	C=CC(=O)Nc1ccc(NC(=O)Nc2ccc(-c3cc(-c4ccccc4)nc4noc(N)c34)cc2)cc1		CHEMBL4247696		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Active	18679017	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Nc1onc2nc(-c3ccccc3)cc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL4245979		IC50			CHEMBL1913	Homo sapiens	IC50		
	18679018	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Nc1onc2nc(-c3ccccc3)cc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL4243899	=	IC50	nM	3250.0	CHEMBL1913	Homo sapiens	IC50	nM	3250.0
	18679019	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Nc1onc2nc(-c3ccccc3)cc(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c12		CHEMBL4242710	=	IC50	nM	290.0	CHEMBL1913	Homo sapiens	IC50	nM	290.0
Not Active	18679020	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	COc1ccc(NC(=O)Nc2ccc(-c3cc(-c4ccccc4)nc4noc(N)c34)cc2)cc1		CHEMBL4238538		IC50			CHEMBL1913	Homo sapiens	IC50		
	18679021	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Cc1ccc(NC(=O)Nc2ccc(-c3cc(-c4ccccc4)nc4noc(N)c34)cc2)cc1		CHEMBL4245698	=	IC50	nM	1260.0	CHEMBL1913	Homo sapiens	IC50	nM	1260.0
	18679022	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Nc1onc2nc(-c3ccccc3)cc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL4241470	=	IC50	nM	2230.0	CHEMBL1913	Homo sapiens	IC50	nM	2230.0
	18679023	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Nc1onc2nc(-c3ccccc3)cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL4249500	=	IC50	nM	3520.0	CHEMBL1913	Homo sapiens	IC50	nM	3520.0
	18679024	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Nc1onc2nc(-c3ccccc3)cc(-c3ccc(NC(=O)Nc4ccc(F)cc4)cc3)c12		CHEMBL4245241	=	IC50	nM	3780.0	CHEMBL1913	Homo sapiens	IC50	nM	3780.0
	18679025	CHEMBL4236212	Inhibition of human PDGFRbeta using biotin labeled substrate after 1 hr by HTFR assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3cc(-c4ccccc4)nc4noc(N)c34)cc2)c1		CHEMBL4238195	=	IC50	nM	1230.0	CHEMBL1913	Homo sapiens	IC50	nM	1230.0
	18689610	CHEMBL4252891	Inhibition of PDGFRbeta (unknown origin) using poly(Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(F)cc2)c1=O		CHEMBL4289577	=	IC50	nM	1.81	CHEMBL1913	Homo sapiens	IC50	nM	1.81
	18694014	CHEMBL4253467	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	18694096	CHEMBL4253549	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	20.0	CHEMBL1913	Homo sapiens	INH	%	20.0
	18697669	CHEMBL4254342	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	83.0	CHEMBL1913	Homo sapiens	Activity	%	83.0
	18751188	CHEMBL4263897	Inhibition of PDGFR-BETA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	44.0	CHEMBL1913	Homo sapiens	INH	%	44.0
	18752117	CHEMBL4264454	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	91.0	CHEMBL1913	Homo sapiens	Activity	%	91.0
	18761552	CHEMBL4266603	Inhibition of recombinant human N-terminal His6-tagged PDGFRB (557 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	12.0	CHEMBL1913	Homo sapiens	INH	%	12.0
	18761823	CHEMBL4266603	Inhibition of recombinant human N-terminal His6-tagged PDGFRB (557 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	18761986	CHEMBL4266603	Inhibition of recombinant human N-terminal His6-tagged PDGFRB (557 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-3.0	CHEMBL1913	Homo sapiens	INH	%	-3.0
	18763067	CHEMBL4266864	Inhibition of PDGFRbeta (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	61.29	CHEMBL1913	Homo sapiens	INH	%	61.29
	18763098	CHEMBL4266895	Inhibition of PDGFRbeta (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	88.03	CHEMBL1913	Homo sapiens	INH	%	88.03
	18765495	CHEMBL4267261	Inhibition of N-terminal GST-tagged human PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	30.4	CHEMBL1913	Homo sapiens	INH	%	30.4
	18765496	CHEMBL4267261	Inhibition of N-terminal GST-tagged human PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	29.4	CHEMBL1913	Homo sapiens	INH	%	29.4
	18765497	CHEMBL4267261	Inhibition of N-terminal GST-tagged human PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	74.1	CHEMBL1913	Homo sapiens	INH	%	74.1
	18765498	CHEMBL4267261	Inhibition of N-terminal GST-tagged human PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	24.2	CHEMBL1913	Homo sapiens	INH	%	24.2
	18765499	CHEMBL4267261	Inhibition of N-terminal GST-tagged human PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	10.3	CHEMBL1913	Homo sapiens	INH	%	10.3
	18765500	CHEMBL4267261	Inhibition of N-terminal GST-tagged human PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	18768304	CHEMBL4267753	Inhibition of PDGFRbeta (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4279457	=	IC50	nM	19.46	CHEMBL1913	Homo sapiens	IC50	nM	19.46
	18769885	CHEMBL4268027	Inhibition of recombinant human PDGFRbeta at 1000 nM after 60 mins by ELISA relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	75.7	CHEMBL1913	Homo sapiens	INH	%	75.7
	18769886	CHEMBL4268027	Inhibition of recombinant human PDGFRbeta at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	41.0	CHEMBL1913	Homo sapiens	INH	%	41.0
Not Determined	18769887	CHEMBL4268027	Inhibition of recombinant human PDGFRbeta at 1000 nM after 60 mins by ELISA relative to control	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	18769888	CHEMBL4268029	Inhibition of recombinant human PDGFRbeta at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	13.2	CHEMBL1913	Homo sapiens	INH	%	13.2
	18786386	CHEMBL4271717	Inhibition of recombinant PDGFRbeta (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method relative to control	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3)ccc12		CHEMBL4290371	=	Inhibition	%	59.5	CHEMBL1913	Homo sapiens	INH	%	59.5
	18811982	CHEMBL4276181	Inhibition of human PDGFRbeta at 100 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	70.6	CHEMBL1913	Homo sapiens	INH	%	70.6
	18811983	CHEMBL4276181	Inhibition of human PDGFRbeta at 100 uM	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	Inhibition	%	5.5	CHEMBL1913	Homo sapiens	INH	%	5.5
	18811984	CHEMBL4276181	Inhibition of human PDGFRbeta at 100 uM	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682	=	Inhibition	%	41.2	CHEMBL1913	Homo sapiens	INH	%	41.2
Not Active	18847285	CHEMBL4304935	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	18848121	CHEMBL4305117	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as enzyme remaining activity at 1 uM by Kinomescan assay relative to control	B	O=C(CC(=O)Nc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)Nc1cccc(F)c1		CHEMBL4446361	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	18848129	CHEMBL4305125	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system after 1 hr by Z-LYTE assay	B	O=C(CC(=O)Nc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)Nc1cccc(F)c1		CHEMBL4446361	=	IC50	nM	2075.0	CHEMBL1913	Homo sapiens	IC50	nM	2075.0
	18851327	CHEMBL4305819	Inhibition of PDGFRbeta (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	=	IC50	nM	392.0	CHEMBL1913	Homo sapiens	IC50	nM	392.0
	18856440	CHEMBL4307558	Inhibition of PDGFRbeta (unknown origin) using TK substrate incubated for 60 mins by FRET assay	B	FC(F)(F)c1ccc(COc2ccc(Nc3ncnc4cc5c(cc34)OCCOCCOCCOCCO5)cc2)cc1		CHEMBL4520064	=	IC50	nM	673.6	CHEMBL1913	Homo sapiens	IC50	nM	673.6
	18856441	CHEMBL4307558	Inhibition of PDGFRbeta (unknown origin) using TK substrate incubated for 60 mins by FRET assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	582.7	CHEMBL1913	Homo sapiens	IC50	nM	582.7
	18858118	CHEMBL4307964	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	99.0	CHEMBL1913	Homo sapiens	Activity	%	99.0
	18864275	CHEMBL4309598	Inhibition of human PDGFRb at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1		CHEMBL4436746	=	Inhibition	%	-9.26	CHEMBL1913	Homo sapiens	INH	%	-9.26
	18881253	CHEMBL4312063	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	10.0	CHEMBL1913	Homo sapiens	Ki	nM	10.0
	18885098	CHEMBL4313073	Inhibition of human PDGFRbeta using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	A	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	18885117	CHEMBL4313084	Inhibition of human PDGFRbeta at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	=	Inhibition	%	58.8	CHEMBL1913	Homo sapiens	INH	%	58.8
	18886110	CHEMBL4313415	Inhibition of human PDGFRbeta at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4559825	=	Inhibition	%	-7.69	CHEMBL1913	Homo sapiens	INH	%	-7.69
	18886137	CHEMBL4313415	Inhibition of human PDGFRbeta at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl	Outside typical range	CHEMBL4553144	=	Inhibition	%	-20.47	CHEMBL1913	Homo sapiens	INH	%	-20.47
	18892937	CHEMBL4314903	Inhibition of recombinant human PDGFRbeta (557 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	117.0	CHEMBL1913	Homo sapiens	Activity	%	117.0
	18893314	CHEMBL4315078	Inhibition of PDGFR beta (unknown origin)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	IC50	nM	170.0	CHEMBL1913	Homo sapiens	IC50	nM	170.0
	18893647	CHEMBL4315123	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	CC(C)c1ccc(/C=C/c2nc(NCCN(C)C)c3ccccc3n2)cc1		CHEMBL4471700	=	Activity	%	68.0	CHEMBL1913	Homo sapiens	Activity	%	68.0
	18919425	CHEMBL4322784	Binding affinity to recombinant human N-terminal his-tagged PDGFRB (558 to 1106 residues) expressed in baculovirus expression system incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	165.0	CHEMBL1913	Homo sapiens	Kd	nM	165.0
	18919613	CHEMBL4322784	Binding affinity to recombinant human N-terminal his-tagged PDGFRB (558 to 1106 residues) expressed in baculovirus expression system incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	257.0	CHEMBL1913	Homo sapiens	Kd	nM	257.0
	18930934	CHEMBL4325592	Inhibition of recombinant human N-terminal His6-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf21 insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	87.9	CHEMBL1913	Homo sapiens	INH	%	87.9
	18930958	CHEMBL4325616	Inhibition of recombinant human N-terminal His6-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	70.5	CHEMBL1913	Homo sapiens	INH	%	70.5
	18930982	CHEMBL4325640	Inhibition of recombinant human N-terminal His6-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	14.7	CHEMBL1913	Homo sapiens	INH	%	14.7
	18938191	CHEMBL4327822	Inhibition of human PDGFRbeta assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	90.49	CHEMBL1913	Homo sapiens	Activity	%	90.49
	18938192	CHEMBL4327822	Inhibition of human PDGFRbeta assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	91.89	CHEMBL1913	Homo sapiens	Activity	%	91.89
	18938667	CHEMBL4328186	Inhibition of human PDGFRbeta assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL1913	Homo sapiens	Activity	%	65.0
	18939051	CHEMBL4328550	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.56	CHEMBL1913	Homo sapiens	IC50	10'-9M	3.56
	18948751	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)Nc3ccccc3)cc1)C(=O)N2		CHEMBL4590038	=	IC50	nM	3640.0	CHEMBL1913	Homo sapiens	IC50	uM	3.64
	18948752	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)Nc3ccc(Cl)cc3)cc1)C(=O)N2		CHEMBL4540917	=	IC50	nM	1820.0	CHEMBL1913	Homo sapiens	IC50	uM	1.82
	18948753	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1ccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Br)cc43)cc2)cc1		CHEMBL4583526	=	IC50	nM	3790.0	CHEMBL1913	Homo sapiens	IC50	uM	3.79
	18948754	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1ccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(OC)cc43)cc2)cc1		CHEMBL4553770	=	IC50	nM	330.0	CHEMBL1913	Homo sapiens	IC50	uM	0.33
	18948755	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1cccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Cl)cc43)cc2)c1		CHEMBL4580040	=	IC50	nM	1290.0	CHEMBL1913	Homo sapiens	IC50	uM	1.29
	18948756	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1cccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Br)cc43)cc2)c1		CHEMBL4471270	=	IC50	nM	1590.0	CHEMBL1913	Homo sapiens	IC50	uM	1.59
	18948757	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1cccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(OC)cc43)cc2)c1		CHEMBL4457815	=	IC50	nM	110.0	CHEMBL1913	Homo sapiens	IC50	uM	0.11
	18948758	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	O=C(Nc1ccc(C(=O)N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4461094	=	IC50	nM	450.0	CHEMBL1913	Homo sapiens	IC50	uM	0.45
	18948759	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc1)C(=O)N2		CHEMBL4454772	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	18948760	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)c3ccc(Cl)cc3)cc1)C(=O)N2		CHEMBL4469902	=	IC50	nM	2010.0	CHEMBL1913	Homo sapiens	IC50	uM	2.01
	18948761	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1ccc(C(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Br)cc43)cc2)cc1		CHEMBL4463359	=	IC50	nM	230.0	CHEMBL1913	Homo sapiens	IC50	uM	0.23
	18948762	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	COc1ccc(C(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(OC)cc43)cc2)cc1		CHEMBL4469330	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	uM	0.09
	18948763	CHEMBL4330589	Inhibition of PDGFR-beta (unknown origin) by ELISA	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	130.0	CHEMBL1913	Homo sapiens	IC50	uM	0.13
	18951028	CHEMBL4331426	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	Cc1ccc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1NC(=O)C1(c2ncnc3[nH]cnc23)CC1		CHEMBL4466555	=	IC50	nM	25.3	CHEMBL1913	Homo sapiens	IC50	nM	25.3
	18958642	CHEMBL4333549	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	54.0	CHEMBL1913	Homo sapiens	Activity	%	54.0
	18964564	CHEMBL4335223	Inhibition of human PDGFRbeta (557 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL1913	Homo sapiens	Activity	%	103.0
	18964565	CHEMBL4335223	Inhibition of human PDGFRbeta (557 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	108.0	CHEMBL1913	Homo sapiens	Activity	%	108.0
	18972036	CHEMBL4337046	Inhibition of human PDGFRbeta (557 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	79.0	CHEMBL1913	Homo sapiens	Activity	%	79.0
	18972852	CHEMBL4337351	Inhibition of full-length N-terminal GST-tagged human PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system at 10 uM using propeptide-30 as substrate after 90 mins by electrophoretic mobility shift assay relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	=	Inhibition	%	20.0	CHEMBL1913	Homo sapiens	INH	%	20.0
	18985689	CHEMBL4339988	Inhibition of PDGFRbeta (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	18985986	CHEMBL4340088	Inhibition of recombinant human PDGFRB at 10 uM using Ulight-Poly GAT[EAY(1:1:1)]n substrate incubated for 30 mins by LANCE assay relative to untreated control	B	COc1ccc(Nc2ncc3c(n2)-c2cccnc2SC3)cc1		CHEMBL4582099	=	Inhibition	%	89.0	CHEMBL1913	Homo sapiens	INH	%	89.0
	18985987	CHEMBL4340088	Inhibition of recombinant human PDGFRB at 10 uM using Ulight-Poly GAT[EAY(1:1:1)]n substrate incubated for 30 mins by LANCE assay relative to untreated control	B	COc1ccc(Nc2ncc3c(n2)-c2cccnc2SC3)cc1OC		CHEMBL4463108	=	Inhibition	%	79.0	CHEMBL1913	Homo sapiens	INH	%	79.0
	18985988	CHEMBL4340088	Inhibition of recombinant human PDGFRB at 10 uM using Ulight-Poly GAT[EAY(1:1:1)]n substrate incubated for 30 mins by LANCE assay relative to untreated control	B	COc1cc(Nc2ncc3c(n2)-c2cccnc2SC3)cc(OC)c1OC		CHEMBL4584918	=	Inhibition	%	82.0	CHEMBL1913	Homo sapiens	INH	%	82.0
	18989207	CHEMBL4340749	Inhibition of recombinant human N-terminal GST-His6-fused PDGFR-beta C-terminal domain (R561 to L1106 residues) expressed in Sf9 insect cells using Poly(Ala,Glu,Lys,Tyr)6:2:5:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	81000.0	CHEMBL1913	Homo sapiens	IC50	uM	81.0
	18994672	CHEMBL4342017	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)NS(=O)(=O)Cc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4533153	=	IC50	nM	356.0	CHEMBL1913	Homo sapiens	IC50	nM	356.0
	18994673	CHEMBL4342017	Inhibition of PDGFRbeta (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	9.4	CHEMBL1913	Homo sapiens	IC50	nM	9.4
	18996645	CHEMBL4342553	Inhibition of human PDGFR beta	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	IC50	nM	90.0	CHEMBL1913	Homo sapiens	IC50	nM	90.0
	18997706	CHEMBL4342936	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1		CHEMBL4583691	>	Activity	%	99.0	CHEMBL1913	Homo sapiens	Activity	%	99.0
	18997711	CHEMBL4342941	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1		CHEMBL4583691	=	Kd	nM	14.0	CHEMBL1913	Homo sapiens	Kd	nM	14.0
	19009362	CHEMBL4345233	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by Kinomescan method relative to control	B	Cc1ccc(-n2ccc3c(Nc4cccc(NC(=O)c5ccc(NC(=O)/C=C/CN(C)C)cc5)c4)ncnc32)cc1		CHEMBL4439287	=	Activity	%	70.0	CHEMBL1913	Homo sapiens	Activity	%	70.0
	19009363	CHEMBL4345233	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by Kinomescan method relative to control	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3cc(-c4c[nH]c5ccccc45)ncn3)c2)cc1		CHEMBL4446338	=	Activity	%	4.3	CHEMBL1913	Homo sapiens	Activity	%	4.3
	19021540	CHEMBL4347762	Inhibition of recombinant human PDGFRbeta at 20 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 30 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	20.0	CHEMBL1913	Homo sapiens	INH	%	20.0
	19021541	CHEMBL4347763	Inhibition of recombinant human PDGFRbeta at 200 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 30 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	55.0	CHEMBL1913	Homo sapiens	INH	%	55.0
Not Active	19040094	CHEMBL4351998	Inhibition of recombinant human PDGFRbeta (557 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
Active	19041229	CHEMBL4352490	Inhibition of human PDGFRbeta at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	19043775	CHEMBL4353241	Inhibition of human PDGFR beta using poly (Glu,Tyr) 4:1 as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	76.02	CHEMBL1913	Homo sapiens	INH	%	76.02
	19059742	CHEMBL4358043	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	29.0	CHEMBL1913	Homo sapiens	Activity	%	29.0
	19067265	CHEMBL4360644	Inhibition of recombinant N-terminal His6-tagged human PDGFR-beta (557 to end residues) using EAIYAAPFAKKK as substrate after 10 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	19069476	CHEMBL4361185	Inhibition of recombinant human His-tagged PDGFRB cytoplasmic domain (558 to 1106 residues) expressed in baculovirus expression system by Z-lyte assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779	=	IC50	nM	97.0	CHEMBL1913	Homo sapiens	IC50	nM	97.0
	19069682	CHEMBL4361176	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779	<	Activity	%	1.0	CHEMBL1913	Homo sapiens	Activity	%	1.0
	19090307	CHEMBL4365881	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	35.0	CHEMBL1913	Homo sapiens	Activity	%	35.0
	19092060	CHEMBL4366534	Inhibition of human PDGFRbeta at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	0.28	CHEMBL1913	Homo sapiens	INH	%	0.28
	19114521	CHEMBL4371363	Inhibition of PDGFRbeta (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL1913	Homo sapiens	Efficacy	%	83.0
	19114522	CHEMBL4371362	Inhibition of PDGFRbeta (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL1913	Homo sapiens	Efficacy	%	83.0
	19114585	CHEMBL4371363	Inhibition of PDGFRbeta (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL1913	Homo sapiens	Efficacy	%	83.0
	19114586	CHEMBL4371362	Inhibition of PDGFRbeta (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL1913	Homo sapiens	Efficacy	%	83.0
	19114671	CHEMBL4371362	Inhibition of PDGFRbeta (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL1913	Homo sapiens	Efficacy	%	83.0
	19114672	CHEMBL4371363	Inhibition of PDGFRbeta (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL1913	Homo sapiens	Efficacy	%	83.0
Active	19114762	CHEMBL4371397	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115		Activity			CHEMBL1913	Homo sapiens	Activity		
Active	19114787	CHEMBL4371397	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225		Activity			CHEMBL1913	Homo sapiens	Activity		
	19114822	CHEMBL4371362	Inhibition of PDGFRbeta (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL1913	Homo sapiens	Efficacy	%	83.0
	19114823	CHEMBL4371363	Inhibition of PDGFRbeta (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL1913	Homo sapiens	Efficacy	%	83.0
	19144740	CHEMBL4377756	Inhibition of recombinant human PDGFRbeta (557 to end residues) at 1 uM using poly[Glu:Tyr] (4:1) as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	2.0	CHEMBL1913	Homo sapiens	INH	%	2.0
	19146896	CHEMBL4378896	Inhibition of recombinant human PDGFRbeta (557 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	3.0	CHEMBL1913	Homo sapiens	INH	%	3.0
	19147982	CHEMBL4379290	Inhibition of human PDGFRbeta (557 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	19148355	CHEMBL4379611	Inhibition of human PDGFR beta at 100 nM using poly (Glu,Tyr) 4:1 as substrate in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CCN1CCN(c2cc(Nc3ncc(-c4ccncc4)s3)nc(C)n2)CC1.Cl		CHEMBL4513768	=	Inhibition	%	88.0	CHEMBL1913	Homo sapiens	INH	%	88.0
	19159570	CHEMBL4382674	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	43.0	CHEMBL1913	Homo sapiens	Activity	%	43.0
	19159838	CHEMBL4382850	Inhibition of recombinant PDGFRbeta (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	19161572	CHEMBL4383418	Inhibition of wild type C-terminal FLAG-tagged human TEL fused PDGFRbeta (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	8.0	CHEMBL1913	Homo sapiens	GI50	uM	0.008
Not Active	19163634	CHEMBL4383848	Inhibition of human PDGFRbeta at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 120 mins [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	19191437	CHEMBL4389393	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.1	CHEMBL1913	Homo sapiens	INH	%	0.1
	19192056	CHEMBL4389870	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	42.0	CHEMBL1913	Homo sapiens	INH	%	42.0
	19200312	CHEMBL4391496	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	2.3	CHEMBL1913	Homo sapiens	Activity	%	2.3
	19237210	CHEMBL4398901	Inhibition of PDGFRbeta (unknown origin) at 1 uM	B	COc1ccc(CC(=O)Nc2ccc3[nH]c(-c4ccc(Cl)cc4)nc3c2)cc1		CHEMBL4557230	=	Inhibition	%	2.7	CHEMBL1913	Homo sapiens	INH	%	2.7
	19238870	CHEMBL4399180	Inhibition of PDGFR beta (unknown origin)	B	CCOC(=O)c1ccc(Nc2ccnc(SCC(=O)c3ccc(C#N)cc3)n2)cc1		CHEMBL4573547	=	IC50	nM	390.0	CHEMBL1913	Homo sapiens	IC50	uM	0.39
	19238871	CHEMBL4399180	Inhibition of PDGFR beta (unknown origin)	B	O=C(CSc1nccc(Nc2ccc(N3CCOCC3)cc2)n1)c1ccc(F)cc1		CHEMBL4449189	=	IC50	nM	150.0	CHEMBL1913	Homo sapiens	IC50	uM	0.15
	19238872	CHEMBL4399180	Inhibition of PDGFR beta (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	60.0	CHEMBL1913	Homo sapiens	IC50	uM	0.06
	19239348	CHEMBL4399256	Inhibition of PDGFR beta (561 to 1106 residues) (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	IC50	nM	1.5	CHEMBL1913	Homo sapiens	IC50	nM	1.5
	19242741	CHEMBL4400076	Inhibition of recombinant human PDGFRbeta (557 to end residues) assessed as residual activity at 10 uM using poly (Glu,Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	101.0	CHEMBL1913	Homo sapiens	Activity	%	101.0
	19250392	CHEMBL4401414	Inhibition of full length human N-terminal GST-tagged PDGFRbeta expressed in baculovirus expression system at 100 nM relative to control	B	C=CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C)C(=O)N2		CHEMBL4553725	=	Inhibition	%	14.0	CHEMBL1913	Homo sapiens	INH	%	14.0
	19251870	CHEMBL4401858	Inhibition of recombinant human His-tagged PDGFRB expressed in baculovirus expression system at 1 uM by kinomescan assay relative to control	B	Clc1cc(NCC2CC2)c2ncc(-c3ccc4[nH]ncc4c3)n2n1		CHEMBL4525939	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
	19266556	CHEMBL4405506	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	19272042	CHEMBL4406987	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	19275220	CHEMBL4407678	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in Escherichia coli BL21 at 1 uM after 1 hr by quantitative PCR based KINOMEscan assay relative to control	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4437631	>	Inhibition	%	90.0	CHEMBL1913	Homo sapiens	INH	%	90.0
	19275225	CHEMBL4407683	Inhibition of human PDGFRB	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4437631	=	IC50	nM	1013.0	CHEMBL1913	Homo sapiens	IC50	nM	1013.0
	19276189	CHEMBL4408192	Inhibition of recombinant human PDGFRbeta (557 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	19279720	CHEMBL4408854	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Fc1ccc(-c2csc(N3N=C(c4ccc(N5CCOCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1		CHEMBL4516916	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	19279721	CHEMBL4408854	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	N#Cc1ccc(-c2csc(N3N=C(c4ccc(N5CCOCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1		CHEMBL4516736	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	19279722	CHEMBL4408854	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	N#Cc1ccc(-c2csc(N3N=C(c4ccc(N5CCCCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1		CHEMBL4557318	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	19279723	CHEMBL4408854	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	IC50	nM	30000.0	CHEMBL1913	Homo sapiens	IC50	uM	30.0
	19292311	CHEMBL4411562	Inhibition of N-terminal GST tagged human PDGFRbeta (557 to 1106 end residues) cytoplasmic domain expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	66.0	CHEMBL1913	Homo sapiens	INH	%	66.0
	19295881	CHEMBL4412358	Inhibition of PDGFR-beta (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	100.0	CHEMBL1913	Homo sapiens	INH	%	100.0
	19295911	CHEMBL4412388	Inhibition of PDGFR-beta (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	99.1	CHEMBL1913	Homo sapiens	INH	%	99.1
	19295941	CHEMBL4412418	Inhibition of PDGFR-beta (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	59.5	CHEMBL1913	Homo sapiens	INH	%	59.5
	19312967	CHEMBL4416522	Inhibition of recombinant human N-terminal His6-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using Poly (Glu4-Tyr) as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL1913	Homo sapiens	INH	%	50.0
	19319997	CHEMBL4417591	Inhibition of N-terminal GST tagged human PDGFRbeta cytoplasmic domain (557 to 1106 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	56.22	CHEMBL1913	Homo sapiens	INH	%	56.22
	19371147	CHEMBL4424899	Inhibition of human N-terminal His6-tagged PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf21 insect cells using Poly (Glu4-Tyr) (4:1) as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	19433054	CHEMBL4429597	Inhibition of partial length human PDGFRbeta expressed in bacterial expression system assessed as activity remaining at 1 uM by kinome scan assay	B	CCC(=O)NCC1CCN(c2ccc(NC(=O)Nc3cccc(Oc4ccnc5cc(OC)c(OC)cc45)c3)cc2C(F)(F)F)CC1		CHEMBL4445808	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	19433059	CHEMBL4429600	Inhibition of TEL-fused partial length human PDGFRbeta expressed in mouse BA/F3 cells after 72 hrs by cell titer-glo assay	B	CCC(=O)NCC1CCN(c2ccc(NC(=O)Nc3cccc(Oc4ccnc5cc(OC)c(OC)cc45)c3)cc2C(F)(F)F)CC1		CHEMBL4445808	=	GI50	nM	5.0	CHEMBL1913	Homo sapiens	GI50	uM	0.005
	19435848	CHEMBL4430398	Inhibition of human PDGFRbeta at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	Inhibition	%	-1.0	CHEMBL1913	Homo sapiens	INH	%	-1.0
	19435849	CHEMBL4430398	Inhibition of human PDGFRbeta at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	Inhibition	%	2.0	CHEMBL1913	Homo sapiens	INH	%	2.0
	19435850	CHEMBL4430398	Inhibition of human PDGFRbeta at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL3353341	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	19445435	CHEMBL4432488	Inhibition of recombinant PDGFR-beta (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl		CHEMBL4582423	=	Inhibition	%	77.8	CHEMBL1913	Homo sapiens	INH	%	77.8
	19445473	CHEMBL4432488	Inhibition of recombinant PDGFR-beta (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	85.9	CHEMBL1913	Homo sapiens	INH	%	85.9
	19469418	CHEMBL4478340	Inhibition of human PDGFRB expressed in bacterial system assessed as remaining enzyme activity at 1 uM relative to untreated control	B	Cc1cc(Nc2ncc3ncc(=O)n(-c4ccc(N)cc4)c3n2)ccc1N1CCN(C)CC1		CHEMBL4550647	<=	Activity	%	1.0	CHEMBL1913	Homo sapiens	Activity	%	1.0
	19475354	CHEMBL4479449	Inhibition of human PDGFRbeta	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	=	IC50	nM	26197.0	CHEMBL1913	Homo sapiens	IC50	nM	26197.0
	20598180	CHEMBL4602909	Inhibition of human PRGFRbeta	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	uM	1.0
	20600621	CHEMBL4603573	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL1913	Homo sapiens	IC50	uM	100.0
	20602477	CHEMBL4604030	Inhibition of PDGFRbeta (unknown origin) by enzymatic assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cn(-c2ccc(F)cc2)c2ccccc2c1=O		CHEMBL4645353	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	20609585	CHEMBL4605814	Inhibition of PDGFRbeta (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	=	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	uM	0.1
	20609586	CHEMBL4605814	Inhibition of PDGFRbeta (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	22.0	CHEMBL1913	Homo sapiens	IC50	uM	0.022
	20609587	CHEMBL4605814	Inhibition of PDGFRbeta (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	41.0	CHEMBL1913	Homo sapiens	IC50	uM	0.041
	20679575	CHEMBL4622439	Binding affinity to recombinant human PDGFRB (582 to 1009 residues) expressed in bacterial expression system by Kinomescan method	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(-c4ccc(OCCN5CCOCC5)cc4Cl)nn3)cc2)no1		CHEMBL4645320	=	Kd	nM	8.1	CHEMBL1913	Homo sapiens	Kd	nM	8.1
	20679576	CHEMBL4622439	Binding affinity to recombinant human PDGFRB (582 to 1009 residues) expressed in bacterial expression system by Kinomescan method	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	4.0	CHEMBL1913	Homo sapiens	Kd	nM	4.0
	20681226	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)cc1)c1ccccc1		CHEMBL4069394	=	IC50	nM	11.0	CHEMBL1913	Homo sapiens	IC50	nM	11.0
	20681227	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4079087	=	IC50	nM	55.0	CHEMBL1913	Homo sapiens	IC50	nM	55.0
	20681228	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)c(C)c1)c1ccccc1		CHEMBL4642920	=	IC50	nM	31.0	CHEMBL1913	Homo sapiens	IC50	nM	31.0
	20681229	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(C)CC2)c(C)c1)c1ccccc1		CHEMBL4641639	=	IC50	nM	206.0	CHEMBL1913	Homo sapiens	IC50	nM	206.0
	20681230	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)nc1)c1ccccc1		CHEMBL4647154	=	IC50	nM	26.0	CHEMBL1913	Homo sapiens	IC50	nM	26.0
	20681231	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN2CCN(C)CC2)nc1)c1ccccc1		CHEMBL4639539	=	IC50	nM	114.0	CHEMBL1913	Homo sapiens	IC50	nM	114.0
	20681232	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cnc(-n2cccc2CN(C)C)c(C)c1)c1ccccc1		CHEMBL4647153	=	IC50	nM	71.0	CHEMBL1913	Homo sapiens	IC50	nM	71.0
	20681233	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cnc(-n2cccc2CN2CCN(C)CC2)c(C)c1)c1ccccc1		CHEMBL4641415	>	IC50	nM	300.0	CHEMBL1913	Homo sapiens	IC50	nM	300.0
	20681234	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN(C)C)cc1)c1ccccc1		CHEMBL4640617	=	IC50	nM	45.3	CHEMBL1913	Homo sapiens	IC50	nM	45.3
	20681235	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4644718	=	IC50	nM	9.9	CHEMBL1913	Homo sapiens	IC50	nM	9.9
	20681236	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	CCN(CC)Cc1ccc(C)n1-c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)OC)ccc32)c2ccccc2)cc1		CHEMBL4634687	=	IC50	nM	23.8	CHEMBL1913	Homo sapiens	IC50	nM	23.8
	20681237	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCOCC2)cc1)c1ccccc1		CHEMBL4649259	=	IC50	nM	37.0	CHEMBL1913	Homo sapiens	IC50	nM	37.0
	20681238	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN(C)C)nc1)c1ccccc1		CHEMBL4638817	=	IC50	nM	32.0	CHEMBL1913	Homo sapiens	IC50	nM	32.0
	20681239	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)nc1)c1ccccc1		CHEMBL4640302	=	IC50	nM	123.0	CHEMBL1913	Homo sapiens	IC50	nM	123.0
Not Determined	20681240	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	Cc1ccc(CN2CCN(C)CC2)n1-c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)O)ccc32)c2ccccc2)cc1		CHEMBL4639712		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	20681241	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4648781		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	20681242	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	Cc1ccc(CN2CCN(C)CC2)n1-c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)C)ccc32)c2ccccc2)cc1		CHEMBL4643300		IC50			CHEMBL1913	Homo sapiens	IC50		
	20681243	CHEMBL4623160	Inhibition of N-terminal GST-fused human PDGFRbeta cytoplasmic domain (557 to 1106 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	3.8	CHEMBL1913	Homo sapiens	IC50	nM	3.8
	20683663	CHEMBL4623642	Inhibition of human PDGFRbeta at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl	Outside typical range	CHEMBL4644985	=	Inhibition	%	-12.0	CHEMBL1913	Homo sapiens	INH	%	-12.0
	20683664	CHEMBL4623643	Inhibition of human PDGFRbeta at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-10.0	CHEMBL1913	Homo sapiens	INH	%	-10.0
	20704526	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1ccc(C(=O)Nc2cccc(N3CCN(C)CC3)c2)cc1Nc1nccc(-c2ccc(F)cc2)n1		CHEMBL4632839	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704527	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cc(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)cc(N3CCN(C)CC3)c2)on1		CHEMBL4648729	=	IC50	nM	5520.0	CHEMBL1913	Homo sapiens	IC50	uM	5.52
	20704528	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)cc(N3CCOCC3)c2)cn1		CHEMBL4638611	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704529	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCCC[C@H]3C(N)=O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)c2)cn1		CHEMBL4646469	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704530	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCCC[C@H]3C(=O)O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)c2)cn1		CHEMBL4639891	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704531	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCC[C@H](N)C3)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc(F)cc5)n4)c3)c2)cn1		CHEMBL4637487	=	IC50	nM	2040.0	CHEMBL1913	Homo sapiens	IC50	uM	2.04
	20704559	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	CCCCc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4ccccc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL4633069	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704560	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CCS(N)(=O)=O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)c2)cn1		CHEMBL4642587	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704561	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CCC(=O)O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)c2)cn1		CHEMBL4637172	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704562	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(/C=C/C(=O)O)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)c2)cn1		CHEMBL4642089	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704563	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCN(C)CC3)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)c2)cn1		CHEMBL4635318	=	IC50	nM	5420.0	CHEMBL1913	Homo sapiens	IC50	uM	5.42
	20704564	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)cc(N3CCN(C)CC3)c2)cn1		CHEMBL4642128	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704565	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)cc(N3CCNCC3)c2)cn1		CHEMBL4638783	=	IC50	nM	1510.0	CHEMBL1913	Homo sapiens	IC50	uM	1.51
	20704566	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL4642181	=	IC50	nM	2480.0	CHEMBL1913	Homo sapiens	IC50	uM	2.48
	20704567	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	25.0	CHEMBL1913	Homo sapiens	IC50	uM	0.025
	20704608	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL4638092	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704609	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1ccc(C(=O)Nc2cc(N3CCN(C)CC3)cc(-n3cnc(C)c3)c2)cc1		CHEMBL4637818	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704610	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)cc(N3CCN(C)CC3)c2)cn1		CHEMBL4649103	=	IC50	nM	7660.0	CHEMBL1913	Homo sapiens	IC50	uM	7.66
	20704611	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Oc4cccc5ccncc45)c3)cc(N3CCN(C)CC3)c2)cn1		CHEMBL4638350	=	IC50	nM	3290.0	CHEMBL1913	Homo sapiens	IC50	uM	3.29
	20704612	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(C(=O)c4cccc(C#N)c4)c3)cc(N3CCN(C)CC3)c2)cn1		CHEMBL4649346	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	20704613	CHEMBL4628024	Inhibition of recombinant human N-terminal GST-tagged PDGFRbeta cytoplasmic domain (557 to 1106 residues) expressed in baculovirus expression system using FAM-labelled P22 peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr in presence of ATP by fluorescence assay	A	Cc1cn(-c2cc(CN3CCC[C@H](N)C3)cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)c2)cn1		CHEMBL4643586	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	22423353	CHEMBL4674252	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	94.32	CHEMBL1913	Homo sapiens	Activity	%	94.32
	22423354	CHEMBL4674252	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	59.97	CHEMBL1913	Homo sapiens	Activity	%	59.97
	22458811	CHEMBL4682591	Inhibition of human His-tagged PDGFRB cytoplasmic domain expressed in baculovirus expression system using peptide substrate measured after 1 hr by mobility shift assay	B	COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4776125	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	22458812	CHEMBL4682591	Inhibition of human His-tagged PDGFRB cytoplasmic domain expressed in baculovirus expression system using peptide substrate measured after 1 hr by mobility shift assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4764463	>	IC50	nM	200.0	CHEMBL1913	Homo sapiens	IC50	uM	0.2
	22757145	CHEMBL4701071	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	Cc1cc(-c2ncnc3[nH]ccc23)ccc1CNC(=O)c1ccc(C(C)(C)C)cc1		CHEMBL4756023	>	Activity	%	80.0	CHEMBL1913	Homo sapiens	Activity	%	80.0
	22757149	CHEMBL4701075	Binding affinity to wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system by Kinomescan method	B	CC(C)(C)c1ccc(C(=O)NCc2ccc(-c3ncnc4[nH]ccc34)cc2)cc1		CHEMBL4755663	=	Kd	nM	53.0	CHEMBL1913	Homo sapiens	Kd	nM	53.0
	22771680	CHEMBL4704540	Inhibition of GST-tagged recombinant PDGFRbeta (unknown origin) expressed in baculovirus expression system incubated for 15-45 mins in presence of [gamma32P]-ATP by radiometric assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	IC50	nM	2600.0	CHEMBL1913	Homo sapiens	IC50	uM	2.6
	22804201	CHEMBL4712065	Inhibition of PDGFRB (unknown origin) at 100 uM pre-incubated for 20 mins followed by 33P-gamma-ATP addition and measured after 120 mins by filter-binding method relative to control	B	COc1ccc(-n2cc(-c3ccc4nonc4c3)c3cc(-c4ccc(C(=O)O)cc4)cnc32)cc1		CHEMBL4747136	=	Inhibition	%	4.0	CHEMBL1913	Homo sapiens	INH	%	4.0
	22804202	CHEMBL4712065	Inhibition of PDGFRB (unknown origin) at 100 uM pre-incubated for 20 mins followed by 33P-gamma-ATP addition and measured after 120 mins by filter-binding method relative to control	B	O=C(O)c1ccc(-c2cnc3[nH]cc(-c4ccc5nonc5c4)c3c2)cc1		CHEMBL4752578	=	Inhibition	%	43.0	CHEMBL1913	Homo sapiens	INH	%	43.0
	22809753	CHEMBL4713288	Inhibition of recombinant human PDGFRbeta (557 to end residues) assessed as residual activity at 1 uM using poly[Glu:Tyr] 4:1 as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	68.0	CHEMBL1913	Homo sapiens	Activity	%	68.0
	22814219	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1		CHEMBL492399	=	IC50	nM	5.6	CHEMBL1913	Homo sapiens	IC50	nM	5.6
	22814220	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	83.1	CHEMBL1913	Homo sapiens	IC50	nM	83.1
	22814221	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	IC50	nM	12.2	CHEMBL1913	Homo sapiens	IC50	nM	12.2
	22814222	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	COc1ccc2c(c1)CCCN2c1nc(C)nc2ccccc12		CHEMBL2420866	=	IC50	nM	7.8	CHEMBL1913	Homo sapiens	IC50	nM	7.8
	22814223	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	CSc1ccc(N(C)c2nc(C)nc3ccccc23)cc1		CHEMBL516047	=	IC50	nM	231.5	CHEMBL1913	Homo sapiens	IC50	nM	231.5
	22814224	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	COc1cccc2cc(N(C)c3nc(C)nc4ccccc34)ccc12		CHEMBL4746488	=	IC50	nM	29.4	CHEMBL1913	Homo sapiens	IC50	nM	29.4
	22814225	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	COc1ccc2c(c1)CCCN2c1ncnc2ccccc12		CHEMBL3604205	=	IC50	nM	54.0	CHEMBL1913	Homo sapiens	IC50	nM	54.0
	22814226	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	COc1ccc(N(C)c2nc(Cl)nc3ccccc23)cc1		CHEMBL444724	=	IC50	nM	76.6	CHEMBL1913	Homo sapiens	IC50	nM	76.6
	22814227	CHEMBL4714415	Inhibition of PDGFRbeta in human SH-SY5Y cells preincubated for 60 mins followed by PDGF stimulation and measured after 10 mins by ELISA	B	COc1ccc2c(c1)CCCN2c1nc(Cl)nc2ccccc12		CHEMBL2420867	=	IC50	nM	80.6	CHEMBL1913	Homo sapiens	IC50	nM	80.6
	22814230	CHEMBL4714418	Potency index, ratio of IC50 for sunitinib to IC50 for test compound for inhibition of PDGFRbeta in human SH-SY5Y cells	B	COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1		CHEMBL492399	=	Ratio IC50		15.0	CHEMBL1913	Homo sapiens	Ratio IC50		15.0
	22814232	CHEMBL4714420	Potency index, ratio of IC50 for erlotinib to IC50 for test compound for inhibition of PDGFRbeta in human SH-SY5Y cells	B	COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1		CHEMBL492399	=	Ratio IC50		2.0	CHEMBL1913	Homo sapiens	Ratio IC50		2.0
	22820538	CHEMBL4716271	Inhibition of recombinant N-terminal His6-tagged human PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	83.0	CHEMBL1913	Homo sapiens	Activity	%	83.0
	22820539	CHEMBL4716271	Inhibition of recombinant N-terminal His6-tagged human PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	53.0	CHEMBL1913	Homo sapiens	Activity	%	53.0
	22826343	CHEMBL4717528	Inhibition of recombinant N-terminal His6-tagged human PDGFRbeta (557 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Inhibition	%	60.0	CHEMBL1913	Homo sapiens	INH	%	60.0
	22836348	CHEMBL4718880	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-5.0	CHEMBL1913	Homo sapiens	INH	%	-5.0
	22836349	CHEMBL4718880	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	11.0	CHEMBL1913	Homo sapiens	INH	%	11.0
	22836350	CHEMBL4718880	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	10.0	CHEMBL1913	Homo sapiens	INH	%	10.0
	22836351	CHEMBL4718880	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	8.0	CHEMBL1913	Homo sapiens	INH	%	8.0
	22836352	CHEMBL4718880	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	22836353	CHEMBL4718880	Inhibition of recombinant human His-tagged PDGFRbeta cytoplasmic domain expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	-1.0	CHEMBL1913	Homo sapiens	INH	%	-1.0
	22843622	CHEMBL4720608	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.34	CHEMBL1913	Homo sapiens	IC50	10^-9M	2.34
	22843966	CHEMBL4720952	Inhibition of human PDGFRbeta assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	88.42	CHEMBL1913	Homo sapiens	Activity	%	88.42
	22844817	CHEMBL4721492	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	90.92	CHEMBL1913	Homo sapiens	Activity	%	90.92
	22874814	CHEMBL4725505	Inhibition of human PDGFRbeta assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	55.0	CHEMBL1913	Homo sapiens	Activity	%	55.0
	22884305	CHEMBL4727763	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2ccccc2n1		CHEMBL4740381	=	IC50	nM	1250.0	CHEMBL1913	Homo sapiens	IC50	nM	1250.0
	22884306	CHEMBL4727763	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4788859	=	IC50	nM	7450.0	CHEMBL1913	Homo sapiens	IC50	nM	7450.0
	22884307	CHEMBL4727763	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4786529	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	nM	10000.0
	22884308	CHEMBL4727763	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2ccccc2n1		CHEMBL4742906	=	IC50	nM	2820.0	CHEMBL1913	Homo sapiens	IC50	nM	2820.0
	22884309	CHEMBL4727763	Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4778971	=	IC50	nM	6903.0	CHEMBL1913	Homo sapiens	IC50	nM	6903.0
Not Determined	22889181	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1cc(COc2ccc3nc(NC4CCCCC4)sc3c2)ccn1		CHEMBL4777344		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	22889182	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Clc1cnccc1COc1ccc2nc(NC3CCCCC3)sc2c1		CHEMBL4764974		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	22889183	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2ccc3nc(NC4CCCCC4)sc3c2)c1Cl		CHEMBL4788945		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	22889184	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2ccc3nc(N[C@H]4CCCC[C@@H]4O)sc3c2)c1Cl		CHEMBL4741283		IC50			CHEMBL1913	Homo sapiens	IC50		
	22889185	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4759047	=	IC50	nM	446.0	CHEMBL1913	Homo sapiens	IC50	nM	446.0
Not Determined	22889186	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2ccc3nc(N[C@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4798876		IC50			CHEMBL1913	Homo sapiens	IC50		
Not Determined	22889187	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@@H]4O)sc3c2)c1Cl		CHEMBL4756510		IC50			CHEMBL1913	Homo sapiens	IC50		
	22889188	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	COc1cc(OCc2ccnc(N)c2Cl)cc2sc(N[C@@H]3CCCC[C@H]3O)nc12		CHEMBL4746711	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	nM	50000.0
Not Determined	22889189	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2cc(OC(F)(F)F)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4798920		IC50			CHEMBL1913	Homo sapiens	IC50		
	22889190	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2cc(Cl)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4751287	=	IC50	nM	4114.0	CHEMBL1913	Homo sapiens	IC50	nM	4114.0
	22889191	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2cc(F)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4763875	=	IC50	nM	1339.0	CHEMBL1913	Homo sapiens	IC50	nM	1339.0
	22889192	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2Cl)c1Cl		CHEMBL4798601	=	IC50	nM	250.0	CHEMBL1913	Homo sapiens	IC50	nM	250.0
Not Determined	22889193	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2F)c1Cl		CHEMBL4795462		IC50			CHEMBL1913	Homo sapiens	IC50		
	22889194	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	COc1cc(OCc2ccnc(N)n2)cc2sc(N[C@@H]3CCCC[C@H]3O)nc12		CHEMBL4788832	=	IC50	nM	41000.0	CHEMBL1913	Homo sapiens	IC50	nM	41000.0
	22889195	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	COc1cc(OCc2ccnc(N)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4762843	>	IC50	nM	50000.0	CHEMBL1913	Homo sapiens	IC50	nM	50000.0
	22889196	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	COc1cc(OCc2ccnc(N)n2)c(Cl)c2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4779878	=	IC50	nM	34254.0	CHEMBL1913	Homo sapiens	IC50	nM	34254.0
	22889197	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740	=	IC50	nM	3560.0	CHEMBL1913	Homo sapiens	IC50	nM	3560.0
	22889198	CHEMBL4728933	Inhibition of human PDGFRbeta phosphorylation in PDGF-DD induced human HEK293-TetR cells incubated for 1 hr followed by PDGF-DD stimulation and measured after 5 mins by HTRF assay	B	CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1		CHEMBL4227505	=	IC50	nM	579.0	CHEMBL1913	Homo sapiens	IC50	nM	579.0
Not Determined	22889235	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1cc(COc2ccc3nc(NC4CCCCC4)sc3c2)ccn1		CHEMBL4777344		Kd			CHEMBL1913	Homo sapiens	Kd		
Not Determined	22889236	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Clc1cnccc1COc1ccc2nc(NC3CCCCC3)sc2c1		CHEMBL4764974		Kd			CHEMBL1913	Homo sapiens	Kd		
	22889237	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(NC4CCCCC4)sc3c2)c1Cl		CHEMBL4788945	=	Kd	nM	3.8	CHEMBL1913	Homo sapiens	Kd	nM	3.8
	22889238	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@H]4CCCC[C@@H]4O)sc3c2)c1Cl		CHEMBL4741283	=	Kd	nM	0.84	CHEMBL1913	Homo sapiens	Kd	nM	0.84
	22889239	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4759047	=	Kd	nM	19.0	CHEMBL1913	Homo sapiens	Kd	nM	19.0
	22889240	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4798876	=	Kd	nM	1.2	CHEMBL1913	Homo sapiens	Kd	nM	1.2
	22889241	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@@H]4O)sc3c2)c1Cl		CHEMBL4756510	=	Kd	nM	5.6	CHEMBL1913	Homo sapiens	Kd	nM	5.6
	22889242	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	COc1cc(OCc2ccnc(N)c2Cl)cc2sc(N[C@@H]3CCCC[C@H]3O)nc12		CHEMBL4746711	=	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd	nM	30000.0
Not Determined	22889243	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2cc(OC(F)(F)F)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4798920		Kd			CHEMBL1913	Homo sapiens	Kd		
	22889244	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2cc(Cl)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4751287	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd	nM	30000.0
	22889245	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2cc(F)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4763875	=	Kd	nM	230.0	CHEMBL1913	Homo sapiens	Kd	nM	230.0
	22889246	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2Cl)c1Cl		CHEMBL4798601	=	Kd	nM	4.1	CHEMBL1913	Homo sapiens	Kd	nM	4.1
	22889247	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2F)c1Cl		CHEMBL4795462	=	Kd	nM	6.7	CHEMBL1913	Homo sapiens	Kd	nM	6.7
	22889248	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	COc1cc(OCc2ccnc(N)n2)cc2sc(N[C@@H]3CCCC[C@H]3O)nc12		CHEMBL4788832	=	Kd	nM	4900.0	CHEMBL1913	Homo sapiens	Kd	nM	4900.0
	22889249	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	COc1cc(OCc2ccnc(N)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4762843	>	Kd	nM	30000.0	CHEMBL1913	Homo sapiens	Kd	nM	30000.0
	22889250	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	COc1cc(OCc2ccnc(N)n2)c(Cl)c2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4779878	=	Kd	nM	27000.0	CHEMBL1913	Homo sapiens	Kd	nM	27000.0
	22889251	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740	=	Kd	nM	450.0	CHEMBL1913	Homo sapiens	Kd	nM	450.0
	22889252	CHEMBL4728936	Binding affinity to human wild type PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by kinome scan assay	B	CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1		CHEMBL4227505	=	Kd	nM	46.0	CHEMBL1913	Homo sapiens	Kd	nM	46.0
Not Active	22889543	CHEMBL4729062	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL1913	Homo sapiens	INH		
	22916325	CHEMBL4735614	Inhibition of PDGFRbeta (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control	B	CNC(=O)c1cc(-n2ccc3cc(NC(=O)Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)ccc32)ccn1		CHEMBL4797840	=	Inhibition	%	47.5	CHEMBL1913	Homo sapiens	INH	%	47.5
	22916326	CHEMBL4735614	Inhibition of PDGFRbeta (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Inhibition	%	99.1	CHEMBL1913	Homo sapiens	INH	%	99.1
	22922028	CHEMBL4736835	Inhibition of wild-type human partial length PDGFRB (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	COc1cc(-c2cnc3c(N4CCC[C@H](CNC(=O)C5CC5)C4)snc3c2)ccc1N		CHEMBL4745028	<	Activity	%	10.0	CHEMBL1913	Homo sapiens	Activity	%	10.0
	22950622	CHEMBL4766189	Inhibition of human recombinant PDGFRbeta (557 to end residues) using poly(Glu, Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	>	IC50	nM	10000.0	CHEMBL1913	Homo sapiens	IC50	uM	10.0
	22952945	CHEMBL4766882	Inhibition of human PDGFRbeta (557 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	4.0	CHEMBL1913	Homo sapiens	Activity	%	4.0
	22953075	CHEMBL4767012	Inhibition of human PDGFRbeta (557 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	686.0	CHEMBL1913	Homo sapiens	IC50	uM	0.6859999999999999
	22972837	CHEMBL4771076	Inhibition of PDGFR beta (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay	B	COCC/C(=N\S(=O)(=O)Cc1ccc(Cl)cc1)Nc1ccc(Oc2ccnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(F)c1		CHEMBL4799113	=	IC50	nM	565.0	CHEMBL1913	Homo sapiens	IC50	nM	565.0
	22972838	CHEMBL4771076	Inhibition of PDGFR beta (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	10.63	CHEMBL1913	Homo sapiens	IC50	nM	10.63
	22987256	CHEMBL4774506	Inhibition of PDGFRbeta (unknown origin)	B	COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OC		CHEMBL4794496	=	IC50	nM	1359.0	CHEMBL1913	Homo sapiens	IC50	nM	1359.0
	22987257	CHEMBL4774506	Inhibition of PDGFRbeta (unknown origin)	B	COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3)c2cc1OC		CHEMBL4784431	>	IC50	nM	2000.0	CHEMBL1913	Homo sapiens	IC50	nM	2000.0
	22988694	CHEMBL4774723	Inhibition of TEL fused PDGFRbeta (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL4794404	=	GI50	nM	1.4	CHEMBL1913	Homo sapiens	GI50	nM	1.4
	22988720	CHEMBL4774737	Inhibition of human PDGFRB assessed as remaining enzyme activity at 1 uM by Kinomescan method relative to control	B	Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL4794404	=	Activity	%	0.0	CHEMBL1913	Homo sapiens	Activity	%	0.0
	22988730	CHEMBL4774747	Inhibition of human PDGFR beta by Z-LYTE or ADP-Glo assay	B	Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL4794404	=	IC50	nM	95.7	CHEMBL1913	Homo sapiens	IC50	nM	95.7
	22990702	CHEMBL4775143	Inhibition of PDGFR-beta (unknown origin)	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	IC50	nM	100.0	CHEMBL1913	Homo sapiens	IC50	nM	100.0
	23122727	CHEMBL4805078	Inhibition of human PDGFRB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	94.0	CHEMBL1913	Homo sapiens	Activity	%	94.0
	23123422	CHEMBL4805666	Inhibition of human PDGFRB assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	93.0	CHEMBL1913	Homo sapiens	Activity	%	93.0
	23123879	CHEMBL4806123	Inhibition of DNA-tagged human PDGFRB assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL1913	Homo sapiens	Activity	%	100.0
	23124934	CHEMBL4806683	Inhibition of human PDGFRB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL1913	Homo sapiens	Activity	%	100.0
	23124935	CHEMBL4806683	Inhibition of human PDGFRB assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	93.0	CHEMBL1913	Homo sapiens	Activity	%	93.0
	23127429	CHEMBL4807605	Inhibition of PDGFRbeta (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	6.0	CHEMBL1913	Homo sapiens	Activity	%	6.0
	23127430	CHEMBL4807605	Inhibition of PDGFRbeta (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	2.0	CHEMBL1913	Homo sapiens	Activity	%	2.0
	23128428	CHEMBL4807951	Inhibition of PDGFRbeta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL1913	Homo sapiens	Activity	%	25.0
	23128429	CHEMBL4807951	Inhibition of PDGFRbeta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL1913	Homo sapiens	Activity	%	25.0
	23128430	CHEMBL4807951	Inhibition of PDGFRbeta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL1913	Homo sapiens	Activity	%	25.0
	23128866	CHEMBL4808078	Inhibition of PDGFR-beta (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	55.0	CHEMBL1913	Homo sapiens	INH	%	55.0
	23128867	CHEMBL4808078	Inhibition of PDGFR-beta (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3n[nH]nc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4853006	=	Inhibition	%	60.0	CHEMBL1913	Homo sapiens	INH	%	60.0
	23128868	CHEMBL4808078	Inhibition of PDGFR-beta (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(NC)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4855979	=	Inhibition	%	61.0	CHEMBL1913	Homo sapiens	INH	%	61.0
	23128869	CHEMBL4808078	Inhibition of PDGFR-beta (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)n(CCN(C)C)c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4847460	=	Inhibition	%	70.0	CHEMBL1913	Homo sapiens	INH	%	70.0
	23128870	CHEMBL4808078	Inhibition of PDGFR-beta (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	40.0	CHEMBL1913	Homo sapiens	INH	%	40.0
	23148922	CHEMBL4810015	Inhibition of PDGFRbeta (unknown origin)	B	COc1cccc(-c2cc(-c3c(O)c4ccccc4oc3=O)nc(N)c2C#N)c1		CHEMBL4868909	=	IC50	nM	20.0	CHEMBL1913	Homo sapiens	IC50	uM	0.02
	23148923	CHEMBL4810015	Inhibition of PDGFRbeta (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	55.0	CHEMBL1913	Homo sapiens	IC50	uM	0.055
	23149787	CHEMBL4810180	Inhibition of PDGFR-beta (unknown origin) incubated for 90 mins in presence of ATP by HTRF assay	A	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]c(-c5cnn(C)c5)cc4c3N(C)C2=O)c1F		CHEMBL4871581	=	IC50	nM	5.7	CHEMBL1913	Homo sapiens	IC50	nM	5.7
	23149788	CHEMBL4810180	Inhibition of PDGFR-beta (unknown origin) incubated for 90 mins in presence of ATP by HTRF assay	A	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1F		CHEMBL4870179	=	IC50	nM	406.0	CHEMBL1913	Homo sapiens	IC50	nM	406.0
	23158859	CHEMBL4812111	Inhibition of PDGFRbeta (557 to 1106 residues) (unknown origin) expressed in Sf21 at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	-1.19	CHEMBL1913	Homo sapiens	INH	%	-1.19
	23177563	CHEMBL4815761	Inhibition of PDGFR beta (unknown origin) using FAM-labelled peptide as substrate in presence of ATP at 10 uM measured by microplate reader method	B	O=C(Nc1ccc(Oc2ncnc3[nH]ccc23)cc1)c1cn(-c2ccc(C(F)(F)F)cc2Cl)c2ncccc2c1=O		CHEMBL4864264	=	Inhibition	%	38.0	CHEMBL1913	Homo sapiens	INH	%	38.0
	23180018	CHEMBL4816231	Inhibition of PDGFRbeta (unknown origin) at 1 uM by ELISA	B	CCCC(C)Oc1ccc(C(=O)Nc2ccc3nc(SCC(=O)N[C@@H](C)c4ccccc4)sc3c2)c(OC)c1C		CHEMBL4864495	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	23180019	CHEMBL4816231	Inhibition of PDGFRbeta (unknown origin) at 1 uM by ELISA	B	CCCC(C)Oc1ccc(C(=O)Nc2ccc3nc(SCC(=O)N[C@@H](C)c4ccc(OC)cc4)sc3c2)c(OC)c1C		CHEMBL4846365	=	Inhibition	%	0.0	CHEMBL1913	Homo sapiens	INH	%	0.0
	23180020	CHEMBL4816231	Inhibition of PDGFRbeta (unknown origin) at 1 uM by ELISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	76.1	CHEMBL1913	Homo sapiens	INH	%	76.1
	23208887	CHEMBL4822245	Inhibition of wild-type human partial length PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	CCc1cc(NC(=O)[C@H](O)c2cc(F)cc(F)c2)ccc1-c1cnc(N)c(C(=O)NC(C)C)c1		CHEMBL4857782	=	Activity	%	60.0	CHEMBL1913	Homo sapiens	Activity	%	60.0
	23208888	CHEMBL4822245	Inhibition of wild-type human partial length PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		CHEMBL2441340	=	Activity	%	0.2	CHEMBL1913	Homo sapiens	Activity	%	0.2
	23213438	CHEMBL4822972	Inhibition of human recombinant PDGFRB in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	-2.0	CHEMBL1913	Homo sapiens	INH	%	-2.0
	23216088	CHEMBL4823603	Inhibition of human PDGFRbeta (557 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	23216539	CHEMBL4823739	Inhibition of PDGFRbeta (unknown origin) incubated for 30 mins in presence of ATP by mobility shift assay	B	Cc1c(NC(=O)CCN2CCCC2)c[nH]c1/C=C1\C(=O)Nc2ccc(F)cc21		CHEMBL4869059	=	IC50	nM	41.8	CHEMBL1913	Homo sapiens	IC50	nM	41.8
	23216540	CHEMBL4823739	Inhibition of PDGFRbeta (unknown origin) incubated for 30 mins in presence of ATP by mobility shift assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	10.5	CHEMBL1913	Homo sapiens	IC50	nM	10.5
	23265656	CHEMBL4834283	Inhibition of PDGFRbeta (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	420.0	CHEMBL1913	Homo sapiens	IC50	uM	0.42
	23265657	CHEMBL4834283	Inhibition of PDGFRbeta (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	270.0	CHEMBL1913	Homo sapiens	IC50	uM	0.27
	23265658	CHEMBL4834283	Inhibition of PDGFRbeta (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	>	IC50	nM	11000.0	CHEMBL1913	Homo sapiens	IC50	uM	11.0
	23285152	CHEMBL4838197	Inhibition of PDGFRbeta (unknown origin) by ELISA	B	CC(C)n1cc(C(=O)Nc2cc(F)c(-c3c[nH]c4ncnc(N)c34)cc2F)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4871361	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
	23289724	CHEMBL4839225	Inhibition of PDGFRbeta (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	57.0	CHEMBL1913	Homo sapiens	IC50	nM	57.0
	23289725	CHEMBL4839225	Inhibition of PDGFRbeta (unknown origin)	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	=	IC50	nM	15.0	CHEMBL1913	Homo sapiens	IC50	nM	15.0
	23289726	CHEMBL4839225	Inhibition of PDGFRbeta (unknown origin)	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	IC50	nM	5.0	CHEMBL1913	Homo sapiens	IC50	nM	5.0
	23289727	CHEMBL4839225	Inhibition of PDGFRbeta (unknown origin)	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	84.0	CHEMBL1913	Homo sapiens	IC50	nM	84.0
	23289728	CHEMBL4839225	Inhibition of PDGFRbeta (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	39.0	CHEMBL1913	Homo sapiens	IC50	nM	39.0
	23291276	CHEMBL4839541	Inhibition of human recombinant PDGFRbeta (557 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	12.0	CHEMBL1913	Homo sapiens	INH	%	12.0
	23291277	CHEMBL4839541	Inhibition of human recombinant PDGFRbeta (557 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	1.0	CHEMBL1913	Homo sapiens	INH	%	1.0
	23291278	CHEMBL4839541	Inhibition of human recombinant PDGFRbeta (557 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	18.0	CHEMBL1913	Homo sapiens	INH	%	18.0
	23291348	CHEMBL4839565	Inhibition of human recombinant PDGFRbeta (557 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	54.0	CHEMBL1913	Homo sapiens	INH	%	54.0
	23291349	CHEMBL4839565	Inhibition of human recombinant PDGFRbeta (557 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	13.0	CHEMBL1913	Homo sapiens	INH	%	13.0
	23291350	CHEMBL4839565	Inhibition of human recombinant PDGFRbeta (557 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	6.0	CHEMBL1913	Homo sapiens	INH	%	6.0
	23291420	CHEMBL4839589	Inhibition of human recombinant PDGFRbeta (557 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	83.0	CHEMBL1913	Homo sapiens	INH	%	83.0
	23291421	CHEMBL4839589	Inhibition of human recombinant PDGFRbeta (557 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	71.0	CHEMBL1913	Homo sapiens	INH	%	71.0
	23291422	CHEMBL4839589	Inhibition of human recombinant PDGFRbeta (557 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	12.0	CHEMBL1913	Homo sapiens	INH	%	12.0
	23297794	CHEMBL4841274	Inhibition of PDGFRB (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL1913	Homo sapiens	IC50	nM	1000.0
Active	23299338	CHEMBL4841769	Induction of PDGFR degradation in human MOLM-13 cells at 0 to 25 nM after 24 hrs by Western blot analysis	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4872919		Activity			CHEMBL1913	Homo sapiens	Activity		
Active	23299339	CHEMBL4841769	Induction of PDGFR degradation in human MOLM-13 cells at 0 to 25 nM after 24 hrs by Western blot analysis	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038		Activity			CHEMBL1913	Homo sapiens	Activity		
Active	23299340	CHEMBL4841770	Induction of PDGFR degradation in human MV4-11 cells at 0 to 25 nM after 24 hrs by Western blot analysis	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4872919		Activity			CHEMBL1913	Homo sapiens	Activity		
Active	23299341	CHEMBL4841770	Induction of PDGFR degradation in human MV4-11 cells at 0 to 25 nM after 24 hrs by Western blot analysis	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038		Activity			CHEMBL1913	Homo sapiens	Activity		
	23315114	CHEMBL4845027	Inhibition of wild-type human partial length PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system by Kinomescan method	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)nc4)cc3)ncnc2c1		CHEMBL4847875	=	IC50	nM	31.5	CHEMBL1913	Homo sapiens	IC50	nM	31.5
Not Active	23317563	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23318031	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	86.0	CHEMBL1913	Homo sapiens	% Control	%	86.0
Not Active	23318697	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23319181	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	97.0	CHEMBL1913	Homo sapiens	% Control	%	97.0
Not Active	23319818	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23320293	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	99.0	CHEMBL1913	Homo sapiens	% Control	%	99.0
Not Active	23320971	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23321439	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23322069	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23322537	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23323226	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23323694	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23324089	CHEMBL4880708	PDGFRbeta(h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-12.0	CHEMBL1913	Homo sapiens	% inhibition	%	-12.0
Not Active	23324548	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23325183	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	88.0	CHEMBL1913	Homo sapiens	% Control	%	88.0
Not Active	23325651	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23326298	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	76.0	CHEMBL1913	Homo sapiens	% Control	%	76.0
Not Active	23326766	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	90.0	CHEMBL1913	Homo sapiens	% Control	%	90.0
Not Active	23327466	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	92.0	CHEMBL1913	Homo sapiens	% Control	%	92.0
Not Active	23327934	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	77.0	CHEMBL1913	Homo sapiens	% Control	%	77.0
Not Active	23328521	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	87.0	CHEMBL1913	Homo sapiens	% Control	%	87.0
Not Active	23328989	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	76.0	CHEMBL1913	Homo sapiens	% Control	%	76.0
Not Active	23329466	CHEMBL4881173	PDGFRbeta(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	107.0	CHEMBL1913	Homo sapiens	% residual kinase activity	%	107.0
Not Active	23329935	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	95.0	CHEMBL1913	Homo sapiens	% Control	%	95.0
Not Active	23330403	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	95.0	CHEMBL1913	Homo sapiens	% Control	%	95.0
Not Active	23331159	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23331627	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23331882	CHEMBL4881422	Bayer in-house kinase assay with PDGFRB	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1	Non standard unit for type	CHEMBL3907057	>	IC50	µM	20.0	CHEMBL1913	Homo sapiens	IC50	µM	20.0
Not Active	23332214	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	74.8	CHEMBL1913	Homo sapiens	% Control	%	74.8
Not Active	23332680	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23333398	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	94.0	CHEMBL1913	Homo sapiens	% Control	%	94.0
Not Active	23334037	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	91.0	CHEMBL1913	Homo sapiens	% Control	%	91.0
Not Active	23334505	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	99.0	CHEMBL1913	Homo sapiens	% Control	%	99.0
Not Active	23334928	CHEMBL4881551	PDGFRbeta (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12	Outside typical range	CHEMBL1971943		Inhibition	%	-28.0	CHEMBL1913	Homo sapiens	% inhibition	%	-28.0
Not Active	23335484	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	83.0	CHEMBL1913	Homo sapiens	% Control	%	83.0
Not Active	23335952	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	96.0	CHEMBL1913	Homo sapiens	% Control	%	96.0
Not Active	23336579	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	90.0	CHEMBL1913	Homo sapiens	% Control	%	90.0
Not Active	23337047	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	84.0	CHEMBL1913	Homo sapiens	% Control	%	84.0
Not Active	23337714	CHEMBL4882085	PDGFRB Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	94.5	CHEMBL1913	Homo sapiens	% Ctrl	%	94.5
Not Active	23338128	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	82.0	CHEMBL1913	Homo sapiens	% Control	%	82.0
Not Active	23338596	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	94.0	CHEMBL1913	Homo sapiens	% Control	%	94.0
Not Active	23339208	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23339676	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23340313	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	93.0	CHEMBL1913	Homo sapiens	% Control	%	93.0
Not Active	23340781	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23341438	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23341906	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	95.0	CHEMBL1913	Homo sapiens	% Control	%	95.0
Not Active	23342522	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	89.0	CHEMBL1913	Homo sapiens	% Control	%	89.0
Not Active	23342990	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	98.0	CHEMBL1913	Homo sapiens	% Control	%	98.0
Not Active	23343276	CHEMBL4882461	PDGFRB Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	96.0	CHEMBL1913	Homo sapiens	% Ctrl	%	96.0
Not Active	23343620	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	86.0	CHEMBL1913	Homo sapiens	% Control	%	86.0
Not Active	23344088	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	96.0	CHEMBL1913	Homo sapiens	% Control	%	96.0
Not Active	23344726	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	88.0	CHEMBL1913	Homo sapiens	% Control	%	88.0
Not Active	23345299	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	94.0	CHEMBL1913	Homo sapiens	% Control	%	94.0
Not Active	23345767	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	87.0	CHEMBL1913	Homo sapiens	% Control	%	87.0
Not Active	23346344	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23346812	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23347414	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	95.8	CHEMBL1913	Homo sapiens	% Control	%	95.8
Not Active	23347904	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23348483	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23348951	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	95.0	CHEMBL1913	Homo sapiens	% Control	%	95.0
Not Active	23349538	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23350156	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23350624	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23351229	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	97.0	CHEMBL1913	Homo sapiens	% Control	%	97.0
Not Active	23351697	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	86.0	CHEMBL1913	Homo sapiens	% Control	%	86.0
Not Active	23352167	CHEMBL4882856	PDGFRB (PDGFR beta) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	6.433	CHEMBL1913	Homo sapiens	% Inhibition	%	6.4332
Not Active	23352721	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	73.0	CHEMBL1913	Homo sapiens	% Control	%	73.0
Not Active	23353189	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23354071	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23354539	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23355271	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23355739	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23356375	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23356843	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23357452	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23358099	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	97.0	CHEMBL1913	Homo sapiens	% Control	%	97.0
Not Active	23358567	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	81.0	CHEMBL1913	Homo sapiens	% Control	%	81.0
Not Active	23359153	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	99.0	CHEMBL1913	Homo sapiens	% Control	%	99.0
Not Active	23359751	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	83.0	CHEMBL1913	Homo sapiens	% Control	%	83.0
Not Active	23360219	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	84.0	CHEMBL1913	Homo sapiens	% Control	%	84.0
Not Active	23360804	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	90.0	CHEMBL1913	Homo sapiens	% Control	%	90.0
Not Active	23361272	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23361845	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	58.0	CHEMBL1913	Homo sapiens	% Control	%	58.0
Not Active	23362381	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	98.0	CHEMBL1913	Homo sapiens	% Control	%	98.0
Not Active	23362849	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	92.0	CHEMBL1913	Homo sapiens	% Control	%	92.0
Not Active	23364491	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	99.0	CHEMBL1913	Homo sapiens	% Control	%	99.0
Not Active	23364959	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23365698	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	94.0	CHEMBL1913	Homo sapiens	% Control	%	94.0
Not Active	23366241	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	80.0	CHEMBL1913	Homo sapiens	% Control	%	80.0
Not Active	23366831	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23367299	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23367694	CHEMBL4884047	PDGFR-beta ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	96.0	CHEMBL1913	Homo sapiens	% Residual activity with Skepinone-L	%	96.0
Not Active	23368177	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23368645	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23369244	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	82.0	CHEMBL1913	Homo sapiens	% Control	%	82.0
Not Active	23369712	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23370184	CHEMBL4884426	PDGFRbeta(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	108.0	CHEMBL1913	Homo sapiens	% residual kinase activity	%	108.0
Not Active	23370680	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	82.0	CHEMBL1913	Homo sapiens	% Control	%	82.0
Not Active	23371148	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	94.0	CHEMBL1913	Homo sapiens	% Control	%	94.0
Not Active	23371957	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23372425	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	86.0	CHEMBL1913	Homo sapiens	% Control	%	86.0
	23372841	CHEMBL4884806	PDGFRbeta(PDGBIHC1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL1913	Homo sapiens	pIC50		6.0
	23373250	CHEMBL4885097	PDGFRbeta(PDGBIHC1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL1913	Homo sapiens	pIC50		6.0
	23373607	CHEMBL4885384	PDGFRbeta(PDGBIHC1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL1913	Homo sapiens	pIC50		6.0
Not Active	23375852	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	97.0	CHEMBL1913	Homo sapiens	% Control	%	97.0
Not Active	23376320	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23376897	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	83.0	CHEMBL1913	Homo sapiens	% Control	%	83.0
Not Active	23377365	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	83.0	CHEMBL1913	Homo sapiens	% Control	%	83.0
Not Active	23378225	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23378693	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	87.0	CHEMBL1913	Homo sapiens	% Control	%	87.0
Not Active	23379860	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23380328	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	86.0	CHEMBL1913	Homo sapiens	% Control	%	86.0
Not Active	23381022	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23381670	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	91.0	CHEMBL1913	Homo sapiens	% Control	%	91.0
Not Active	23382138	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23382762	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	83.0	CHEMBL1913	Homo sapiens	% Control	%	83.0
Not Active	23383230	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	69.0	CHEMBL1913	Homo sapiens	% Control	%	69.0
Not Active	23383919	CHEMBL4887533	PDGFRB Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	89.0	CHEMBL1913	Homo sapiens	% Ctrl	%	89.0
Not Active	23383920	CHEMBL4887533	PDGFRB Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	87.0	CHEMBL1913	Homo sapiens	% Ctrl	%	87.0
Not Active	23384397	CHEMBL4887992	PDGFRbeta(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	9.33	CHEMBL1913	Homo sapiens	% inhibition	%	9.33
Not Active	23385145	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23385612	CHEMBL4879869	KinomeScan assay: inhibition of PDGFRB	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL1913	Homo sapiens	% Control	%	100.0
Not Active	23385898	CHEMBL4888371	PDGFRbeta Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	5.0	CHEMBL1913	Homo sapiens	% inhibition	%	5.0
